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Abstract
A diversity-oriented investigation of the chemical space associated with the ancient blue
dye, indigo (31), was undertaken, investigating its reactivity with a variety of coupling
partners, namely terminally-substituted (aryl)propargylic halides, various ring-strained
epoxides and aziridines, and substituted organometallic reagents.
The reaction of indigo with 3-bromo-1-phenyl-1-propyne (132b) gave the new ringexpanded indolobenzonaphthryidinone 133 in 35% yield, in addition to the known
azepinodiindole 122 in an improved 37% yield, and the suspected oxadiazepinodiindole
123 in 12% yield. The (4-methoxyphenyl)propargyl bromide 132a also yielded an
analogous ring-expanded indolobenzonaphthryidinone (134) in 21% yield. The isolation
of this pair of molecules supports the hypothesis that the stronger bromide facilitates dialkylation prior to N,Nꞌ-cyclisation, leading to increase proportions of ring-expanded
materials which were subjected to biological testing.
The optimized reaction of indigo with (S)-epichlorohydrin (144) gave a mixture of the
N,Nꞌ-cyclic pyrazinodiindole 152, and the N,Oꞌ-cyclised epoxyoxazocinodiindoles 153155 in 95% overall yield, while the reaction of indigo with the corresponding (R)-N-tosyl2-(chloromethyl)aziridine 148 (synthesized in 3 steps from 144) afforded exclusively the
N,Nꞌ-cyclic pyrazinodiindoles 176-178 in a combined 63% yield. Mechanistic studies
revealed that both the leaving group and the heteroatom had a significant effect on the
reaction pathway, with bioxirane 149 leading exclusively to N,Oꞌ-cyclisation in 81%
yield, while epoxides bearing strong leaving groups (145-146) and biaziridine 150 yielded
exclusively products of N,Nꞌ-cyclisation in 76-93% yield. These cascade reactions
proceeded without erosion of the stereochemical identity of their precursor epoxides or
aziridines, allowing stereospecific access to a variety of new heterocyclic frameworks
whose biological applications were then assessed.
A new methodology for the generation of non-symmetrical [1H,3ꞌH]-3-substituted-2,2ꞌdiindol-3ꞌ-ones was devised from a two-step addition-dehydration reaction of indigo with
various Grignard reagents. Where only three examples of this scaffold had been reported
previously, this method allowed chemoselective access to twenty-seven new members of
this class of molecules in yields ranging 72-95%, as well as a previously-unknown
1'H,1''H,3H-[2,2':3',5''-terindol]-3-one in 61% yield by NMR. Using Boc2O as a both a
dehydrating and N-trapping agent, fifteen examples featuring alkyl, aryl, and heterocyclic
substituents, of which eleven N-Boc materials were successfully deprotected to their free
iii

indoles using TFA under standard conditions. Additionally, the methyl adduct 218 was
isolated by a PPh3.I2-mediated dehydration in 74% yield, where Boc2O had failed, and
the collected twelve final compounds (in addition to selected N-Boc precursors) were
subjected to biological testing.
Preliminary antiplasmodial screening of all generated final compounds revealed potent
and selective P. falciparum inhibition down to 76 nM for 152, and 52 nM for 218, with
SI values >100 for 152 and >1500 for 218, making these scaffolds viable leads for further
medicinal chemistry studies. A mode of action for 218 was proposed, where it undergoes
hypoxia-induced reduction in parasitised erythrocytes to an active radical species, which
is in agreement with previous mechanistic studies of 2-substituted-3H-indol-3-ones, and
the preliminary SAR data from this molecule library.
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Chapter 1:
Introduction
1.1

The role of nature in modern synthetic chemistry

The design and synthesis of small-molecule inhibitors has long been at the forefront of
modern drug discovery and medicinal chemistry efforts. Classically, many of these
molecules have been derived from Nature, which remains an indispensable tool for the
health and pharmaceutical industries. Examples range from the relatively-simple
salicylates (1), derived from pulverised willow bark,[1] to the more complex polycyclic
opioids such as morphine (2), derived from the dried latex of Papaver somniferum
bulbs,[2] to the large and highly-complex vancomycin (3), derived from Amycolatopsis
orientalis (formerly Streptomyces orientalis),[3] and used as an antibiotic of last-resort for
the treatment of drug-resistant infections (Figure 1). The innate specificity of Nature in
the design of highly-complex, three-dimensional molecules cannot be overstated, and
remains a constant source of inspiration for the synthetic chemist, however the need for
large quantities of specific inhibitors means that relying on Nature alone may only afford
milli- (or micro-)grams of materials from large scale extractions. One example of this is
the isolation of the kinase inhibitor staurosporine (4), where only 1.1 g was isolated from
a 200 L Streptomyces staurosporius broth (5.5 ppm/volume of culture).[4] A more extreme
example is the marine sponge isolate muironolide A (5),[5] of which only 97 μg could be
isolated from an individual Phorbas sp. weighing 236 g (0.41 ppm/dry wt. sponge) – as
an indicative figure, the isolation of one gram of muironolide A would require the
extraction of over 2.4 tonnes of dry sponge material. It is therefore imperative that new
and accessible means are developed for both the discovery and synthesis of new,
biologically-active molecules.

1

Figure 1: Selected bioactive natural products, salicyclic acid (1), morphine (2), vancomycin (3),
stauorosporine (4), and muironolide A (5).

1.2

Target-oriented synthesis for drug discovery

The development of modern synthetic chemistry has grown upon retrosynthetic analysis,
whereby a complex final product may be visualised as a series of ‘disconnections’ of
individual fragments by simple bond-forming processes.[6] Continued disconnections,
guided by simple chemical principles, allows for the design of a synthetic pathway in the
forward direction, and in modern times is a process which may be automated for simple
molecules.[7] These principles of target-oriented synthesis (TOS) are based on the concept
of ‘ideality’ in chemical synthesis, first coined by Hendrickson in 1975, and refers to the
minimisation of unnecessary chemical processes, such as those involving protecting
groups, extraneous redox or functional group manipulations, and correction of undesired
stereochemistry.[8] In short, an ‘ideal’ synthesis would afford “…a complex molecule
from...available small molecules…in a sequence of only construction reactions involving
no intermediary re-functionalisations.” While an imperfect metric for the evaluation of
synthetic worth (i.e. it does not consider the synthetic feasibility of particular
2

transformations, instead relying on a mathematical step-count), it informs a prima facie
comparison between synthetic pathways. For example, in the synthesis of the polyketide
marine natural product brevetoxin B (6), a comparison of the step count for the firstgeneration synthesis (Nicolaou et al, 1995 – 123 steps),[9] and later synthetic strategies
toward its construction (Nakata et al, 2004 – 90 steps),[10] would deem the latter process
the more-ideal of the two – perhaps unsurprising, since the latter relies upon synthetic
disconnections made in the former synthesis to complete the natural product, though with
several modifications to the upfield synthesis of the key fragments (Scheme 1).

Scheme 1: Comparison of two syntheses of the marine natural product brevetoxin B (6) by the
Nicolaou and Nakata groups.

This approach is not without its drawbacks. While the synthesis proved an herculean
effort, and resulted in the development of numerous new synthetic transformations, the
original Nicolaou synthesis of brevetoxin B amounted to an investment of twelve years
of intensive study,[11] and resulted in the isolation of just 4.8 mg of material, in an overall
process yield of 9.2×10-4% due to the number of physical manipulations required. It is
therefore clear that while contiguous step-wise transformations do allow access to highly
complex polycyclic molecules, linear TOS does not outright solve the problems of
scalability and diversity, considering that modification to the core skeleton of the natural
product would likely require years of investment, assuming the desired modifications do
not interfere with other key steps further downstream. Moreover, this effectively limits
the structural diversity of the molecules that are able to be synthesised in this manner, as
they would represent analogues of scaffolds which have already been synthesised. With
respect to the discovery of new molecules for medicinal application, it is simply not
practicable to adopt a linear, target-oriented approach to synthesis for all desired
molecules.

3

1.3

Diversity-oriented synthesis for drug discovery

There is a growing appreciation for a diversity-based approach to drug discovery
(diversity-oriented synthesis, DOS), particularly where the precise identity of the target
is not of critical importance e.g. in medicinal or materials applications.[12] In comparison
to a traditional target-based synthetic methodology, where a single precise chemical
architecture is the focus, DOS aims to generate a library of diverse chemical species for
rapid scaffold discovery, which may be then iteratively modified based upon the desired
characteristics for the particular application, for example, in high-throughput biological
screening.[13] As an orthogonal approach to TOS, DOS utilises a forward-planning
approach, whereby simple molecules may be iteratively combined across multiple
(usually no more than five) steps, with the aim of developing a library made up of
compounds of varied frameworks and functionalities (Figure 2).

Figure 2: Comparison of the overall rationale of target-oriented (left) and diversity-oriented
(right) synthesis.

The major advantage to diversity-oriented synthesis is that the process relies on coupling
each fragment together iteratively, thereby allowing a vast window for derivatisation at
each of the individual stages. Considering a hypothetical starting point of a single
molecule, and utilising three iterative stages of 20 derivatives at each stage, this would
constitute a library of up to 8,000 final compounds, which are themselves only three
synthetic steps from the starting molecule but diverse in functionality. The major
disadvantages of DOS are practicality, for in order for this to be a successful means of
generating molecule libraries, each stage must involve reactions which must be robust
and produce only the desired product with no by-products, as the necessity of intermediate
purification would make this diversity-oriented process exponentially more timeconsuming with each iteration. This requirement leads to a second disadvantage, owing
to the scarcity of ‘perfect’ reactions, meaning that only specific transformations can
realistically be performed in the search of diversity – thus limiting the idea of ‘diversity’
in the first instance. This combined with the predisposition of synthetic chemists toward
4

well-behaved, accessible starting materials (or privileged scaffolds as starting points)[14]
leads to selection bias, and narrowing of the overall chemical diversity of the library. This
is illustrated by analysis of a random selection of ‘diverse’ molecules, deemed to be
largely comprised of products from amide coupling and Suzuki-Miyaura reactions,[15] and
containing greater proportions of para- substituted phenyl substituents (particularly those
with para-chloro-, fluoro-, or trifluoromethyl groups) than other substituent patterns.[16]
Particularly in the case of reaction discrimination, this may result in an overall narrowing
of the accessible chemical space than is idealised for diversity-oriented synthesis. Finally,
a common criticism of a DOS approach is that while generating large libraries leads to
greater statistical chance of identifying a ‘hit’, there is no overall guarantee that the
generated molecule library will contain any viable leads to begin with, and may instead
result in 8,000 individual iterations of how best to generate inactive molecules.
One means by which these issues may be circumvented is through collaborative efforts
such as those of the European Lead Factory project,[17] where a group of 30 institutions
have worked cooperatively since the project’s inception in 2013, with the aim of
developing a vast library (consisting of ca. 326,000 molecules provided by the Joint
European Compound Library, in addition to a further 200,000 new molecules synthesised
as part of the project – a milestone reached in June of 2018) of potential leads, which can
be assessed for ‘lead-likeness’ and structural diversity via computational means,[18] as
well as through ultrahigh-throughput screening methods.[19] An early analysis of a
selection of the library (ca. 55,000 compounds) revealed considerable structural and
functional diversity within typical Lipinski’s rule-of-five parameters,[20] expanding into a
broad region of unexplored chemical space as denoted by a low Tanimoto coefficient of
0.2 (<20% inter-collection similarity) across these compounds, as well as retaining a high
degree of sp3 character (>40% sp3 for 86% of the library) – a desirable characteristic for
drug design and specificity.[21] The project has utilised a series of methodologies, broadly
classified as multicomponent reactions,[22] and divergent or combinatorial synthesis[23] to
afford a broad variety of compounds – a small selection of which are depicted in Figure
3.

5

Figure 3: A selection of scaffolds synthesised as part of the European Lead Factory DOS project.
References are as noted.

It is therefore the case that while ‘perfect’ diversity-oriented synthesis would provide
significant benefits over target-oriented synthesis with respect to the rapid generation of
chemical libraries, there exist significant barriers toward its widespread adoption as the
major means of exploring new chemical space, which may be overcome by further
exploration.

1.4

The role of cascade reactions in modern synthetic chemistry

The major pitfall for both target-oriented and diversity-oriented synthesis is the necessity
of performing multiple sequential synthetic steps, most-often requiring purification of the
intermediate product mixtures. While a not-insurmountable obstacle, it would be more
convenient to perform multiple synthetic steps in a single reaction vessel, thus providing
synthetic shortcuts to the desired architecture.[24] This demonstrates, in part, the power of
cascade reactions for the construction of new molecular architectures, as they would serve
to eliminate intermediate reaction steps entirely, making the overall start-to-finish process
more efficient.[25] To re-invoke the idea of ‘ideality’ in organic synthesis,[8] cascade
6

reactions represent one logical endpoint, where entire processes can be circumvented, and
multiple new bonds can be formed in a single reaction vessel, thus rapidly and efficiently
building molecular complexity whilst eliminating intermediate isolation and purification
procedures entirely.[26] In the context of current environmental concerns, cascade
reactions could also offer a more environmentally-benign means of generating complex
molecules, as they necessitate only a single solvent, reagent, and purification, compared
with an equivalent bond-forming process over multiple sequential steps.
There are many classical examples (e.g. the Robinson ‘double-Mannich’ synthesis of
tropinone)[27] of the use of cascade reactions as late-stage tools in synthesis, and these
have been extensively-reviewed in the past.[24, 26a, 28] One particularly elegant example of
the power of this approach is the Corey synthesis of the putative structure of the
squalenoid natural product glabrescol (7), where a pentaoxirane precursor underwent
Brønsted acid-mediated cyclisation with CSA (camphor-10-sulfonic acid) to afford the
desired polyfuran scaffold in 31% yield (Scheme 2).[29] Based on these synthetic studies,
the structure of glabrescol was revised to 8, and confirmed by synthesis via a modified
protocol, though this too relied on an electrophilic cascade reaction from a polyepoxide
precursor.[30]

Scheme 2: Key cascade cyclisation from the Corey synthesis of the putative structure of
glabrescol 7, and the true structure of glabrescol (8) as confirmed by synthesis.

Cascade reactions can be broadly classified as following one of eight fundamental modes
7

of reactivity, as depicted in Table 1, where each sequential chemical transformation may
be used as a means of discrimination. For the above example of the polycationic epoxide
ring-opening to give polyfuran 7, this could be classified as a 1a/2a/3a/4a/5a-type
cascade utilising this framework.[28a, 31]
Table 1: Classification of different types of cascade reactions. Adapted from Teitze.[28a]

First Step

Second Step

Third Step

1a Cationic

2a

Cationic

3a Cationic

1b Anionic

2b

Anionic

3b Anionic

1c

2c

Radical

3c

1d Pericyclic

2d

Pericyclic

3d Pericyclic

1e

Photochemical

2e

Photochemical

3e

Photochemical

1f

Carbenoid

2f

Carbenoid

3f

Carbenoid

1g Metal-catalysed

2g

Metal-catalysed

3g Metal-catalysed

1h Redox

2h

Redox

3h Redox

Radical

Radical

This classification mode allows for modularity in describing cascade processes where the
reactivity differs as the reaction proceeds. For the below example (Scheme 3), where an
amine-mediated (ethylenediamine diacetate, EDDA) Knoevenagel condensation (anionic
– 1b) between Meldrum’s acid (9) and O-prenylsalicylaldehyde (10) precedes a heteroDiels Alder cyclisation (pericyclic – 2d), to afford the fused-ring system 11 in 73% yield,
and with >99% diastereoselectivity toward the cis diastereomer.[32]

Scheme 3: Tandem Knoevenagel/hetero-Diels Alder cyclisation to produce 11 via a 1b/2d-type
cascade reaction.

In more complex examples such as multicomponent reactions, several reagents may be
combined to afford densely-functionalised systems. One key example of this is the Ugi
reaction, which is typically accomplished between four coupling partners: an aldehyde or
8

ketone, an amine, an isocyanide, and a fourth variable component (typically a carboxylic
acid, though this can be substituted for – among others – H2O, H2S, H2Se, CO2 and an
alcohol, HN3, HCNO, or HCNS).[33] A general schematic for the Ugi reaction is shown
in Scheme 4.

Scheme 4: The Ugi four-component reaction is one example of a cascade process with multiple
coupling partners, and proceeds via a multi-step mechanism. General schematic and mechanism
adapted from Kürti and Czacó.[34]

There are several factors to consider with the use of cascade reactions in synthesis.
Cascade reactions typically require densely-functionalised starting materials, requiring
multiple synthetic steps of pre-functionalisation. Additionally, as cascade reactions rely
on the sequential participation of multiple functional groups, the desired product is
typically only obtained in good yields where a) competing reactions are in equilibrium
with the desired process (i.e. not irreversible), b) there is a considerable enthalpic or
entropic benefit to the formation of the desired product, or c) where the final step in the
cascade reaction is irreversible. This is exemplified in the Ugi reaction, where a) the
formation of salts, hemiaminals, etc. are reversible, and b) acyl transfer occurs in the final
9

step to generate a pair of amide bonds – the stability of the dipeptide effectively rendering
the final step irreversible. It is not to say that side-reactions can be eliminated entirely in
all instances, and in many circumstances, multiple branches in the mechanism can result
in undesired (or unexpected) products. Therefore, to effectively utilise cascade reactions
for the construction of complex molecular frameworks, an intimate understanding of the
underlying process and mechanism of the reaction must be present, as well as the desired
starting point and products, to discern conditions most conducive to generating the
desired endpoint.

1.5

Applications of cascade reactions to diversity-oriented and

target-oriented synthesis
One of the key considerations in utilising cascade reactions as a means of either a)
selectively generating the desired product via a TOS approach, or b) developing a library
of compounds via a DOS approach, is the potential manipulations that are possible –
ideally, the selected starting point would possess a variety of functional groups in close
physical proximity, with the ability to undergo spontaneous further reactions upon
addition of a second coupling partner. By moderating the coupling partners, or by using
different chemical additives e.g. Lewis acids, it would therefore be possible to design
specific cascade reactions to favour certain reactive pathways, and thus the formation of
particular chemical scaffolds.
The application of cascade reactions to diversity-oriented synthesis is aptly demonstrated
by the work of the Stockman group, where utilising the relatively-simple keto-diester 12
as the starting point, nucleophilic addition to the central ketone allowed for subsequent
intramolecular cyclisation onto the outer α,β-unsaturated systems, forming a broad
variety of cyclic adducts (13–24) via twelve unique reactive pathways, via both stepwise
and concerted processes.[35] A summary of the major outcomes of this initial study is
presented in Scheme 5.
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Scheme 5: Divergent synthesis of structurally-diverse products 13-24 via cascade reactions from
common precursor 12.

Spirocycles 13 and 14 were proposed to arise from a three-stage cascade process, where
upon condensation of the central ketone with hydroxylamine, the oxime adduct
underwent spontaneous Michael addition to forge the piperidine ring while generating an
iminium-N-oxide 1,3-dipole. Subsequent nitrone [3+2]-cycloaddition to the remaining
olefin gave either the O-internal (13) or C-internal (14) adducts. When oxime
condensation was performed in the presence of NaOEt, compound C-internal adduct 14
underwent N,O-fragmentation and recombined to give lactone 15,[36] while heating 14 in
chlorobenzene led to the formation of O-internal product 13 via a retro-[3+2]/[3+2]
11

cycloaddition, indicating 14 to be the kinetic product, and 13 to be the thermodynamic
product. This cascade/interconversion protocol could also be achieved utilising ketodinitrile 25, with the rearrangement of kinetic product 26 to thermodynamic product 27
occurring upon heating in toluene in a sealed tube, and was utilised in a short-step racemic
synthesis of histrionicotoxin 28, isolated originally from poison dart frogs (Scheme 6).[37]

Scheme 6: Retro-[3+2]/[3+2]cycloaddition methodology toward histrionicotoxin (28).

An analogous hydrazone [3+2] cycloaddition also occurred using tosylhydrazine, with
subsequent oxidative desulfuration affording cyclic hydrazone 19 in 41% yield. Ti(IV)mediated reductive amination of 12 with ammonia lead to trans-octahydroquinolizine 16
via twofold aza-Michael addition in 74% yield, while aniline underwent sequential
Michael/aza-Michael addition via an intermediate enamine, affording transoctahydroquinoline 17 in 65% yield. Ethyl glycinate could also be condensed with 12 to
generate an azomethine ylid in situ, which similarly underwent [3+2]-cycloaddition to
afford the cis-tricarboxylate 18 in 71% yield. Interestingly, in the absence of a secondary
partner, treatment of 12 with sodium hydride prompted a spontaneous, diastereospecific
twofold Michael addition to afford trans-decalin 20, containing four contiguous
stereocentres in 70% yield.
Single-electron reduction of 12 with SmI2 afforded either lactone 21 (using 2 eq. SmI2)
or cyclopentanol 22 (using 5 eq. SmI2). The divergence in stereochemical outcome was
proposed to be a result of the higher degree of SmIII-chelation where fewer equivalents of
SmI2 were used, resulting in radical 29 with the alkyl groups positioned trans to oneanother, while steric hindrance between samarium ions in ketyl radical 30 led to the cisdiastereomer (Scheme 7).
12

Scheme 7: Radical cyclisation of 12 to either lactone 21 or cyclopentanol 22 with SmI2.

Finally, treatment of ketone 12 with lithium-based nucleophiles led to tetrahydropyran
adduct 23 by addition to the ketone and subsequent oxa-Michael addition in 50% yield
using super-hydride (LiBEt3H), or 19% yield using MeLi. Comparatively, using MeMgBr
in place of MeLi gave the acyclic Grignard adduct 24 in 86% yield.
Developing a fundamental understanding of the reactivity of polyfunctional materials can
be a powerful tool in reaction discovery. The use of the discretely-functionalised ketodiester 12 allowed for the preparation of twelve distinct chemical scaffolds from a single
precursor, lending considerable use toward a diversity-oriented approach. Moreover,
modulation of the reactive species allowed specific mechanistic pathways to be favoured.
Being able to control these cascade reactions can also be seen to have significant synthetic
utility in target-oriented synthesis, as the products can be further elaborated to provide
rapid access to highly-functionalised materials.[38] Therefore, it would be of considerable
worth to explore the synthetic utility of other highly-functionalised materials, with a view
toward utilising cascade reactions for both reaction discovery and diversity-oriented
synthesis, as well as for the synthesis of scaffolds of particular interest.
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1.6

The chemistry of indigo

Indigo (31) is an ancient natural dye, derived from a wide variety of plant-based sources
(e.g. Indigofera sp., Isatis sp., Persicaria sp.), and has been used in the production of
textiles and artworks for millennia.[39] The molecule itself consists of a dimeric 2,2ꞌbiindoline core, flanked by carbonyl groups at the 3 and 3ꞌ positions. The trans-geometry
about the central olefin is held rigid by intermolecular hydrogen bonding between the
adjacent indole and ketone groups, which also contributes to indigo’s characteristic
intense-blue colour; hydrogen bonding and π-stacking can also occur between individual
indigo molecules, leading to indigo’s poor solubility in many solvents.[40]
Indigo has a rich history of international trade through the ages, forming the basis of the
export industry for many countries, including as a major economic commodity in the
colonial Americas. At several points throughout history, indigo was worth greater than
its weight in gold, and alongside gold and spices, it was one of the primary commodities
traded by the East India Company, forming the basis of the modern global economy.[41]
In more recent times, indigo has become synonymous with its use in the production of
blue denim jeans since their invention in 1872. The surge in demand associated with the
widespread use of blue denim cultivated significant interest in the chemistry of indigo,
resulting in a lab-scale synthesis of indigo by Baeyer in 1878, for which in-part he was
awarded the 1905 Nobel prize for chemistry.[42] This eventually led to indigo’s industrialscale synthesis by the early 20th century.[43] Today, most of the indigo produced
worldwide is synthetic,[44] though there continues to be considerable interest in
developing more environmentally-conscious methods for its production.[45] The first
economically-viable industrial methods were based off the second-generation Heumann
process (Scheme 8),[43, 46] where anthranilic acid is alkylated with chloroacetic acid to
give 2-carboxyphenylglycine (32), which is fused in a NaOH/KOH melt to give a salt of
indoxyl-2-carboxylate 33, which upon decarboxylation to indoxyl 34, undergoes
spontaneous air oxidation to afford indigo.
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Scheme 8: Overview of the second-generation Heumann process for synthesising indigo (31)
from anthranilic acid via 2-carboxyphenylglycine 32. Counterions are not depicted for clarity.

The synthesis of indigo proved to be an important contributor to the invention of factoryscale organic chemistry, and indigo factories quickly superseded natural indigo as the
dye-of-choice for many applications due to its lower price and higher quality, with fewer
indigoid (isoindigo, 35 and indirubin, 36, Figure 4) impurities. The ready availability of
indigo led to the development of most of the modern understanding of the chemistry of
the indigo family, including fundamentals of redox chemistry, reactions with acids and
bases, electrophilic and nucleophilic chemistry, as well as tandem reactions of indigo. An
overview of the known chemistry of indigo follows, however much of its history predates
modern spectroscopic techniques, and thus the validity of these reported outcomes is
variable.

Figure 4: The indigo family: indigo, isoindigo, and indirubin with their respective colours.

1.6.1 Redox chemistry of indigo
The reduction of indigo is of particular importance to the textiles industry, as leucoindigo
37 is relatively water-soluble and adheres well to fabrics, allowing for back-oxidation to
indigo upon air-drying. For this reason, the reduction of indigo is well-known, and can
be achieved via a number of methods – most commonly using sodium dithionite or zinc
15

dust, or through electrochemical methods,[47] though methods involving urine, arsenic
trisulfate and bacterial cultures are also known.[48] Using a Clemmensen-type reduction
with zinc, iron, tin or zinc-mercury amalgam in a mixed AcOH/Ac2O solvent, various
deoxygenated and/or acetylated adducts such as 38 may be isolated (Scheme 9).[49]

Scheme 9: Reduction of indigo to leucoindigo. Further reduction of leucoindigo is also possible
in the presence of acetic anhydride.

The oxidation of indigo follows two general pathways (Scheme 10) – under aqueous
acidic conditions, or under harshly oxidising conditions (e.g. with concentrated nitric or
chromic acids, ozone, aqueous bromine or chlorine) indigo undergoes cleavage of the
central double bond to afford isatin 39, or under anhydrous or milder conditions (e.g. with
PbO2 or Pb(OAc)4 in benzene/acetic acid, Cl2 in CCl4, or KMnO4/AcOH then pyridine
via 2,2ꞌ-diacetoxyindigo 40), affords dehydroindigo 41,[50] which is also accessible via
electrochemical oxidation.[51] The oxidation of indigo carmine (42) to the corresponding
isatin has also been utilised as a means of detecting ozone or superoxide in biological
systems.[52]

Scheme 10: Oxidation of indigo affords either isatin 39 or dehydroindigo 41, depending on
reagent choice.
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1.6.2 Reactions of indigo with acids and bases
Like other indolic compounds, indigo undergoes deprotonation with a variety of strong
or weak bases. Indigo was also reported to react with mineral acids to give indigo salts in
1902; i.e. treating indigo with a 5:1 mixture of acetic and sulfuric acids, and precipitation
with diethyl ether yields indigo monosulfate (43a), while the prolonged digestion of
indigo by sulfuric acid (13.5 M) under the same conditions was reported to yield indigo
disulfate, 43b.[53] Notably, indigo becomes soluble in acetic acid, benzene and chloroform
when dry HCl gas passes through the suspension, while addition of ether to the solution
precipitates the hydrochloride salt 44 (Figure 5).

Figure 5: Salts reported from the reaction of indigo with mineral acids.

In a recent study of the closely-related ‘Nindigo’ (indigo-3-arylimine) family (45), it was
determined that reversible protoisomerisation takes place upon treatment with strong
acids to furnish cis salt adducts (46).[54] While both mono- and di-iminoindigoids react
readily with a variety of acids, indigo was noted to be far less reactive, given the low
basicity of the indigo carbonyl relative to its imine equivalent, though the reactions of
indigo with triflic or sulfuric acids in chloroform were reported to give green, solvated
indigo derivatives. These could not be isolated due their instability, therefore it is
unknown whether indigo undergoes similar isomerisation upon acidification. The sulfuric
acid adduct was observed to gradually form indigosulfonic acid products (47);
unsurprising given the known, and controllable sulfonation of indigo with sulfuric
acid/SO3 mixtures.[55] Treatment of the cis-acid adduct with organic bases (e.g. DBU,
NEt3) restored the trans-configuration about the double bond, presumably due to restoring
intramolecular H-bonding between adjacent donor-acceptor functionalities (Scheme 11).
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Scheme 11: Salt formation and reversible protoisomerisation of indigo-N-arylimines.

1.6.3 Electrophilic chemistry of indigo with nitrogen nucleophiles
Imine derivatives of indigo were first reported in 1909, by the boric acid-catalyzed
condensation of indigo with aniline derivatives, affording the corresponding diimine 48
as purple needles, reported in good yields (Scheme 12).[56] In 1914, the reaction of indigo
with ZnCl2 and aqueous ammonia resulted in the formation of a mixture of indigo
monoimine 49 and diimine 50, separable by crystallisation from benzene. Of these, the
former method has been demonstrated to be irreproducible, and no yield was reported for
the latter, which prompted investigation into indigo-N-imines.[57]

Scheme 12: Initial investigations into the formation of imines from indigo and ammonia or aniline
derivatives.

A more-robust procedure for the generation of indigo-N-arylimines was developed in
2010 by Hicks et al,[58] by treating indigo with a pre-formed titanium-imido complex,[59]
generated in situ by the addition of TiCl4 to a solution of the desired amine and DABCO
in bromobenzene. Heating the resulting complex at reflux led to the desired diimine
‘Nindigo’ 48 in good yields (Scheme 13).[60] This can then be oxidised using silver oxide,
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and the resulting ‘dehydroNindigo’ isolated by complexation to a suitable metal, such as
PdII, RuII, or CoII, affording adduct 51 via ligand displacement of their corresponding bishexafluoroacetoacetonato (hfac) complexes.[61] Dimetallic species are then able to be
transmetallated, to afford redox-active, bimetallic Nindigo-metal-boronate complexes. It
is known that indigo diimines undergo facile keto-enol tautomerisation to adopt an
asymmetric structure (i.e. 52), and this process occurs by a dual proton-transfer
mechanism.[62]

Scheme 13: Synthesis of 'Nindigo' imines (48) via nucleophilic addition of a titanium imide
complex, and their use as ligands for the synthesis of transition metal complexes (51). Diimides
such as 48 have been shown to exist as a mixture of the ‘imine’ form 48 and the ‘enamine’ 52,
and interconvert easily by proton transfer.

The Wolff-Kishner reduction of indigo was first reported in 1921, performed by heating
indigo in an alkaline, alcoholic solution of phenylhydrazine.[63] This firstly generated a
proposed phenylhydrazone intermediate 53, which upon thermal decomposition gave the
desired methylene compound, mono-desoxyindigo 54 (Scheme 12). In 1945, monodesoxyindigo 54 was demonstrated to be formed by the action of hydrazine hydrate on
indigo, in addition to a reported diazine side-product, 55. In both instances however, no
yields were reported, and little characterization beyond elemental analysis was
undertaken.[64]
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Scheme 14: The reaction of indigo with hydrazine hydrate or phenylhydrazine is reported to give
the mono-hydrazone 53, which is reported to either decompose into desoxyindigo 54, or condense
into diazinoindigo 55. No yields were reported for either reaction.

Finally, indigo oxime 56 was obtained in 40% yield from the reaction of indigo with
hydroxylamine.[65] Subsequently, it was found that heating an alkaline solution of indigo
and hydroxylamine hydrochloride at reflux resulted in isolation of bis-oxime 57, though
its yield was not reported (Scheme 15).[66]

Scheme 15: Oximation of indigo with hydroxylamine afforded either 56 in modest yield, or 57.
Yields were not reported for compound 57.

1.6.4 Electrophilic chemistry of indigo with carbon nucleophiles
Despite the development of an innumerable array of carbon-based nucleophiles in the 20th
century, and the demonstrated electrophilicity of the indigo core (particularly at C3), the
body of knowledge surrounding the reactions of indigo with readily-accessible carbon
nucleophiles is astoundingly limited. The reaction of indigo with several Grignard
reagents in diethyl ether was reported in 1909, and resulted in a handful of nonsymmetrical adducts (58) in good to excellent yields, though yields were not reported for
all compounds, and the absolute structure of these molecules was not unambiguously
determined (Scheme 16).[67] The authors of this study ascertained that the Grignard
reagent and indigo had reacted in a 1:1 ratio based off elemental analysis, however in the
absence of then-unknown spectroscopic techniques, the only structural evidence obtained
was from derivatisation of the products. It was determined that nucleophilic attack had
occurred at the carbonyl group by the presence of a hydroxyl functionality, and reacting
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with cold KMnO4 revealed the presence of a C=C double bond. Furthermore, this
molecule could be alkylated using ethyl iodide and KOH in ethanol, and subjecting this
alkylated material to Zeisel’s test (cleaving the alkyl groups with HI, then precipitating
the iodide with AgNO3) revealed the addition of two ethyl groups. The authors
determined that the product was likely one of two tautomers (58a or 58b), and that 58b
fit better to their observations, however they stated that “attempts to establish the
constitution (did not lead) to a uniform, crystallised and well-defined connection” and
“partially due to the (rest of the) molecule, did not yield unambiguous results.”

Scheme 16: Reaction of indigo with Grignard reagents to afford the corresponding tertiary alcohol
adduct 58, as one of two tautomers. The exact structure was not unambiguously determined, and
yields were reported for several compounds, but not for all examples.

1.6.5 Diels-Alder chemistry of dehydroindigo
The oxidation of indigo to dehydroindigo (41) generates a 4π system, which is amenable
to [4+2]-cycloaddition chemistry. Several examples of dehydroindigo’s cycloaddition
chemistry have been reported previously, and in good yields where specified. The first
aza-Diels Alder reactions of dehydroindigo were reported in 1940, where a selection of
electron-rich and electron-poor substrates were reported to give the expected N,Nꞌbridged cycloadducts in good yield. Further reports disclosed similar outcomes, albeit in
modest yields.[68] The stereochemical outcome was not investigated in any case (Scheme
17).
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Scheme 17: Reactions of dehydroindigo with selected dienophiles via [4+2]-cycloaddition. The
yield for compound 60 was not reported.

These bridged structures were also reported to undergo post-synthetic modifications, as
in the addition of methyl propiolate to dehydroindigo, to give the expected methyl ester
adduct 68. Thermal decarboxylation of the ester gave N,Nꞌ-vinylindigo 69 in 22% yield,
which could be oxidised by nitric acid to N,Nꞌ-oxalylindigo 70 in 31% yield (Scheme
18).[69]

Scheme 18: Synthesis of N,N'-oxalylindigo 70 via N,N'-vinylindigo from decarboxylation of the
cycloadduct 68. The yield for compound 68 was not reported.
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1.6.6 Nucleophilic chemistry of indigo – electrophilic aromatic substitution
As is typical for other 2,3-disubstituted indoles, electrophilic substitution of indigo,
leucoindigo or dehydroindigo affords sulfonated, halogenated or nitro derivatives, firstly
at the C5- and C5ꞌ-positions, then at C7 and C7ꞌ. It is important to re-emphasise that for
the derivatives of indigo summarised here, many were reported in the early 20th century,
and structural elucidation of these derivatives was based primarily on elemental analysis.
Percentage yields were largely unreported, thus the validity or reproducibility of these
outcomes cannot be assessed without conducting further experimentation. A summary of
reported outcomes follows.
Direct halogenation of indigo using aqueous bromine or chlorine generally affords
halogenated isatins from oxidation and/or hydrolysis, while halogenation in glacial acetic
acid typically affords mono or di-halogenated indigo.[70] The preparation of 5chloroindigo has been reported by direct halogenation of indigo in glacial acetic acid, and
the procedure was also found to be amenable to the synthesis of 5,5'-dichloroindigo.[71]
5,5'-Dibromoindigo was obtained from the addition of bromine to a solution of indigo in
nitrobenzene, under microwave-aided conditions.[72] A quantitative preparation of
5,5',7,7'-tetrabromoindigo (71) from the reaction of indigo with bromine and sodium
nitrite in sulfuric acid has also been patented,[73] while 5,5',7,7'-tetraiodoindigo could be
prepared from dehydroindigo by the action of iodine monochloride in presence of sodium
bisulfate.[74]
Similarly to halogenation, nitration of indigo in water, acetic acid or sulfuric acid leads
to the formation of nitroisatins, thus anhydrous media were demonstrated to be essential
for the nitration of indigo to 5,5ꞌ-dinitroindigo.[75] Treatment of indigo by concentrated
sulfuric acid gives indigo carmine (42) as a highly water-soluble blue-green powder,[76]
typically isolated and handled as the disodium salt. Application of fuming sulfuric acid
was also reported to produce indigo-5,5',7,7'-tetrasulfonic acid.[55, 77]
Halogenated derivatives of indigo demonstrate a variety of colours, based on the position
of the halogens on the aromatic rings. For example, 5,5',7,7'-tetrabromoindigo (Ciba blue
B, 71) is electric-blue, 6-bromoindigo 72 is a deep violet colour and Tyrian purple (6,6′dibromoindigo, 73) is bright purple (Figure 10). Perhaps the most widely-acknowledged
derivative of indigo is indigo carmine (42), which due to its high water solubility has
found common use as a pH indicator with a range of 11.4-13.0, a redox indicator for the
detection of ozone and superoxide,[52, 78] and has niche medical uses such as for the
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detection of amniotic leakages, and for imaging sections of the renal and urinary tracts
(Figure 6).[79]

Figure 6: Selected indigo derivatives bearing substituents on the outer phenyl rings.

Tyrian purple (73), is an ancient pigment among the oldest of dyes, and has been used
since the Iron Age by Phoenicians, Chinese and Peruvians as a sacred pigment. [80] In
Rome, Emperor Nero decreed the exclusive right for the emperor to wear purple robes,[81]
and the colour purple has been seen as a sign of the opulence of the British monarchy for
centuries, earning the name ‘Royal Purple.’ Based on biblical notes, the vestments of
Catholic priests are also dyed with Tyrian purple. The history of Tyrian purple is wellrecorded, and it has been the subject of numerous synthetic studies.[82] Historically, the
pigment could only be obtained from exposure of extracts of marine Murex sp. to light,
and due to its low abundance, the secretions of over 10,000 individual Murex were
required to produce a gram of the pigment.[83] This extreme scarcity, combined with its
political and religious significance has meant its value has historically been 10-20 times
higher than its weight in gold during different periods of time.[84] Much has been reported
on the biosynthesis of Tyrian purple and its progeny – a summary of which is depicted in
Scheme 19.[85]
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Scheme 19: Biosynthetic pathway responsible for the generation of Tyrian purple 73 from
tyrindoxyl sulfate 74 via the antimicrobial tyriverdin 77.

Briefly, tyrindoxyl sulfate 74 is hydrolysed under the action of either a purpurase or an
arylsulfatase to give tyrindoxyl 75. Oxidation to tyrindoleninone 76 leads to dimerization,
which results in the green pigment tyriverdin 77. Photolysis of tyriverdin gives rise to
Tyrian purple, along with the elimination of odorous dimethyldisulfide.[86] Both
tyriverdin and tyrindoleninone exhibit potent antimicrobial activity, though the exact
mode of action is unknown, and it is unclear whether this is the result of the molecule
itself acting as an inhibitor, or the ready elimination of toxic sulfides or disulfides upon
UV irradiation.[87]
1.6.7 Metal complexes of indigo
There has been some interest in the complexes of indigo with metals in the past, owing
to indigo’s abundance, strong absorptive characteristics, and low cost. Indigo was first
demonstrated to form coordination complexes with metals in 1922, forming bis-indigo
homoleptic chelates, such as those of CuII, ZnII, NiII and CoII (78), though yields were not
reported.[88] More recently, mono-metalated (M = PdII, PtII) adducts (79) were reported
from the addition of chlorido-bridged [(PBu3)(Cl)M(µ-Cl)]2 complexes to indigo salts in
THF solution (Scheme 20).[89]
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Scheme 20: Reported metal complexes of indigo. Yields were not reported for complexes of type
78.

The recent resurgence of interest in metal-indigoid complexes, such as those of ‘Nindigo’
and ‘thioNindigo’ ligands[90] with noble metals led to the isolation of several complexes
of indigo with RuII bearing acetylacetonato (acac),[91] and 2-(phenylazo)pyridinyl (pap)[92]
ligands (79–82) in 2016 (Scheme 21). In subsequent studies, diruthenium complexes were
also accessible using Ru(acac)2.[93]

Scheme 21: Mono- and dimetallic complexes of indigo with ruthenium, bearing acac and pap
ligands.

26

1.6.8 Nucleophilic chemistry of indigo with alkyl, acyl, and aryl halides
Early work by Baeyer suggested that indigo’s poor solubility meant that it could not be
alkylated.[42c] However, it was found that indigo readily undergoes N-alkylation in DMF
solution with barium oxide and methyl iodide, affording quantitatively N,Nꞌdimethylindigo 83 (Scheme 22).[94]

Scheme 22: Synthesis of dimethylindigo 83 via N-alkylation of indigo.

An alternative approach used sodium hydride in DMF, and gave 83 in 53% yield.[95]
Under these conditions, cis-N,Nꞌ-bridged indigo derivatives 84–87 were synthesised in
low yields from various alkyl dichlorides via sequential nucleophilic displacement by the
indigo dianion (Scheme 23). In a similar fashion, indigo was reacted with acyl chlorides
to afford cyclic scaffolds 88 and 89 in modest yields.

Scheme 23: Synthesis of cyclic indigo derivatives 84–87 via dual-displacement of alkyl
dichlorides, or 88–89 via reaction with oxalyl (88) or malonyl (89) dichlorides.

The N-acylation of indigo with acyl chlorides or anhydrides has been widely utilised as a
means of solubilising indigo, as well as performing subsequent chemical
transformations.[96] Photochemical isomerisation between the cis- and trans- isomers of
indigo derivatives occurs readily in visible light, and has been studied with a view toward
the development of photosensors.[96c,

97]

Interestingly, in many instances, indigo

undergoes intramolecular Knoevenagel condensation upon N-acylation. The alkylation of
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indigo with diethyl malonate, and subsequently with ethyl phenylacetate in 1926 revealed
cyclic, conjugated products by the elimination of water from N-acylindigo
intermediates.[98] Such Knoevenagel-type reactions with indigo are relatively wellknown, and reliable means of generating intense red pigments containing bay-annulated
systems, which have been the subject of numerous recent studies toward the synthesis of
new organic semiconducting polymers due to their electron-accepting nature, and small
HOMO-LUMO bandgap.[97b, 99] In one recent example, thiophene bay-annulated indigo
(90) was synthesised in 73% yield by heating a suspension of indigo and 2thiopheneacetyl chloride in xylene at reflux, and could be further elaborated via metalmediated cross-coupling chemistry to polymers such as 91, which have been
demonstrated to have useful photophysical and charge-transporting properties (Scheme
24).[100]

Scheme 24: Knoevenagel condensation of substituted acetyl chlorides gives bay-annulated indigo
adducts such as 90, which was converted into polymer 91 over 4 steps.

Early attempts at Ullmann-type N-substitution of indigo with aryl iodides under Cu0mediated conditions led instead to products resulting from fragmentation of indigo, and
subsequent radical dimerization.[101] Reinvestigation of the reaction in 2003 revealed
conditions amenable to the synthesis of a variety of N-aryl (92b–f) and N,Nꞌ-diarylindigos
(93a–d) in modest to excellent yields (Scheme 25).[102]
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Scheme 25: Aza-Ullmann cross-coupling of indigo with aryl iodides to afford either mono- (92)
or bis-arylated (93) indigo adducts.

This methodology was recently adapted toward the preparation of fullerene-free organic
photodiodes (OPDs), by the synthesis of 94 from Tyrian purple (73),[103] which
demonstrated comparable responsivity and detectivity to silicon- and fullerene-based
OPDs, suggesting possible further application of solution-processable N-arylindigo
scaffolds as semi-conducting materials (Scheme 26).

Scheme 26: CuI-catalysed cross-coupling of indigo and 1-((2-ethylhexyl)oxy)-4-iodobenzene to
afford adduct 94.

1.6.9 Summary of the fundamental chemistry of indigo
A variety of chemical transformations of indigo have been reported previously, including
redox chemistry (including reduction to water-soluble substances, oxidation to reactive
substances, deoxygenation, and oxidative cleavage reactions), reactions with acids and
bases, nucleophilic chemistry (including alkylation, acylation, arylation, and electrophilic
aromatic substitution reactions), electrophilic chemistry (including formation of imines,
hydrazones, and oximes, and Grignard reactions) as well as tandem reactions of indigo
(such as where N-acylation allows for subsequent Knoevenagel condensation). While on
face-value, this seems a considerable body of knowledge, closer analysis of many
publications from the early 20th century reveals that they did not disclose percentage
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yields, and characterisation of derived products was solely by melting point, elemental
analysis, or by derivatisation, as these works pre-date contemporary spectroscopic and/or
crystallographic techniques. As a result, much of the information reported on the
reactivity of indigo is of unknown validity and would require confirmation.

1.7

Cascade reactions of indigo

Where the reactivity of indigo has been re-investigated, its compact heterocyclic core has
served as a useful matrix for the synthesis of biologically-relevant heterocycles,[49b, 49c,
104]

though much of the fundamental chemistry of indigo remains unknown, or requires

further study. There have been several reported examples of indigo undergoing cascade
reactions, resulting in the generation of complex (and in many instances, unexpected)
heterocycles in a one-pot setting. Indigo’s extended conjugation is key to its ability to
participate in these cascade reactions, as tautomerisation of the indole and carbonyl
groups allows its electron density to be delocalised throughout the biindole system,
resulting in rapid oscillation of localised partial positive and negative charges. The ability
for multiple sites to act as potential nucleophiles (or electrophiles) as the reaction
progresses toward an energetically stable product therefore allows for a complex
reactivity profile. These reported cascade reactions are summarised below.
1.7.1 The hundred years’ controversy: cascade reactions of indigo with benzoyl chloride
The reaction of indigo with benzoyl chloride sparked a well-catalogued dispute, the
outcome of which became a point of contention for more than a century.[105] The
controversy surrounding the reaction stems from independent reports from several
research groups, each claiming different isolated structures from the same reaction,
highlighting in part both the intricacies of indigo’s chemistry, as well as a number of
inconsistencies within the literature.
Initially performed in 1863, Schwartz isolated a brown amorphous solid from the
prolonged reflux of indigo in excess benzoyl chloride, which was incorrectly assigned the
structure N,N'-dibenzoylindigo (95).[106] Compound 95 was however later (correctly)
reported as a crystalline violet powder by Posner, obtained from the reaction of indigo
with benzoyl chloride in pyridine.[107] Hydrolysis of Posner’s dibenzoylindigo was
additionally known to result in the regeneration of indigo, however Schwartz’s unknown
compound produced different results, prompting further analysis. The empirical formula
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of Schwartz’s product was later found to be C30H17O3N2Cl, identical to that of a
compound reported by Dessoulavy in 1909 (commonly referred to as ‘Dessoulavy’s
compound,’ 96), obtained by the prolonged reflux of indigo with excess benzoyl
chloride.[108] More confusingly, later reports on the reaction of indigo with benzoyl
chloride in the presence of copper powder, sodium nitrate, or in nitrobenzene solution
resulted in the production of Ciba Yellow G (97).[109] The true structure of 97 however
proved evasive, and structural elucidation of Ciba Yellow G attracted the attention of
organic chemists for decades, during which time a number of structures were proposed,
and subsequently modified, however the correct structure was proposed in 1949,[110] and
confirmed in 1986 through x-ray crystallography.[111] This final confirmation allowed
ambiguities surrounding this compound to finally be put to rest over a century after its
discovery (Scheme 27).

Scheme 27: Annulation of indigo with benzoyl chloride leads to diverse structures, with
compound 96 as a central intermediate. Unless specified, yields were not reported.

The chemistry of Dessoulavy’s compound 96 lies at the heart of the controversy
surrounding this reaction, as it serves as a divergence point for a variety of closely-related
derivatives. While attempting to elucidate the structure for Ciba yellow G (97), Lucius
reported in 1903 that Dessoulavy’s compound 96 could be converted into 97 via expulsion
of benzoyl chloride at elevated (300-380 ˚C) temperatures. Simultaneously, the reaction
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of indigo with benzoyl chloride in the presence of ZnCl2 as an additive gave a yellow
substance (Hoscht yellow R, 98),[112] which could also be generated from 96 by acidic
hydrolysis at room temperature. Finally, upon heating either 96 or 98 with sulfuric acid,
both afforded Hoscht yellow U (99) by elimination of benzoic acid.
In summary, the attempted benzoylation of indigo resulted in the production of five
diverse structures, depending on the specific conditions under which the reactions were
performed. The unanticipated complexity of this process is reflected by the timeline
between the initial experiments in 1863 and the finalisation of the outcome in 1986, more
than a century later.
1.7.2 Photochemical cascade reactions of N,Nꞌ-diacylindigos
While investigating the photochemical interconversion of N,Nꞌ-diacylindigo derivatives
(100), it was observed that many underwent an irreversible photobleaching process.[113]
Closer inspection revealed that the compounds underwent a photo-mediated
rearrangement, generating cyclic carbamates 101a–e in 40-65% yield. Mechanistically, it
was proposed that stabilised diradical 102 is formed upon photoexcitation, which then
underwent a 1,3-alkyl migration to give compounds 101a–e (Scheme 28).

Scheme 28: Photochemical rearrangement of N,N'-diacylindigo to compounds 101a–e via
diradical 102.

Performing the reaction under an oxygen atmosphere instead resulted in the formation of
benzoxazinoindoles 103a–f via molecular oxygen intercepting this radical pathway.
Irradiation of the acylindigo material under an O2 atmosphere gave peroxyl diradical 104,
which undergoes O-O fission to give 105 and subsequent ring-expansion to C,O-diradical
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106. Attack of the O-radical on the adjacent amide leads to 107, and subsequent C-N bond
fission terminates the cascade, affording products 103a–f (Scheme 29).[114]

Scheme 29: Photooxidation of N,N'-diacylindigoids, resulting in ring-expansion to afford
benzooxazine-indoles 103a–f.

1.7.3 Cascade reactions of indigo with allylic and propargylic halides
As part of an ongoing project focused on the discovery of new cascade chemistry of
indigo, our research group have previously reported on the cascade reactions of indigo
with substituted allylic and propargylic halides, producing a diverse array of product
heterocycles. Electrophiles with π-systems such as substituted acyl, allyl and propargyl
moieties insert additional electron density to the indigo core, and the high reactivity of
such systems may influence subsequent transformations. In the case of the allylation of
indigo, tautomerisation of the indigo core triggers a variety of tandem cyclisationisomerisation processes, which furnish a number of structurally complex, highlyfunctionalised 2,2-biindoles and spiro-bonded moieties.[115] A selection of isolated
products from this series of allylation reactions is illustrated in Scheme 30.
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Scheme 30: Cascade reactions of indigo with allyl bromide. a) the anticipated reaction to give Nallylindigo 108 b) major isolated products 109–111 c) scaffolds accessible from substituted allylic
electrophiles. Stereoindicators depict relative stereochemistry.

The structural complexity of the above scaffolds demonstrates both the novelty and the
complexity of the cascade reactions that indigo undergoes. It was noted that in short (5 s)
reactions that the mono-allylated product 108 predominated (83%), however this quickly
undergoes further alkylation, and subsequent cyclisation to give 109 as the major product
(41%) after 1 h. Increasing the reaction time to 3 h allowed for the isolation of 110 as the
major product (72%), in addition to 111 in 15% yield. Significant control over the product
type could also be achieved by moderating the steric environment of the inserted πsystem, leading to substrate-dependent control over the cascade process. For example, the
use of terminal 1,1-dimethyl and phenyl substituents was found to hinder the formation
of analogues of 110, instead affording products 111 and 112 in 26% and 16% yields,
respectively.
The complexity of the mechanisms involved in these cascade processes is demonstrated
further by examining the outcomes of the reaction of indigo with propargyl bromide. Over
a short reaction time (5 min), indigo can be seen to have undergone a number of dramatic
transformations, producing heterocycles featuring allenic and ring-expanded scaffolds as
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part of a complex mixture (Scheme 31).[116] Most notably, the enhanced reactivity of the
propargyl substrate promotes rapid, cascading nucleophilic processes from Npropargylindigo (114), such that the cascade reaction proceeds to over 80% completion
within five minutes.

Scheme 31: The reaction of propargyl bromide with indigo results in the rapid formation of a
variety of polycyclic derivatives.

In developing an understanding of the unorthodox transformations that indigo undergoes,
mechanistic considerations are of considerable importance. Several mechanistic branches
diverge from N-propargylindigo 114, most simply where it undergoes a base-mediated 6exo-dig hydroamination to afford 115, which could also be accomplished in 98% yield
by stirring 114 with Cs2CO3 in DMF for 5 min. Compound 116 is generated from an
intermediate enol ether, which undergoes a Claisen rearrangement to generate the allene.
The core heterocycles of compounds 117 and 118 are the product of three propargyl units,
where nucleophilic addition to the indigo carbonyl results in a strain-driven ringexpansion from cyclic allene 119, and simultaneous addition of a nearby electrophile –
either H+ or CO2 for 117 and 118, respectively. Further proton abstraction and Oalkylation generates the ring-expanded products (Scheme 32).
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Scheme 32: Abbreviated mechanism for the formation of compound 117 from indigo via cyclic
allene zwitterion 119.

This propargylation reaction was observed to be affected significantly by the nature of
the leaving group, where replacing the bromide with a mesylate instead led exclusively
to allene 116 and naphthyridinone 117 in 28% and 59% yield, respectively. The
mechanistic pathway could also be controlled by the addition of a terminal methyl
substituent, which led to the formation of acyclic compound 120 and ring-expanded
product 121. Surprisingly, using 3-chloro-1-phenyl-1-propyne as the electrophile resulted
in products 122 and 123, which bear little resemblance to any of the molecules accessible
from propargyl bromide. Regarding compound 123, exhaustive NMR studies and HRESI mass spectral analyses have allowed the assignment of a tentative structure, however
the observation of atypically-strong, apparent five-bond correlations in the HMBC
spectrum from the H9-C1ꞌ would suggest this structure to be incorrect, and its precise
structure is as-yet unconfirmed. Furthermore, no logical mechanism has been proposed
which would account for the formation of 123 under these conditions. The use of
bromoacetonitrile as an electrophile also led mostly to polymerisation over longer
reaction times, though the mono-alkylated derivative 124 could be isolated over very
short (5 s) reaction times (Scheme 33).[116b] It is apparent that the nature of both the
leaving group and the terminal substituent (i.e. the substituent’s steric, and electronic
characteristics) have a considerable impact on the accessible mechanistic pathways of the
reaction, though the full extent of these impacts have not been fully-established.
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Scheme 33: Reactions of 1-bromo-2-butyne, 3-chloro-1-phenyl-1-propyne, and bromoacetonitrile
with indigo to give compounds 120–124. The exact structure of 123 is in doubt, due to apparent
HMBC correlations from H9 to C1ꞌ through five bonds.

In summary, while there has been significant development to date of the use of cascade
reactions of indigo for the synthesis of new, bioactive heterocycles, there are significant
areas requiring further investigation. Our current diversity-oriented approach has allowed
for the exploration of a window of chemical space, however this has been limited by the
exclusive use of allylic and propargylic systems to date. Due to both the degree of
unsaturation and the trigonal-planar or linear geometry of the incoming electrophile, the
products from these reactions are largely two-dimensional in shape, and in the limited
examples where stereogenic atoms are generated in the products – e.g. spirocycles 110
and 111 – these molecules have only been synthesised racemically. In developing a more
thorough understanding of these cascade processes, it would be advantageous to probe
the use of new electrophilic species with greater three-dimensionality, to determine
whether the chirality of the products can be controlled by the stereochemistry of the
electrophile. In the process of developing more “drug-like” architectures, it could also be
advantageous to insert additional H-bonding sites to improve aqueous solubility, hence
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sp3-rich electrophiles containing heteroatoms would seem ideal.
A broad array of chemical transformations of indigo were reported in the early 20 th
century, however these predate many modern characterisation techniques, and in several
instances, have been reported to be unreliable, or the products have been the subject of
many years of repeated structural revision. While previous studies within our group have
demonstrated indigo’s nucleophilicity to be a starting point for cascade reactions, there
are only a handful of modern reports on indigo’s electrophilic potential, and none have
utilised this as a platform for the construction of new, biologically-active molecules.

1.8

Project aims

Therefore, the aims of this project are:
•

To further develop the chemistry of indigo with substituted propargylic halides

(Chapter 2),
•

To develop new nucleophilic cascade chemistry of indigo with multifunctional

electrophiles (Chapter 3),
•

To re-investigate the electrophilic chemistry of indigo with substituted

nucleophiles (Chapter 4), and
•

To establish the biological profile of derived species, toward the generation of

new, bioactive heterocycles (Chapter 5).
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Chapter 2:
Reactions of indigo with propargylic electrophiles
2.1

Propargylic systems in organic synthesis

2.1.1 Synthesis and properties of propargylic systems
Investigation of the synthesis and reactivity of propargylic systems has been one avenue
of significant interest within the synthetic chemistry community, due to their ease of
incorporation, robustness under many conditions, and unique reactivity under metalcatalysed conditions. Since the development and widespread appreciation of coppercatalysed azide-alkyne (“Click”) cycloaddition chemistry in the early 2000s,[117] there has
been a considerable increase in interest for propargyl units as functional handles for
synthetic manipulation. A Scifinder scholar search reveals significant growth in the field
of propargylic chemistry since the mid-1970s, as represented by an upward trend in the
number of publications concerning propargylic systems over time (Figure 7).

Number of publications reporting propargylic systems
in modern synthetic literature from 1976-2018
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Figure 7: The growth of propargylic systems in synthetic chemistry over time. Data collected
from Scifinder Scholar data.

In most instances, the propargyl unit is appended to the desired scaffold by nucleophilic
substitution of propargyl bromide onto an amine, alcohol or thiol nucleophile, or by using
alkyne synthetic strategies including elimination of haloalkenes or 1,2-dihaloalkanes
(easily accessed by halogenation of olefins), and a broad variety of alkyne-substituted
systems may be accessed in excellent yields from Sonogashira cross-coupling reactions
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between terminal alkynes and aryl halides under dual Pd0/CuI catalysis. Other methods
include Seyferth-Gilbert homologation of ketones, nucleophilic addition of metalated
acetylenes (e.g. ethynylmagnesium bromide) to aldehydes and ketones, or to alkyl halides
by transmetalation with CuI to produce the corresponding Gilman reagent, which
participate readily in SN2 displacement reactions (Scheme 34).[118]

Scheme 34: Common methods for the synthesis of alkynes: Path A: elimination of dihaloalkanes
and haloalkenes, Path B: Sonogashira coupling, Path C: Seyferth-Gilbert homologation, and
Path D: addition of metallated acetylenes to electrophiles.

2.1.2 Reactions of propargylic systems
Much of the reactivity of propargylic systems may be attributed to the Lewis basicity of
the alkyne moiety,[119] and owing to the growing popularity of propargyl units in organic
synthesis, their reactivity has been the subject of several reviews.[120] Briefly, in the
presence of soft Lewis acids, e.g. AgI, AuI, PdII and RhII among others, the alkyne πsystem can undergo reversible coordination, rendering the alkyne electrophilic – this
mode of catalysis is common, though Pd and Au catalysts are of particular note due to
their applicability toward carbon-carbon π-bond activation. In considering the reactivity
of alkynes with various nucleophiles under Lewis acid catalysis (Scheme 35), the degree
of back-bonding character that the metal possesses determines whether the Lewis pair
acts primarily as a metal-stabilised carbocation (125) or a metallocarbene (126).
Nucleophilic addition to carbocation 125 affords the metalated adduct 127, which
undergoes protodemetalation to give the substituted product 128. Where the incoming
nucleophile is a water molecule, the enol 128 typically tautomerises to afford a ketone –
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for this reason alkyne hydration is both a robust methodology for ketone synthesis at low
catalyst loading, and a common side-product from reactions not performed under
anhydrous conditions.[121]

Scheme 35: Activation of alkynes toward nucleophilic addition under Lewis acid catalysis.

Intercepting this pathway is possible using various alkyne-tethered nucleophiles, leading
to intramolecular cyclisation and rearrangement to afford functionalised cyclic systems.
One such example involves the intramolecular cyclisation of N-propargylamidines to
substituted imidazoles under AuI catalysis (Scheme 36).[122] The reaction proceeds via
Lewis acid activation of the pendant alkyne, which undergoes nucleophilic attack from
the nearby nitrogen nucleophile. A [1,3]-hydride shift leads to aromatisation of the
imidazolium ion, which affords the trisubstituted imidazole upon protodeauration.

Scheme 36: Gold-catalysed cyclisation of N-propargylamidines to substituted imidazoles.
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In similar fashion, this pathway can be intercepted by intermolecular addition to the
alkyne upon Lewis acid activation. One elegant example of this is in the gold-catalysed
addition of aliphatic alkynes or ynamides to anthranils by the Hashmi group, where N,Ofission of the anthranil-adduct affords a gold vinylidene ion, which undergoes
regioselective Friedel-Crafts addition to the adjacent phenyl group, affording 2substituted-7-acylindoles (129) in good yields and with high selectivity.[123] Interestingly,
using propargylic silyl ethers under analogous conditions instead led exclusively to the
formation of 3-acylquinolines (130) by rapid protodeauration and subsequent Mukaiyama
aldol condensation due to the high nucleophilicity of the silyl enol ether pendant (Scheme
37).[124]

Scheme 37: Intermolecular cyclisation of anthranils with nonsymmetrical alkynes to give
divergent access to either 7-acylindoles (129) or 3-acylquinolines (130) under AuI-catalysis.

As could be expected from their high degree of unsaturation, alkynes readily participate
in cycloaddition reactions with various coupling partners. One example which has
achieved widespread acclaim and practical use is the Cu-catalysed “Click” cycloaddition
of alkynes and azides to afford 4-substituted 1,2,3-triazoles. Key intermediates in this
mechanism

have

been

observed

spectroscopically,

computationally

and
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crystallographically, and as such it is known that the reaction mechanism proceeds via
formation of a dinuclear copper acetylide,[125] with the second CuI-ion acting to both
chelate the incoming azide to the alkyne, and to activate the alkyne to nucleophilic attack
(Scheme 38). Elimination of a copper ion forms the triazole heterocycle and subsequent
protolysis of the organocuprate leads to elimination of the product, and propagation of
the catalytic cycle.[126]

Scheme 38: Catalytic cycle for the copper-catalysed azide-alkyne "Click" cycloaddition reaction,
and several key intermediates observed by crystallography.
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2.2

Cascade reactions of propargylic systems with indigo

2.2.1 Limitations of previously-explored chemistry
From the established chemistry of indigo in reactions with propargylic halides, it is
apparent that the nature of the leaving group has a significant effect on the reaction
pathway, evidenced by the observation that exchanging the bromide leaving group for a
mesylate led exclusively to products 116 and 117 in a combined 87% yield,[116b] while the
corresponding chloride led instead to compounds 114 and 115 in combined 82% yield
(Scheme 39).[127]

Scheme 39: The reaction of indigo with propargyl mesylate led exclusively to compounds 116
and 117 in high yield, while propargyl chloride instead gave 114 and 115 in high yield.
44

Our current working hypothesis is therefore that with weaker leaving groups, spontaneous
N,Nꞌ-cyclisation occurs prior to a second N-alkylation, producing higher yields of 115 and
related structures, while stronger leaving groups lead to more rapid Nꞌ-alkylation, which
serves as the starting point for subsequent cascade reactions toward the more-complex
heterocycles 116 and 117. As a result, it is unknown whether the divergence in outcomes
from those reported for the reaction of the methyl-substituted 1-bromo-2-butyne and the
phenyl-substituted 3-chloro-1-phenyl-1-propyne are a result of the increased steric effect
of the phenyl group, the conjugation of the phenyl group, the weaker chloride leaving
group, or a combination of all three factors (Scheme 40). The primary reason for using
the (chloro)-phenylpropargyl electrophile in previous studies was its commercial
availability, and it is unknown whether the corresponding bromide would show similar
or disparate reactivity with indigo. Similarly, if the conjugation of the phenyl group has
a significant effect on the outcome of the reaction, it should be possible to tune this
reactivity by utilising electron-donating or -withdrawing groups. This effect has not yet
been adequately examined, and is the subject of this chapter.

Scheme 40: Differing reactivity of the methyl- and phenyl-substituted propargyl electrophiles,
and proposed methodology for determining the cause of this disparate reactivity.
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2.3

Cascade reactions of (aryl)propargyl electrophiles with indigo

2.3.1 Synthesis of starting materials
The synthesis of the required aryl-substituted propargyl electrophiles was accomplished
on multi-gram scale by a two-step sequence, involving Sonogashira coupling of propargyl
alcohol with an aryl iodide to afford an intermediate (aryl)propargyl alcohol, which was
brominated under Appel conditions using PPh3/Br2. The Pd(PPh3)2Cl2 catalyst utilised for
the Sonogashira coupling was prepared on multigram-scale by ligation of PPh3 to (PdCl2)n
in benzonitrile following a previously-reported procedure;[128] the mixture was heated to
reflux under an N2 atmosphere with vigorous stirring for 20 min, then allowed to cool to
room temperature overnight and the collected solids triturated with ether to furnish the
desired bis-phosphine complex as small, bright yellow crystals in 95% yield. Initially, the
cross-coupling reaction between 4-iodoanisole and propargyl alcohol was run at reflux
for 3.5 h in neat diethylamine using Pd(PPh3)2Cl2 (3 mol%) and CuBr (10 mol%),[119h]
which upon workup and flash chromatography afforded the desired p-methoxyphenyl
adduct 131a in 62% yield. Optimal conditions were found using propargyl alcohol (5.0
eq.) and NEt3 (7.0 eq.) in a 1:1 toluene:MeCN (v/v) mixed solvent, with CuI (10 mol%)
and Pd(PPh3)2Cl2 (2 mol%) at room temperature for 2 days, which afforded 131a in 99%
yield. This reaction proved amenable to the synthesis of various functionalised arylated
substrates, affording the corresponding alcohols 131b–d on gram-scale in high yield
(Scheme 41).

Scheme 41: Optimised conditions for the Sonogashira coupling of aryl iodides with propargyl
alcohol to yield the substituted propargyl alcohols 131a–d.

Analysis of the HRESI mass spectrum of 131a revealed a peak at 163.0760, assigned to
the molecular ion [C10H11O2]+, revealing the substitution of the iodide handle for the
propargylic alcohol. Analysis of the 1H NMR spectrum revealed a pair of 2H doublets at
δ 7.37 and δ 6.84, assigned to the alkyne-adjacent H2ꞌ/H6ꞌ and methoxy-adjacent H3ꞌ/H5ꞌ
respectively of the para-disubstituted phenyl group. Further upfield, the 2H apparent
singlet at δ 4.48 was assigned to the H1 methylene protons of the propargyl fragment,
which coupled to a broad singlet resonance at δ 1.68 in COSY experiments, which was
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assigned to the free hydroxyl proton. The remaining 3H singlet at δ 3.81 was assigned to
the para-methoxy group of the aryl substituent. Analysis of the

13

C NMR spectrum

revealed a downfield quaternary resonance at δ 159.8 and an upfield quaternary resonance
at δ 114.7, which were assigned to C4ꞌ and C1ꞌ of the aryl substituent, while the remaining
two aromatic-range resonances at δ 133.2 and δ 114.0 were assigned to C2ꞌ/C6ꞌ and
C3ꞌ/C5ꞌ, respectively. A pair of adjacent quaternary resonances appeared at δ 85.6 and δ
85.9, which were assigned to the alkyne carbons C2 and C3, respectively, and the
remaining resonances at δ 55.3 and δ 51.7 were assigned to the methoxy and methylene
carbons, respectively.
Subjecting alcohols 131a–c to a mixture of PPh3/Br2 afforded the desired alkyl bromides
132a–c in excellent yield. Briefly, to a cooled (0 ˚C) solution of PPh3 (1.1 eq.) in dry
CH2Cl2 was added dropwise neat Br2 (1.1 eq.), and the resulting bright yellow suspension
warmed to room temperature over 1 h. To this was added slowly dropwise a solution of
the selected propargyl alcohol (1.0 eq.) in CH2Cl2, and the mixture stirred at room
temperature for 1 h. The resulting triphenylphosphine oxide was precipitated by adding
hexanes, then either subjected to repeated recrystallisation from hexane (131a) or
subjected to column chromatography (131b–c) to afford the corresponding alkyl
bromides 132a–c in excellent yield (Scheme 42).

Scheme 42: Conversion of alcohols 131a–c to alkyl bromides 132a–c by reacting with PPh3/Br2.

The methoxy-substituted (phenyl)propargyl bromide 132a was isolated in 99% yield,
following repeated recrystallisation from hexane. Analysis of the EI(+) mass spectrum
revealed peaks at 224+ and 226+ in a 1:1 ratio in 8% relative abundance, assigned to the
isotopic pair of [C10H10O79Br]+ and [C10H10O81Br]+ ions, and a base peak at 145+,
corresponding to the [M-Br•]+ fragment, demonstrating the substitution of the hydroxyl
group for the alkyl bromide. Analysis of the 1H NMR spectrum revealed a 2H singlet
resonance at δ 4.17, assigned to the bromine-adjacent methylene protons H1a/b, and a 3H
singlet resonance at δ 3.81, assigned to the methoxy protons of the aryl substituent.
Analysis of the 13C NMR spectrum revealed a highly-shielded resonance at δ 15.9, and a
pair of quaternary resonances at δ 83.0 and δ 87.0, which were assigned to C1, C3 and
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C2 of the propargylic moiety, respectively. Further downfield, the resonances at δ 133.6
and δ 114.1 were assigned to C2ꞌ/C6ꞌ and C3ꞌ/C5ꞌ of the 4-methoxyphenyl substituent,
and the remaining resonances at δ 160.1, δ 114.3, and δ 55.5 assigned to C4ꞌ, C1ꞌ, and the
methoxy carbon, respectively.
Under optimised conditions, this reaction proved reliable and consistently afforded the
desired bromides in 90-99% yield, though it proved sensitive to the rate of alcohol
addition, as evidenced by diminished yields and the formation of complex mixtures with
faster addition rates to the PPh3.Br2 complex generated in situ. The methoxy-substituted
bromide 132a also proved unstable toward silica gel chromatography, though the phenyl(132b) and 4-nitrophenyl-substituted (132c) propargyl bromides could be easily purified
by flash chromatography.
2.3.2 Reactions with indigo
As a direct analogue to the previously-explored (phenyl)propargyl chloride, we examined
the reaction between (phenyl)propargyl bromide 132b with indigo under identical
conditions to those used previously.[116b] Therefore, a sonicated suspension of indigo (1.0
mmol) in anhydrous DMF (40 mL) was transferred by cannula into a round-bottomed
flask containing anhydrous cesium carbonate (3.7 mmol) and 4 Å molecular sieves under
a N2 atmosphere, and the mixture warmed in an oil bath pre-heated to strictly 85-87 ˚C
for 1 h with vigorous stirring.* The N2 flow was cut, then a solution of 132b (5.0 mmol)
in DMF (2 mL) injected through the septum, and the resulting mixture stirred for 30 min.
Following aqueous workup, the crude mixture was fractionated on silica, then the
individual fractions subjected to flash chromatography, affording the ring-expanded
indolobenzonapthyridinone 133 in 35% yield, as well as the known compounds
azepinodiindole 122 in 37% yield, and diindolooxadiazepine 123 in 12% yield (Scheme
43).

*

These conditions were optimised previously by Dr. Alireza Shakoori for reactions of indigo with
propargylic halides, and were used without modification to allow comparison between systems. The
rationale behind this strict temperature control is that in general, the poor solubility of indigo in DMF
means that at lower temperatures (e.g. 70 ˚C), more unreacted starting materials are recovered, and the
slower rate of reaction leads to increased proportions of isatins and other byproducts from oxidation
and/or hydrolysis.
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Scheme 43: Reaction of (phenyl)propargyl bromide 132b with indigo, to afford the known
products azepinodiindole 122, oxadiazepinodiindole 123, and the ring-expanded
indolobenzonaphthyridinone 133. Adjacent to the structure is a photograph of a single crystal of
133 grown from CH2Cl2/hexane, visualised under a light microscope at 40× magnification.

The ring-expanded indolobenzonaphthyridinone 133 was isolated as deep red crystals in
35% yield from indigo following fractionation on silica and flash chromatography using
10% EtOAc/hexane as eluent. Analysis of the HRESI mass spectrum revealed a peak at
m/z 491.1762, assigned to the molecular ion [C34H23N2O2]+, revealing the addition of two
(phenyl)propargyl units to the indigo core, while its characteristic deep red colour
qualitatively suggested through-conjugation to have been interrupted in the molecule.
Analysis of the 1H NMR spectrum revealed a pair of doublets at δ 5.18 and δ 4.91, which
were assigned to the methylene protons of the N-phenylpropargyl pendant, made
chemically-distinct by restricted rotation about the N13-C1ꞌ axis, as was observed in the
1

H spectrum for the methyl analogue 121.[116b] This assignment was supported by analysis

of the HSQC spectrum, which showed direct attachment of both doublets to a resonance
at δ 44.9, assigned as C1ꞌ (Figure 8). The distinctive enamine protons H6 and H7 were
assigned to a pair of doublets at δ 6.83 and δ 5.51, respectively, evidenced by COSY
correlations to one-another, and the presence of a strong three-bond HMBC correlation
between H6 and the quaternary 13C resonance at δ 57.2, assigned to the stereogenic carbon
atom C7a (Figure 9, Figure 10). Analysis of the

13

C NMR spectrum revealed a pair of

carbonyl resonances at δ 191.6 and δ 178.9, assigned to the C8 and C14 ketone groups,
respectively. Analysis of the HMBC spectrum revealed a strong correlation between C14
and a 1H resonance at δ 7.77, assigned as H1, while C8 coupled strongly to a resonance
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at δ 8.01, and coupled weakly to a resonance at δ 7.08, assigned as three-bond and fourbond correlations to the nearby H9 and H10, respectively. The C8 ketone group was
additionally correlated to the adjacent enamine H7 through three bonds, confirming the
insertion of the propargyl moiety between the indolic C2/C3 bond of the indigo precursor.

Figure 8: HSQC spectrum for compound 133, with key correlations highlighted.

Figure 9: COSY spectrum for compound 133 with key correlations highlighted.
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Figure 10: HMBC spectrum for compound 133, with key correlations highlighted.

X-ray quality crystals of compound 133 were grown from slow evaporation of a
hexane/CH2Cl2 solution, and its structure was unequivocally confirmed by x-ray
crystallography (Figure 11).†

Figure 11: ORTEP depiction of compound 133. Note that the atom numbers as denoted by x-ray
crystallography do not reflect systematic numbering of atom positions.

†

X-ray crystallography performed by Dr. Anthony Willis (ANU).
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The formation of 133 by nucleophilic ring-expansion was unexpected for several reasons.
Firstly, it was hypothesised that the relatively-large steric presence of the terminal phenyl
substituent would hinder nucleophilic attack of the alkyne π-system to the indigo
carbonyl. Furthermore, there was no evidence for the formation this compound in the
previous reaction of 3-chloro-1-phenyl-1-propyne,[116b] with repeated attempts of this
reaction giving similar isolated yields of compounds 122 (24%) and 123 (35%) to those
reported with no 133 present. Using the bromide leaving group however, phenylsubstituted 133 was isolated in higher yield (35%) than that reported for the methylsubstituted 121 (31%), suggesting the steric effect of this substituent to be negligible. It
is therefore the case that the nature of the leaving group has a significant impact on
product distribution in reactions with indigo with terminally-substituted propargylic
electrophiles.
To determine whether increasing the electron density of the ring system would increase
the nucleophilicity of the alkyne system and lead to higher yields of ring-expanded
products like 121 and 133, we examined the reaction of indigo with 3-(4methoxyphenyl)propargyl bromide 132a under identical conditions to those for 132b.
Therefore, a sonicated suspension of indigo (1.0 mmol) in dry DMF (40 mL) was
transferred by cannula to a round-bottomed flask containing anhydrous cesium carbonate
(3.7 mmol) and 4 Å molecular sieves, and the mixture warmed in an oil bath pre-heated
to strictly 85-87 ˚C for 1 h with vigorous stirring.‡ The N2 flow was cut, then a solution
of 132a (5.0 mmol) in DMF (2 mL) injected through the septum, and the resulting mixture
stirred for 30 min. Following aqueous workup, fractionation on silica and flash
chromatography afforded the 4-methoxyphenyl-substituted ring-expanded product 134 in
21% yield as part of a complex mixture of polymers, baseline materials, and other
decomposition products (Scheme 44).

‡

These conditions were optimised previously by Dr. Alireza Shakoori for reactions of indigo with
propargylic halides, and were used without modification to allow comparison between systems.
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Scheme 44: Reaction of (4-methoxyphenyl)propargyl bromide 132a with indigo, to afford the
ring-expanded indolobenzonaphthyridinone 134. Adjacent to the structure is a photograph of a
single crystal of 134 grown from CH2Cl2/hexane, visualised under a light microscope at 40×
magnification.

The methoxy-substituted indolobenzonaphthyridinone 134 was isolated as small reddishpink crystals following repeated chromatographic separation. Analysis of the HRESI
mass spectrum revealed a peak at m/z 551.1959, assigned to the molecular ion
[C36H27N2O4]+, revealing the addition of two units of the (aryl)propargyl electrophile to
the indigo core. Analysis of the 1H NMR spectrum revealed a pair of 3H singlet
resonances at δ 3.51 and δ 3.76, assigned to the two para-methoxy groups attached to the
unconjugated Ar1 and conjugated Ar2 substituents respectively. The pair of doublets at δ
5.14 and δ 4.87 were assigned to the methylene protons of the N-propargyl substituent
due to hindered rotation about the N-C linkage, which were correlated to each other by
both HSQC and COSY experiments (Figure 12, Figure 13). Further downfield, a pair of
doublets at δ 5.49 and δ 6.82 were correlated to each other by COSY experiments, and
assigned to the enamine protons H7 and H6, respectively. HMBC analysis revealed that
both H6 and a 2H proton resonance at δ 7.18 assigned as H2/H6 of Ar1 showed a strong
correlation to a weak quaternary 13C resonance at δ 56.4, assigned to the quaternary centre
C7a, originally from the alkyne aryl-terminus (Figure 14). The H1ꞌa/b methylene protons
showed additional HMBC correlations to a pair of quaternary carbons at δ 81.5 and δ
85.8, which were assigned to C2ꞌ and C3ꞌ of the propargylic pendant.
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Figure 12: HSQC spectrum for compound 134 with key correlations highlighted.

Figure 13: COSY spectrum for compound 134 with key correlations highlighted.
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Figure 14: HMBC spectrum for compound 134 with key correlations highlighted.

X-ray quality crystals of compound 134 were grown by slow evaporation of a
CH2Cl2/hexane solution, and its structure confirmed by x-ray crystallography (Figure
15).§

Figure 15: ORTEP depiction of compound 134. Note that the atom numbers as denoted by x-ray
crystallography do not reflect systematic numbering of atom positions.

§

X-ray crystallography performed by Dr. Anthony Willis (ANU).
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Interestingly, an additional product (135) arising from hydrobromination of the alkyne
was also observed within the crystal matrix, though this was not observed within the crude
mixture (Figure 16).** The incorporation of the bromide into the final molecule could be
a consequence of the preceding step in its synthesis, whereby one of two pathways may
lead to undesired hydrobromination. The generation of HBr from the reaction of PPh3.Br2
with alcohols occurs rapidly and in stoichiometric quantities, hence it is possible that the
electron-rich propargyl bromide 132a may undergo Markovnikov-addition of HBr to give
bromostyrene 136, promoted by the para-methoxy substituent. Alternatively, an ethereal
Br• radical from the decomposition of trace Br2 in the product could result in mixtures of
132a and 136. This bromostyrene could also act as a competent electrophile, undergoing
N-alkylation in situ to form 135 (Scheme 45), however the exact nature of the formation
of 135 is unknown as it was isolated in trace quantities in a single run, and only observed
crystallographically. Furthermore, the proposed bromostyrene 136 was not observed
spectroscopically in any samples of 132a, hence it is not apparent if it may have been
formed in situ in trace quantities, or indeed whether it is involved in the formation of 135
at all.

Scheme 45: Possible origin of 136 from hydrohalogenation of 132a with residual bromine en
route toward adduct 135.

**

X-ray crystallography performed by Dr. Anthony Willis (ANU).
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Figure 16: ORTEP depiction of compound 135. Note that the atom numbers as denoted by x-ray
crystallography do not reflect systematic numbering of atom positions.

Given the formation of both the phenyl (133) and 4-methoxyphenyl (134) substituted
indolobenzonaphthyridinones from electron-rich substituted (aryl)propargyl bromides, it
was of interest to probe the use of electron-poor aryl systems in these reactions. In a
tandem study performed by a fellow PhD student,[127] indigo was reacted with (4nitrophenyl)propargyl bromide (132c) under numerous sets of conditions, however these
overwhelmingly led to decomposition and/or extensive polymerisation of the reaction
mixture into uncharacterizable baseline materials, and in a control experiment, 132c was
treated with cesium carbonate in DMF, and was observed to undergo rapid
autopolymerisation within minutes.[127] It is likely that the strongly electron-withdrawing
nature of the nitro group led to an increase in the acidity of the methylene H1 protons,
forming the resonance-stabilised carbanion 137 in the presence of the weak carbonate
base. Elimination of the pendant bromide could then generate a highly-reactive
propargylic carbene (138), which would then be susceptible to decomposition (Scheme
46). Given the rapid nature of this decomposition, electron-poor (aryl)propargyl
electrophiles such as 132c are unsuitable for application to this methodology.
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Scheme 46: Proposed mechanism for the decomposition of (4-nitrophenyl)propargyl bromide
with weak base via carbanion 137, and carbene 138 generated by stepwise deprotonation and
halide elimination.

2.3.3 Mechanistic discussion
For both the phenyl- and 4-methoxyphenyl-substituted compounds 133 and 134, the
reaction mechanism is likely analogous to that for the formation of the methyl-substituted
123 reported previously (Scheme 47), which overlaps with the proposed mechanism for
ring-expansion with unsubstituted propargyl halides (See Chapter 1, Scheme 32).[116b]
Briefly, N,Nꞌ-dialkylation of indigo affords 139, which in the presence of amphiprotic
bicarbonate ions in solution may be protonated to give N-alkyliminium ion 140. With
stronger leaving groups (i.e. with R-Br, rather than R-Cl), this second alkylation would
prove more favourable, accounting for the observed disparate reactivity of the
phenylpropargyl chloride and bromides. Deprotonation by excess carbonate base may
then afford ylid 141, rendering the alkyne nucleophilic. Nucleophilic addition of the ylid
to the adjacent carbonyl could then afford key intermediate 142, which features a strained
seven-membered ring with an internal allene, for which relief of the ring-strain energy
would allow significant driving force for ring-expansion.[129] Reformation of the ketone
could then promote simultaneous 1,2-migration of the indole C2 to attack the allene
terminus and protonation of C7 to give the iminium ion 143, which is deprotonated to
give the isolated compounds 123, 133, and 134. Where the terminal R-group is a proton,
the reaction would then continue via enolization of the α,β-unsaturated system and Oalkylation to afford 117, however this pathway does not proceed for substituted propargyl
substrates as this abstraction step would require the unfavourable fragmentation of the
C7a quaternary centre by loss of cationic alkyl or aryl fragments.
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Scheme 47: Proposed mechanism for the formation of compounds 123, 133, and 134 from the
reaction of indigo with terminally-substituted propargylic halides.

2.4

Conclusions

Indigo undergoes cascade reactions with terminally-substituted propargyl bromides to
afford deep-red crystalline indolobenzonaphthyridinones in modest yields. It was found
that the nature of the bromide leaving group was necessary for ring-expansion,
presumably due to the faster rate of N,Nꞌ-dialkylation with stronger leaving groups. This
would allow for tuneable and predictable access to the desired heterocycles, with the
reaction pathway dictated by the leaving group. Throughout the course of this brief study,
the electron-rich phenyl and 4-methoxyphenyl substituents were found to be tolerated for
the reaction, however the 4-nitrophenyl equivalent proved unstable toward the reaction
conditions and the desired product was not isolated.
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Chapter 3:
Reactions of indigo with ring-strained electrophiles
3.1

The role of ring-strained electrophiles in organic synthesis

3.1.1 Synthesis and properties of ring-strained electrophiles
In both linear and cyclic sp3-hybridised systems, VSEPR theory dictates that covalentlybonded atoms typically adopt a tetrahedral geometry, where four substituents are
separated by an average bond angle of 109.5˚, minimizing steric and electronic
interactions between atoms.[130] While this general approach has been criticised in the
physical chemistry community for its oversimplification,[131] it remains the most widelytaught model for predicting structural features of simple organic molecules. In small or
large ring systems where bond angles deviate from these ideal geometries, ring-strain is
introduced due to unfavourable steric and/or electronic clashes between adjacent atoms.
This ring-strain energy can provide significant driving force toward ring-opening
reactions, and is one primary factor responsible for the high reactivity of three- and fourmembered ring systems with both nucleophiles and Lewis acids.[132] The synthetic utility
of substituted oxiranes, aziridines, thiiranes and cyclopropanes has been well-established,
and these are widely-utilised in the synthesis of functional materials.[133] In particular,
oxiranes and aziridines have found widespread use in the pharmaceutical and
agrochemical industries as synthetic building blocks, and in the polymer industry as
precursors in the production of plastics, resins, and adhesives.
Owing to their widespread use and high global demand, there are a broad variety of
methods for the synthesis of oxiranes and aziridines from simple chemical feedstocks
(Scheme 48). In general, many of these can be classified into one of two approaches –
either nucleophilic ring-closing of amines or alcohols by displacement of an α(pseudo)halide, or direct oxidation of alkenes to the strained system – though there are
several alternatives, e.g. Corey-Chaykovsky epoxidation of ketones or imines with sulfurylids, and ring-contraction of cyclic carbonates or carbamates. Olefin epoxidation has
been one avenue of particular interest due to the wide commercial availability and low
cost of many alkenes, as well as their facile accessibility from cross-metathesis and
Wittig- or Horner-Wadsworth-Emmons-type reactions. Classically, epoxidation reactions
involve the use of either inorganic or organic peroxides (e.g. H2O2/NaOH, TBHP), or
peroxy-acids (e.g. m-CPBA), though these systems typically suffer from limited
enantioselectivity. The development of asymmetric alkene oxidation methods by
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Sharpless was the subject of the 2001 Nobel prize for chemistry, and enantioselective
allylic epoxidation featured prominently among these – as a result of this and other
methods, a vast array of chiral oxiranes are now commercially-available, with many
gaining broad appreciation as ‘chiral pool’ precursors to sp3-rich frameworks.[134]
Methods for direct aziridination of alkenes are less-common and less-general in scope
than for epoxidation, though a variety of catalytic processes for asymmetric aziridination
are possible using N-haloamines or -sulfonamides, either in the presence or absence of an
external oxidant,[135] though there remain issues of stereoselectivity and generality. In
practice, chiral aziridines are most-commonly accessed via ring-closure reactions of αhalosulfonamides or -carbamates.

Scheme 48: Common methods used to synthesise oxiranes and aziridines: nucleophilic ringclosure, and direct oxidation of alkenes, as well as C-O or C-N insertion of sulfur ylids, and
decarboxylation of carbonates and carbamates.

3.1.2 Reactions of ring-strained electrophiles
The main synthetic application of these strained systems is their use as potent
electrophiles. The ring-strain energies of cyclopropane, oxirane, and aziridine have each
been experimentally determined as ca. 27 kcal/mol, making ring-opening a highlyfavourable process.[136] The high degree of polarisation of the C-O or C-N bond renders
both C2 and C3 electrophilic, allowing for alkylation with a broad variety of nucleophiles
(Scheme 49). Ring-opening also serves to extrude a nucleophilic heteroatom, which may
be used for subsequent derivatisation, though this may also lead to undesired
polymerisation.
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Scheme 49: Nucleophilic ring-opening of oxiranes and aziridines, leading to one of two
regioisomers, depending on the steric environment of the particular substrate.

Given the bifunctional reactivity of epoxides and aziridines toward both electrophiles and
nucleophiles, these would seem ideal moieties for designing new cascade reactions. As
aforementioned, polyepoxide cascade reactions feature prominently in the total synthesis
of various marine polyketides (see Chapter 1, Scheme 2),[137] and there are numerous
examples of strained-ring species undergoing tandem reactions upon ring-opening,
including Friedel-Crafts alkylation, oxa- and aza-Michael addition, hydroamination,
aminohalogenation, and heterocyclisation reactions.[119a, 138] Given their high reactivity,
synthetic accessibility, and applicability toward use in cascade reactions, strained-ring
systems represent ideal reactive moieties for the development of new cascade chemistry
of indigo.

3.2

Cascade reactions of ring-strained electrophiles with indigo

3.2.1 Substrate selection – 2-(halomethyl)oxiranes and aziridines
In establishing a fair comparison with the three-carbon allylic and propargylic
electrophiles previously studied, it was important to select a range of strained
electrophiles with similar chain length. For this reason, a series of chloromethyl- and
bromomethyl-substituted strained systems were proposed – of these, the chiral oxiranes
(S)-epichlorohydrin (144), (±)-epibromohydrin (145) and (R)-glycidyl tosylate (146)
were available from commercial sources, while the remaining substrates were synthesised
from simple materials. Additionally, while there have been previous studies into the
reactivity

of

(±)-N-tosyl-2-bromomethylaziridine

(147),[139]

the

related

chloromethylaziridine (148) had neither been reported previously, nor was there an
established protocol amenable to its enantioselective synthesis (Scheme 50).
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Scheme 50: Selected strained electrophiles for evaluation: (S)-epichlorohydrin (144),
epibromohydrin (145), (R)-glycidyl tosylate (146), 2-(bromomethyl)-N-tosylaziridine (147), and
R-2-(chloromethyl)-N-tosylaziridine (148).

As a broad class of molecules, these selected species are 1,2- or 1,3-dication synthons,
bearing a potentially-nucleophilic heteroatom at C2. We anticipated that these additional
electrophilic sites would facilitate twofold nucleophilic attack by indigo, allowing for
controllable N,Nꞌ-cyclisation, allowing either six- or seven-membered heterocycles to be
generated. Alternatively, liberation of the nucleophilic oxygen or nitrogen atom from the
strained ring could allow for nucleophilic addition to the indigo carbonyl or via Michael
addition to the central double bond, allowing access to spirocyclic derivatives. Assuming
the stereochemical integrity of the epoxide or aziridine could be retained under the
reaction conditions, these spirocycles could be accessed diastereoselectively as
influenced by the set chirality of the electrophile.
3.2.2 Substrate selection – 2,2ꞌ-bioxirane and 2,2ꞌ-biaziridine
Previous work within our group has focused on the generation of vicinal diamine libraries
for screening as ligands in atropselective cross-coupling reactions. For the generation of
C2-symmetric scaffolds, both 2,2ꞌ-bioxirane (149), and later 2,2ꞌ-biaziridine (150) have
been utilised as synthetic starting points for further elaboration after ring-opening.[140]
Accessible in enantiopure form over multiple steps from D- or L-tartaric acid,[140c, 141]
both enantiomers may be accessed in multigram quantities from the common acetonideprotected dimesylate 151 by stepwise substitution and deprotection reactions (Scheme
51).
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Scheme 51: Synthesis of 2,2ꞌ-bioxirane (149) and 2,2ꞌ-biaziridine (150) from common dimesylate
151. The penultimate steps were replicated here, and are described in the experimental section
(see Chapter 7).

Both dimeric species have been previously reported to undergo selective C1/C4 di-ringopening upon treatment with various nucleophiles.[140-141] Currently, this reactivity has
not been explored using di-nucleophiles, and as such it is unclear whether ring-opening
these bis-electrophiles with indigo would proceed via this known 1,4 pathway to produce
an eight-membered ring, or whether the formation of a more-favourable seven-membered
ring would instead promote sequential 1,3-cyclisation. Alternatively, the nucleophilicity
of the heteroatom may instead lead to spirocyclisation, allowing access to more complex
heterocyclic frameworks.

3.3

Cascade reactions of epihalohydrins with indigo

3.3.1 Reaction discovery and structure elucidation
In developing reaction conditions for this methodology, we sought to use the previouslyoptimised conditions described for the allylation and propargylation of indigo as an initial
basis.†† Therefore, a suspension of indigo (1 mmol) in DMF (40 mL) was sonicated for
30 min, then transferred to a round-bottomed flask containing pre-dried Cs2CO3 (3.7 eq.)
and 3 Å molecular sieves, and the mixture warmed in an oil bath preheated to strictly 8587 ˚C for 1 h under nitrogen. The N2 flow was cut, and (±)-epichlorohydrin (rac-144, 5.0
eq.) injected, and the mixture stirred vigorously for 2 h, after which TLC analysis showed
complete consumption of indigo. The deep purple reaction mixture was quenched over
crushed ice, and TLC analysis revealed a complex mixture of more than ten distinct
††

Attempts to lower the reaction temperature generally led to increased recovery of unreacted starting
materials, and raising the temperature increased polymerisation and isolation of baseline materials.
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individual components. Fractional crystallisation of the crude mixture from 60%
CH2Cl2/petroleum spirit, and subsequent flash chromatography on silica (gradient
elution, 5%-50% EtOAc/CH2Cl2) afforded the N,Nꞌ-cyclic product 152 (43%), as well as
spiroketal 153 (6%), cyclic carbonate 154 (6%), and allylic alcohol 155 (7%) in addition
to polymeric baseline materials comprising 46% of the dry weight of the crude residue
(Scheme 52).

Scheme 52: Products from the cascade reaction of indigo with (±)-epichlorohydrin after 2 h.
Stereoindicators show relative configuration of diastereomers.

Tetrahydropyrazinodiindole 152 was isolated as an intense dark blue powder in 43% yield
from indigo. Analysis of the HRESI mass spectrum indicated a peak at m/z 341.0888,
assigned as [C19H14N2O3Na]+, revealing the addition of a single glycidyl subunit to the
indigo core. The UV-Vis spectrum of 152 in CH2Cl2 had an intense absorption band at
303 nM (ε = 6339), and its intense deep blue-purple colour suggested that the central
double bond had remained intact. Analysis of the FTIR spectrum revealed a broad
absorption band centred at 3432 cm-1, suggesting the presence of a hydroxyl substituent.
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Analysis of the 13C APT spectrum indicated the retention of both carbonyls of the parent
scaffold, assigned to resonances at δ 179.9 and δ 179.7 ppm. Analysis of the 1H NMR
spectrum showed a broad singlet resonance at δ 5.28 which exchanged with D2O and was
assigned as the hydroxyl group. The aliphatic protons of the alkyl tether were assigned
by analysis of the COSY spectrum, which revealed correlations between the hydroxyl
proton and the 2H multiplet from δ 3.60-3.49, assigned as the methylene protons H1ꞌa
and H1ꞌb of the hydroxymethyl pendant. This methylene correlated to a multiplet at δ
4.72-4.65, assigned as H6, which correlated to both a doublet at δ 4.46, and a doublet of
doublets at δ 3.73, which were assigned as H7b and H7a, respectively (Figure 17).
Analysis of the NOESY spectrum revealed through-space correlation of H6 and H7b to
H4 and H9, respectively, while there was no apparent correlation between H9 and H7a,
supporting the assignment of the diastereotopic C7 methylene protons (Figure 18). The
gHMBC spectrum revealed strong, three-bond correlations between methylene H7b with
both C8a, and C13a, and the alkyl chain was therefore determined to bridge both indigo
nitrogen atoms (Figure 19).

Figure 17: COSY spectrum of compound 152, with key correlations highlighted.
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Figure 18: The NOESY spectrum of compound 152 with key correlations highlighted.

Figure 19: Partial HMBC spectrum of compound 152.
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The mother liquor from 152 was subjected to flash chromatography, resulting in the
isolation of a fraction with a characteristic yellow-green fluorescence in ambient
conditions, and upon irradiation with UV light. The spiroketal 153 was isolated from this
fraction as bright orange crystals in 6% yield from indigo. Analysis of the HRESI mass
spectrum revealed a peak at 341.0900, assigned as [C19H14N2O3Na]+, and revealing the
addition of a single glycidyl chain. Analysis of the FTIR spectrum revealed a sharp band
at 3310 cm-1, assigned to an indolic NH stretch, as well as a sharp peak at 1689 cm -1,
assigned as a benzylic ketone C=O stretch. Analysis of the 1H NMR spectrum revealed
the molecule to be non-symmetrical, due to the presence of eight distinct aromatic
resonances, assigned as the eight aromatic peaks of the parent indigo scaffold. Further
upfield, five distinct aliphatic protons were identified and assigned based on analysis of
the COSY and HSQC spectra (Figure 20) – a multiplet at δ 5.16-5.09 assigned to H7, a
geminal triplet at δ 4.38 and doublet of doublets at δ 4.25 assigned to the oxygen-bound
methylene protons H8b and H8a respectively, and a second geminal pair of a doublet of
doublets at δ 4.20 and a doublet at δ 3.74, assigned as the nitrogen-bound methylene
protons H6a and H6b respectively (Figure 21). The individual assignment of the two
methylenes was confirmed by analysis of the NOESY spectrum, which revealed throughspace coupling of H6a and H8a via the rigid spirocyclic tether, suggesting a syn
arrangement, and there was no evident correlation between H6a and H8b, suggesting
these to be anti. This assignment was further supported by correlations between H6b and
H8b, suggesting these to be syn. The bridgehead proton H7 also showed through-space
correlation to all other aliphatic protons of the chain (Figure 22). Analysis of the 13C NMR
spectrum revealed the retention of a single downfield carbonyl peak at 188.2 ppm,
assigned to the C15 ketone moiety. Analysis of the HMBC spectrum revealed correlations
between H8a, H8b and H7 to a weak quaternary resonance in the

13

C NMR spectrum

located at 111.5 ppm, assigned to the spiro carbon C9a (Figure 23).
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Figure 20: HSQC spectrum for compound 153.

Figure 21: COSY spectrum of compound 153 with key correlations highlighted.
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Figure 22: NOESY spectrum for compound 153 with key correlations highlighted.

Figure 23: HMBC spectrum for compound 153.
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In a subsequent experiment using (S)-epichlorohydrin, orthorhombic crystals of 153 were
obtained from slow evaporation of a solution in ethyl acetate, and its absolute structure
and stereochemistry was confirmed by x-ray crystallography (Figure 24).‡‡

Figure 24: ORTEP depiction of compound 153. Note that the atom numbers as denoted by x-ray
crystallography do not reflect systematic numbering of atom positions.

Further elution with 30% EtOAc/CH2Cl2 afforded a deep orange residue. Removal of the
solvent and recrystallisation from EtOAc gave the cyclic carbonate 154 as small,
luminescent orange crystals in 6% yield from indigo. HRESI mass spectral analysis
revealed a peak at m/z 441.1082, assigned to the molecular ion [C23H18N2O6Na]+,
showing the addition of two glycidyl subunits to the indigo core, as well as a molecule of
CO2. Analysis of the FTIR spectrum revealed two peaks at 1800 cm-1 and 1734 cm-1,
assigned as carbonate and ketone C=O stretches, respectively. Analysis of the 1H NMR
spectrum revealed ten aliphatic proton peaks, confirming the presence of two glycidyl
fragments. Analysis of the 13C NMR spectrum revealed a pair of carbonyl resonances at
δ 182.3 and δ 178.4, assigned to C15 and the carbonate C=O, respectively. Crossreferencing the COSY spectra for compounds 153 and 154, the spirocyclic N5-O9 linkage
was identified by correlating the multiplet at δ 5.00-4.94 to the doublet at δ 3.68, assigned
as H7 and H6b, respectively (Figure 25). H6b showed strong geminal coupling to part of
a broad multiplet resonance at δ 4.23-4.17, assigned as H6a. The multiplet at δ 5.53-5.43
was assigned to the C2ꞌ methine, which showed strong COSY correlations to a triplet at
δ 5.20, and multiplets centred at δ 4.30, δ 4.28 and δ 4.11, assigned as H3ꞌb, H3ꞌa, H1ꞌb
and H1ꞌa, respectively. These assignments were supported by HSQC experiments, which
‡‡

X-ray crystallography performed by Dr. Anthony Willis (ANU).
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showed four distinct methylene carbons at δ 69.1, δ 67.9, δ 55.5 and δ 52.4, assigned as
C3ꞌ, C8, C1ꞌ and C6, respectively (Figure 26).

Figure 25: COSY spectrum of compound 154.

Figure 26: HSQC spectrum of compound 154.
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Monoclinic crystals of 154 were grown from slow evaporation of a CH2Cl2/EtOAc
solution, and its structure was confirmed by x-ray crystallography (Figure 27).§§

Figure 27: ORTEP depiction of compound 154. Note that the atom numbers as denoted by x-ray
crystallography do not reflect systematic numbering of atom positions.

Further elution with 50% EtOAc/CH2Cl2 gave a deep red-orange residue, which was
separated by preparative thin-layer chromatography to afford compound 155 in 7% yield
as small orange crystals. Analysis of the HRESI mass spectrum revealed a peak at m/z
375.1357 which was assigned to the molecular ion [C22H19N2O4]+, demonstrating the
addition of two glycidyl substituents to the indigo core. Analysis of the FTIR spectrum
revealed a broad absorbance band centred at 3395 cm-1, assigned to a hydroxyl O-H
stretch, as well as a peak at 1726 cm-1 assigned to the ketone C=O stretch. The 13C NMR
spectrum did not contain all relevant resonances due to small sample quantity, however
2D HMBC analysis revealed a strong, three-bond correlation between a doublet at δ 7.78
and a 13C resonance at δ 181.8, assigned to H1 and C15, respectively (Figure 28). Analysis
of the HSQC spectrum revealed three methylene carbons at δ 67.6, δ 61.9, and δ 52.2,
§§

X-ray crystallography performed by Dr. Anthony Willis (ANU).
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assigned as C8, C3ꞌ, and C6, respectively (Figure 29). Analysis of the TOCSY spectrum
revealed long-range 1H-1H correlations between the doublet at δ 6.87, the doublet of
triplets at δ 6.07, and part of a broad multiplet centred at δ 4.36, assigned as H1ꞌ, H2ꞌ, and
H3ꞌ of the trans-enamine moiety. The spirocyclic linkage was also evident in the TOCSY
spectrum, which showed correlations between the multiplet spanning δ 5.05-5.01, the
doublet at δ 3.74, and a broad multiplet containing an additional three protons, assigned
as H7, H6b and H6a/H8a/H8b respectively (Figure 30). The individual protons were
assigned by analysis of the COSY and ROESY spectra (Figure 31, Figure 32).

Figure 28: HMBC spectrum for compound 155 with key correlations highlighted.
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Figure 29: HSQC spectrum of compound 155 with key correlations highlighted.

Figure 30: TOCSY spectrum of compound 155 with key correlations highlighted.
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Figure 31: COSY spectrum for compound 155 with key correlations highlighted.

Figure 32: ROESY spectrum for compound 155 with key correlations highlighted.
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In a subsequent experiment using (S)-epichlorohydrin 144, x-ray quality crystals of 155
were grown by slow evaporation of a 9:1 CH2Cl2/hexane solution, and its absolute
structure and stereochemistry were confirmed by x-ray crystallography (Figure 33).***

Figure 33: ORTEP depiction of compound 155 with absolute stereochemistry. Note that the atom
numbers as denoted by x-ray crystallography do not reflect systematic numbering of atom
positions.

3.3.2 Reaction optimisation
The initial reaction was run for 2 hours, and while it allowed access to each of the
heterocycles 152–155, the total mass return for the reaction was only 62%. A summary
of the optimisation process for this reaction can be found in Table 2.

***

X-ray crystallography performed by Dr. Anthony Willis (ANU).
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Table 2: Summary of optimisation data for the reactions of indigo with epichlorohydrin (144,
X=Cl), epibromohydrin (145, X=Br), and glycidyl tosylate (146, X=OTs).
X

Time

Additives

152 (%)

153 (%)

154 (%)

155 (%)

B/L
(%mass)

1

Cla

2

a

Cl

1h

3 Å Sieves

3

Cla

30 min

4

Cl
Cl

5

2h

3 Å Sieves

44

6

6

7

46

41

9

b

b

30

3 Å Sieves

43

17

8

9

30 min

--

44

30

21

30 min

--

41

30

a

Cl

30 min

--

32

21

7

Cla

30 min

KId

5

b

8

Br

30 min

--

84

9

OTs

10 min

--

76

6

c

20
6
84

B/L = Baseline materials as a percentage of the mass of the crude reaction mixture. aRacemic
materials used. bDetected by TLC/ESI-MS analyses of the crude mixture, but not isolated. cReaction
performed using acetonitrile as solvent at reflux. d0.1 eq. (based on electrophile).

It was hypothesised that the high degree of polymerisation and decomposition would be
reduced by using a shorter reaction time, therefore the reaction was repeated, except that
the mixture was allowed to react for 1 h instead of 2 h (Table 2, Entry 2), which led to an
increase in the yield of spirocycle 153 from 6% to 9%, and a small decrease in the yield
of N,Nꞌ-cyclic 152 from 43% to 41%. Compounds 154 and 155 were evident in trace
quantities by TLC and ESI-MS analysis of the crude mixture, but not isolated. Further
shortening the reaction time to 30 min led to a 17% yield of 153, in addition to a 43%
yield of 152 and an 8% yield of 155 (Entry 3).
During the workup procedure, it was noted that the large surface area of the crushed 3 Å
molecular sieves retained considerable quantities of the products even after repeated
washing, so the reaction was repeated in the absence of molecular sieves using (S)epichlorohydrin (144), and gratifyingly led to an improved 30% yield of 153 in addition
to 152 (44%) and 155 (21%), for a total mass return of 95% based on indigo (Entry 4).
Attempts to replicate this outcome however were variable, with repeated runs instead
leading to mixtures of 152 (41%), 153 (30%), and 154 (20%), with no 155 evident by
TLC or ESI-MS analysis (Entry 5). The exact reason for this variability is unknown,
though could be related to the hygroscopicity of the DMF solvent leading to differing
quantities of trace water in the absence of a drying agent (Scheme 53).
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Scheme 53: Optimised reaction conditions and outcome for the reaction of indigo with (S)epichlorohydrin. Yields reflect Table 2, entries 4 and 5 respectively.

Due to the low volatility, aqueous miscibility, and high boiling point of the DMF solvent,
the reaction was repeated using acetonitrile as the solvent at reflux (82 ˚C), which gave a
mixture of 152 (32%), 153 (21%), and 155 (6%), as well as a 26% isolated recovery of
unreacted indigo due to its poor solubility in acetonitrile (Table 2, Entry 6). The overall
lower yield of this process however was countered by the significantly shorter processing
time for the reaction, whereby the acetonitrile solvent could be removed in vacuo and
replaced with EtOAc and filtered prior to aqueous washing. For larger (eq. gram-scale)
scale preparations this may prove a more practical approach than using larger volumes of
DMF, albeit at the cost of yield due to unreacted indigo.
Yields for the N,Nꞌ-cyclic compound 152 were not significantly affected by changes in
reaction time, and it was thought that modifying the pendant halide may affect the product
distribution. Therefore, indigo was reacted with (±)-epibromohydrin (145) under identical
conditions to those for (S)-epichlorohydrin (144), resulting in an 84% isolated yield of
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152 with no other significant products detected by TLC analysis (Entry 7). Repeating this
reaction using (R)-glycidyl tosylate (146), except with a reaction time of 10 min also led
to a 76% isolated yield of the (R)-isomer of 152 (Scheme 54).

Scheme 54: Selective formation of (R)-152 from the alkylation of indigo with (R)-glycidyl
tosylate. Yields reflect Table 2, Entry 8

3.3.3 Mechanistic discussion
The regioselectivity of nucleophilic attack on halohydrins has been studied previously,
where it was shown that epoxide ring-opening is up to 200 times more favourable than
direct nucleophilic halide displacement in polar solvents.[142] Therefore, it is likely that
ring-opening of the epoxide precedes any processes involving the pendant leaving group,
as reflected by the observation that increasing the strength of the leaving group had a
dramatic effect on the product distribution, and exclusively gave N,Nꞌ-cyclised product
152. The identity of the halide likely plays a crucial role in determination of the
mechanistic pathway of the reaction, such that nucleophilic addition of indigo to
epichlorohydrin affords key intermediate 156, which serves as a branching point between
N,Nꞌ-cyclisation (Path A, Scheme 55) and N,Oꞌ-cyclisation (Path B, Scheme 56).
Compound 152 is derived from 156 via Path A, where the leaving group is displaced by
the vicinal alkoxide, resulting in a net epoxide migration from C1-C2 to C2-C3 with
retention of stereochemistry. This elimination would become more favourable with better
leaving groups, as reflected by the increase in the yield of 152 from 44% to 84% upon
replacing X=Cl with X=Br. Reversible base-mediated prototropic isomerisation of the
indigo core affords the cis-anion 157, which undergoes an irreversible 6-exo-tet
cyclisation to ring-open the newly-reformed epoxide, resulting in inversion of the C2stereochemistry and the formation of 152 upon protonation (Scheme 55).
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Scheme 55: Proposed mechanism for the formation of pyrazinodiindole 152 from key
intermediate 156 via Path A. Cesium counter-ions omitted for clarity.

With weaker leaving groups, epoxide reformation would become less-favourable, and
where key intermediate 156 lingers, deprotonation of the indigo nitrogen atom may
instead lead to Oꞌ-attack on the pendant chloride via a dearomative 8-exo-tet cyclisation,
leading to semi-rigid intermediate 158. The rigidity of this macrocyclic intermediate may
restrict nucleophilic attack by the adjacent alkoxide to the nearby indole C3-position to
the re-face, thereby defining the stereochemistry of the C9a position of spirocycle 153
(Scheme 56). An alternative mechanism for ketalisation involves the halide being
eliminated by water to give a diol, which undergoes condensation with the ketone,
however the presence of 153 was not detected from a trialled reaction between indigo and
2-hydroxymethyloxirane (glycidol), suggesting the mechanism does not involve a diol
intermediate.
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Scheme 56: Dearomative cyclisation of key intermediate 156 to macrocycle 158 by halide
displacement en route to spiroketal product 153.

Spirocycle 153 could then undergo further N-alkylation with a further equivalent of
epichlorohydrin, and subsequent elimination of the halide could give the intermediate Nglycidyl adduct 159. Ring-opening of this epoxide with either carbonate or bicarbonate
could then give an intermediate α-hydroxycarbonate (160), which upon dehydration
would afford cyclic carbonate 154. Alternatively, base-mediated elimination of the
epoxide 159 – or E2 elimination of the carbonate 154 – could then lead to formation of
the allylic alcohol adduct 155 (Scheme 57). The precise mechanism for the formation of
alcohol 155 is unknown, as despite its isolation from multiple attempts during the
optimisation of the reaction, a reliable means of synthesising it could not be established.
Briefly, attempted decarboxylation of carbonate 154 by treatment with potassium tertbutoxide in THF led to decomposition, and attempted alkylation of unsubstituted 153 with
additional epichlorohydrin in the presence of cesium carbonate gave a mixture of 154
(43% yield) and polymeric baseline materials, while in the absence of cesium carbonate
(e.g. using bases such as K2CO3, n-BuLi, LDA and NaH), only unreacted 153 was
isolated.
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Scheme 57: Proposed divergent mechanism for the formation of spiro-oxazocinodiindoles 154
and 155 from indigo via alkylation of compound 153.

There are several previously-reported examples of the addition of oxiranes to ketones to
form ketals, though these typically proceed via Lewis or Brønsted acid catalysis, where
the oxirane is highly-activated by coordinating to the cationic species.[143] Carboxylation
of epoxides with carbon dioxide is also known, though this reaction typically proceeds
under high-pressure and/or at elevated temperatures.[144] Here, the relatively-low yields
(maximum 20%) of 154 are attributed to the previously-noted nucleophilicity of cesium
carbonate.[116]
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3.4 Cascade reactions of 2-(halomethyl)aziridines and 2phenylaziridine with indigo
3.4.1 Synthesis of starting materials
Considering the generation of various spiroketal-containing molecules from reactions of
indigo with (halomethyl)oxiranes, we sought to explore whether substituting oxiranes for
aziridines would lead to further N,Nꞌ-cyclised pyrazinodiindoles via Path A (see Scheme
55), or instead allow access to N,Oꞌ-cyclised spirooxazolidines via Path B (see Scheme
56). The synthesis of several N-substituted-2-(bromomethyl)aziridines has been reported
previously,[139a, 145] though these were generated racemically and by non-stereoselective
means. The necessity of using chlorine gas as a reagent was also deemed prohibitive
toward the synthesis of chloromethyl derivatives,[146] hence a less-hazardous,
stereoselective method for the generation of chiral 2-(halomethyl)aziridines had to be
devised.
Bromomethylaziridine 147 was prepared as previously reported from the acidic
bromination of allylamine (161), and subsequent one-pot N-sulfonylation/ring-closure
reaction in excellent yield (Scheme 58).[139a] Briefly, allylamine 161 was treated with 1.3
eq. Br2 in aqueous HBr solution at 0 ˚C and then warmed to RT and stirred for 4 h, which
upon removal of excess bromine by distillation and repeated recrystallisation of the crude
mixture from isopropanol afforded the intermediate hydrobromide salt 162 in 80% yield.
This brominated salt was then reacted with tosyl chloride in aqueous sodium hydroxide
solution, to afford the desired aziridine product 147 in quantitative yield. This overall
process was amenable to multigram-scale preparation of the desired aziridine, as no
further purification was necessary. In two repeated runs, 17.7-17.9 grams of salt 162 was
synthesised (79-80% yield), which was reacted over multiple 5.0-gram batches, reliably
affording between 4.6-4.8 g (94-99% yield) of N-tosyl-2-(bromomethyl)aziridine 147.

Scheme 58: Synthesis of racemic (bromomethyl)aziridine 147 on multi-gram scale from
allylamine 161 via hydrobromide salt 162.
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Analysis of the ESI(+) mass spectrum revealed a pair of peaks at m/z 312+ and 314+ in a
1:1 ratio, assigned as the [M+Na]+ molecular ion peaks for the

79

Br and

81

Br isotopes,

respectively. Analysis of the 1H NMR spectrum revealed a pair of 2H aromatic doublets
at δ 7.82 and δ 7.34, assigned to H2ꞌ/H6ꞌ and H3ꞌ/H5ꞌ, respectively. Further upfield, the
2H doublet at δ 3.26 was assigned to the methylene protons of the bromomethyl
substituent, and the multiplet ranging from δ 3.12-3.04 was assigned to H2. The 3H
singlet assigned to the tosyl methyl group was flanked on either side by a pair of doublets
at δ 2.78 and δ 2.21, assigned to H3a and H3b, respectively.
Chloromethylaziridine 148 on the other hand proved more challenging to synthesise than
its bromo-substituted equivalent. We sought to utilise a direct substitution of
hydroxymethylaziridine 163 via a robust, two-step mesylation-chloridation procedure,
necessitating the preparation of 163 on multigram-scale. Direct aziridination of allyl
alcohol 164 with chloramine-T trihydrate (165) under I2 catalysis afforded a mixture of
two major products after 3 d at room temperature. Flash chromatography (40% EtOAc/pet
spirit) on silica gave good resolution between the desired aziridine 163 (36% yield) and
the unexpected by-product disulfonamide 166 (56% yield) from undesired ring-opening
of 163 with additional 165.

Scheme 59: Synthesis of (hydroxymethyl)aziridine 163 and the unexpected disulfonamide 166
from allyl alcohol (164).

Hydroxymethylaziridine 163 was isolated as a clear oil in 36% yield following flash
chromatography. Analysis of the ESI(+) mass spectrum revealed a peak at m/z 250,
corresponding to the molecular ion [C10H13NO3SNa]+, revealing the incorporation of a
one equivalent of chloramine-T across the alkene. Analysis of the 1H NMR spectrum
revealed a pair of 2H doublets at δ 7.82 and δ 7.35, assigned as the N-tosyl aromatic
protons. The pair of doublet-of-doublets at δ 3.81 and δ 3.54 were assigned to the
diastereotopic methylene protons of the hydroxymethyl group, and the broad singlet at δ
2.18 assigned to the hydroxyl proton. The multiplet at δ 3.04-2.99 was assigned to H2,
and the remaining pair of doublets at δ 2.61 and δ 2.30 assigned to the diastereotopic
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methylene protons of the aziridine terminus C3.
Disulfonamide 166 was isolated as a pale cream amorphous solid in 56% yield. Analysis
of the ESI(+) mass spectrum revealed a peak at m/z 421, assigned as the molecular ion
[C17H22N2O5S2Na]+, revealing the addition of two sulfonamide units to the allylic starting
material 164. Analysis of the 1H NMR spectrum revealed a pair of 2H doublets at δ 7.73
and δ 7.64 and a 4H multiplet ranging from δ 7.32-7.20, assigned to the aromatic protons
of the two tosyl substituents, in addition to a 6H singlet at δ 2.39, assigned to both methyl
substituents. The downfield doublet at δ 5.88 and its neighbouring triplet at δ 5.77 showed
no direct

13

C attachment by HSQC experiments, and were assigned as the two discrete

sulfonamide -NHTs groups attached to C2 and C1, respectively. The C1-adjacent
sulfonamide was correlated to a broad 2H multiplet centred at δ 2.97, which was assigned
as the C1 methylene protons, and the C2-adjacent sulfonamide was correlated to a
multiplet ranging from δ 3.35-3.26, assigned as the C2 methine (Figure 34). The broad
singlet resonance ranging from δ 3.30-3.08 was assigned as the hydroxyl proton, and the
remaining multiplets located at δ 3.63-3.56 and δ 3.54-3.46 were assigned to the C3
methylene protons.

Figure 34: COSY spectrum for compound 166 with relevant crosspeaks indicated.
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The desired aziridine 163 was produced initially in 36% yield alongside 166 in 56% yield.
Reducing the reaction time from three days to two days produced 163 in an improved
43% yield, in addition to 166 (21%) and a mixture of products from undesired
aminohalogenation in a combined crude yield of 10%. Repeated attempts did not lead to
significant improvements in the yield of 163, which was consistently isolated in 35-45%
yield, though this reaction could be run at a multi-gram scale with no significant
diminishing of yield, producing sufficient aziridine for our purposes.
The formation of 166 was unexpected and represents a net diamination of the olefin
starting material. This was an intriguing outcome, as despite many previous attempts,[147]
as well as the well-established and celebrated protocols for dihydroxylation, epoxidation
and aminohydroxylation of olefins,[148] there remains no reliable method for
intermolecular diamination of non-activated alkenes. This is particularly interesting given
that the reaction utilises the inexpensive and environmentally-benign chloramine-T
(otherwise used in water treatment, and in iodometric analysis)[149] as the nitrogen source
and oxidant. Treatment of allyl alcohol with 2.1 eq. of chloramine-T gave the
disulfonamide 166 in 75% yield after 16 h at room temperature, suggesting this
aziridination/ring-opening process to be highly favourable.
To probe the tolerance of this method to other alkene species, the reaction was trialled for
the diamination of cyclohexene (167) in a single unoptimized run (Scheme 60), and
afforded a mixture of meso-aziridine 168 (78% yield) and trans-disulfonamide 169 (20%
yield). This is therefore a promising starting point for the development of new methods
for olefin diamination and despite being beyond the scope of this dissertation, warrants
further examination.

Scheme 60: Unoptimised yield for the reaction of cyclohexene (167) with Chloramine-T (165) to
afford aziridine 168 and diaminated product 169.

With the desired hydroxymethylaziridine 163 in hand, it was subjected to a two-step
mesylation-chloridation. The aziridinyl alcohol was dissolved in dry CH2Cl2, and treated
with methanesulfonyl chloride and triethylamine at 0 ˚C for 1 h, then warmed to room
temperature and stirred for a further hour, at which time TLC analysis showed complete
consumption of starting material. The reaction mixture was subjected to aqueous workup,
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the crude mesylate combined with excess LiCl (5.0 eq.) and a phase-transfer catalyst
(TBA+Cl-, 0.2 eq.) in THF, and the mixture stirred at 50 ˚C overnight. Aqueous workup
and removal of the solvent afforded the hydrolysis product 170 in quantitative yield
(Scheme 61).

Scheme 61: Attempted synthesis of chloromethylaziridine 148 via mesylation/chloridation,
resulting in the formation of hydrolysis product 170.

Compound 170 was isolated as off-white crystals in 99% yield from undesired hydrolysis
of the desired chloromethylaziridine on aqueous workup. Analysis of the ESI(+) mass
spectrum revealed a pair of peaks at m/z 286 and 288 in a 3:1 ratio, assigned to the two
isotopic molecular ions [C10H1435ClNO3SNa]+ and [C10H1437ClNO3SNa]+, respectively.
Analysis of the 1H NMR spectrum revealed a doublet at δ 6.05 and a broad singlet at δ
3.18, assigned to the sulfonamide and hydroxyl protons, respectively. The five remaining
aliphatic protons formed a broad multiplet ranging from δ 3.78-3.44, which could not be
easily disentangled.
Repeated attempts toward chlorination of 163 using this method continually resulted in
170, as did the use of SOCl2, which afforded 170 in 76% yield. Attempted Appel
chloridation using PPh3/CCl4 led to extensive decomposition, and attempted O-tosylation
using tosyl chloride and pyridine led to ring-opening with residual chloride ions. A
successful route was identified from the acidic ring-opening of bromomethylaziridine 147
with 36% HCl(aq) to give the mixed bromo/chloro species 171 in 82% yield, which
underwent selective bromide elimination using cesium carbonate (1.1 eq.) in anhydrous
CH2Cl2 (0.01 M), affording the desired chloromethylaziridine 148 in 90% yield, for a
total of 74% from the bromomethylaziridine.

Scheme 62: Synthesis of chloromethylaziridine 148 from bromomethylaziridine 147 via mixed
dihalide 171.

Dihalide 171 was isolated as a white solid in 82% yield from bromomethylaziridine 147.
Analysis of the ESI(+) mass spectrum revealed a cluster of multiple peaks at m/z 348+,
350+, and 352+ in a 3:5:2 ratio, assigned to the molecular ion [C10H13NO2BrClSNa]+ due
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to the 35Cl/79Br, 35Cl/81Br, 37Cl/79Br, and 37Cl/81Br isotopic pairings. Analysis of the 1H
NMR spectrum revealed a doublet at δ 5.03 assigned as the sulfonamide NH, in addition
to a 3H multiplet ranging from δ 3.79-3.70, assigned to H2 and the chloride-adjacent
H3a/H3b, and a 2H multiplet ranging from δ 3.52-3.46, assigned to the bromide-adjacent
H1a/H1b methylene protons.
Chloromethylaziridine 148 was isolated in 90% yield from 171 as a colourless, viscous
oil which slowly crystallised into a low-melting solid (mp. 42-44 ˚C) on standing.
Analysis of the 1H NMR spectrum revealed a broad doublet-of-doublet-of-doublets at δ
3.46, assigned to the methylene protons of the chloromethyl group, which showed HSQC
correlation to a peak in the DEPTQ 13C NMR spectrum at δ 43.5 (Figure 35). The pair of
doublets at δ 2.74 and δ 2.26 were assigned to the methylene protons of the C3 aziridine
terminus by HSQC analysis, which showed strong correlations between both protons and
a resonance in the DEPTQ 13C NMR spectrum at δ 32.8, and by COSY analysis, which
revealed strong correlations between both protons and the multiplet at δ 3.09-2.99,
assigned to H2 (Figure 36). Analysis of the HMBC spectrum revealed strong three-bond
correlations between the chloromethyl methylene and C3, and between the 3H singlet at
δ 2.44 and both C3ꞌ and C4ꞌ of the tosyl group (Figure 37).

Figure 35: HSQC spectrum for chloromethylaziridine 148.
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Figure 36: COSY spectrum for chloromethylaziridine 148 with key correlations highlighted.

Figure 37: HMBC spectrum of chloromethylaziridine 148 with key correlations highlighted.
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While this procedure proved robust, it did not solve the problem of enantioselectivity, as
the precursor bromomethylaziridine 147 was generated racemically. Therefore, an
alternative synthesis of 148 from (S)-epichlorohydrin (144) was devised, where the
enantiopure starting material was ring-opened using chloramine-T (165) to afford the
chiral chlorosulfonamide 172 in 97% yield upon reductive workup. This was then
subjected to O-mesylation using MsCl/NEt3 to give the corresponding O-mesylate 173 in
96% yield, followed by mesylate displacement using Cs2CO3 in CH2Cl2 (0.01 M) to
afford the ring-closed enantiopure aziridine 148 in 73% yield, or 64% yield from epoxide
144 with complete stereocontrol, and only requiring a single purification step.

Scheme 63: Second-generation, enantiospecific synthesis of 148 from (S)-epichlorohydrin (144)
over three steps.

Finally, to probe the dependence of the cascade process on the presence of a halide, we
sought to synthesise N-tosyl-2-phenylaziridine (174) via direct aziridination of styrene
(175). Optimal conditions were found using a slight excess of styrene (1.05 eq.), where
the desired aziridine could be synthesised in 93% yield on multigram-scale (30 mmol),
requiring no purification beyond hexane/acetonitrile extraction to remove unreacted
styrene, and aqueous workup.

Scheme 64: Synthesis of N-tosyl-2-phenylaziridine on multi-gram scale under optimised
conditions.
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Compound 174 was isolated as a chunky, off-white amorphous solid in 93% yield after
hexane/acetonitrile extraction, and aqueous workup. Analysis of the ESI(+) mass
spectrum revealed a peak at m/z 296+, assigned to the molecular ion [C15H15NO2SNa]+.
Analysis of the 1H NMR of 174 revealed a doublet of doublets at δ 3.77, assigned to the
benzylic proton H2, as well as a pair of doublets at δ 2.97 and δ 2.38, assigned to the
diastereotopic methylene of the aziridine.
3.4.2 Reaction discovery and structure elucidation
With optimised conditions from investigating the ring-opening reactions of
halomethyloxiranes, we initially applied these conditions to the reaction of indigo and Ntosyl-2-(bromomethyl)aziridine (147), however it was quickly determined that extended
reaction times (i.e. >5 min) led to extensive, uncontrollable polymerisation, hence shorter
reaction times were essential. Briefly, a suspension of indigo (1.0 mmol) in DMF (40 mL)
was prepared by sonicating in a 60 ˚C water bath for one hour, and transferred by cannula
into a round-bottomed flask containing pre-dried Cs2CO3 (3.7 eq.) and a large magnetic
stir bar, and the mixture stirred vigorously under N2 in an oil bath preheated to strictly
85-87 ˚C for one hour. The N2 flow was then cut, and 147 (5.0 eq.) injected as a solution
in DMF (1 mL), and the mixture stirred vigorously for 5 seconds, then quenched over
crushed ice. Aqueous workup and removal of the solvent afforded an intense blue residue
which was subjected to flash chromatography, which after difficult separation resulted in
the isolation of N,Nꞌ-cyclic products 176 and 177, from the addition of one and two units
of 147 to the indigo core, respectively (Scheme 65).

Scheme 65: Outcome of the 5 second reaction of indigo with bromomethylaziridine 147 to give
N,N'-cyclised products 176 and 177.
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Dihydropyrazinodiindole 176 was isolated as an intense-blue, glassy amorphous solid in
21% yield following flash chromatography. Analysis of the HRESI mass spectrum
revealed a peak at m/z 472.1319, assigned to the molecular ion [C26H22N3O4S]+, revealing
the addition of a single aziridinyl subunit to indigo. Its deep-blue colour and physical
characteristics were similar to that of pyrazinodiindole 152, suggesting it to be an
analogue of this scaffold. The UV-Vis spectrum (CH2Cl2) showed a pair of broad
absorption bands centred at 302 (14297) and 576 (8879) nm. Analysis of the FTIR
spectrum revealed a broad absorption peak at 3385 cm-1, assigned to a sulfonamide NH,
and a peak at 1730 cm-1 assigned to the C13 and C14 carbonyls. Analysis of the 1H NMR
spectrum revealed a downfield triplet at δ 8.08 which exchanged with D2O and was not
correlated to any carbon in HSQC experiments and was assigned to the sulfonamide NH
proton (Figure 38). Further upfield, the multiplet at δ 4.70-4.61 showed correlations to a
pair of methylene carbons by analysis of the HSQC and COSY spectra (Figure 39), and
was assigned to H6, and C6 was correlated weakly to both adjacent methylenes in HMBC
experiments (Figure 40). The pair of doublets at δ 4.42 and δ 3.70 were assigned to the
H6a/H6b methylene, and the broad 2H multiplet ranging δ 3.06-2.81 was assigned to the
amide-adjacent methylene protons, which showed strong correlations to the sulfonamide
NH in COSY experiments.

Figure 38: HSQC spectrum for compound 176 with relevant peaks highlighted.
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Figure 39: COSY spectrum for compound 176.

Figure 40: HMBC spectrum for compound 176.
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N,Nꞌ-Cyclic compound 177 was isolated as an intense dark blue amorphous solid
following flash chromatography. Analysis of the HRESI mass spectrum revealed a peak
at m/z 703.1661, assigned to the molecular ion [C36H32N4O6S2Na]+, revealing the addition
of two aziridinyl subunits. Analysis of the 1H and 13C spectra revealed extensive peakdoubling, suggesting the presence of a 1:1 mixture of diastereomers. This is due to the
proposed structure containing a pair of stereogenic atoms, and resulting from a statistical
mixture of two units of the racemic starting aziridine, thus producing a 1:1 mixture of
both enantiomers of the two possible diastereomers. Where both incoming aziridine
molecules have the same stereochemistry, this would lead to the (6R,2ꞌS)(6S,2ꞌR) pair, or
where both aziridines have opposite stereochemistry, this would lead to the
(6R,2ꞌR)(6S,2ꞌS) pair, for a total of four individual stereoisomers. These isomers proved
irresolute by fractional crystallisation, flash chromatography and by reverse-phase HPLC
separation, hence the reported 35% yield refers to the crude yield of the mixture of
diastereomers. Compound 177 was isolated in enantiopure form as the (6R,2ꞌS)
diastereomer from (R)-N-tosyl-2-chloromethylaziridine (148, vide infra), and comparing
the overlaid 1H NMR spectra for both this individual isomer and the mixture of isomers,
it is evident that 50% of this mixture corresponds to the (6R,2ꞌS)(6S,2ꞌR) pair of
diastereomers, hence it would follow that the remaining portion of the mixture
corresponds to the (6R,2ꞌR)(6S,2ꞌS)-diastereomeric pair (Figure 41, Figure 42).

Figure 41: 1H NMR spectral overlay from δ 8.00-6.60 for the mixture of diastereomers of 177
(teal) and the 6R,2ꞌS isomer of 177 (maroon),
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Figure 42: 1H NMR spectral overlay from δ 5.30-2.00 for the mixture of diastereomers of 177
(teal) and the 6R,2ꞌS isomer of 177 (maroon),

3.4.3 Reaction optimisation
The isolation of a 35% yield of di-alkylated product 177 within a 5 second reaction time
is testament to the high reactivity of the bromomethylaziridine 147. This however meant
that over extended reaction times, greater proportions of polymeric materials were
isolated. In a repeated run, using a 30 minute reaction time, a similar diastereomeric
mixture of 177 was isolated in 43% yield, with the remainder of the mixture being
uncharacterisable polymer. Repeating the reaction with a 5 minute reaction time and with
a reduced quantity of aziridine (3.5 eq.) afforded a 52% yield of 176, in addition to a 38%
yield of 177. In an effort to reduce the reactivity of the aziridine, the tosyl activator was
replaced with the N-mesyl activator, however upon treatment with indigo, this led to rapid
decomposition, and the exclusive isolation of baseline materials, presumably due to the
high acidity of the methyl group of the methanesulfonamide substituent, thus generating
additional reactive nucleophilic sites for polymerisation.
Replacing the electrophile with (R)-N-tosyl-2-(chloromethyl)aziridine (148) and allowing
the mixture to react for 30 minutes similarly afforded 176 (46%), in addition to an
inseparable mixture of three additional components. The mixture was subjected to
preparative RP-HPLC over 5×2.0 mL injections, and afforded three major fractions at tR
= 35 min (177, 8%), 37 min (178, 9%), and 47.7 min (polymer) (Scheme 66).
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Scheme 66: Synthesis of chiral pyrazinodiindoles 176, 177, and 178 from the cascade reaction of
indigo with (chloromethyl)aziridine 148.

The N-aziridinylpyrazinodiindole 177 was isolated in 8% yield from indigo following
preparative HPLC separation. Analysis of the 1H NMR spectrum revealed sixteen
aromatic-range protons, assigned to the two tosyl groups, and the eight indigo aryl
protons. In the alkyl region, a pair of overlapping 3H singlets at δ 2.39/2.38 were assigned
to the two tosyl methyl groups. Key to the structural assignment of 177 was analysis of
the TOCSY spectrum, allowing for disentanglement of the ten individual proton
resonances in the aliphatic range, and revealing the two individual alkyl chains (Figure
43). By cross-referencing the TOCSY, COSY and HSQC spectra, each proton and carbon
resonance could be individually assigned in these two subunits.
In chain A, the multiplet ranging from δ 4.69-4.58 was assigned to H6, and showed COSY
correlations to resonances at δ 3.25 and δ 2.93, assigned as the sulfonamide-adjacent
methylene protons H5ꞌa/H5ꞌb, and δ 4.47 and δ 3.46, assigned to the indole-adjacent
methylene protons H7a/H7b (Figure 45). HSQC analysis allowed for assignment of the
resonances at δ 49.4, δ 49.7, and δ 40.6 to C5ꞌ, C6, and C7, respectively (Figure 45). In
chain B, the shielded methylene proton resonances at δ 2.21 and δ 2.57 were assigned to
the terminal aziridine protons H1ꞌa/H1ꞌb, which showed COSY correlations to a
resonance at δ 2.93, assigned to H2ꞌ. The remaining methylene protons at δ 3.64 and δ
3.00 were assigned to the amide-adjacent H3ꞌa/H3ꞌb couple. HSQC analysis allowed the
remaining 13C resonances at δ 30.9, δ 37.4, and δ 51.6 to be assigned to C1ꞌ, C2ꞌ, and C3ꞌ,
respectively.
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Figure 43: TOCSY spectrum for compound 177 with correlations highlighted for both chains.
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Figure 44: COSY spectrum for compound 177 with key correlations highlighted.

Figure 45: HSQC spectrum for compound 177.
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The N-chloroalkylpyrazinodiindole 178 was isolated as an intense dark-blue amorphous
solid in 9% yield from indigo following RP-HPLC separation. Analysis of the HRESI
mass spectrum revealed a peak at m/z 739.1448, assigned to the molecular ion
[C36H33N4O6S235ClNa]+, revealing the incorporation of two aziridinyl subunits and one
chlorine atom. Analysis of the 1H NMR spectrum revealed a broad multiplet ranging from
δ 5.71-5.60 which did not show correlation to a carbon resonance in the HSQC spectrum,
and was assigned to the free N2ꞌ sulfonamide proton on the B chain. This proton showed
correlations in the TOCSY spectrum to resonances at δ 3.99, δ 3.85, δ 3.42, δ 3.41 and δ
3.19, which were assigned by COSY and HSQC analysis as H2ꞌ, H1ꞌa, H1ꞌb, H3ꞌb and
H3ꞌa, respectively, and the 13C resonances at δ 45.3, δ 53.9 and δ 53.0 assigned to C1ꞌ,
C2ꞌ and C3ꞌ, respectively (Figure 46, Figure 47, Figure 48). The doublet at δ 4.40 showed
through-space correlations to H10 in the ROESY spectrum, and was assigned as H7b of
the pyrazinodiindole core (Figure 49). TOCSY analysis revealed long-range coupling to
1

H resonances at δ 4.61, δ 3.52, δ 3.47, and δ 2.66, which were assigned as H6, H7a, H5ꞌa

and H5ꞌb, respectively, and the 13C resonances at δ 50.9, δ 49.4, and δ 40.2 were assigned
to C5ꞌ, C6 and C7, respectively. The direct linkage of the two chains through N4ꞌ was
supported by through-space correlation of H5ꞌa and H3ꞌa in the ROESY spectrum,
suggesting the pair to be in close proximity.

Figure 46: TOCSY spectrum of compound 178 with correlations highlighted for both chains.

100

Figure 47: HSQC spectrum for compound 178.

Figure 48: COSY spectrum for compound 178.
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Figure 49: ROESY spectrum for compound 178.

To examine whether indigo could undergo cascade reactions in the absence of a
halomethyl substituent, it was reacted with N-tosyl-2-phenylaziridine (174) under the
optimised conditions. In a single run, indigo was treated with 174 (5.0 eq.) for 10 minutes,
after which TLC analysis showed complete indigo consumption. The reaction was
quenched over crushed ice and subjected to aqueous workup, and subsequent flash
chromatography of the deep blue-green residue afforded the acyclic, mono-addition
products 179 and 180 in a combined 98% yield (Scheme 67).
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Scheme 67: Synthesis of acylic aziridine adducts 179 and 180 from phenylaziridine 174.

The terminally ring-opened aziridine adduct 179 was isolated as a deep blue-green
powder in 62% yield from indigo following flash chromatography and recrystallisation
from 9:1 pet spirit/CHCl3. Analysis of the HRESI mass spectrum revealed a peak at m/z
536.1664, assigned to the molecular ion [C31H26N3O4S]+, demonstrating the addition of a
single unit of the phenylaziridine. Analysis of the 13C NMR spectrum revealed a pair of
downfield quaternary resonances at δ 188.9 and δ 188.7, assigned as C3 and C3ꞌ
respectively, showing the retention of both carbonyls. Analysis of the 1H NMR spectrum
revealed a deshielded sharp singlet resonance at δ 10.65, assigned to the hydrogen-bound
indigo NH, which correlated with C3ꞌ by HMBC experiments, in addition to quaternary
resonances at δ 151.6 and δ 119.8, assigned as C7aꞌ and C2ꞌ, respectively (Figure 51).
Analysis of the HSQC spectrum showed correlations between the 1H resonances at δ 5.20
and δ 3.94 and the 13C resonance at δ 51.7, and the 1H resonance at δ 4.95 and the

13

C

resonance at δ 55.4, assigned to the methylene and methine groups of the pendant αphenylethylamine, respectively (Figure 51). Further analysis of the HMBC spectrum
revealed correlations between the aziridine methine group and 13C resonances at δ 139.8
and δ 126.5, assigned as two- and three-bond coupling to C1ꞌꞌ and C2ꞌꞌ of the phenyl
substituent, and COSY experiments showed coupling with the adjacent sulfonamide NH,
confirming the assigned regiochemistry of the product (Figure 52).
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Figure 50: HMBC spectrum for compound 179 with key correlations highlighted.

Figure 51: HSQC spectrum of compound 179 with expansion of the aromatic region (inset).
Assignments for the Ph and Ts substituents are omitted for clarity.
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Figure 52: COSY spectrum for compound 179, with the key correlations between H1ꞌꞌ and the
adjacent sulfonamide NH highlighted.

The benzylic aziridine adduct 180 was isolated as small, fluffy dark-blue crystals in 36%
yield from indigo following flash chromatography and recrystallisation from 9:1 pet
spirit/CHCl3. Analysis of the HRESI mass spectrum revealed a peak at m/z 558.1481,
assigned to the molecular ion [C31H25N3O4SNa]+, revealing the addition of a single unit
of the phenylaziridine. Analysis of the 13C NMR spectrum revealed a pair of downfield
quaternary resonances at δ 189.3 and δ 188.2, showing both indigo carbonyls to be intact,
and these were assigned as C3 and C3ꞌ, respectively by HMBC experiments, which
showed correlations between C3ꞌ and the 1H resonance at δ 10.74, assigned to the indolic
NH proton (Figure 53). The methylene resonance at δ 4.12 was correlated to the

13

C

resonance at δ 43.4 by HSQC experiments (Figure 54), and showed COSY correlations
to both the adjacent methine proton at δ 6.56, and the sulfonamide NH proton at δ 5.89,
inferring the assigned regiochemistry of the product (Figure 55).
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Figure 53: HMBC spectrum for compound 180 with key correlations highlighted.

Figure 54: HSQC spectrum for compound 180 with expansion of the aromatic region (inset).
Assignments for the Ph and Ts groups are omitted for clarity.
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Figure 55: COSY spectrum for compound 180, with key correlations highlighted.

X-ray quality crystals of compound 180 were grown by slow vapour-diffusion of
petroleum spirit into a solution of 180 in 1:1 MeOH/CHCl3 in a sealed chamber at room
temperature, and its structure confirmed by x-ray crystallography (Figure 56).†††

Figure 56: ORTEP depiction of compound 180. Note that the atom numbers as denoted by x-ray
crystallography do not reflect systematic numbering of atom positions.

†††

X-ray crystallography performed by Dr. Anthony Willis (ANU).
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3.4.4 Mechanistic discussion
In all reactions of indigo with (halomethyl)aziridines examined, there was no evidence of
spirocyclisation having occurred, despite the high reactivity of these strained
electrophiles. Presumably this is a result of the steric influence of the large tosyl activating
group preventing intramolecular N,Oꞌ-cyclisation. This is evident for the case of the 2phenylaziridine adducts 179 and 180, which showed no evidence of internal cyclisation
even upon prolonged heating, despite the close proximity of the nucleophilic sulfonamide
and electrophilic ketone functionalities. In considering a similar divergent mechanism for
the reactions of aziridines to that previously determined for reactions of oxiranes (Scheme
55, Scheme 56), it is therefore the case that contrary to oxiranes, aziridines exclusively
follow Path A, where steric impedance from the N-tosyl group prevents halide elimination
by the adjacent oxygen atom of intermediate 181, instead leading to aziridine reformation
and prototropic isomerisation to intermediate 182. Nucleophilic inversion of the aziridine
C2 leads to the final C6 stereochemistry of the pyrazinodiindole, and subsequent Nꞌꞌalkylation of 176 leads to both Nꞌꞌ-chloroalkyl 178 and Nꞌꞌ-aziridinyl 177, in addition to
polymeric species from prolonged reactions.

Scheme 68: Proposed mechanism for the formation of aziridine adducts 176–178 from Path A
cyclisation of key intermediate 181 to give intermediate 182.
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Phenylaziridine adducts 179 and 180 were isolated in a 1.7:1 ratio of terminal- and
benzylic ring-opened products. The preferential benzylic electrophilicity of 2arylaziridines has been established in the presence of strong Lewis acids (e.g. BF3.OEt2
or PdII), where spontaneous ring-opening of the aziridine forms an externally-stabilised
1,3-dipole where a benzylic carbocation and a negatively-charged sulfonamide-Lewis
acid complex are formed, which readily participate in [3+2]-cycloaddition, benzylic
nucleophilic addition and/or dimerization reactions.[150] Under basic conditions and in the
absence of transition metals, the 36% yield of compound 180 reflects the partial hindrance
of C2-attack at 85 ˚C by the pendant phenyl group.

3.5 Cascade reactions of 2,2ꞌ-bioxirane and 2,2ꞌ-biaziridine with
indigo
As direct, dimeric homologues of the investigated (halomethyl)-substituted aziridines and
oxiranes, we sought to investigate the reactions of 2,2ꞌ-bioxirane and N,Nꞌ-ditosyl-2,2ꞌbiaziridine with indigo, to determine whether these too could participate in cascade
reactions, and if so, whether they follow similar trends in reactivity to their monomeric
counterparts. As previously-mentioned, these are accessible on multigram-scale over
several steps from D- or L-tartaric acid (see Scheme 51), and for the purposes of this
investigation,

both

(2S,2'S)-2,2'-bioxirane

(149)

and

(2R,2ꞌR)-N,Nꞌ-ditosyl-2,2ꞌ-

biaziridine (150) were synthesised in divergent fashion via literature methods using
dimesylate 151 as the starting material, as derived from L-tartaric acid.[140c, 141]
3.5.1 Reaction discovery and structure elucidation
Indigo was reacted with 2,2ꞌ-bioxirane 149 under analogous conditions to those optimised
for the reaction with (S)-epichlorohydrin 144. Therefore, a suspension of indigo (1 mmol)
in DMF (40 mL) was sonicated while warming to 60 ˚C for one hour, then transferred by
cannula to a round-bottomed flask containing pre-dried Cs2CO3 (3.7 eq.) and a large
magnetic stir bar, and the mixture warmed in an oil bath preheated to strictly 85-87 ˚C for
one hour. The N2 flow was cut and (2S,2'S)-2,2'-bioxirane (3.3 mmol) injected, and the
bright-orange mixture stirred vigorously for 30 min. The mixture was quenched over
crushed ice and separation of the crude mixture afforded spirocyclic adducts 183 and 184
in a combined 81% yield.
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Scheme 69: Synthesis of spiroketals 183 and 184 from the reaction of indigo with 2,2ꞌ-bioxirane
149. Adjacent to both molecules is a picture of a solution in acetone, depicting their colour. Note:
The photograph of 183 shows a solution upon UV irradiation (365 nM).

The hydroxymethyl-substituted spiroketal 183 was isolated as small bright-orange
crystals in 62% yield from indigo following fractionation on silica gel and subsequent
flash chromatography, and exhibited a characteristic, brilliant-green fluorescence in
solution under ambient conditions, or upon long-wave (λ=365 nM) UV irradiation.
Analysis of the HRESI mass spectrum revealed a peak at m/z 349.1192, assigned to the
molecular ion [C20H17N2O4]+, showing the addition of a single unit of the bioxirane
starting material to indigo. Analysis of the FTIR spectrum revealed a broad absorptive
band centred at 3420 cm-1, assigned to the hydroxyl O-H stretch of the hydroxymethyl
pendant. Analysis of the 13C DEPTQ spectrum revealed a single downfield resonance at
δ 184.1, assigned to the C15 carbonyl, which showed correlations in the HMBC spectrum
to a downfield 1H doublet resonance at δ 7.81, assigned to H1 (Figure 57). Analysis of
the COSY spectrum revealed successive correlations from H1 to a resonance at δ 7.00,
which coupled to δ 7.50, which itself correlated with δ 7.10. These three resonances were
assigned as H2, H3 and H4, respectively (Figure 58). Analysis of the ROESY spectrum
revealed through-space coupling of H4 with a diastereotopic methylene proton at δ 4.38
assigned to H6b. Further analysis of the ROESY spectrum revealed correlations from H6b
to both the doublet of doublets at δ 3.70 (assigned to H6a) and a doublet of triplets at δ
5.01, assigned to H7 (Figure 59). Methine protons H7 and H8 additionally showed strong
ROESY correlations, suggesting them to be syn to one-another on the cis-dioxolane ring.
The remaining diastereotopic methylene protons were assigned through HSQC analysis,
which showed strong coupling between a pair of doublet-of-doublets at δ 4.17 and δ 3.96
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and a 13C resonance at δ 60.3, assigned as the hydroxymethyl carbon C1ꞌ (Figure 60). The
spiroketal carbon was identified by analysis of the HMBC spectrum, which revealed
three-bond coupling of both H10 and H7 to a weak quaternary resonance at δ 111.7,
assigned to C9a.

Figure 57: HMBC spectrum for compound 183 with key correlations highlighted.
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Figure 58: COSY spectrum for compound 183 with key correlations highlighted.

Figure 59: ROESY spectrum of compound 183 with key correlations highlighted.
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Figure 60: HSQC spectrum for compound 183 with assignments as indicated.

X-ray quality crystals of 183 were grown by slow evaporation of a saturated solution in
hexane/EtOAc, and its absolute structure and stereochemistry were confirmed by X-ray
crystallography (Figure 61).‡‡‡

Figure 61: ORTEP depiction of compound 183. Note that the atom numbers as denoted by x-ray
crystallography do not reflect systematic numbering of atom positions.
‡‡‡

X-ray crystallography performed by Dr. Anthony Willis (ANU).
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The epoxy alcohol-substituted spirocycle 184 was isolated as a pale lime-green
amorphous solid in 19% yield from indigo following fractionation on silica gel and
subsequent flash chromatography. Analysis of the HRESI mass spectrum revealed a peak
at m/z 435.1556, assigned to the molecular ion [C24H23N2O6]+, demonstrating the addition
of two bioxirane units to the indigo core. Analysis of the

13

C and 1H NMR spectra in

CDCl3 solution showed evidence of peak doubling, presumably due to slow rotation about
the N14-C1ꞌꞌ axis and/or rotational tumbling, which was eliminated by instead using d6DMSO for the acquisition of 1D and 2D NMR spectra.[151] Analysis of the 13C DEPTQ
spectrum revealed the presence of a deshielded quaternary resonance at δ 193.5, assigned
to the C15 ketone. Integration analysis of the aliphatic region of the 1H spectrum revealed
fourteen protons, which HSQC analysis revealed to consist of four methylene groups,
four methine groups, and two doublets at δ 5.83 and δ 5.22 which were not directly
attached to a carbon, assigned to the two distinct hydroxyl groups at C1ꞌ and C2ꞌꞌ,
respectively (Figure 62). Analysis of the TOCSY spectrum revealed long-range throughbond coupling of each distinct alkyl chain, and paired with COSY, HSQC, and ROESY
analysis, allowed for the individual assignment of each proton and carbon environment
(Figure 63). Briefly, the C2ꞌꞌ-hydroxyl of the epoxy alcohol unit showed COSY
correlations to a doublet-of-doublet-of-doublets at δ 3.24, assigned as H2ꞌꞌ, which was
adjacent to the diastereotopic methylene protons at δ 3.83 and δ 3.73, assigned as H1ꞌꞌa
and H1ꞌꞌb (Figure 64). H2ꞌꞌ also showed COSY correlations to the multiplet spanning δ
2.73-2.66, assigned to H3ꞌꞌ, which also showed correlations to both the triplet at δ 2.57
and the doublet of doublets at δ 2.33, assigned as the geminal protons of the terminal
oxirane unit at C4ꞌꞌ. On the hydroxymethyl spiroketal chain, the assigned cis-dioxolane
stereochemistry was supported by analysis of the ROESY spectrum, which showed
through-space correlation of the C1ꞌ-hydroxyl group to the doublet at δ 4.53, assigned to
the nearby H6b (Figure 65). The overlap of the H1ꞌa and H8 resonances led to difficulties
in unambiguous identification from COSY and ROESY analysis alone, however HMBC
analysis revealed correlations between the hydroxyl proton and 13C resonances at δ 43.2,
δ 62.8, and δ 70.7, assigned to C1ꞌ, C8, and C7, respectively (Figure 66).
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Figure 62: HSQC spectrum for compound 184, with assignments as indicated.

Figure 63: TOCSY spectrum for compound 184, with key correlations of the hydroxyl protons to
both chains highlighted.
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Figure 64: COSY spectrum for compound 184.

Figure 65: ROESY spectrum for compound 184.
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Figure 66: HMBC spectrum for compound 184 with key correlations of the two hydroxyl groups
highlighted.

Given the noted tendency of the aziridines 147 and 148 to undergo Path A-type
cyclisation, it was anticipated that N,Nꞌ-cyclic derivatives would predominate from
reactions of indigo with 2,2ꞌ-biaziridine. To probe this hypothesis, indigo was reacted
with (2R,2ꞌR)-2,2ꞌ-biaziridine (150, 1.3 eq.) under the previously-optimised conditions for
(R)-N-tosyl-2-(chloromethyl)aziridine

(148),

which

afforded

cleanly

the

diazepinodiindole 185 in excellent yield (Scheme 70).

Scheme 70: Synthesis of diazepinodiindole 185 from the reaction of indigo with biaziridine 150.
Adjacent to the structure is pictured a solution in dichloromethane.
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The diazepinodiindole 185 was isolated as an intense dark-blue powder in 93% yield from
indigo, following repeated recrystallisation of the crude reaction mixture. Analysis of the
HRESI mass spectrum revealed a peak at m/z 677.1513, assigned to the molecular ion
[C34H30N4O6S2Na]+, revealing the incorporation of a single biaziridine fragment to the
indigo core. Analysis of the 13C NMR spectrum revealed a pair of downfield quaternary
resonances at δ 180.9 and δ 180.8, assigned to the C14 and C15 ketone groups, and the
presence of 32 peaks in the

13

C NMR spectrum indicated the molecule to be non-

symmetrical. Analysis of the 1H NMR spectrum revealed a distinct pair of 3H singlet
resonances, assigned to the two tosyl methyl substituents in discrete chemical
environments to each other. Analysis of the HSQC spectrum revealed a pair of methylene
carbons at δ 42.4 and δ 39.4, assigned as C1ꞌ and C8, respectively, and two peaks which
showed no direct attachment to a carbon at δ 6.69 and δ 5.71, which were assigned to the
two sulfonamide groups at C7 and C1ꞌ, respectively. Analysis of the COSY spectrum
revealed coupling between the C7 sulfonamide NH and a vicinal methine proton
resonance at δ 3.61, assigned as H7, which was coupled to a doublet at δ 4.63, assigned
to H8a. ROESY experiments determined H7 to show strong through-space coupling to an
apparent triplet methine resonance at δ 4.95, assigned to H6, supporting the assigned cisstereochemistry of the C7-sulfonamide and C6-(sulfonamidomethyl) substituents. Weak
through-space coupling was also observed between H8a and H6, due to their proximity
in the bent 7-membered ring. The remaining methylene protons were assigned from
HSQC analysis, which showed direct attachment of the diastereotopic proton resonances
at δ 3.06 and δ 2.84 to C1ꞌ. Closer examination of the resonance assigned to H6 revealed
a 3JH-H coupling constant of 4.7 Hz, which is consistent with axial-equatorial coupling
with H7 (3Jax-eq expected 1-6 Hz), suggesting the two protons to be cis to one-another and
supporting the assigned stereochemistry.
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Figure 67: HSQC spectrum for compound 185 with assignments as indicated. Correlations for the
Ts groups are omitted for clarity.

Figure 68: COSY spectrum for compound 185 with key correlations highlighted.
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Figure 69: ROESY spectrum for compound 185, with key correlations highlighted.

3.5.2 Mechanistic discussion
Comparing the outcomes of the 2,2ꞌ-bioxirane reaction with the reaction of
epichlorohydrin, there was considerably greater preference toward

Path

B

spirocyclisation reactions using 2,2ꞌ-bioxirane, while epichlorohydrin showed little
discrimination between Path A and Path B. This is evidenced by comparing the isolated
yields of compounds isolated from both mechanistic pathways in each reaction, where
epichlorohydrin showed a 46:54 ratio, and bioxirane showed a 0:100 ratio of products
resulting from Paths A:B, respectively. As noted previously, both the strength of the
leaving group and the steric environment of the released heteroatom contribute
significantly to pathway discrimination, and for the case of the bioxirane, it is apparent
that both factors contribute to promote spirocyclisation. Therefore, we propose that monoring-opening of 149 generates key intermediate 186, which undergoes Oꞌ-alkylation via
an 8-exo-tet ring closure to give macrocycle 187. The defined stereochemistry of the
bioxirane C2 position results in facial selectivity upon re-aromatisation, and attack at the
si-face via a 5-exo-trig hydroalkoxylation affords spirocycle 183, which upon alkylation
with a second equivalent of bioxirane 149 affords 184 (Scheme 71). The observed
conservation of the stereochemical identity for spirocycle 183 in the x-ray crystal
structure suggests that Payne rearrangement of intermediate 186 to an internal epoxide
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(which could also undergo Oꞌ-nucleophilic attack to afford the trans-dioxolane 8-epi-183
via the C8-epimer of intermediate 187) had not occurred. It is also interesting to note that
relative to sequential ring-opening reactions of bioxiranes reported previously (which
proceed via nucleophilic attack at the less hindered C1 and C4),[140a,

140b, 141]

intramolecular cyclisation occurs exclusively by initial C1 ring-opening, and subsequent
ring-opening at the more-hindered C3 position. Attack at C4 is likely disfavoured by the
entropic penalty and ring-strain of the larger nine-membered ring, making C3-attack more
kinetically-favourable despite the enthalpic barrier of overcoming the increased steric
bulk of internal attack.

Scheme 71: Proposed mechanism for the formation of spiroketals 183 and 184 from the reaction
of indigo and 2,2'-bioxirane via Path B.

Contrary to bioxirane 149, the reaction of indigo with biaziridine 150 afforded exclusively
the N,Nꞌ-cyclised product 185, and there was no evidence of any additional products in
the mixture. Therefore, upon ring-opening of biaziridine to key intermediate 188, basemediated protoisomerisation affords the cis-anion 189, which undergoes a 7-exo-trig ringclosure to afford the cis-diazepinodiindole product 185 (Scheme 72). Similarly to the
sequential C1, C3 ring-opening of bioxirane, biaziridine also underwent sequential C1,
C3 ring-opening under these conditions, in contrast to its previously-established
reactivity.[140b-d] Presumably this is due to both the decreased entropic cost of forming the
seven-membered ring, and the considerable enthalpic barrier of orienting the C4 position
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toward the indigo nitrogen due to unfavourable steric interactions between adjacent tosyl
groups and the aromatic indigo core.

Scheme 72: Proposed mechanism for the formation of diazepinodiindole 185 from the reaction of
indigo with biaziridine 150.

3.6

Conclusions

Indigo undergoes cascade reactions with a variety of (halomethyl)oxiranes to afford
mixtures of both N,Nꞌ- and N,Oꞌ-cyclic heterocycles by one of two major mechanistic
pathways. By moderating the leaving group, these reactions could be optimised to either
produce exclusively N,Nꞌ-cyclic products in up to 84% yield, or predominantly N,Oꞌcyclic products in a combined 51% yield by changing the rate of halide elimination from
a

common

mechanistic

intermediate.

Under

similar

reaction

conditions,

(halomethyl)aziridines showed considerably-greater preference toward N,Nꞌ-cyclisation,
however the high reactivity of these electrophiles led to uncontrollable polymerisation
over longer reaction times. Optimal conditions afforded a combined 63% yield of
enantiomerically-pure adducts bearing useful functional groups. Furthermore, optimising
this reaction led to a practical synthesis of the useful chiral starting material 148 from
readily-available materials, which could be used as an entry point toward the
enantioselective synthesis of non-symmetrical 1,2-diamines or amino alcohols.
Reactions of indigo with the dimeric bioxirane and biaziridine had distinct mechanistic
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pathway preferences to one-another, however they both followed a common trend in
regioselectivity, reacting exclusively by sequential 1,3-ring opening, rather than the
established 1,4-ring opening. For bioxirane, selective N,Oꞌ-cyclisation afforded a pair of
spirocycles in 81% combined yield, while biaziridine led exclusively to a single N,Nꞌcyclic adduct in 93% yield. The observation of this 1,3-selectivity in both instances
suggests that by selecting appropriate di-nucleophiles, that intramolecular cyclisation of
both bioxirane and biaziridine should favour attack at C1 and C3, allowing access to
enantiomerically-pure desymmetrised systems, further demonstrating the synthetic value
of these simple chiral precursors.
Compared with the previously-studied reactions of indigo with allylic and propargylic
electrophiles, π-nucleophiles tend to undergo cascade reactions by C2 or C3 nucleophilic
attack leading to spirocyclic adducts for allylic substrates, or ring-expansion of the
biindole core to indolonaphthiridinones for propargylic substrates, whereas these
reactions with strained-ring systems have largely preserved the structural integrity of the
indigo nucleus. These reactions proceed with conservation of the stereochemical identity
of their precursors, allowing for the chemo- and stereoselective generation of
desymmetrised, three-dimensional polycycles. The generation of the epoxyoxazocinodiindole framework had not been established previously, and compounds 153155, 183 and 184 represent the first known examples of this ring system. The presence of
pendant functional groups in all generated molecules moreover could allow for their
incorporation into other scaffolds, allowing for rapid diversification and/or library
generation with a broad variety of coupling partners.
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Chapter 4:
Reactions of indigo with organometallic nucleophiles
4.1

The role of organometallic compounds in synthetic chemistry

The ubiquity of carbon in all manner of natural and synthetic molecules have rendered
the formation of new carbon-carbon bonds an area of continuous interest in both
methodology development, and in the design and synthesis of new molecular
architectures. With a Pauling electronegativity of 2.54,[152] carbon is amphoteric and can
adopt numerous oxidation states ranging ±4, hence it is rendered either an electrophile or
nucleophile depending on its electronic environment. Carbon electrophiles are common
(e.g. functional groups including alkyl (pseudo)halides and carboxylates) where the net
oxidation state of the carbon atom is positive, while it is rendered nucleophilic when
bonded to more-strongly electropositive elements such as metals.
Organometallic complexes are those which features carbon-metal bonds, and feature
prominently both as reagents and as intermediates in numerous metal-catalysed crosscoupling reactions. Grignard reagents are distinguished by the presence of a carbonmagnesium bond – the strongly-electropositive magnesium atom renders the carbon atom
both highly nucleophilic and strongly basic, allowing it to react with a broad variety of
functional groups (Scheme 73).[153] This high reactivity however means that Grignard
reagents are typically unstable toward air, moisture, and often undergo undesired
reactions with even relatively-inert substituents such as esters, amides, and terminal
alkynes. Nevertheless, their simple generation, low cost, and wide applicability to a broad
variety of chemical transformations has made the Grignard reaction a mainstay of
contemporary organic chemistry, and Victor Grignard was awarded the Nobel Prize for
Chemistry in 1912 for its discovery.
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Scheme 73: A brief summary of the reactivity of Grignard reagents with various common
functional groups. Clockwise from top left: deprotonation of acidic functional groups, formation
of alcohols from aldehydes and ketones, ketones from Weinreb amides, imines from nitriles,
alcohols from esters or amides, carboxylic acids from CO2, and alkyl groups from transmetallation
and nucleophilic substitution.

Grignard reagents can be readily generated by direct oxidative addition of Mg0 to alkylor aryl halides, or by magnesium-halogen exchange with commercially-available
isopropylmagnesium chloride (190). Of these methods, there are several advantages to
the magnesium-halogen exchange as pioneered by the Knochel group, which occurs
rapidly under mild conditions and allows highly-functionalised Grignard reagents to be
generated in situ (Scheme 74).[154] These reactions can be performed at cryogenic
temperatures (typically -40 ˚C), allowing functional groups such as nitriles, esters, amides
and nitro groups to be tolerated, and polyhalogenated compounds may be regioselectively
metalated in a predictable and reliable fashion.[155] The addition of LiCl to these reactions
is typically beneficial to both reaction rate and regioselectivity, and is thought to activate
the incoming Grignard reagent by formation of a lithium dichloromagnesiate “turboGrignard” complex (191),[156] which significantly enhances the nucleophilicity of the
adjacent carbon atom. Addition of a suitable halogenated starting material (e.g. the tribrominated pyridine 192) results in metal-halogen exchange selectively at the 3-position,
and the eventual formation of the desired heteroaryl “turbo-Grignard” reagent 193.
Combined with the well-established methodology for directed ortho-metalation,[157] and
developing methods for regioselective directed meta- and para-metalation of various
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substituted (hetero)aryl C-H bonds,[158] a vast array of functionalised organometallic
nucleophiles are now readily-accessible.

Scheme 74: The metal-halogen exchange reaction for the formation of substituted Grignard
reagents. Above: an example of the reaction using “turbo-Grignard” 191 toward the formation of
dibromopyridylmagnesiate 193. Below: selected examples of tolerated functionalities to this
reaction, with the metallation site highlighted in blue, and typically-incompatible functional
groups highlighted in red.

4.2

Reactions of indigo with Grignard reagents

As mentioned previously, the reaction of indigo with Grignard reagents was first reported
in 1909, and resulted in the isolation of eight mono-addition products in modest to
excellent yields.[67] The authors of the original study did not unambiguously assign a
structure to the products, however they proposed the structure to be one of a pair of
tautomeric species (58a and 58b) on the basis of elemental analysis and synthesis of
derivatives. The reported selectivity for mono-addition to indigo is intriguing, as this
allows for desymmetrisation of the biindole nucleus. The high functional density of indigo
could therefore allow for the facile and selective synthesis of various 3-aryl-2,2ꞌ-diindoles
(194) from a conceptually-simple dehydration of the tertiary alcohol adduct (Scheme 75).
This reaction was serendipitously re-discovered through the course of our exploration,
though it was quickly recognised to be a useful starting point for the development of new
methods toward the synthesis of functional diindoles (see Section 4.2.1 Reaction
discovery and structural assignment, vide infra).
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Scheme 75: Above: the previously-reported (1909) synthesis of mono-Grignard adducts from
indigo, and the proposed possible structures of the product: 58a and 58b. Below: the overall
synthetic strategy of this study, involving a two-step addition-dehydration procedure toward the
synthesis of desymmetrised adducts such as 194.

Non-symmetrical 2,2ꞌ-diindole moieties are a key component of numerous natural
products and pharmaceuticals (Figure 70). These include the natural product
staurosporine (4), and its derivatives lestaurtinib (195), and midostaurin (196), which are
highly-potent and selective kinase inhibitors – midostaurin recently gained FDA approval
for the treatment of FLT3+ acute myeloid leukaemia under the name Rydapt.[159] Other
significant examples of the 2,2ꞌ-biindole moiety include the natural products iheyamine
A (196) and indimicins A-D (197–200), as well as the clinical lead birinapant (201),
investigated for the treatment of myelodysplastic syndrome and chronic myelomonocytic
leukaemia. Furthermore, while 1H-3ꞌH-2,2ꞌ-biindoles have received sporadic attention as
synthetic intermediates[104b,

104c, 160]

and oxidation products,[161] there are only three

reported examples of 3ꞌ-oxoindolenine-indoles – the natural product bisindigotin (202)
and two synthetic precursors (203 and 204) encountered in Sperry’s 2016 total synthesis
of iheyamine A and a des-methoxy analogue.[162] Neither the innate biological profile, nor
the synthetic value of these molecules has been adequately established, therefore making
this an avenue worthy of closer examination. Furthermore, this would allow a simple
means of exploring the chemistry of indigo’s carbonyl groups, which until now has been
an area of very limited study.

127

Figure 70: Selected significant examples of the 2,2'-biindoline scaffold (highlighted in blue), as
exhibited in natural products, clinical leads, and synthetic intermediates.

4.2.1 Reaction discovery and structural assignment
During the course of our exploration of the chemistry of indigo in reactions with strainedring systems (see Chapter 3, vide supra), we sought to examine the reactivity of the
doubly-strained 1-azabicyclo[1.1.0]butane (205).[163] Highly-strained molecules such as
these have been used recently by the Baran group for the direct azetidinylation,
cyclobutylation (206) and “propellerisation” (207) of secondary amines in the presence
of i-PrMgCl.LiCl (191) as an activator – generating a highly nucleophilic R2N-MgCl.LiCl
“turbo-amide” intermediate species in situ (Scheme 76, A).[164] Given the vast substrate
scope reported for this transformation, we sought to replicate the reaction of 205 using
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indigo in place of the secondary amine to determine whether the appended azetidine ring
would be sufficiently-strained to undergo further reactions with the indigo core.
Therefore, to a cooled (-84 ˚C) suspension of dibromoamine hydrobromide salt 162 (3.0
mmol) in dry THF (10 mL) was added a freshly-titrated (0.98 M) solution of
phenyllithium in THF (9.0 mmol) slowly dropwise, and the mixture stirred for 2 h.
Meanwhile, to a vigorously-stirred suspension of indigo (1.0 mmol) and LiCl (2.5 mmol)
in THF (10 mL) was added a freshly-titrated (0.87 M) solution of i-PrMgCl in THF (2.5
mmol), and the mixture stirred at room temperature for 2 h. The resulting indigo/turboGrignard solution was transferred by cannula into the azabicyclobutane solution at -84
˚C, and the intense-red mixture allowed to warm to room temperature overnight. This
mixture was then cooled to 0 ˚C, and a solution of Boc2O (6.0 mmol) in THF (5 mL)
added slowly, and the resulting red-brown solution stirred for 3 h. Aqueous workup and
subsequent flash chromatography afforded a mixture of four major components – the deep
burgundy mono-N-Boc indigo 208, the deep purple N-H isopropyl adduct 209, and the
bright orange N-Boc isopropyl 210 and phenyl 211 adducts in a combined 77% yield,
with no azetidine incorporation (Scheme 76, B).
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Scheme 76: A: Literature protocol for 'strain-release' functionalisation of amines by addition
across the highlighted (red) bond,[164] B: Outcome of the attempted 'strain-release' azetidinylation
of indigo, producing N-Boc indigo 208 and Grignard adducts 209–211. Adjacent to the structure
of 208 is a photograph showing its colour in its crystalline form. Adjacent to 209–211 is a
photograph of a solution in acetone at a concentration of approximately 0.1 mM.

Mono-N-Boc indigo 208 was isolated as small burgundy crystals in 20% yield following
flash chromatography. Analysis of the HRESI mass spectrum revealed a peak at m/z
363.1342, assigned to the molecular ion [C21H19N2O4]+, revealing the addition of a Boc
substituent to the indigo molecule, and its deep red-purple colour in solution qualitatively
suggested the indigo core to have remained intact. Analysis of the 1H spectrum revealed
eight distinct aromatic resonances, and a pair of carbonyl resonances were evident in the
C NMR spectrum, suggesting the molecule to be unsymmetrical. The 9H singlet at δ

13

1.62 was assigned to the degenerate methyl groups of the N-Boc substituent, while the
broad singlet at δ 10.02 was assigned to the free NH group.
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Isopropyl adduct 209 was isolated as small, dark purple crystals in 21% yield following
flash chromatography, with its deep purple colour qualitatively suggesting the retention
of intramolecular hydrogen bonding. Analysis of the HRESI mass spectrum revealed a
peak at m/z 289.1349, assigned to the molecular ion [C19H17N2O]+, revealing the net
substitution of one oxygen atom for an isopropyl group. Analysis of the 1H NMR
spectrum revealed a 1H heptet at δ 4.55, which showed COSY correlations to a 6H
doublet at δ 1.54, assigned to H2ꞌꞌ and the adjacent H1ꞌꞌ methyl groups, respectively
(Figure 71). Further downfield, the broad singlet at δ 10.11 exchanged with D2O, and was
therefore assigned to the free NH of the indole. Analysis of the ROESY spectrum revealed
through-space correlation of the H1ꞌꞌ methyl groups with a doublet at δ 7.92, assigned to
H4 of the adjacent aromatic ring (Figure 72). Having identified H4, this was used as an
entry point to this ring, and analysis of the COSY spectrum allowed the assignment of
H5, H6 and H7 to resonances at δ 7.08, δ 7.29, and δ 7.41, respectively, therefore allowing
for the assignment of C4, C5, C6 and C7 to 13C resonances at δ 122.6, δ 119.8, δ 125.7,
and δ 112.2, respectively, by analysis of the HSQC spectrum (Figure 73). These
assignments were confirmed by HMBC experiments, which showed strong, three-bond
coupling between H4-C6, H6-C4, H5-C7, and H7-C5 (Figure 74). Both H4 and H6
additionally showed three-bond coupling to a quaternary

13

C resonance at δ 138.8,

assigned to the indole C7a, and both H5 and H7 were coupled to a quaternary resonance
at δ 126.6, assigned to C3a, which also showed three-bond coupling to the isopropyl H2ꞌꞌ.
The remaining positions of the indole were assigned by identifying HMBC correlations
to the isopropyl substituent – both H1ꞌꞌ and H2ꞌꞌ were coupled to a quaternary resonance
at δ 135.0, assigned to C3, however only H2ꞌꞌ was coupled to the resonance at δ 123.8,
assigned to C2.
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Figure 71: COSY spectrum for compound 209, with expansion of the aromatic region (inset), and
key correlations highlighted.

Figure 72: ROESY spectrum for compound 209 with key correlations highlighted.
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On the opposite hemisphere, the remaining C3ꞌ carbonyl was assigned to the resonance at
δ 197.1, and showed HMBC correlations to a 1H resonance at δ 7.54, assigned to H4ꞌ.
This was coupled to a protic 13C resonance at δ 137.6, and a quaternary resonance at δ
162.7, assigned to C6ꞌ and C7aꞌ, respectively. The C2ꞌ C=N group was assigned to a
quaternary resonance at δ 154.6, and while its remoteness meant it did not show any
correlations in the HMBC spectrum, in the twelve synthesised examples of this scaffold
(vide infra), the indolenine C2ꞌ was always observed within the range of δ 156.3±2.8. The
chemical shift of this position, as well as the considerable downfield shift of the C6ꞌ and
C7ꞌ positions (cf. C6 and C7a on the opposite ring, located at δ 125.7 and δ 138.8,
respectively) is typical of other reported 2-aryl-3H-indol-3-ones,[165] supporting the
assignment of this ring system. Therefore, we were able to definitively assign all proton
and carbon environments of the molecule (Figure 75).

Figure 73: HSQC spectrum for compound 209 with expansion of the aromatic region (inset) and
assignments as indicated.
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Figure 74: HMBC spectrum for compound 209 with key correlations highlighted.

Figure 75: Summary of correlations from 2D NMR data allowing the structural assignment of
compound 209.
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The N-Boc isopropyl adduct 210 was isolated as bright orange crystals in 12% yield
following flash chromatography on silica gel. Analysis of the HRESI mass spectrum
revealed a peak at m/z 389.1860, assigned to the molecular ion [C24H25N2O3]+, revealing
the substitution of one oxygen for an isopropyl unit, and the addition of a Boc substituent.
Analysis of the 1H NMR spectrum revealed a 9H singlet at δ 1.49, assigned to the
degenerate methyl groups of the Boc group, as well as a 1H heptet at δ 3.58 and a 6H
doublet at δ 1.46 which correlated strongly to one-another in the COSY spectrum, and
were assigned to H2ꞌꞌ and H1ꞌꞌ of the isopropyl unit, respectively (Figure 76). Analysis of
the ROESY spectrum revealed through-space correlation between the Boc CH3 group and
a heavily-deshielded doublet at δ 8.21, assigned to the nearby H7, as well as correlations
of the isopropyl protons H2ꞌꞌ and H1ꞌꞌ with a doublet at δ 7.83, assigned to H4 (Figure 77).
H4 showed correlations in the COSY spectrum to an apparent triplet at δ 7.25, assigned
to H5, and both H5 and H7 showed correlations with the apparent triplet at δ 7.38, which
was assigned to H6. With H4-H7 unambiguously assigned, HSQC analysis allowed
assignment of C4, C5, C6, and C7 to the 13C resonances at δ 121.8, δ 122.7, δ 126.1, and
δ 115.9, respectively. Of the remaining carbons of the indole moiety, C2, C3, and C7a
were assigned to carbon resonances at δ 124.0, δ 134.0, and δ 137.6, respectively, by
analysis of the HMBC spectrum (Figure 79). The precise chemical shift of C3a was
ambiguous due to peak overlap in the 13C NMR spectrum. The shape of the overlapped
C resonance ranging δ 128.54–128.47 was broadened and asymmetric in the 1D
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spectrum, and the HMBC spectrum demonstrated correlations to both H7 and H7ꞌ which
are chemically-distinct and separated by a shortest path of nine covalent bonds, therefore
correlation of either H7-C3aꞌ or H7ꞌ-C3a are highly unlikely. Therefore, the broad
resonance at δ 128.54–128.47 was assigned as a pair of overlapped resonances at δ 128.51
and δ 128.50, with both peaks belonging to either C3a or C3aꞌ.
The 3H-indol-3-one fragment of the N-Boc indole 210 showed similar chemical shifts
and 2D connectivity to the N-H indole 209, with the exceptions of C2ꞌ, which was
relatively-deshielded by Δδ +6.1 in the 13C NMR spectrum (δ 160.7 in 210, cf. δ 154.6 in
209), and C3ꞌ, which was relatively-shielded by Δδ -5.0 (δ 192.1 in 210 cf. δ 197.1 in
209). These values are consistent across fifteen derivatives of this N-Boc scaffold (vide
infra), and lie within the range of δ 160.4±0.9 at C2ꞌ and δ 191.9±1.2 at C3ꞌ. We can
therefore confidently assign each proton and carbon environment of 210 (Figure 80).
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Figure 76: COSY spectrum for 210, with expansion of the aromatic region (inset) and key
correlations highlighted.

Figure 77: ROESY spectrum for compound 210, with key correlations highlighted.
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Figure 78: HSQC spectrum for compound 210 with expansion of the aromatic region (inset) and
assignments labeled.

Figure 79: HMBC spectrum for compound 210, with key correlations highlighted.
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Figure 80: Summary of correlations from 2D NMR data allowing the structural assignment of
compound 210.

The N-Boc phenyl adduct 211 was isolated in 24% yield as small, bright orange crystals
following flash chromatography. Analysis of the HRESI mass spectrum revealed a peak
at m/z 423.1702, assigned to the molecular ion [C27H23N2O4]+, demonstrating the
substitution of a phenyl group for one oxygen atom, and the addition of an N-Boc
substituent to the indigo core. Analysis of the 1H spectrum revealed a lone doublet
resonance at δ 8.24 which was correlated to the Boc group in the ROESY spectrum, and
therefore assigned to H7 (Figure 81). The 13C resonance at δ 191.8 was assigned to C3ꞌ,
which showed a strong three-bond correlation in the HMBC spectrum to the doublet at δ
7.54, assigned to H4ꞌ. Using the H7 and H4ꞌ protons as entry points to both rings, the
remaining proton and carbon environments were assigned from analysis of the COSY
(Figure 82), HMBC (Figure 83), and HSQC spectra (Figure 84). The H2ꞌꞌ/H6ꞌꞌ and
H3ꞌꞌ/H5ꞌꞌ protons of the phenyl substituent were assigned to a pair of multiplets at δ 7.447.38 and δ 7.66-7.60, respectively, and H4ꞌꞌ was assigned to a multiplet at δ 7.38-7.34.
The

13

C resonances at δ 128.3, δ 131.0, and δ 122.7 were therefore assigned to carbon

atoms C2ꞌꞌ/C6ꞌꞌ, C3ꞌꞌ/C5ꞌꞌ, and C4ꞌꞌ, respectively, and H3ꞌꞌ/H5ꞌꞌ showed strong three-bond
coupling to a quaternary resonance at δ 128.1 in the HMBC spectrum, and was therefore
assigned to C1ꞌꞌ.
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Figure 81: ROESY spectrum for compound 211 with key correlations highlighted.

Figure 82: COSY spectrum for compound 211 with assignments.
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Figure 83: HMBC spectrum for compound 211 with assignments listed.

Figure 84: HSQC spectrum for compound 211 with assignments listed.
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Large crystals of 211 were grown by slow evaporation of a hexane solution, and its
structure was therefore unambiguously determined by x-ray crystallography (Figure
85).§§§ Of note is the loss of planarity despite the retained conjugation of the system, as a
result of the steric repulsion of the N-tert-butylcarbamate group. The N1-C8-C9-C10
linkage exhibits a dihedral angle of 60.3˚ in the solid state,[166]**** thus preventing orbital
overlap and limiting electronic interaction between the 3H-indole and 1H-indole moieties.

Figure 85: ORTEP depiction of compound 211. Note that the atom numbers as denoted by x-ray
crystallography do not reflect systematic numbering of atom positions.

4.2.2 Reaction optimisation
Despite indigo’s poor solubility in THF and the presence of numerous extraneous
reagents, the combined 57% yield of Grignard adducts suggested nucleophilic addition of
the organometallic species to the indigo core to be highly favourable. Using iPrMgCl.LiCl 191 as a model substrate (5.0 eq.), we sought to optimise the reaction by
§§§

X-ray crystallography performed by Dr. Anthony Willis (ANU).
Calculated using Mercury v. 3.9, © Cambridge Crystallographic Data Centre.

****
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removing both the competing phenyllithium and the extraneous dibromoammonium salt
(162) and repeating the reaction under identical conditions in a one-pot setting. We
observed complete consumption of the indigo, however despite the presence of excess
Boc2O, dehydration of the intermediate alcohol (212) to 209 was sluggish, and only diBoc indigo (213) was isolated in 19% yield, as identified by analysis of the LRESI mass
spectrum (M+H+ = m/z 463+), comparison of the 1H NMR and

13

C NMR spectra with

those previously-reported,[167] and x-ray crystallographic analysis of crystals grown from
CH2Cl2 (Figure 86).††††

Figure 86: ORTEP depiction of di-Boc indigo 213. Note that the atom numbers as denoted by xray crystallography do not reflect systematic numbering of atom positions.

We surmised that the amine’s absence may have slowed the rate of dehydration, and thus
repeated the reaction in the presence of TMEDA (6.0 eq.), however this gave inconsistent
yields ranging 20-40% on repeated attempts, and considerable quantities of the
intermediate alcohol remained unreacted, as detected by TLC analysis. Therefore, to
determine the best conditions for displacing the oxygen atom, a variety of dehydration

††††

X-ray crystallography performed by Dr. Anthony Willis (ANU).
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reactions were trialled on small-scale using the crude isopropyl alcohol adduct (212, ca.
5 mg), and the outcomes of this are presented in Table 3.
Table 3: Summary of small-scale attempts at dehydration (dehyd.) of isopropyl adduct 212.
Reactions were performed on ca. 5 mg of material, and the outcome determined by TLC and/or
ESI-MS analysis. Decomposition is denoted as dec.
Solvent

Reagent

Temp.

Dehyd.?

Dec.?

1

MeOH

HCl(aq)

Δ

✕

✓

2

MeOH

NaOMe

RT

✕

✓

3

CH2Cl2

--

Δ

✕

✕

4

CH2Cl2

BF3.OEt2

RT

✓

✓

5

CH2Cl2

SOCl2

RT

✕

✓

6

CH2Cl2

MsCla

RT

✓

✓

7

CH2Cl2

Boc2Ob

RT

✓

✕

8

CH2Cl2

TiCl4

RT

✕

✓

9

CH2Cl2

PPh3.I2c

RT

✕

✓

10

Toluene

--

Δ

✓

✕

11

Toluene

H2SO4

RT

✓

✓

12

Toluene

P2O5

RT

✕

✓

13

Pyridine

--

Δ

✕

✓

14

H2SO4

--

RT

✓

✓

15

THF

PCl3

Δ

✕

✓

a

NEt3 added bDMAP added cImidazole added

Of these trialled conditions, dehydration was observed with BF3.OEt2 (Entry 4),
MsCl/NEt3 (Entry 6), and H2SO4 (Entry 14), however only Boc2O/DMAP (Entry 7), and
heating in toluene (Entry 10) did not lead to significant decomposition. On full-scale (0.5
mmol), attempted dehydration using toluene in the presence of 3 Å molecular sieves
showed moderate progression by TLC analysis after heating at reflux for 3 h, however
the dehydrated material decomposed after leaving at reflux overnight, and trace products
from undesired Wurtz coupling of i-PrMgCl.LiCl with 4- or 7-metallated indigo were
isolated. We hypothesised that the inconsistency of the one-pot addition/dehydration with
Boc2O may be due to the remaining strongly-coordinating Li+ or Mg2+ ions, which were
not present in the small-scale reaction, therefore the reaction was repeated with an
additional aqueous workup between the Grignard addition and Boc2O addition. Treatment
with Boc2O/DMAP in CH2Cl2 quickly led to the formation of 210, which was isolated in
80% yield following flash chromatography (Scheme 77).
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Scheme 77: Optimised reaction outcome for the two-step isopropylation/Boc-mediated
dehydration of indigo with i-PrMgCl.LiCl (191).

Treating indigo with PhMgCl under these conditions gave a combined 92% yield of NBoc phenyl adduct 211 and N-H phenyl adduct 214, and while this yield was somewhat
diminished by using PhLi in place of PhMgCl (71%), it suggested that both organolithium
and organomagnesium aryl nucleophiles were tolerated in the first instance (Scheme 78).
It was later found that the dehydration reaction could be greatly accelerated by the
addition of NEt3, and while this did not lead to an increase in isolated yield, the reaction
was typically deemed to be complete within 20 min by TLC analysis.

Scheme 78: Reaction of indigo with PhMgCl and PhLi under optimised conditions.

The phenyl adduct 214 was isolated as an intense, dark-purple powder in 13% yield from
indigo, following fractionation on silica and subsequent flash chromatography. Analysis
of the HRESI mass spectrum revealed a peak at m/z 323.1187, assigned to the molecular
ion [C22H15N2O]+, revealing the net substitution of the phenyl group for one oxygen atom,
and analysis of the FTIR spectrum revealed a sharp absorbance band at 3370 cm-1,
assigned to the N-H stretch. Analysis of the 1H NMR spectrum revealed a broad singlet
resonance at δ 10.25 which exchanged with D2O and was assigned to the free NH group,
and analysis of the 13C NMR spectrum revealed a resonance at δ 196.1, assigned to the
C3ꞌ ketone group. The considerable degree of overlap of the proton environments made
disentanglement of the individual protons difficult, however cross-referencing the HMBC
and HSQC spectra for 214 with those acquired for 209 allowed for identification of
distinctive 13C resonances at δ 112.0 and δ 137.4, assigned to C7 and C6ꞌ, respectively
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(Figure 87, Figure 88). The phenyl protons H2ꞌꞌ/H6ꞌꞌ, H3ꞌꞌ/H5ꞌꞌ, and H4ꞌꞌ were assigned to
resonances at δ 7.54, δ 7.70, and δ 7.41, thus allowing assignment of C2ꞌꞌ/C6ꞌꞌ, C3ꞌꞌ/C5ꞌꞌ,
and C4ꞌꞌ to 13C resonances at δ 128.1, δ 131.0, and δ 127.7.

Figure 87: HSQC spectrum for compound 214 with assignments as indicated.

Figure 88: HMBC spectrum for 214 with key assignments highlighted.
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4.3

Substrate scope

4.3.1 Substrate scope – alkyl nucleophiles
Having determined the optimal conditions for this reaction, we sought to explore the use
of a small selection of simple, commercially-available organometallics. The good yield
of isopropyl adduct 210 suggested moderate steric bulk was not detrimental to the
reaction, hence a handful of alkyl substituents – namely methyl, allyl, benzyl, and butyl
– were selected to generate a selection of small-to-moderate steric impactors. Given the
applicability of organolithium reagents to this reaction, we elected to utilise the
methyllithium and n-butyllithium reagents we had on-hand, activated in situ by
complexing with TMEDA, while the allylmagnesium bromide and benzylmagnesium
chloride solutions were pre-activated by stirring with flame-dried LiCl.
Treating a well-dried suspension of indigo (0.5 mmol) in anhydrous THF with nbutyllithium (5.0 eq.) at -84 ˚C in the presence of TMEDA (1.1 eq. based on BuLi) gave
an intense dark-red complex which was warmed to room temperature over one hour with
vigorous stirring, and stirred at room temperature for a further hour. Aqueous workup
afforded a deep golden residue, which was dissolved in CH2Cl2, to which DMAP (2.2
eq.), NEt3 (2.0 eq.), and Boc2O (3.0 eq.) were added sequentially in air, and the mixture
stirred for one hour. Aqueous workup and flash chromatography afforded the n-butyl
adduct 215 in 80% yield (Scheme 79).

Scheme 79: Synthesis of n-butyl adduct 215 from the addition of n-BuLi to indigo.

Analysis of the HRESI mass spectrum for 215 revealed a peak at m/z 403.2036, assigned
to the molecular ion [C25H27N2O3]+, demonstrating the net substitution of the butyl moiety
for one oxygen atom, and the addition of a Boc group. Analysis of the 1H NMR spectrum
revealed the expected eight distinct aromatic resonances, which were assigned on the
basis of COSY (Figure 89) and HMBC experiments (Figure 90). Further upfield, four
distinct aliphatic multiplets were identified at δ 2.93 (dd), δ 1.70 (dq), δ 1.36 (dq), and δ
0.90 (t), which were assigned to H1ꞌꞌ, H2ꞌꞌ, H3ꞌꞌ, and H4ꞌꞌ, respectively, based on HMBC,
COSY and H2BC analyses (Figure 91). Analysis of the 13C DEPTQ spectrum revealed a
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trio of negatively-phased aliphatic resonances at δ 32.7, δ 24.1, and δ 22.6, in addition to
a single positively-phased resonance at δ 13.8, which were assigned to C2ꞌꞌ, C1ꞌꞌ, C3ꞌꞌ and
C4ꞌꞌ by analysis of the HSQC spectrum (Figure 92).

Figure 89: COSY spectrum for compound 215 with assignments as indicated.

Figure 90: HMBC spectrum for compound 215 with key correlations highlighted.
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Figure 91: H2BC spectrum for compound 215, showing two-bond correlations in the aliphatic
region, demonstrating the connectivity of the alkyl chain.

Figure 92: HSQC spectrum for compound 215 with expansion of the aromatic region (inset).
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With two aliphatic examples in hand, we aimed toward the synthesis of the N-Boc methyl
adduct 216 from the substitution of methyllithium to indigo. We quickly found however
that the reduced steric effect of the methyl-substituted alcohol 217 precluded dehydration
with Boc2O, and did not lead to the desired product, instead leading to mixtures of Nacylated and O-acylated materials (Scheme 80). Therefore, a series of small-scale trial
reactions were conducted to determine a suitable dehydrating agent for less stericallyencumbered adducts – the outcomes of which are presented in Table 4.

Scheme 80: The attempted dehydration of methyl adduct 217 to 216 using Boc2O was
unsuccessful, and the desired product was not obtained.
Table 4: Summary of small-scale attempts at dehydration (dehyd.) of methyl adduct 217.
Reactions were performed on ca. 5 mg of material, and the outcome determined by TLC and/or
ESI-MS analysis. Decomposition is denoted as dec.
Solvent

Reagent

Temp.

Dehyd.?

Dec.?

1

MeCN

CF3COOH

RT

✓

✕

2

MeCN

H2SO4

RT

✓

✕

3

CH2Cl2

--

Δ

✕

✕

4

CH2Cl2

BF3.OEt2

RT

✕

✓

5

CH2Cl2

SOCl2

RT

✕

✓

6

CH2Cl2

MsCl

a

RT

✕

✓

7

CH2Cl2

Boc2Ob

RT

✕

✓

8

CH2Cl2

TiCl4

RT

✕

✓

9

CH2Cl2

PPh3.I2c

RT

✓

✕

10

Toluene

--

Δ

✓

✓

11

Toluene

H2SO4

RT

✓

✓

12

Toluene

P2O5

RT

✕

✓

13

Pyridine

POCl3

Δ

✕

✓

14

H2SO4

--

RT

✓

✓

15

THF

PCl3

Δ

✕

✓

a

NEt3 added bDMAP added cImidazole added
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Of these trialled methods, the three best outcomes were noted in entries 1, 2, and 9, using
either TFA or H2SO4 in MeCN, or with PPh3.I2 and imidazole in CH2Cl2. Of these, the
outcomes for TFA on small-scale could not be replicated on 0.5 mmol scale, and though
H2SO4 led to decomposition, it afforded the dehydrated adduct 218 in 33% yield over 2
steps. This method however was surpassed by the use of PPh3.I2/imidazole, which led
exclusively to the dehydrated product 218 in 93% yield from 217, or 74% from indigo
over two steps.

Scheme 81: Synthesis of dehydrated methyl adduct 218 from Appel dehydration of alcohol 217.

The methyl adduct 218 was isolated as feathery, dark purple crystals in 74% yield from
indigo. Analysis of the UV-Vis spectrum (acetone) revealed a pair of broad absorptive
bands centred at λ(ε) 326 (8389) and 538 (4881) nM, and FTIR analysis revealed a sharp
absorptive band at 3376 cm-1, assigned to a N-H stretch. Analysis of the HRESI mass
spectrum revealed a peak at m/z 261.1022, assigned to the molecular ion [C17H13N2O]+,
confirming the net substitution of the methyl group for one oxygen atom. Analysis of the
1

H NMR spectrum revealed a broad singlet at δ 9.98, assigned to the NH, and a 3H singlet

at δ 2.84, assigned to the pseudo-benzylic methyl group. Analysis of the

13

C NMR

spectrum revealed quaternary resonances at δ 196.9 and δ 154.8, assigned to C3ꞌ and C2ꞌ,
respectively, and an upfield resonance at δ 11.6, assigned to the methyl group.
The addition of BnMgCl.LiCl to indigo afforded the benzylic adduct 219 in 91% yield,
following Boc-mediated dehydration and flash chromatography (Scheme 82). Analysis
of the HRESI mass spectrum revealed a peak at m/z 437.1880, assigned to the molecular
ion [C28H25N2O3]+, demonstrating the net substitution of the benzyl group for one oxygen
atom, as well as the addition of the N-Boc substituent. Analysis of the 1H NMR spectrum
revealed thirteen aromatic protons, and a 2H singlet at δ 4.32, assigned to the benzylic
methylene group. The characteristic quaternary 13C resonances at δ 191.9, and δ 160.5,
and the protic resonance at δ 136.8 were assigned to C3ꞌ, C7aꞌ and C6ꞌ of the 3-oxo-3Hindole moiety, and the resonances at δ 150.1, δ 85.1, and δ 28.1 were assigned to the C=O,
Cq and CH3 carbons of the N-Boc substituent.
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Scheme 82: Synthesis of Boc-protected benzyl adduct 219 from the addition of BnMgCl.LiCl to
indigo.

We next turned our attention to allyl adduct 220, though despite its comparable steric
presence to the successful n-butyl addition, compound 220 proved evasive due to the low
observed reactivity of the lithium-ate complex, and only unreacted starting materials were
recovered as N-Boc and N,Nꞌ-di-Boc indigo adducts (Scheme 83). The reason for this low
reactivity is unknown, as the precursor allylmagnesium bromide solution was titrated
immediately prior to its use, however given the water sensitivity and hygroscopic nature
of lithium-ates, trace water or oxygen in the nitrogen line, the LiCl salt or the THF solvent
may have prematurely quenched the reagent. The comparatively-lower reactivity of
organomagnesium bromides (cf. organomagnesium chlorides) is known, however under
these circumstances, this does not sufficiently explain its poor reactivity, and requires
further exploration.

Scheme 83: Unsuccessful attempted allylation of indigo with allylmagnesium bromide to give
220. Compound 220 was not detected, and only unreacted starting materials were recovered.

4.3.2 Substrate scope – aryl nucleophiles
Having determined that aryl and alkyl Grignard reagents can be readily inserted into the
indigo core, we sought to explore the accessible space from metal-halogen insertion, to
generate substituted aryl Grignard reagents. We initially chose 4-iodoanisole as a model
substrate for magnesium-halogen exchange using i-PrMgCl (190) as the metal donor, and
adapting conditions reported previously for the in situ preparation of complex 221, where
the metal-halogen insertion was performed using a 10% molar excess of 190 at room
temperature for 1 h.[168] Under these conditions, a 41% yield of the desired 4151

methoxyphenyl adduct 222 was isolated, in addition to the undesired isopropyl adduct
210. This insertion step was optimised by use of excess iodoanisole (1.25 eq.), the
addition of LiCl (1.25 eq.), and extending the reaction time to 1.5 h to encourage the
complete consumption of i-PrMgCl. Under these modified conditions, an improved 72%
yield of 222 was obtained, in addition to the isopropylated 210, isolated in 11% yield
(Scheme 84).

Scheme 84: Optimised conditions for the synthesis of p-methoxyphenyl adduct 222 from indigo.

The para-methoxyphenyl adduct 222 was isolated as a bright-orange powder in 72% yield
from indigo. Analysis of the HRESI mass spectrum revealed a peak at m/z 453.1807,
assigned to the molecular ion [C28H25N2O4]+, revealing the net substitution of one oxygen
atom for the anisole moiety, and the addition of an N-Boc substituent. Analysis of the 1H
NMR spectrum revealed a pair of 2H doublet resonances at δ 7.59 and δ 6.96, and a 3H
singlet at δ 3.83, assigned to H2ꞌꞌ/H6ꞌꞌ, H3ꞌꞌ/H5ꞌꞌ, and the pendant methoxy substituent of
the newly-incorporated aryl ring, respectively. H2ꞌꞌ/H6ꞌꞌ, H3ꞌꞌ/H5ꞌꞌ and the methoxy
protons all showed strong correlations in the HMBC spectrum to a quaternary

13

C

resonance at δ 159.5, assigned to C4ꞌꞌ (Figure 93). H3ꞌꞌ/H5ꞌꞌ also correlated to a resonance
at δ 124.0, assigned to C1ꞌꞌ, and H2ꞌꞌ/H6ꞌꞌ showed a correlation to a resonance at δ 128.0,
assigned to the indole C3. Further downfield, the resonance at δ 191.9 was assigned to
C3ꞌ, and showed HMBC correlation to the doublet resonance at δ 7.55 via three bonds,
assigned to H4ꞌ. The chemical shifts of C2ꞌꞌ and C3ꞌꞌ were determined by HSQC analysis,
and were assigned to the resonances at δ 132.2 and δ 113.7, respectively (Figure 94).
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Figure 93: HMBC spectrum for compound 222 with key assignments highlighted.

Figure 94: HSQC spectrum for compound 222 with assignments as indicated.
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The meta-methoxy 223 and ortho-methoxy 224 adducts were prepared via identical
means, and were isolated in 72% yield and 94% yield, respectively (Scheme 85). The
considerably-higher yield of the ortho-methoxy adduct 224 is here attributed to the
favourable interaction of a lone pair from the methoxy group of 2-iodoanisole 225 and
the i-PrMgCl.LiCl complex 191, with the formation of the Lewis acid-base pair 226
stabilising the interaction between the magnesium atom and the adjacent aryl iodide,
increasing the probability of orbital overlap and eventual metalation of the C-I bond.

Scheme 85: Synthesis of the meta- and ortho-methoxy substituted adducts 223 and 224 from
indigo under optimised conditions, and mechanism for the ortho-assisted metalation of 2iodoanisole, with Li+ and Cl- ions omitted for clarity.

Monoclinic crystals of 224 were grown by evaporation of a saturated CH2Cl2/hexane
solution, and its structure confirmed by x-ray crystallography (Figure 95).‡‡‡‡
Interestingly, relative to the unsubstituted phenyl 211, the magnitude of the dihedral angle
of the two indole hemispheres was reduced from 60.3˚ (211) to 55.3˚ (224), possibly due

‡‡‡‡

X-ray crystallography performed by Dr. Anthony Willis (ANU).

154

to orbital interactions between C3ꞌ and the nearby oxygen of the methoxy group, which
were separated by a distance of 3.01 Å in the crystalline matrix.§§§§

Figure 95: ORTEP depiction of compound 225. Note that the atom numbers as denoted by x-ray
crystallography do not reflect systematic numbering of atom positions.

To determine whether di-substituted aryl Grignard reagents were tolerated, 1-iodo-2,4dimethoxybenzene (227) was metalated with i-PrMgCl.LiCl (191) at 0 ˚C for 2 h, and the
resulting Grignard reagent combined with indigo. Subsequent Boc-mediated dehydration
afforded the desired 2,4-dimethoxyphenyl adduct 228 in 72% yield as a deep orange
powder (Scheme 86). Analysis of the HRESI mass spectrum revealed a peak at m/z
483.1914, assigned to the molecular ion [C29H27N2O5]+, demonstrating the net
substitution of the dimethoxyphenyl group for one oxygen atom, and the incorporation of
the N-Boc group. Analysis of the 1H NMR spectrum revealed a pair of 3H singlets at δ
§§§§

Calculated using Mercury v. 3.9, © Cambridge Crystallographic Data Centre.
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3.83 and δ 3.36, assigned to the C4ꞌꞌ-adjacent and C2ꞌꞌ-adjacent methoxy groups,
respectively. The 1H doublet at δ 6.40 had a coupling constant of 4JH3ꞌꞌ-H5ꞌꞌ = 2.4 Hz,
indicative of meta-coupling to the doublet of doublets at δ 6.63, and these resonances
were assigned to H3ꞌꞌ and H5ꞌꞌ of the aryl substituent, respectively. Analysis of the COSY
spectrum revealed coupling of H5ꞌꞌ to part of an overlapped 2H multiplet at δ 7.50-7.45,
which HSQC experiments revealed was due to the incidental overlap of two aryl carbons
at δ 132.5 and δ 136.5, assigned to C6ꞌꞌ and C6ꞌ, respectively. Interestingly, H3ꞌꞌ
overlapped with a minor resonance which appeared to show COSY correlations to an
extraneous resonance at δ 7.29 (Figure 96), which correlated weakly in the HSQC
spectrum to a 13C resonance at δ 128.9 (Figure 97). This was attributed to the hindered
rotation about the C3-C1ꞌꞌ biaryl axis due to the presence of three ortho-substituents,
giving rise to major and minor rotamers in equilibrium.[151, 169] The extraneous resonances
at 1H δ 7.29 and

13

C δ 128.9 were therefore assigned to H6ꞌꞌ (min) and C6ꞌꞌ (min),

respectively. This assignment was also supported by the presence of additional HSQC
correlations of H4 and H5 to weak 13C resonances at δ 123.1 and δ 126.1, assigned to C4
(min) and C5 (min) respectively. This suggests that the orientation of the overhanging
aryl group has an appreciable deshielding effect on the chemical shift of the adjacent C4
and C5 positions of the indole in 228, however this phenomenon was not observed for
any other Grignard reagents examined.

Scheme 86: Synthesis of dimethoxyphenyl adduct 228, with the biaryl axis highlighted in red.
Below are depicted the proposed major (where the C3ꞌ carbonyl and C2ꞌꞌ methoxy are syn) and
minor (where the C3ꞌ carbonyl and C2ꞌꞌ methoxy are anti) rotameric conformations, and the 1H
(black) and 13C (blue) chemical shifts for the affected positions.
156

Figure 96: COSY spectrum of compound 228 at low (top) and high (bottom) intensities, showing
the appearance of additional peaks corresponding to the minor rotamer.
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Figure 97: HSQC spectrum of compound 228 at low (top) and high (bottom) intensities, showing
the appearance of additional peaks corresponding to the minor rotamer.
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Next, the incorporation of halogenated substrates was investigated. Therefore, using
para-fluoroiodobenzene (229) and ortho-chloroiodobenzene (230) as coupling partners,
the corresponding fluorinated 231 and chlorinated 232 adducts were isolated in good
yields (Scheme 87).

Scheme 87: Synthesis of halogenated desymmetrised diindoles 231 and 232 from their
corresponding halogenated Grignard reagents.

Analysis of the HRESI mass spectrum for the fluorophenyl adduct 231 revealed a peak at
m/z 441.1608, assigned to the molecular ion [C27H22N2O3F]+, demonstrating the net
substitution of the fluorophenyl moiety for an oxygen atom, and the addition of the NBoc group, and the 1H-decoupled 19F spectrum revealed a single resonance at δ -114.0,
typical of the aryl C-F moiety. Characteristic 19F-13C spin-coupling was also apparent in
the 13C NMR spectrum, causing splitting of the C4ꞌꞌ (1JC-F = 248.2 Hz), C3ꞌꞌ (2JC-F = 21.3
Hz), C2ꞌꞌ (3JC-F = 8.1 Hz) and C1ꞌꞌ (4JC-F = 2.5 Hz) resonances, in decreasing magnitude
as the C-F distance increased.
Analysis of the HRESI mass spectrum for the chlorophenyl adduct 232 revealed a 3:1
ratio of two peaks at m/z 457.1313 and 459.1285, assigned to the isotopic molecular ions
[C27H22N2O335Cl]+ and [C27H22N2O337Cl]+, confirming the insertion of the chlorophenyl
moiety and the addition of the N-Boc group. The x-ray crystal structure for 232
additionally revealed a dihedral angle of 44.5˚ and an intramolecular Cl…C3ꞌ distance of
3.54 Å (Figure 98).*****

*****

Calculated using Mercury v. 3.9, © Cambridge Crystallographic Data Centre.
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Figure 98: ORTEP depiction of compound 232. Note that the atom numbers as denoted by x-ray
crystallography do not reflect systematic numbering of atom positions.

4.3.3 Substrate scope – heterocyclic nucleophiles
To assess the applicability of heterocyclic substrates to this transformation, we selected
five simple heterocycles containing a variety of N, O, and S heteroatoms – pyridyl, Nmethylimidazolyl, thiophenyl, benzofuranyl, and N-methylindolyl moieties were selected
to determine whether these were tolerated by the reaction. The magnesium-iodine
exchange reaction of 3-iodopyridine was therefore initially investigated as a direct 3-aza
analogue of the phenyl system. Early difficulties were encountered where, despite the use
of scrupulously-anhydrous conditions, distilled and dried solvent and meticulouslypurified starting materials, the generated Grignard reagent was rendered inactive by the
presence of water, resulting in the exclusive isolation of unreacted indigo. Systematic
troubleshooting of each component in the closed system determined that despite the
efficacy of the gas drying tube (assessed using self-indicating desiccant in the tube), the
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in-house nitrogen gas line still contained sufficient water to prematurely quench the
generated Grignard reagent. Gratifyingly, repeating the reaction under identical
conditions – except for the addition of a second drying tube containing activated CaCl2
to the nitrogen line – afforded exclusively the desired 3-pyridyl diindole 233 in 89% yield
(Scheme 88).

Scheme 88: Synthesis of the 3-pyridyl-substituted diindole 233 from indigo.

Analysis of the HRESI mass spectrum for 233 revealed a peak at m/z 424.1656, assigned
to the molecular ion [C26H22N3O3]+, confirming the incorporation of the pyridyl moiety
and the addition of a Boc group. Analysis of the 1H NMR spectrum revealed three
deshielded resonances at δ 8.90, δ 8.60, and δ 8.02, assigned to H2ꞌꞌ, H4ꞌꞌ, and H6ꞌꞌ of the
3-pyridyl ring, in addition to a doublet at δ 8.26, assigned to the Boc-adjacent H7.
Analysis of the COSY spectrum revealed correlation of both H4ꞌꞌ and H6ꞌꞌ to a resonance
at δ 7.38, assigned to H5ꞌꞌ (Figure 99). Coupling this information with HSQC experiments
therefore revealed the chemical shift of the protic C2ꞌꞌ, C4ꞌꞌ, C5ꞌꞌ, and C6ꞌꞌ carbon atoms,
which were assigned to the resonances at δ 151.3, δ 148.9, δ 123.0, and δ 138.2,
respectively (Figure 100). Analysis of the ROESY spectrum, revealed correlations
between both H2ꞌꞌ and H6ꞌꞌ and a doublet at δ 7.60, assigned to H4 of the nearby indole,
confirming the regioselectivity of the metalation reaction to exclusively C3 of the
iodopyridine (Figure 101).
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Figure 99: COSY spectrum for compound 233, with key correlations about from H4''-H5''-H6''
on the pyridyl ring highlighted (blue).

Figure 100: HSQC spectrum for compound 233, with assignments as listed. Note that the C7'-H7'
and C5''-H5'' correlations overlap at the 2D resolution of the experiment, however the pair are
resolved in the 1D 13C NMR spectrum.
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Figure 101: Weak through-space correlations in the ROESY spectrum from H2'' and H6'' to H4
confirm the regiochemical identity of the pyridine moiety. Key correlations are highlighted
(black).

With the successful incorporation of a basic nitrogen heterocycle, we next turned our
attention to the analogous N-methylimidazolyl system. Given that the desired 2-metalated
imidazole 234 is commonly generated in situ from directed metalation of Nmethylimidazole with n-BuLi, a 0 ˚C solution of N-methylimidazole (2.5 mmol) in THF
was treated with n-BuLi (2.2 mmol), and the mixture stirred at 0 ˚C for 1.5 h. The resulting
pale-golden solution of 234 was transferred to a vigorously-stirred suspension of indigo
in THF at -84 ˚C, and the mixture allowed to warm to room temperature over one hour.
After stirring at room temperature for a further hour, the reaction was worked up and the
residue subjected to Boc-mediated dehydration, affording exclusively the desired 3-(Nmethylimidazol-2-yl)-diindole 235 in 94% yield (Scheme 89).
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Scheme 89: Regiospecific metalation of N-methylimidazole to give lithioimidazole 234.
Combining 234 with indigo afforded the desired diindole 235 in excellent yield.

Analysis of the HRESI mass spectrum for 235 revealed a peak at m/z 427.1264, assigned
to the molecular ion [C25H23N4O3]+, corresponding to the insertion of the imidazole
moiety and the addition of a Boc group. Analysis of the 1H NMR spectrum revealed a 3H
singlet at δ 3.68, assigned to the N-methyl substituent, in addition to a pair of apparent
singlet resonances at δ 7.16 and δ 7.04, assigned to the imidazole protons H4ꞌꞌ and H5ꞌꞌ,
respectively. Closer inspection revealed an unusually-low 3JH4-H5 coupling constant of 0.9
Hz, however this has been observed previously in the 1H NMR spectra for various
substituted N-methylimidazoles, and imidazole coupling constants are known to be pHdependent.[23h, 170] This weak 3JH4-H5 coupling was accompanied by an unusually-weak 3bond correlation in the COSY spectrum (Figure 102), however the ortho-configuration of
these two protons was confirmed by analysis of the HMBC spectrum, which showed
strong 3-bond correlations from the N-methyl group protons, H4ꞌꞌ, and H5ꞌꞌ to the
quaternary 13C resonance at δ 140.0, assigned to the imidazole C2ꞌꞌ (Figure 103).
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Figure 102: COSY spectrum for compound 235 at high intensity. Unusually-weak coupling was
observed for the imidazole protons H4'' and H5'' (highlighted in blue).

Figure 103: HMBC spectrum for compound 235, with expansion of the aromatic region (inset)
and key correlations highlighted.
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Next, the sulfur-containing heterocycle thiophene was investigated, and rapid conversion
of 2-iodothiophene to lithium dichloro(thiophen-2-yl)magnesate (236) was observed
upon treatment with i-PrMgCl.LiCl at 0 ˚C. The pale gold solution of the ate complex
was combined with indigo and warmed from -84 ˚C to room temperature over one hour,
then the intense yellow solution stirred for an additional hour prior to quenching. Bocmediated dehydration of the resulting golden residue afforded cleanly the thiophene
adduct 237 in 95% yield (Scheme 90).

Scheme 90: Synthesis of thiophene adduct 237 from 2-thiophenyl Grignard reagent 236. Li+ and
Cl- ions omitted for clarity.

Analysis of the HRESI mass spectrum of 237 revealed a peak at m/z 429.1267, assigned
to the molecular ion [C25H21N2O3S]+, corresponding to the net substitution of the
thiophene moiety for an oxygen atom, and the addition of the N-Boc substituent. Analysis
of the 1H NMR spectrum revealed a characteristic doublet-of-doublets at δ 7.14, which
showed COSY correlations to two sets of doublet-of-doublets at δ 7.40 and δ 7.60 (Figure
104), which were assigned to H4ꞌꞌ, H5ꞌꞌ, and H3ꞌꞌ of the thiophene moiety, respectively –
this assignment was supported by through-space correlation of H5ꞌꞌ to a doublet at δ 7.94
in the ROESY spectrum (Figure 105), assigned to H4 of the adjacent indole ring. Analysis
of the HMBC spectrum revealed strong, three-bond coupling of H4ꞌꞌ and H5ꞌꞌ to a
quaternary 13C resonance at δ 132.4 which also showed weak, two-bond coupling to H3ꞌꞌ,
and was therefore assigned to C2ꞌꞌ (Figure 106). H3ꞌꞌ additionally was coupled through
three bonds to a quaternary resonance at δ 121.0, assigned to the indole C3. The
oxoindolenine fragment was confirmed by the lone carbonyl resonance at δ 191.4
assigned to C3ꞌ and the characteristic

13

C resonances at δ 159.6, δ 136.6 and δ 160.3,

assigned to C2ꞌ, C6ꞌ and C7aꞌ, respectively.
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Figure 104: COSY spectrum for 235, with relevant assignments. Key correlations of the thiophene
moiety are highlighted (blue).

Figure 105: ROESY spectrum for compound 237 with relevant assignments and key correlations
between H3'' and H4 highlighted (black).
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Figure 106: HMBC spectrum for compound 237. Key correlations of the thiophene protons H3'',
H4'' and H5'' to C2'', and H3'' and H4 to C3 are highlighted (blue).

Crystals of 237 were grown by slow evaporation of a saturated hexane/CH2Cl2 solution,
and the structure unambiguously confirmed by x-ray crystallography (Figure 107).†††††
The thiophene moiety showed disordered packing in the solid state, where the two
possible rotational isomers about the biaryl axis (i.e. 237a, where the sulfur atom is
oriented toward the indole fragment, and 237b where the sulfur atom is oriented toward
the indolenine fragment) were observed in a 4:1 ratio, respectively. The central axis of
the molecule was observed to be twisted by an angle of 56.5˚, ‡‡‡‡‡ and there was no
apparent interaction between the thiophene moiety and the C3ꞌ ketone group.

†††††
‡‡‡‡‡

X-ray crystallography performed by Dr. Anthony Willis (ANU).
Calculated using Mercury v. 3.9, © Cambridge Crystallographic Data Centre.
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Figure 107: ORTEP depiction of compound 237. Top: superposition of the two isomers (237a
and 237b) resulting from disordered packing of the thiophene moiety. Bottom: The major isomer
237a, where the sulfur atom is oriented toward the 1H-indole moiety.
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Directed metalation of benzofuran has been reported to exclusively afford 2lithiobenzofuran (328),[157a] which was utilised as a means of probing the reaction’s
tolerance for oxygen heterocycles. Therefore, a solution of benzofuran (2.5 mmol) in THF
was cooled to -84 ˚C, then n-BuLi solution (2.2 mmol) added slowly, and the mixture
allowed to warm to room temperature over one hour. The resulting lithiobenzofuran
solution was added to indigo at -84 ˚C, and the deep red solution warmed to room
temperature over one hour, then stirred vigorously for a further hour. Aqueous workup
and Boc-mediated dehydration of the deep golden residue afforded a dark orange mixture,
which was separated by flash chromatography to yield the benzofuran adduct 329 in 85%
yield (Scheme 91).

Scheme 91: Regiospecific metalation of benzofuran to afford 2-lithiobenzofuran 238, used to
synthesise the benzofuran-indigo adduct 239 via Boc-mediated dehydration. Below are pictured
indicative colour changes at each point of the reaction. Steps 1), 2), and 3) are as denoted above
the reaction arrow.
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Finally, the insertion of a third indole moiety was investigated, to determine whether this
reaction would allow access to substituted terindole scaffolds. Direct lithiation of Nmethylindole afforded 2-lithio-N-methylindole (240), which upon combining with indigo
gave a deep golden adduct which underwent Boc-mediated dehydration to an unstable
product (presumably 241), which rapidly decomposed upon attempted purification by
flash chromatography, producing various polymeric materials and no viable products.
Therefore, starting from 5-iodoindole 242, N-methylation on gram-scale afforded the
corresponding N-methylindole 243 in quantitative yield. Magnesium-halogen exchange
using i-PrMgCl.LiCl gave a solution of Grignard reagent 244, which was combined with
indigo, then subjected to Boc-mediated dehydration, affording 245 in 78% crude yield
after repeated purification (Scheme 92).

Scheme 92: Attempts toward the synthesis of terindoles from indigo. Top: direct lithiation of Nmethylindole to give 241, which decomposed rapidly upon attempted purification. Middle:
preparation of indol-5-ylmagnesium chloride reagent 244. Bottom: Reaction of 244 with indigo
to give 2,2':3',5''-terindole 245.
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Terindole 245 was isolated as a crude mixture and degraded upon attempted further
purification by flash chromatography, however its structure was able to be definitely
assigned based on the isolated sample. Analysis of the HRESI mass spectrum of terindole
245 revealed a peak at 476.1968, assigned to the molecular ion [C30H26N3O3]+, revealing
the substitution of the oxygen atom for an N-methylindolyl moiety, and the incorporation
of the N-Boc substituent. Analysis of the 1H NMR spectrum revealed the sample to be
78% pure, consisting of a 4:1 ratio of the desired product and an unknown impurity which
could not be resolved by chromatographic separation, and elevated-temperature NMR
experiments (DMSO-d6, 60 ˚C) demonstrated that these additional peaks were not
attributable to previously-encountered rotamers about the biaryl and/or carbamate axes.
The sample and impurity resonances however were able to be disentangled by numerous
2D NMR experiments, allowing the structure of the major component to be confirmed.
Analysis of the 1H NMR spectrum revealed a 3H singlet at δ 3.79, assigned to the Nmethyl substituent of the indole moiety. Further downfield, the doublet at δ 6.52 showed
correlations in the COSY spectrum to the doublet at δ 7.06, assigned to H3ꞌꞌ and H2ꞌꞌ,
respectively (Figure 108). Analysis of the HMBC spectrum revealed correlations between
both H2ꞌꞌ and H3ꞌꞌ to a pair of quaternary 13C resonances at δ 128.1 and δ 136.4, assigned
to C3aꞌꞌ and C7aꞌꞌ, respectively (Figure 109). C7aꞌꞌ was also correlated to a doublet
resonance at δ 7.93, which showed meta-coupling (4JH4ꞌꞌ-H6ꞌꞌ = 1.0 Hz) to a resonance at δ
7.44, assigned to H4ꞌꞌ and H6ꞌꞌ, respectively. The remaining H7ꞌꞌ was assigned to part of
a multiplet at δ 7.34, and showed strong three-bond coupling to a quaternary resonance
at δ 122.6, assigned to C5ꞌꞌ, therefore confirming both the presence of the additional 1Hindole moiety and the regiochemistry of the C3-C5ꞌꞌ biaryl linkage. Therefore, despite the
presence of significant impurity in the sample, every individual 1H and
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C resonance

could be confidently assigned.
4.3.4 Substrate scope – summary of outcomes
Under the trialled conditions, this newly-discovered two-stage addition/dehydration
reaction of indigo with numerous alkyl, aryl, and heterocyclic organometallics afforded
rapid access to a variety of densely-functionalised desymmetrised 2,2ꞌ-diindoles, with
good functional tolerance, and in good-to-excellent yields ranging 61–95%. A summary
of the preceding outcomes of this work is provided in Figure 110.
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Figure 108: COSY spectrum for compound 245 with relevant assignments and key correlations
of the N-methylindol-5-yl moiety highlighted.

Figure 109: HMBC spectrum of compound 245, with key proton (black) and carbon (blue)
assignments as annotated on the molecule.
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Figure 110: Summary of heterocyclic compounds accessed directly from indigo via this two-stage
addition/dehydration methodology.
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4.4

Mechanistic discussion

Given both the modularity and consistency of this transformation, it is likely that all
reactions explored herein proceed via an identical mechanism, though the question
remains as to why indigo only undergoes a single nucleophilic addition, despite the
presence of both: a) two electrophilic carbonyl moieties, and b) a considerable excess
(4.0–5.0 eq.) of powerful organometallic nucleophiles. A simple answer to this question
is the considerable acidity of the indole NH groups depleting the excess reagent, however
this would only account for the loss of 2.0 equivalents of the incoming Grignard, leaving
sufficient nucleophile remaining that twofold addition would appear facile. One
explanation is related to the self-indicating nature of the reaction, where the mixture
turned an intense scarlet colour upon addition of the nucleophilic species at low
temperature. It is therefore proposed that the indigo di-anion forms a stable six-membered
chelate complex (246), where the hard Lewis acidic lithium or magnesium atoms are
bonded to the indigo core via one nitrogen atom and one oxygen atom, thus sequestering
the negative charges to one hemisphere of the diindole and deactivating one ketone group
by converting it to a stable enolate. Nucleophilic attack of the residual Grignard reagent
on the active carbonyl on the opposite hemisphere therefore would generate adduct 247,
which is hydrolysed to alcohol 58a upon aqueous workup (Scheme 93). This proposed
mechanism is consistent with our own observations, and also with the observed monoselectivity from the original 1909 study.[67]
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Scheme 93: Proposed mechanism for selective mono-Grignard addition to indigo, proceeding via
chelate complexes 246 and 247, and photographic depiction of an observed, brightly-coloured
complex (inset), showing its colour in solution at -84 ˚C.

In most cases, treatment of the resulting alcohol 58a with Boc2O resulted in rapid
dehydration, with the isolation of mixtures of N-H and N-Boc adducts 210 and 211 from
the reaction of PhMgCl suggesting that dehydration either occurs prior or independently
of N-acylation. Upon adding Boc2O to the solution of the alcohol, DMAP and NEt3, gas
evolution and an immediate endotherm were observed, and NMR analysis revealed the
presence of tert-butanol in the crude reaction mixture. This suggested that elimination of
the alcohol necessitated the formation of CO2 gas and t-BuOH as by-products, explained
by the in-situ generation and decomposition of a tert-butyl carbonate ester moiety (248)
by condensation of the alcohol with Boc anhydride. Conjugate 1,4-elimination would then
give the non-symmetrical N-H diindole 194, which could undergo N-acylation to give the
corresponding N-Boc diindole (Scheme 94). The high isolated yields and rapid reactions
of aryl Grignard reagents, combined with the failed dehydration of the methyl adduct 217
suggests that Boc-mediated dehydration requires at least moderate steric buttressing
between the substrate and the carbonate ester to proceed, and/or to prevent competing
acylation of the pro-indolenine nitrogen atom Nꞌ. Conversely, the optimal dehydration
using PPh3.I2 was only possible for the methyl adduct (see Section 4.3.1), presumably due
to the steric demands of the phosphonium species (249) generated in situ, which extrudes
PPh3O to give diindole 218.
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Scheme 94: Proposed mechanism for the Boc-mediated dehydration of alkyl- and aryl-Grignard
adducts, and the phosphine-mediated dehydration toward the methyl adduct 218.

4.5

Boc-deprotection of isolated scaffolds

With our sights set on evaluating the biological potential of these newly-accessed
heterocyclic scaffolds, the derived N-Boc indoles required deprotection to their
corresponding free N-H indoles. This could be accomplished by the action of TFA, either
neat or in CH2Cl2 solution, typically affording the free indole cleanly, and in good yields
(Scheme 95). The reaction progress was monitored by TLC analysis and by monitoring
the colour change of the reaction mixture from orange to deep blue-green, and royal
purple upon aqueous workup. In most cases, the reaction was deemed to be complete
within 2 h, however several substrates required longer reaction times in order for
complete consumption of the starting material. In addition, treatment of the N-Boc 3methoxyphenyl (223), N-methylimidazol-2-yl (235), and benzofuran-2-yl (239) adducts
(as well as the crude N-methylindol-5-yl adduct 245) led to rapid and extensive
decomposition under these conditions, and the desired free indoles were not isolated. The
exact reason for this is unknown as degradation was non-specific and led mostly to
polymeric tars and anthranilic acid derivatives, offering little information as to why it had
occurred. One common element of these substrates is their high electron density, which
may have led to acid-catalysed intramolecular cyclisation onto the adjacent carbonyl or
imine functionalities, however electron density alone does not account for the reaction’s
discrimination between the successful 2-methoxy (224), 4-methoxy (222), and 2,4dimethoxy (228), and the unsuccessful 3-methoxy (223) substrates. Degradation also
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occurred rapidly upon attempted neutral deprotection (using TBAF.H2O in THF), hence
the absence of an acid catalyst did not hinder this reactivity. The exact cause for
decomposition thus remains elusive, and requires further investigation.

Scheme 95: Isolated yields from N-Boc deprotection of synthesised substrates.
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4.6

Conclusions

As was first reported more than a century ago, indigo reacts rapidly with a variety of
Grignard reagents and organolithium species to yield tertiary alcohol adducts in excellent
yields.[67] Herein, we have re-investigated and utilised this robust reaction as a starting
point for methodology development toward the generation of diverse, functionalised, and
desymmetrised 2,2ꞌ-biindoles in high yields from this cheap and plentiful starting
material. We determined that the formation of an intramolecular chelate complex is key
for the specific insertion of a single equivalent of the desired nucleophile, and it is this
predictability and reliability that lends it toward the target-oriented synthesis of functional
materials. Where previously there were only three previously-reported examples of 3ꞌoxo-1H-3ꞌH-2,2ꞌ-biindoles, we have developed new chemistry which has allowed for the
synthesis of a total of twenty-seven novel molecules of this class, bearing either N-H or
N-Boc substituents, and featuring an array of useful functional moieties for both
incorporation into new chemical scaffolds, and for drug discovery purposes.
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Chapter 5:
Biological activity testing of indigo derivatives
5.1

Biological activity of indigo derivatives

Despite the vast body of knowledge regarding the biological activity of the isomeric 2,3ꞌlinked indirubin (36) and its derivatives as kinase inhibitors and apoptotic agents,[171]
there has been very little investigation of the biological application of the corresponding
2,2ꞌ-linked indigo (31) and its derivatives. The 5,5ꞌ-dichloroindigo-N-glycosides
akashines A-C (259–261) showed potent in vitro inhibition of numerous tumour cell lines
with reported IC50 values of 5.1–5.9 μM against human CCL-HT29 (colon carcinoma),
MEXF-514L (melanoma), LXFA-526L (lung carcinoma), MCF-7 (breast cancer), and
RXF-631L (kidney tumour) lines, among others.[172] The pseudo-dimeric natural product
bisindigotin (202) was found to inhibit dioxin-mediated ethoxyresorufin-O-deethylase
(EROD) activity for the Hep-G2 (immortalised human liver cancer) cell line (IC50 = 0.8
μM), moderating toxicity versus untreated cells,[173] and showed dual activity as an
inhibitor of both EROD and CYP1A1 (Cytochrome P450, 1-A1) induction in H4IIE (rat
hepatoma) cells.[174] Previous studies into the cascade chemistry of indigo also revealed
several potent inhibitors of the NCI-H187 (human lung cancer), and KB (human oral
cancer) cell lines, as well as the malarial vector P. falciparum K1 (drug-susceptible)
parasites. The N,Nꞌ-cyclised propargyl adduct 115 in particular showed IC50 values of
6.24 μM, 4.36 μM and 0.85 μM, respectively, against these three targets (Figure 111). We
therefore sought to examine the biological profile of all final synthesized species from the
preceding chapters. The low-micromolar inhibitory activity against P. falciparum
parasites was particularly promising, hence we sought primarily to investigate the
antiplasmodial activity of these compounds to identify potential leads for future
elaboration.
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Figure 111: Previously-reported biological activity of indigo derivates. All concentrations listed
represent IC50 values. For akashines A-C (259–261) these represent inhibition of the CCL-HT29
cell line, while for bisindigotin 202, this represents inhibition of EROD in the Hep-G2 cell line.
IC50 values for the propargyl adduct 115 are as listed for the assigned cell lines.

5.2

Antiplasmodial activity of propargylic and strained-ring adducts

The fourteen final derived species from Chapters 2 and 3 were assessed against
Plasmodium falciparum 3D7 (chloroquine sensitive) and Dd2 (drug resistant) parasite
strains, and preliminary cytotoxicity assessment was carried out using Human Embryonic
Kidney (HEK293) cells, with reference standards of artesunate, dihydroartemisinin
(DHA), chloroquine, puromycin and pyrimethamine, and 0.4% DMSO and 5 µM
puromycin used as negative and positive in-plate controls, respectively.§§§§§ The
outcomes of these assays are presented in Table 5.

§§§§§

All biological assays were performed by collaborators at Griffith University (Prof. Vicky Avery and
Dr. Leonardo Lucantoni).
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Entry

Table 5: Summary of outcomes from antiplasmodial and toxicity assays for compounds derived
from cascade reactions of indigo, as synthesised in Chapters 2 and 3.

#

1

133

Compound

3D7
(nM)

Dd2
a

(nM)

HEK293
a

11000

14000

5.6% at

±8000

±6000

80 μMb

28.4%
2

134

(nM)

a

at 80

IA

at 80

rac-

76.6

201.7

7726

152

±4.0

±7.4

±467

S-

105.6

195.5

10361

152

±37.4

±0.2

±1028

R-

88.6

164.5

10708

152

±16.3

±32.2

±1090

4

5

17.4%
at 80
μMb

>7

--

μMb

3

153

(HEK/3D7)

-31.4%

μMb

6

SI

101

98.1

120.9

-30.7%
IA

at 80

--

μMb

182

7

8

154

155

9

176

10

177

11

178

12

179

10000

22000

34.1% at

±3000

±6000

80 μMb

98.7%

73.2%

25.5%

at 160

at 160

at 160

μMb

μMb

μMb

6000

25000

14.9% at

±2000

±5000

80 μMb

3100

4000

65.9% at

±600

±2000

80 μMb

5000

8000

47.3% at

±2000

±6000

80 μMb

3700

6000

12.5% at

±700

±2000

80 μMb

>8

--

>14

--

>17

>21

183

13

14

15

16

180

183

184

185

4000

8120

6.0% at

±800

±60

80 μMb

98.6%

97.7%

65.4%

at 80

at 80

at 80

μMb

μMb

μMb

9000

16000

64.0% at

±2000

±4000

80 μMb

2800

5000

15000

±700

±2000

±2000

>20

--

--

5.3

1.1
1.7
70.7% at
-b
±0.0
±0.5
10 μM
5.8
94.6
67.4%
at
-18
Chloroquine
±0.1
±24.9
40 μMb
0.4
0.6
62.3% at
-19
Dihydroartemisinin
±0.1
±0.1
10 μMb
141.9
147.4
20
Puromycin
1202 ± 2.8
8.5
±12.7
±23.3
4.0
5.0% at
72.8% at
-21
Pyrimethamine
b
b
±0.1
40 μM
40 μM
a
Concentrations reflect calculated IC50 values. bPercentage inhibition is given where an IC50 value could
not be calculated due to the dose-response curve not reaching a full inhibition plateau at the maximum
concentration. IA = inactive.
17

Artesunate
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Of the molecules submitted for testing, the N,Nꞌ-cyclic compounds 152, 176–178, and
185 were considerably more-active than both the N,Oꞌ-cyclic molecules 153–155 and
183–184, and the propargylic adducts 133–134, which showed weak inhibitory activity
>10 μM. There was no significant difference in the activity of the isomeric
hydroxymethylpyrazinodiindoles rac-152, S-152 and R-152, which showed IC50 values
of 77.6–105.6 nM for the 3D7 parasite strain – an eight-fold improvement from the
previous benchmark 115. The structural homology of 152 and 115 (differing only by the
net hydration of the exocyclic olefin) supports the hypothesis that the incorporation of
new heteroatoms could lead to an improvement in the biological profile of the indigo
derivatives (see Chapter 3). Notable for all trialled compounds is their low cell toxicity,
with only compounds 152 and 185 showing appreciable HEK293 inhibition at their
maximum concentrations. The calculated IC50 values for 152 demonstrate it to be two
orders-of-magnitude more-potent against the 3D7 line than HEK293 line, leading to high
selectivity (SI 100-120) for the parasites over the human control. There was a noted
decrease in activity against the resistant Dd2 parasites, with IC 50 ratios Dd2:3D7 of ca.
1.5–2, however this discrepancy falls within the accepted parameters of equipotency for
this assay and does not indicate cross-species resistance.

5.3

Antiplasmodial activity of non-symmetrical 2,2ꞌ-diindoles

The non-symmetrical 2,2ꞌ-diindoles synthesised in Chapter 4 were also subjected to the
same assays, to assess their antiplasmodial potency and toxicity. Where the final
deprotected N-H indoles were unable to be synthesised, their precursor N-Boc-protected
diindoles (i.e. the 3-methoxyphenyl adduct 223, imidazole adduct 235 and benzofuran
adduct 239) were tested, and their relative activity benchmarked against a small selection
of other Boc-protected diindoles (i.e. the isopropyl adduct 210, phenyl adduct 211, 2methoxyphenyl adduct 224 and thiophene adduct 237) to determine the relative effect of
the induced substituent.****** The outcomes of this testing are summarised in Table 6.

******

All biological assays were performed by collaborators at Griffith University (Prof. Vicky Avery and
Dr. Leonardo Lucantoni).
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Table 6: Summary of outcomes from antiplasmodial and toxicity assays for compounds derived
from addition-dehydration reactions of indigo, as synthesised in Chapter 4.
Dd2
(nM)a

HEK293
(nM)a

SI
(HEK/3D7)

Entry

3D7
(nM)a

#

1

209

610.2
±39.7

811.1
±72.2

22394
±1432

36.7

2

210

2207
±1043

2832
±1142

10356
±994

4.7

3

211

7485
±2512

9690
±2331

66.1% at
80 μMb

--

4

214

6911
±637

8236
±1321

4.2% at
80 μMb

>12

5

218

51.8
±4.2

84.7
±11.1

22.9% at
80 μMb

>1544

6

223

3958
±423

4694
±1044

20.1% at
80 μMb

>20

7

224

7036
±1221

7561
±1695

55.8% at
80 μMb

--

Compound

186

8

235

6380
±1321

6160
±1127

9.7% at
80 μMb

>12

9

237

2724
±674

2582
±577

53.1% at
80 μMb

--

10

239

2344
±1122

2642
±818

35.1% at
80 μMb

>34

11

250

951
±289

841
±80

2.1% at
80 μMb

>84

12

251

800
±167

747
±55.7

17.2% at
80 μMb

>100

13

252

1449
±264

1686
±311

1.1% at
80 μMb

>70

14

253

5003
±1511

6543
±1018

3.2% at
80 μMb

>16

187

15

254

3617
±173

4000
±544

4.7% at
80 μMb

>22

16

255

5770
±1620

4948
±339

7.9% at
80 μMb

>14

17

256

765
±128

733
±111

-0.6% at
80 μMb

>104

18

257

4145
±1115

3923
±255

3.6% at
80 μMb

>19

19

258

5103
±1373

4207
±528

7.1% at
80 μMb

>15

6.0
6.4
35.7% at
>1666
±2.5
±2.2
10 μMb
29.3
308.8
56.2% at
21
Chloroquine
-±7.5
±82.7
40 μMb
100.4
75.1
819.6
22
Puromycin
8.16
±29.5
±22.5
±84.8
14.5
17.3% at 56.2% at
23
Pyrimethamine
-±2.8
40 μMb
40 μMb
14.4
3572
24
Pyronaridine
248
±4.6
14.7
±349
a
Concentrations reflect calculated IC50 values. bPercentage inhibition is given where an IC50 value could
not be calculated due to the dose-response curve not reaching a full inhibition plateau at the maximum
concentration. IA = inactive.
20

Artesunate
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The free indoles 209, 214, 218, and 250–258 exhibit a broad array of IC50 values against
the 3D7 line, ranging 51.8 nM (218) to 6.91 μM (214). In general, compounds with
smaller alkyl substituents were more-active than those bearing aromatic substituents,
however notable substituent effects were observed for the substituted aryl adducts. Aryl
adducts bearing para-substituents (e.g. the 4-fluorophenyl 256 – 0.765 μM; and 4methoxyphenyl 252 – 1.44 μM) led to increased potency as compared with the parent
phenyl compound. The exceptionally-low toxicity of all tested compounds (evidenced by
low percentage inhibition of HEK293 at the maximum concentration 80 μM) is notable,
and led to the outstanding selectivity of 218 (SI >1544).

5.4

Proposed mechanism of action

Previous study into the synthesis and mode-of-action of other 2-substituted-3H-indol-3ones and indolone-N-oxides against P. falciparum (FcB1 strain) suggested that these
readily undergo single-electron reduction of the C=N functionality to give persistent
carbon-centred radicals,[165a] which may activate a redox signalling pathway, leading to
eventual haemolysis and death of the nascent parasites.[175] The substituents examined
largely consist of substituted-phenyl (typically electron-donating, e.g. the 4dimethylaminophenyl 262 and 263 or 4-isopropoxyphenyl 264 and 265, though the 4nitrophenyl-substituted 266 showed similar potency) moieties at the 2-position, providing
stabilisation to the indolyl C2 radical generated.[176] The nature of the stabilisation is
likely mesomeric, as the replacement of the phenyl substituent with alkyl groups led to
complete loss of activity (e.g. the n-propyl adduct 267, which showed three orders-ofmagnitude lower potency). Many of these molecules exhibit similar potency and
specificity against P. falciparum to the lead methyl compound 218, therefore it is
hypothesised that these share a common mode-of-action, whereby the rapid reduction of
the C=N group under hypoxic conditions (in the presence of cysteine- and methioninerich reductases or glutathione, both of which are prevalent in red blood cells) leads to the
stable radical 268.[176] The oxidising potential of 268 leads to hyperphosphorylation of
tyrosine residues in the cell membrane and consequent membrane-cytoskeleton
decoupling.[177] The high concentration of reactive oxygen species (e.g. H2O2) in infected
haemocytes have also been hypothesised to participate in pseudo-catalytic recycling of
the pro-radical, possibly contributing to its high potency.[165a]
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Scheme 96: Comparison of the lead compound 218 with previously-investigated 2-substituted3H-indol-3-ones with similar biological activity against P. falciparum (FcB1), and the proposed
mechanism-of-action of the methyl adduct 218.[165a, 175-177]

It is demonstrated here that the 3-methyl-2-indolyl substituent shows similar activity,
presumably due to the extended conjugation of the diindole system, and the stabilising
effect of the methyl substituent.[178] This radical mode-of-action also explains the
unexpected potency of the 4-fluorophenyl (256) and 4-methoxyphenyl (252) adducts
relative to the corresponding phenyl adduct 214, with both the para-fluoro and methoxy
groups acting as strong radical stabilisers.
In summary, of the thirty-five compounds subjected to biological testing, thirty-one
showed micromolar activity against P. falciparum (3D7), and of these, seven showed submicromolar IC50 values, with the pyrazinodiindole 152 and the 3-methyl-2,2ꞌ-biindol-3one 218 emerging as promising leads with exceptional activity and selectivity.
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Chapter 6:
Conclusions and future directions
The pursuit of diversity in small-molecule libraries is of paramount importance to the
discovery and development of new heterocyclic molecules for pharmaceutical, industrial,
and material applications. We have utilised the unique, multi-faceted reactivity of the
ancient dye indigo as the foundation for the development of new heterocyclic libraries
and synthetic methodologies, employing both its ability to undergo cascade reactions, and
its overlooked ability to undergo Grignard reactions to generate new, highly-potent and
selective leads for drug discovery.

6.1

Reactions of indigo with propargylic electrophiles (Chapter 2)

This brief study into the reactivity of substituted arylpropargyl bromides was intended to
supplement both previous and parallel studies within our group.[116b, 127] Previous study
of the reaction of 3-chloro-1-phenyl-1-propyne with indigo resulted in the isolation of
compounds 122 (27%) and 123 (35%), however it was unclear whether these arose from
the conjugated phenyl group or the weaker chloride leaving group. Using the bromide
leaving group under optimised conditions, compounds 122 (37%) and 123 (12%) were
isolated in addition to the new ring-expanded adduct 133 in 35% yield (Scheme 97). The
disparate outcomes of the two reactions indicate the nature of the leaving group to play a
pivotal role in pathway discrimination for these cascade reactions. The methoxysubstituted arylpropargyl bromide gave a 21% yield of the ring-expanded 134, though
parallel studies have shown that the presence of electron-withdrawing substituents leads
to rapid polymerisation, making these unsuitable substrates. Initial biological studies of
133 and 134 suggested these to be nontoxic, however their poor aqueous solubility
contributed to their mediocre antiplasmodial activity in vitro, suggesting that aryl
substituents do not confer favourable characteristics.
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Scheme 97: Cascade reactions of aryl-substituted propargyl bromides gave access to 122, 123 and
133-134.

While there has been considerable progression in understanding of the cascade reactions
of indigo with propargylic systems, there are several remaining avenues worthy of
exploration. One involves a two-step protocol, whereby treating indigo with propargyl
chloroformate (270) would give N,Nꞌ-di-proc indigo (271), which could undergo
decarboxylation using Pd(0), as has been previously-explored with N,Nꞌ-di-alloc indigo
(272). Under these conditions, 272 underwent transformation firstly to N,Nꞌ-di-allyl
indigo (273), then to the azepinodiindole 274 in quantitative yield by N,Oꞌ-cyclisation.
The corresponding transformation of 271 could afford selective access to N,Nꞌ-dipropargyl indigo (275) in situ, which may then undergo further cyclisation and/or
derivatisation to more-complex chemical scaffolds.
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Scheme 98: Proposed future development of decarboxylative rearrangement of diproc indigo 271
to dipropargyl indigo 275, which may be derivatised into other useful molecules.

6.2

Reactions of indigo with ring-strained electrophiles (Chapter 3)

Our study into the cascade reactions of indigo with ring-strained electrophiles revealed a
pair of divergent mechanisms, whereby a heteroatom-dependent N,Nꞌ- or N,O-cyclisation
gave

rise

to

either

substituted

pyrazinodiindoles

and/or

spirocyclic

epoxyoxazocinodiindoles in good yields in a one-pot setting (Scheme 99). The reaction
of indigo with (S)-epichlorohydrin (144) was optimised to give the N,Nꞌ-cyclic 152 and
N,Oꞌ-spirocyclic 153, and the allylic alcohol 155 in a combined 95% yield, or instead to
give mixtures of 152, 153 and the cyclic carbonate 154 in similar yields. Replacing the
halide pendant with a bromide or tosylate led to exclusive formation of 152, in 84% and
76% yield, respectively. Compound 152 showed potent and selective P. falciparum
inhibition, with IC50 values as low as 76 nM and SI values >100. This was an order-of
magnitude more-active than the non-hydroxylated analogue 115, suggesting the
additional heteroatom to be beneficial toward its antiplasmodial activity.
The (chloromethyl)aziridine 148 was synthesised in enantiopure fashion in 64% yield
over three steps from (S)-epichlorohydrin (144), or in 74% yield over two steps from
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racemic (bromomethyl)aziridine 147 via a mixed bromo-chloro species (171). Treatment
of indigo with (R)-148 gave complex mixtures of the pyrazinodiindoles 176-178 in a
combined 63% yield following flash chromatography and subsequent RP-HPLC
separation. Using the racemic (bromomethyl)aziridine 147 led to rapid polymerisation,
however the racemic 176 was isolated in 52% yield, alongside a statistical mixture of the
diastereomers of N-aziridinyl adduct 177 in 38% yield. Treatment of indigo with
phenylaziridine 174 afforded a 1.7 : 1 ratio of the terminal adduct 179 and the benzylic
adduct 180 in a combined 98% yield, suggesting that cyclisation could not occur in the
absence of a halide pendant.

Scheme 99: Major mechanistic pathways from the reactions of indigo with ring-strained
electrophiles – Path A involves N,N'-cyclisation and Path B involves N,O'-cyclisation, or no
cyclisation was observed.

The dimeric bioxirane 149 and biaziridine 150 were synthesised according to literature
procedures, and treatment of indigo with bioxirane 149 led exclusively to the N,Oꞌspirocyclic adducts 183 and 184 in 62% and 19% yield, respectively, while the reaction
of indigo with biaziridine 150 gave a 93% yield of the lone N,Nꞌ-cyclic diazepinodiindole
185. Given that there is an established protocol for the synthesis of mixed epoxy-aziridine
species 276,[179] preferential oxirane ring-opening could lead to an intermediate
epiminoalkoxide (277), which could then lead to the formation of aminomethylsubstituted N,Oꞌ-cyclised spiroketals such as 278. Derivatisation of 278 (e.g. via
bidirectional N- or Nꞌ-alkylation) could allow for tuning of its fluorescent properties for
bioconjugative applications (Scheme 100).
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Scheme 100: The dimeric biaziridine exclusively afforded N,N'-cyclic compound 185 while
bioxirane instead gave exclusively products 183 and 184 via N,O'-spiroketalisation. The proposed
epoxyaziridine 276 could allow access to amino-substituted spiroketals (278) from the putative
alkoxide 277 by dearomative cylisation.

While attempting to synthesise the (chloromethyl)aziridine 148, a potentially-useful
synthetic route toward intermolecular di-sulfonamidation of olefins was serendipitously
discovered using chloramine-T under iodine-catalysed conditions. Under unoptimized
conditions using allyl alcohol as a model substrate, a 1 : 1.5 ratio of aziridine 163 :
diamide 166 was obtained, which could be improved to give a 75% isolated yield of the
di-adduct 166. Under unoptimized conditions, this reaction was also applied to
cyclohexene to give diamide 169 in 20% yield, presumably due to the low reactivity oaf
the azabicyclo[1.1.0]heptane intermediate 168, which was also isolated in 78% yield.
Therefore, while this represents an important net transformation, further optimisation is
necessary to provide a robust methodology for the diamination of alkenes. Given the
success of copper-catalysed asymmetric olefin aziridination using amino acid-derived
box ligands,[180] similar catalyst systems could be utilised as a starting point toward
generating chiral aziridine intermediates (279) in situ, which could be ring-opened to
disulfonamides (280), and chiral diamines (281) upon N-deprotection (Scheme 101).
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Scheme 101: Proposed methodology for diamination of alkenes, stemming from an observed
diamidation of allyl alcohol upon attempted aziridination.

Additionally, the initial (chloromethyl)aziridine target (R)-148 or its enantiomer (S)-148
could themselves be used as a foundation for chiral amine synthesis, by chemoselective
bidirectional ring-opening and subsequent halide-displacement. This could allow
application toward analogues of the spiroindolone drug cipargamin (282), which is
currently under investigation for the treatment of malaria (Scheme 102).[181] Briefly, this
could involve selective indole-3-functionalisation via an indolylcuprate,[182] followed by
displacement of the chloride (e.g. by F-, amines, alkoxides, thiolates, etc.), reductive
deprotection of the N-tosyl group with Mg0, and condensation with 5-chloroisatin to give
the desired cipargamin analogues. The initial ring-opening reaction could also be adapted
toward the synthesis of various other tryptamine-containing natural products, thus making
148 a valuable chiral building block.
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Scheme 102: Proposed synthesis of analogues of the antimalarial drug candidate cipargamin (282)
from (S)-148.

6.3

Reactions of indigo with organometallic nucleophiles (Chapter 4)

Throughout the course of this work, we have developed a new methodology for the
desymmetrisation of indigo by Grignard addition and subsequent dehydration to a variety
of non-symmetrical [1H,3ꞌH]-2,2ꞌ-diindole-3ꞌ-ones in excellent yields over two steps.
Twenty-seven derivatives of this class were synthesised, where previously there had only
been three reported derivatives – one natural product and two synthetic intermediates.
The reaction proved tolerant to alkyl (methyl 218, isopropyl 210, butyl 215, and benzyl
219), phenyl (211) and substituted phenyl (4-methoxy 222, 3-methoxy 223, 2-methoxy
224, 2,4-dimethoxy 228, 2-chloro 232, and 4-fluoro 231) and heteroaryl (3-pyridyl 233,
N-methylimidazol-2-yl 235, 2-thiophenyl 237, and 2-benzofuranyl 239) substrates, with
all compounds isolated in 72-95% yield from indigo (Scheme 103). The N-methylindol5-yl adduct 245 was also synthesised in 78% crude yield (61% by 1H NMR), however it
was isolated alongside an irresolute impurity which could not be removed.

197

Scheme 103: The sixteen isolated scaffolds from reactions of Grignard reagents with indigo.

Of the fifteen isolated N-Boc indoles synthesised, eleven were able to be deprotected to
their corresponding free indoles (209, 214, and 250–258), while the methyl adduct 218
was isolated as the free indole. Evaluation of the biological activity of these twelve free
indoles revealed that 218 exhibited potent and highly-selective antiplasmodial activity,
with IC50 values against P. falciparum of 52 nM, and SI values >1500 in vitro. The
structural homology and similar biological profile of 218 to other 2-aryl-3-oxoindolenines
suggest a similar mechanism of action, where P. falciparum propagation is inhibited by a
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hypoxia-induced single-electron reduction, leading to stable radical intermediates which
trigger hyperphosphorylation and eventual haemolysis of infected blood cells prior to
parasite maturation.[165a] This mechanism of action was supported by SAR trends, where
the strongly-stabilising benzyl 251, 4-fluorophenyl 256 and 4-methoxyphenyl 252
moieties presumably led to increased radical stabilisation,[178] evidenced by their lower
IC50 values of 0.80 μM, 0.77 μM and 1.44 μM, respectively, compared with the parent
phenyl 214 (IC50 6.91 μM) (Scheme 104).

Scheme 104: The twelve isolated free indoles from this study, with comparison of their IC50 values
against P. falciparum (3D7) parasites in vitro.

Given that 2-aryl-3-oxoindolenine-N-oxides have previously showed increased activity
against P. falciparum relative to their parent heterocycle,[165a, 175-177] an obvious direction
for future development would be to examine the biological properties of the N-oxides of
the diindoles synthesised as part of this study. Chemoselective oxidation of nitrogen
heterocycles (e.g. pyridines to pyridine-N-oxides) is well-known using numerous
reagents (e.g. m-CPBA, H2O2-urea complex),[183] and the corresponding transformation
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has been previously-adapted to simple 2,3,3-trisubstituted-3H-indoles by reduction to the
corresponding indoline, and back-oxidation with m-CPBA to yield the N-oxide
species.[184] As the indigo core has previously been demonstrated to be susceptible to
oxidative cleavage, it is unknown whether the conditions required for N-oxide formation
(i.e. to 283) would also trigger C2-C2ꞌ-cleavage to substituted isatins and/or anthranilic
acid derivatives.[116b] Further derivatives with vinyl (284), fluoromethyl (285), and
difluoromethyl (286) substituents could also be explored to improve the stability of the
active radical species, while additional substituents about the indigo core could also
improve its membrane permeability, which in previous studies of 5-methoxy-3oxoindolenines (e.g. 287) was observed to increase antiplasmodial activity relative to
their non-substituted counterparts (288). The 5ꞌ-methoxy and 5,5ꞌ-dimethoxy species 289
and 290 would therefore be attractive scaffolds for further derivatisation (Scheme 105).

Scheme 105: Proposed derivatives for further biological evaluation and optimisation: a) N-oxide
formation, b) new radical-stabilising adducts such as the vinyl 284, and fluorinated adducts 285
and 286, and c) methoxylated adducts 289 and 290.
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This methodology could also be applied as a starting point for the synthesis of complex
polycyclic structures. The natural product indimicin A (197) features a non-symmetrical
2,2ꞌ-diindole core, with a fused N-methylpyrrole substituent, and has not been synthesised
previously.[185] The addition-dehydration of N-methylpyrrol-3-ylmagnesium chloride 291
to 5,5ꞌ-dichloroindigo (292) could give access to the desymmetrised N-Boc adduct 293,
which could then undergo N-methylation and selective reduction of the iminium ion to
give the racemic N-methylindoline 294. Nucleophilic addition to the carbonyl on the lesshindered face with methyllithium could then afford the tertiary alcohol 295, which upon
treatment with TfOH could undergo both Boc deprotection and dehydration of the alcohol
group, leading to cationic intermediate 296, and subsequent Friedel-Crafts alkylation of
the nearby pyrrole at the syn-face to afford the desired diastereomer of indimicin A
(Scheme 106). Using alternatively-substituted pyrroles in the first step could also give
access to indimicins B, C, and D (198–200) following this pathway.

Scheme 106: Proposed synthesis of indimicin A (197) using this developed methodology,
following the addition of a pyrrole substituent to dichloroindigo 292 in the intial step to give the
desymmetrised adduct 293.
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6.4

Conclusion

Throughout the course of this investigation, we have a) examined the cascade reactions
of indigo with propargylic electrophiles to produce various fused-ring and ring-expanded
adducts, b) investigated cascade reactions with ring-strained electrophiles to generate a
variety of N,Oꞌ-spirocyclic and N,Nꞌ-cyclic molecules, and c) developed new
methodology for the construction of non-symmetrical 2,2ꞌ-diindoles by reacting indigo
with various organometallic nucleophiles. Where previously it was thought that indigo
was relatively inert,[50d] we have established a variety of methods for its rapid
derivatisation into highly-functionalised and biologically-active materials. Indigo’s
unique reactivity is a result of the functional density of its core, and our proposed reaction
mechanisms demonstrate that the conjugation of the indigo moiety allows its reactivity to
change between individual steps in the cascade process, rapidly building molecular
complexity. This unusual and rapidly-oscillating reactivity however remains
unpredictable, and we still do not possess a complete understanding of the reactivity of
indigo. These investigations have revealed numerous key pieces of information, however
there is much that requires further exploration, and we have only begun to scratch the
surface of indigo’s unique chemistry.
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Chapter 7:
Experimental Data
7.1.

General experimental information

Reagents and solvents were purchased reagent grade and used without further purification
unless otherwise stated. All reactions were performed in standard oven-dried glassware
under CaCl2-dried nitrogen gas unless otherwise stated. Anhydrous DMF (99.9%) was
purchased from Sigma Aldrich and used without further purification. Indigo dye was
purchased from Sigma Aldrich, or from AK Scientific and used without further
purification. THF was dried by distillation from Na/benzophenone and stored over 3 Å
molecular sieves prior to use. All solutions of Grignard reagents or organolithium
reagents were titrated prior to use, using either 2-butanol or menthol in THF with 1,10phenanthroline as indicator. Melting point temperatures are expressed in degrees Celsius
(˚C) and are uncorrected. 1H and 13C NMR spectra (CDCl3/DMSO) were recorded either
at 500 MHz and 125 MHz, or 400 MHz and 101 MHz, respectively, with chemical shifts
(δ) reported as parts per million relative to TMS (δ = 0.00 ppm), CDCl3 (δ = 7.26; 77.0
ppm) or DMSO-d6 (δ = 2.50 ppm; 39.51 ppm). 19F NMR spectra (CDCl3) were recorded
at 470 MHz or 377 MHz, with chemical shifts (δ) reported as parts per million relative to
CFCl3 (δ = 0.00 ppm). Coupling constants (J) are reported in Hertz (Hz). Multiplicities
are reported as singlets (s), doublets (d), triplets (t), doublet of doublets (dd), quartets (q),
hextets (h), heptets (hept), or multiplets (m). Electrospray (ESI single quadrupole) mass
spectra have their ion mass to charge values (m/z) stated with their relative abundances as
a percentage in parentheses. Peaks assigned to the molecular ion are denoted as [M+H]+
or [M+Na]+. HR-ESI mass spectra were recorded using a XEVO QToF instrument, with
LeuEnk as internal standard. Infrared (IR) spectra were recorded neat. UV-visible
absorption spectra were recorded as solutions in CH2Cl2 or acetone at room temperature.
Optical rotations were recorded in CHCl3 or CH2Cl2 at room temperature. Thin layer
chromatography (TLC) was performed using silica gel F254 aluminium sheets. Column
chromatography was performed using silica gel 60 (0.063-0.200 mm). Eluents are
reported in volume to volume (v:v) ratios. Solvent extracts and chromatographic fractions
were concentrated by rotary evaporation in vacuo. Petroleum spirit had a bp range of 4060 ˚C.
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7.2

Reactions of indigo with propargylic electrophiles

7.2.1. Synthesis of starting materials
bis-(triphenylphosphine)palladium (II) chloride [Pd(PPh3)2Cl2][128]
A suspension of palladium(II) chloride (1.02 g, 5.75 mmol) and
triphenylphosphine (3.26 g, 12.4 mmol) in benzonitrile (30 mL) was
heated at 180 °C with vigorous stirring for 20 min under dry N2, then
allowed to cool to RT overnight. The resulting bright-yellow crystals were collected by
vacuum filtration, washed with ether (3×50 mL) and dried in vacuo to give bis(triphenylphosphine)palladium(II) chloride (3.85 g, 95%) as fine, bright yellow needles.
3-(4-methoxyphenyl)prop-2-yn-1-ol (131a)
A 250 mL round-bottomed flask equipped for magnetic
stirring was charged with 4-iodoanisole (5.03 g, 21.5 mmol),
Pd(PPh3)2Cl2 (300 mg, 0.43 mmol, 2 mol%), and CuI (410 mg,
2.15 mmol, 10 mol%), then evacuated and backfilled thrice with dry nitrogen. The solids
were suspended in toluene (40 mL) and MeCN (40 mL), and the mixture cooled to 0 ˚C,
then NEt3 (14.5 g, 143 mmol) and propargyl alcohol (6.00 g, 107 mmol) were added
slowly. The ice bath was removed, and the resulting thick emulsion stirred vigorously for
2 d under a nitrogen balloon, then the solvent removed in vacuo. The dark-brown, tarry
residue was taken up in EtOAc (200 mL), and filtered over a plug of silica (eluting with
EtOAc, 200 mL), and the combined fractions washed sequentially with 1 M HCl (4×50
mL), and sat. NaHCO3 (4×50 mL), dried (MgSO4), and the solvent removed to afford the
desired arylpropargyl alcohol 131a (3.48 g, 99%) as pale amber crystals, mp. 74–76 ˚C,
lit. 77–78 ˚C.[186] Rf (20% EtOAc/pet spirit) 0.37. 1H NMR (CDCl3, 500 MHz) δ 7.37 (d,
J = 8.5 Hz, 2H, H2', H6ꞌ), 6.84 (d, J = 8.5 Hz, 2H, H3', H5'), 4.47 (s, 2H, H1), 3.81 (s,
3H, OCH3), 1.68 (bs, 1H, OH).

13

C NMR (126 MHz) δ 159.8 (C4ꞌ), 133.2 (C2ꞌ, C6ꞌ),

114.7 (C1ꞌ), 114.0 (C3ꞌ, C5ꞌ), 85.9 (C3), 85.6 (C2), 55.3 (-OCH3), 51.7 (C1). HRESI-MS
calcd. for C10H11O2+ 163.0754, found 163.0760.
3-phenylprop-2-yn-1-ol (131b)
Prepared as 131a, except using iodobenzene (4.38 g, 21.5 mmol),
and a lower catalyst loading of Pd(PPh3)2Cl2 (147 mg, 0.209 mmol,
1 mol%). Following aqueous workup, the residue was subjected to
flash chromatography (45 g silica, 20% EtOAc/hexane), affording the desired
arylpropargyl alcohol (2.83 g, 100%) as a pale amber oil. Rf (60% CH2Cl2/pet spirit) 0.50.
204

1

H NMR (CDCl3, 400 MHz) δ 7.39 (d, J = 8.0 Hz, 2H, H2', H6ꞌ), 7.30 – 7.20 (m, 3H, H3',

H4ꞌ, H5'), 4.43 (s, 2H, H1), 1.71 (bs, 1H, OH). 13C NMR (101 MHz) δ 131.5 (C2ꞌ, C6ꞌ),
128.3 (C4ꞌ), 128.2 (C3ꞌ, C5ꞌ), 122.5 (C1ꞌ), 87.3 (C3), 85.4 (C2), 51.2 (C1). HRESI-MS
calcd. for C9H9O+ 133.0648, found 133.0643.
3-(4-nitrophenyl)prop-2-yn-1-ol (131c)
Prepared as 131a, except using 4-iodonitrobenzene (5.33 g,
21.4 mmol). Following aqueous workup, the residue was
passed through a plug of silica using EtOAc as eluent, and the
desired arylpropargyl alcohol was isolated (3.60 g, 95%) as tan crystals, mp. 109–110 ˚C,
lit. 113–114 ˚C.[187] Rf (60% CH2Cl2/pet spirit) 0.12. 1H-NMR (CDCl3, 500 MHz) δ 8.18
(d, J = 8.5 Hz, 2H, H3', H5ꞌ), 7.57 (d, J = 8.5 Hz, 2H, H2', H6'), 4.53 (s, 2H, H1), 1.69
(bs, 1H, OH). 13C NMR (101 MHz, CDCl3): δ 147.3 (C4ꞌ), 132.4 (C2ꞌ, C6ꞌ), 129.4 (C1ꞌ),
123.6 (C3ꞌ, C5ꞌ), 92.5 (C3), 83.8 (C2), 51.5 (C1). HRESI-MS calcd. for C9H8O3N+
178.0499, found 178.0494.
3-(3-methoxyphenyl)prop-2-yn-1-ol (131d)
Prepared as 131a, except using 3-iodoanisole (0.47 g, 2.0
mmol). Following aqueous workup, the desired arylpropargyl
alcohol was isolated (0.31 g, 96%) as a brown oil. Rf (10%
EtOAc/pet spirit) 0.21. 1H NMR (CDCl3, 400 MHz): δ 7.21 (dd, J = 8.4 Hz, 7.6 Hz, 1H,
H5ꞌ). 7.04 (d, J = 7.6 Hz, 1H, H6ꞌ), 7.01 – 6.97 (m, 1H, H2ꞌ), 6.88 (dd, J = 8.4 Hz, 2.0 Hz,
1H, H4ꞌ), 4.51 (s, 2H, H1), 3.82 (s, 3H, OCH3), 1.55 (bs, 1H, OH). 13C NMR (CDCl3, 101
MHz): δ 158.7 (C3ꞌ), 128.9 (C5ꞌ), 123.8 (C1ꞌ), 123.1 (C2ꞌ), 116.1 (C6ꞌ), 114.5 (C4ꞌ), 86.8
(C3), 84.9 (C2), 54.8 (-OCH3), 50.9 (C1). HRESI-MS calcd. for C10H11O2+ 163.0754,
found 163.0763.
3-bromo-1-(4-methoxyphenyl)-1-propyne (132a)
A solution of triphenylphosphine (1.91 g, 7.3 mmol) in CH2Cl2
(20 mL) was cooled to 0 ˚C, then bromine (1.17 g, 7.3 mmol)
added slowly. The resulting yellow suspension was stirred
vigorously for 30 min at 0 ˚C, then a solution of 131a (0.962 g, 5.93 mmol) in CH2Cl2
(20 mL) added dropwise over 15 min. The mixture was stirred for 1 h, then diluted with
hexanes (70 mL) and filtered through silica to remove precipitated PPh3O. The collected
filtrate was concentrated in vacuo, and the residue taken up in a minimum of Et2O and
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passed through a plug of silica, eluting with pet spirit.†††††† Removal of the solvent gave
the corresponding arylpropargyl bromide 132a (1.32 g, 99%) as a yellow oil. Rf (10%
EtOAc/pet spirit) 0.79. 1H NMR (CDCl3, 500 MHz) δ 7.38 (d, J = 8.5 Hz, 2H, H2', H6ꞌ),
6.84 (d, J = 8.5 Hz, 2H, H3', H5'), 4.17 (s, 2H, H1), 3.81 (s, 3H, -OCH3). 13C NMR (125
MHz) δ 160.1 (C4ꞌ), 133.6 (C2ꞌ, C6ꞌ), 114.3 (C1ꞌ), 114.1 (C3ꞌ, C5ꞌ), 87.0 (C3), 83.0 (C2),
55.5 (-OCH3), 15.9 (C1). EI-MS (+) 226+ (8%, 81BrM+), 224+ (8%, 79BrM+), 145+ (100%,
[M – Br•]+).
3-bromo-1-phenyl-1-propyne (132b)
Prepared as 132a, except using 131b (0.661 g, 5.00 mmol),
triphenylphosphine (1.46 g, 5.56 mmol) and bromine (0.889 g, 5.56
mmol), and the mixture stirred at 0 ˚C for 1 h. The solvent was
removed in vacuo and hexane (10 mL) added, and the precipitated solids washed with
further hexane (2×5 mL). The combined filtrates were concentrated in vacuo, and
subjected to flash chromatography (25 g silica, 60% CH2Cl2/pet spirit), to afford the
desired arylpropargyl bromide (0.968 g, 99%) as a pale-yellow oil. Rf (10% EtOAc/pet
spirit) 0.70. 1H NMR (400 MHz, CDCl3): δ 7.51 – 7.42 (m, 2H, H3ꞌ, H5ꞌ), 7.40 – 7.29 (m,
3H, H2ꞌ, H4ꞌ, H6ꞌ), 4.18 (s, 2H, H1). 13C NMR (101 MHz, CDCl3): δ 131.8 (C1ꞌ), 128.8
(C3ꞌ, C5ꞌ), 128.3 (C2ꞌ, C6ꞌ), 122.1 (C4ꞌ), 86.7 (C3), 84.2 (C2), 15.3 (C1). EI-MS (+) 196+
(8%, 81BrM+), 194+ (8%, 79BrM+), 115+ (100%, [M – Br•]+).
3-bromo-1-(4-nitrophenyl)-1-propyne (132c)
Prepared as 132a, except using 131c (0.885 g, 5.00 mmol),
triphenylphosphine (1.44 g, 5.49 mmol) and bromine (0.870 g,
5.44 mmol), and the mixture stirred at 0 ˚C for 1 h. The solvent
was removed in vacuo and hexane (10 mL) added, and the precipitated solids washed
with further hexane (2×5 mL). The combined filtrates were concentrated in vacuo, and
subjected to flash chromatography (25 g silica, 60% CH2Cl2/pet spirit), to afford the
desired arylpropargyl bromide (1.13 g, 94%) as a bright yellow powder. Rf (30%
CH2Cl2/pet spirit) 0.62. 1H NMR (400 MHz, CDCl3): δ 8.19 (d, J = 8.5 Hz, 2H, H3ꞌ, H5ꞌ),
7.59 (d, J = 8.5 Hz, 2H, H2ꞌ, H6ꞌ), 4.17 (s, 2H, H1). 13C NMR (101 MHz, CDCl3): δ 147.4
(C4ꞌ), 132.6 (C3ꞌ, C5ꞌ), 128.9 (C1ꞌ), 123.6 (C2ꞌ, C6ꞌ), 89.3 (C3), 84.3 (C2), 14.0 (C1). EIMS (+) 241+ (8%, 81BrM+), 239+ (8%, 79BrM+), 160+ (100%, [M – Br•]+).

††††††

Alternatively, the crude mixture could be stirred overnight with anhydrous ZnCl2 (2.0 eq.) in EtOAc,
and the ZnCl2/PPh3O complex removed by filtration. The isolated yield for this procedure was 72%.
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7.2.3. General Procedure A for alkylation of indigo
A suspension of indigo (262 mg, 1.00 mmol) in anhydrous DMF (40 mL) was sonicated
at 60 ˚C for one hour. The resulting hot suspension was transferred by cannula under
positive pressure of nitrogen into a 100 mL round-bottomed flask containing a magnetic
stir bar, pre-dried and ground Cs2CO3 (1.206 g, 3.700 mmol), and fitted with a rubber
septum. The resulting dark-green to amber solution was stirred for one hour in an oil bath,
pre-heated to strictly 85-87 ˚C under dry nitrogen. The nitrogen flow was cut, and the
electrophile (5.0 mmol) injected through the septum either neat, or as a solution in DMF
(2 mL), and the mixture stirred at 85-87 ˚C for the required time. The resulting intenselycoloured solution was quenched over crushed ice (ca. 100 g), and the flask rinsed with
EtOAc (ca. 10 mL) to remove adhered products. Upon warming to RT, the emulsion was
saturated with solid NaCl, and extracted with EtOAc (4×60 mL) or CHCl3 (4×60 mL)
until the aqueous phase became clear. The combined organic fractions were condensed to
ca. 150 mL, then extracted with brine (4×40 mL), dried (MgSO4), and filtered through a
2 cm plug of celite, and the solvent removed in vacuo.
7.2.4. Reaction of indigo with 3-bromo-1-phenyl-1-butyne (131b)
7-hydroxy-8-phenylazepino[1,2-a:3,4-b']diindol-14(13H)-one (122)
Prepared following General Procedure A (see Section
7.2.3), using arylpropargyl bromide 131b (0.985 g, 5.05
mmol), and 4 Å molecular sieves (ca. 0.5 g) and a 30 min
reaction time. The crude residue was fractionated on silica
gel (80 g), eluting sequentially with 1) 60% CH2Cl2/hexane
(Fraction 1), 2) CH2Cl2 (Fraction 2), 3) 10% EtOAc/CH2Cl2 (Fraction 3), and the
column stripped using EtOAc (Fraction 4). Removal of the solvent from Fraction 1
afforded the known azepinodiindolone 122 (139 mg, 37%) as a bright yellow powder, mp
149-151 ˚C. Spectral and physical characteristics were identical to those previously
reported.[116b] Rf (10% EtOAc/hexane) 0.47. 1H NMR (CDCl3) δ 8.76 (d, J = 7.8 Hz, 1H,
H9), 8.22 (d, J = 7.6 Hz, 1H, H12), 8.03 (dd, J = 7.9, 1.4 Hz, 1H, H1), 7.85-7.82 (m, 1H,
H3), 7.73 – 7.66 (m, 2H, H2, H11), 7.60 (d, J = 8.0 Hz, 1H, H4), 7.53 – 7.46 (3H, m, H3ꞌ,
H5ꞌ, H10), 7.39 – 7.35 (3H, m, H2ꞌ, H4ꞌ, H6ꞌ), 6.91 (1H, s, H6). 13C NMR (CDCl3) δ 184.6
(C14), 159.3 (C7), 152.2 (C12a), 144.5 (C8b), 143.0 (C14a), 137.8 (C8a), 135.7 (C8),
135.1 (C13a), 133.8 (C11), 133.5 (C4), 133.0 (C3), 130.9 (C2), 129.7 (C1), 129.0 (C2ꞌ,
C6ꞌ), 128.8 (C1ꞌ), 128.5 (C4ꞌ), 127.4 (C3ꞌ, C5ꞌ), 127.1 (C10), 127.0 (C13b), 123.2 (C9),
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121.8 (13b), 118.0 (C12). IR (neat) 3282 (br, m), 1656 (s), 1601 (s), 1585 (s), 1394 (m),
1119 (s), 734 (s) cm-1. HRESI-MS calcd. for C25H17N2O2+ 377.1291, found 377.1286.
7a-phenyl-13-(3-phenylprop-2-yn-1-yl)benzo[b]indolo[1,2-h][1,7]naphthyridine8,14(7aH,13H)-dione (133)
Fraction 2 was condensed and subjected to flash
chromatography (80 g silica, 10% EtOAc/hexane). Removal
of the solvent from the major band afforded the
benzoindolonaphthyridine-dione 133 (171 mg, 35%) as deep
red crystals, dec. 161 ˚C. X-ray quality crystals were grown
by slow evaporation of a saturated solution in CH2Cl2. Rf (10% EtOAc/hexane) 0.17. 1H
NMR (500 MHz, CDCl3) δ 8.01 (dd, J = 7.8, 1.7 Hz, 1H, H9), 7.77 (ddd, J = 7.7, 1.3, 0.7
Hz, 1H, H1), 7.53 (ddd, J = 8.4, 7.2, 1.3 Hz, 1H, H3), 7.51 – 7.41 (m, 3H, H11, Ph1 or
Ph2 H3/H5), 7.35 – 7.27 (m, 4H, Ph1 or Ph2 H3/H5, Ph1 or Ph2 H2/H6), 7.25 – 7.15 (m,
3H, H4, Ph1 or Ph2 H3/H5), 7.12 (d, J = 7.5 Hz, 1H, H4), 7.10 – 7.06 (m, 1H, H12), 7.04
– 6.99 (m, 3H, H2, Ph1 H4, Ph2 H4), 6.96 (ddd, J = 7.9, 7.2, 0.9 Hz, 1H, H10), 6.83 (d, J
= 7.9 Hz, 1H, H6), 5.51 (d, J = 7.9 Hz, 1H, H7), 5.18 (d, J = 18.4 Hz, 1H, H1ꞌb), 4.91 (d,
J = 18.5 Hz, 1H, H1ꞌa). 13C NMR (126 MHz, CDCl3) δ 191.6 (C8), 178.9 (C14), 147.4
(C4a), 144.0 (C12a), 142.6 (Ph1 C1), 135.8 (C13a), 135.6 (C11), 135.5 (C3), 131.8 (Ph2
C1), 131.7 (Ph1 or Ph2 C3/C5), 129.1 (Ph1 or Ph2 C3/C5), 128.7 (Ph1 or Ph2 C2/C6), 128.4
(C9), 127.8 (Ph1 or Ph2 C2/C6), 127.3 (Ph1 or Ph2 C4), 124.8 (C1), 122.7 (C14a), 122.5
(C13b), 121.2 (C8a), 121.0 (C2), 120.9 (C10), 118.8 (C6), 115.9 (C12), 109.1 (C4), 105.1
(C7), 86.1 (C3ꞌ), 83.0 (C2ꞌ), 57.2 (C7a), 44.9 (C1ꞌ). IR (neat) 1690 (m), 1595 (m), 1571
(m), 1465 (s), 1332 (s), 1148 (m), 1001 (m), 743 (s) cm−1. HRESI-MS calcd. for
C34H23N2O2+ 491.1754, found 491.1762.
(Z)-8-((E)-benzylidene)-6-(phenylethynyl)-8,9-dihydro-6H-[1,3,6]oxadiazocino[3,4a:6,5-a']diindole-15,16-dione (123)‡‡‡‡‡‡
Fraction 3 and Fraction 4 were combined and subjected to
flash chromatography (80 g silica, 10% EtOAc/CH2Cl2),
and removal of the solvent from the major dark blue
fraction gave the proposed dihydrooxadiazocinodiindole
123 (61 mg, 12%) as an intense dark-blue powder, mp 295297 ˚C. Spectral and physical characteristics were identical to those previously

‡‡‡‡‡‡

Assignments for compound 123 are based on the given structure as previously-reported, however
further 2D NMR studies have suggested this structure to be incorrect.
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reported.[116b] Rf (10% EtOAc/CH2Cl2) 0.51. 1H NMR (CDCl3) δ 7.81 (d, J = 7.5 Hz, 1H,
H14), 7.75 (d, J = 7.6 Hz, 1H, H1), 7.46 (d, J = 7.3 Hz, 1H, H11), 7.45 – 7.33 (m, 4H,
H3, H12, H13, Ph2H), 7.17 – 6.98 (m, 10H, H2, 4×Ph2H, 5×Ph1H), 6.86 (d, J = 8.1 Hz,
1H, H4), 6.72 (s, 1H, H1''), 5.67 (s, 1H, H6), 4.75 (ABq, J = 36.9, 16.0 Hz, 2H, H9). 13C
NMR (CDCl3) δ 180.9 (C15), 180.2 (C16), 149.4 (C4a), 148.2 (C10a), 135.4 (C13), 134.5
(C1''), 134.1 (C15b), 132.0 (C11), 129.4 (C12), 129.3 (3×Ar''C), 129.0 (C14a), 128.9
(C3'), 128.7 (Ar'C), 128.5 (Ar''C), 128.0 (C16a), 125.9 (3C, 2×Ar'C, 1×Ar''C), 125.6
(C14), 124.4 (C1), 123.4 (C14a), 122.9 (15a), 121.7 (Ar'C), 121.5 (Ar'C), 117.5 (C9),
114.6 (C2), 109.6 (C4), 89.0 (C2'), 83.0 (C1'), 61.2 (C8), 56.8 (C6). IR (neat) 3076 (m),
1735 (m), 1689 (m), 1459 (m), 1243 (m), 1162 (m), 1102 (s), 761 (s) cm −1. HRESI-MS
calcd. for C34H23N2O3+, 507.1714, found 507.1720.
7.2.5. Reaction of indigo with 3-bromo-1-(4-methoxyphenyl)-1-butyne (131a)
7a-(4-methoxyphenyl)-13-(3-(4-methoxyphenyl)-prop-2-yn-1-yl)benzo[b]indolo[1,2h][1,7]naphthyridine-8,14(7aH,13H)-dione (134)
Prepared following General Procedure A (see Section
7.2.3), using arylpropargyl bromide 131a (1.13 g, 5.02
mmol), and 4 Å molecular sieves (ca. 0.5 g) and a 30 min
reaction time. The crude residue was fractionated on silica
gel (20% EtOAc/pet spirit), and the major red fraction
condensed and subjected to flash chromatography (80 g
silica, gradient elution with 10-25% EtOAc/pet spirit). Removal of the solvent from the
major deep-red fraction afforded the bis-methoxyphenylbenzoindolonaphthyridine 134
(114 mg, 21%) as small, bright pink crystals, dec. 140 ˚C. X-ray quality crystals were
grown by slow evaporation of a solution in EtOAc/pet spirit. Rf (20% EtOAc/pet spirit)
0.33. 1H NMR (500 MHz, CDCl3) δ 8.00 (dd, J = 7.8, 1.6 Hz, 1H, H9), 7.76 (d, J = 7.7
Hz, 1H, H1), 7.53 (ddd, J = 8.4, 7.3, 1.3 Hz, 1H, H3), 7.47 (ddd, J = 7.2, 6.8, 1.7 Hz, 1H,
H11), 7.19 – 7.16 (m, 2H, Ar1 H2/H6), 7.12 (d, J = 8.2 Hz, 1H, H4), 7.08 (d, J = 8.4 Hz,
1H, H12), 7.02 (app t, J = 7.2 Hz, 1H, H2), 6.98 – 6.93 (m, 3H, H10, Ar2 H2/H6), 6.82
(d, J = 7.9 Hz, 1H, H6), 6.72 – 6.67 (m, 4H, Ar1 H3/H5, Ar2 H3/H5), 5.49 (d, J = 7.9 Hz,
1H, H7), 5.14 (d, J = 18.4 Hz, 1H, H1ꞌa), 4.87 (d, J = 18.4 Hz, 1H, H1ꞌb), 3.76 (s, 3H, Ar2
OMe), 3.51 (s, 3H, Ar1 OMe). 13C NMR (126 MHz, CDCl3) δ 191.6 (C8), 178.7 (C14),
159.5 (Ar1C4), 158.9 (Ar2 C4), 147.2 (C4a), 143.9 (C12a), 136.0 (C13a), 135.4 (C11),
135.2 (C3), 134.6 (Ar1 or Ar2 C1), 133.6 (Ar1 or Ar2 C1), 133.0 (Ar2 C2/C6), 128.4 (Ar1
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C2/C6), 128.3 (C9), 124.6 (C1), 122.6 (C14a), 121.0 (C8a), 120.8 (C2), 120.6 (C10),
118.4 (C6), 115.8 (C12), 114.6 (C13b), 114.2 (Ar1 or Ar2 C3/C5), 113.6 (Ar1 or Ar2
C3/C5), 108.9 (C4), 105.0 (C7), 85.7 (C3ꞌ), 81.6 (C2ꞌ), 56.4 (C7a), 55.3 (Ar1-OMe), 54.9
(Ar2-OMe), 44.8 (C1ꞌ). IR (neat) 1688 (m), 1597 (m), 1572 (m), 1469 (s), 1336 (s), 1152
(m), 1002 (m), 743 (s) cm−1. HRESI-MS calcd. for C36H27N2O4+ 551.1965, found
551.1959.

7.3

Reactions of indigo with ring-strained electrophiles

7.3.1. Synthesis of starting materials
2,3-dibromopropan-1-ammonium bromide (162)[139a]
To a solution of allylamine (4.28 g, 75.0 mmol) in water (50 mL)
was added 48% HBr(aq) (9.6 mL, 82.5 mmol) and bromine (18.0 g,
113 mmol) at 0 ˚C, and the mixture stirred at room temperature for 4 h. The mixture was
warmed in a 70 ˚C water bath, at which point the remaining bromine was distilled
off,§§§§§§ then the solution was cooled, and the water removed in vacuo. The off-white
residue was recrystallised from hot i-PrOH (ca. 50 mL) and the collected crystals dried
in vacuo to afford 2,3-dibromopropan-1-ammonium bromide 162 (17.9 g, 80%) as shiny,
white needles, mp 168–170 ˚C, lit. 170–172.5 ˚C.[188]
(±)-N-tosyl-2-bromomethylaziridine (147)[139a]
Tosyl chloride (3.36 g, 17.6 mmol) was added to a solution of
hydrobromide salt 162 (5.00 g, 16.8 mmol) in water (20 mL), then NaOH
(3.43 g, 85.8 mmol) in water (20 mL) was added with vigorous stirring.
The mixture was stirred for 1 h, then extracted with CH2Cl2 (4×50 mL)
and the combined organic layers washed with brine (2×50 mL), dried
(MgSO4) and concentrated to afford the desired bromomethylaziridine 147 (4.83 g, 99%)
as a clear, refractive oil. Rf (20% EtOAc/pet spirit) 0.42. 1H NMR (500 MHz, CDCl3) δ
7.82 (d, J = 8.0 Hz, 2H, H2ꞌ, H6ꞌ), 7.33 (d, J = 8.0 Hz, 2H, H3ꞌ, H5ꞌ), 3.26 (d, J = 6.5 Hz,
2H, CH2Br), 3.05 (dt, J = 6.5 Hz, 4.0 Hz, 1H, H2), 2.78 (d, J = 6.5 Hz, 1H, H1b) 2.44 (s,
3H, TsCH3), 2.22 (d, J = 4.0 Hz, 1H, H1a). 13C NMR (125 MHz) δ 144.9 (Ar C1ꞌ), 134.4
(Ar C4ꞌ), 129.7 (Ar C2ꞌ, C6ꞌ), 128.6 (Ar C3ꞌ, C5ꞌ), 39.8 (C1), 34.3 (C2), 30.6 (CH2Br),
21.6 (TsCH3). ESI-MS (+) 292 (100%, [81Br]M+H+), 290 (100%, [79Br]M+H+].

§§§§§§

Care should be taken to avoid exposure to bromine vapour during this step. Excess bromine was
distilled into a Schlenk tube containing Na2S2O3 solution, and all glassware washed with dilute NaOH after
use.
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(±)-N-tosyl-2-hydroxymethylaziridine (163)[189]
To a vigorously-stirred suspension of chloramine-T trihydrate (8.46 g,
30.0 mmol) and iodine (0.777 g, 3.06 mmol, 10 mol%) in dry MeCN (90
mL) was added allyl alcohol (2.56 g, 44.1 mmol), and the mixture stirred
at room temperature for 3 d. The mixture was filtered, then the solvent
removed in vacuo, and the residue taken up in EtOAc (100 mL) and
washed with sat. Na2S2O3 solution (20 mL) and brine (3×50 mL), and the solvent
removed. Flash chromatography (80 g silica, 40% EtOAc/pet spirit) afforded the desired
hydroxymethylaziridine 163 (2.43 g, 36%) as a clear, viscous oil. Rf (40% EtOAc/pet
spirit) 0.25. 1H NMR (500 MHz, CDCl3) δ 7.82 (d, J = 8.0 Hz, 2H, H2ꞌ, H6ꞌ), 7.35 (d, J
= 8.0 Hz, 2H, H3ꞌ, H5ꞌ), 3.81 (dd, J = 12.5 Hz, 3.0 Hz, 1H, H3a) 3.54 (dd, J = 12.0 Hz,
5.5 Hz, 1H, H3b), 3.08 – 2.96 (m, 1H, H2), 2.61 (d, J = 7.0 Hz, 1H, H1b) 2.45 (s, 3H,
TsCH3), 2.30 (d, J = 4.5 Hz, 1H, H1a), 2.18 (bs, 1H, OH). 13C NMR (125 MHz) δ 145.0
(Ar C1ꞌ), 134.5 (Ar C4ꞌ), 130.0 (Ar C2ꞌ, C6ꞌ), 128.2 (Ar C3ꞌ, C5ꞌ), 61.1 (C3), 40.7 (C1),
31.2 (C2), 21.8 (TsCH3). ESI-MS (+) 250 (100%, M+Na+), 228 (26%, M+H+).
N,N'-(3-hydroxypropane-1,2-diyl)bis(4-methylbenzenesulfonamide) (166)*******
Further elution afforded a second major fraction, and removal of the
solvent afforded the bis-sulfonamide 166 (3.32 g, 56%) as a bonecoloured amorphous solid. Rf (40% EtOAc/pet spirit) 0.13. 1H NMR
(500 MHz, CDCl3) δ 7.73 (d, J = 8.0 Hz, 2H, Ts1 H2ꞌ, H6ꞌ), 7.64 (d, J = 8.0 Hz, 2H, Ts2
H2ꞌ, H6ꞌ), 7.29 – 7.20 (m, 4H, Ts1/Ts2 H3ꞌ, H5ꞌ), 5.88 (d, J = 7.5 Hz, 1H, C2-NH), 5.77
(t, J = 5.0 Hz, 1H, C1-NH) 3.63 – 3.56 (m, 1H, H3a) 3.54 – 3.46 (m, 1H, H3b), 3.35 –
3.26 (m, 1H, H2), 3.22 (bs, 1H, OH), 3.04 – 2.90 (m, 2H, H1a/b) 2.39 (s, 6H, 2×TsCH3).
C NMR (125 MHz) δ 143.70 (Ts1 C1ꞌ), 143.66 (Ts2 C1ꞌ), 137.1 (Ts1 C4ꞌ), 136.3 (Ts2
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C4ꞌ), 129.86 (Ts1 C2ꞌ, C6ꞌ), 129.83 (Ts2 C2ꞌ, C6ꞌ), 127.1 (Ts1 C3ꞌ, C5ꞌ), 127.0 (Ts2 C3ꞌ,
C5ꞌ), 61.7 (C3), 54.1 (C2), 43.6 (C1), 21.56 (Ts1 CH3), 21.53 (Ts2 CH3). ESI-MS (+) 421
(100%, M+Na+), 399 (26%, M+H+).
meso-N-tosyl-7-azabicyclo[4.1.0]heptane (168)
Prepared as per 163 using cyclohexene 167 (1.70 g, 20.7 mmol),
chloramine-T (4.25 g, 15.1 mmol) and iodine (385 mg, 1.51 mmol, 10
mol%) in MeCN (45 mL), and the mixture stirred for 2 d. The crude
residue was subjected to flash chromatography (45 g silica, 40% EtOAc/pet spirit), and
*******

Repeating the reaction on a 7 mmol scale but increasing the amount of chloramine-T to 2.1 eq. gave
a 75% isolated yield of 166.
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removal of the solvent from the major fraction afforded the azabicyclo[4.1.0]heptane 168
(2.94 g, 78%) as white crystals, mp 54–56 ˚C. Rf (40% EtOAc/pet spirit) 0.82. 1H NMR
(500 MHz, CDCl3) δ 7.84 (d, J = 8.0 Hz, 2H, H2ꞌ, H6ꞌ), 7.35 (d, J = 8.0 Hz, 2H, H3ꞌ, H5ꞌ),
3.00 (app s, 2H, H1, H6), 2.47 (s, 3H, TsCH3), 1.85 – 1.78 (m, 4H, H2a, H5a, H3a, H4a),
1.48 – 1.38 (m, 2H, H2b, H5b), 1.32 – 1.20 (m, 2H, H3b, H4b). 13C NMR (125 MHz) δ
144.0 (Ar C1ꞌ), 135.9 (Ar C4ꞌ), 129.6 (Ar C2ꞌ, C6ꞌ), 127.6 (Ar C3ꞌ, C5ꞌ), 39.8 (C1/C6),
22.8 (C2/C5), 21.6 (TsCH3), 19.4 (C3/C4). ESI-MS (+) 274 (100%, M+Na+), 252 (26%,
M+H+).
N,N'-(trans-cyclohexane-1,2-diyl)bis(4-methylbenzenesulfonamide) (169)
Further elution afforded a second fraction, and removal of the solvent
afforded the bis-sulfonamide 169 (0.624 g, 20%) as a white amorphous
solid, mp 178–179 ˚C. 1H NMR (500 MHz, CDCl3) δ 7.76 (d, J = 8.3
Hz, 4H, 2×Ts H2ꞌ, H6ꞌ), 7.31 (d, J = 8.3 Hz, 4H, 2×Ts H3ꞌ, H5ꞌ), 4.98
(br s, 2H, 2×NHTs), 2.78 – 2.73 (m, 2H, H1, H2), 1.83 – 1.79 (m, 2H, H3a, H6a), 1.54 –
1.52 (m, 2H, H4a, H5a), 1.12 – 1.06 (m, 4H, H3b, H4b, H5b, H6b). 13C NMR (125 MHz)
δ 143.3 (2×TsC1ꞌ). 139.6 (2×TsC4ꞌ), 129.7 (2×TsC2ꞌ, C6ꞌ), 127.3 (2×TsC3ꞌ, C5ꞌ), 66.3
(C1 or C2), 54.9 (C1 or C2), 35.3 (C3 or C6), 31.0 (C3 or C6), 26.5 (C4 or C5), 24.0 (C4
or C5), 21.9 (Ts1CH3), 21.7 (Ts2CH3). ESI-MS (+) 445 (100%, M+Na+), 423 (26%,
M+H+).
N-(1-chloro-3-hydroxypropan-2-yl)-4-methylbenzenesulfonamide (170)
To a 0 ˚C solution of hydroxymethylaziridine 163 (0.407 g, 1.79 mmol)
in CH2Cl2 (5 mL) was added NEt3 (0.435 g, 4.30 mmol) and MsCl
(0.444 g, 3.88 mmol), and the mixture stirred at 0 ˚C for 1 h, then allowed to warm to
room temperature over 1 h. The mixture was quenched with sat. NH4Cl solution (5 mL),
then transferred to a separatory funnel and the organic layer washed with sat. NH4Cl (20
mL) and sat. NaHCO3 (20 mL), dried (MgSO4), and the solvent removed. The resulting
crude O-mesylate (0.579 g) was dried in vacuo, then dissolved in THF (10 mL), and
TBAC.2H2O (0.104 g, 0.331 mmol) and LiCl (0.353 g, 8.33 mmol) added, and the
mixture stirred overnight at 50 ˚C under nitrogen. The mixture was taken up in ether (30
mL) and washed with water (20 mL) and brine (20 mL), dried (MgSO4) and the solvent
removed to afford the chloro-substituted hydroxyl adduct 170 (0.436 g, 99%) as off-white
crystals. Rf (20% EtOAc/pet spirit) 0.62. 1H NMR (500 MHz, CDCl3) δ 7.73 (d, J = 8.3
Hz, 2H, TsH3ꞌ, H5ꞌ), 7.25 (d, J = 8.0 Hz, 2H, TsH2ꞌ, H6ꞌ), 6.04 (t, J = 6.2 Hz, 1H, NH),
3.78 – 3.44 (m, 5H, H1a/b, H2, H3a/b), 3.18 (bs, 1H, OH), 2.35 (s, 3H, Ts CH3). 13C
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NMR (125 MHz, CDCl3) δ 144.1 (TsC1ꞌ), 137.6 (TsC4ꞌ), 130.1 (TsC2ꞌ, C6ꞌ), 127.2
(TsC3ꞌ, C5ꞌ), 59.1 (C3), 55.1 (C2), 44.1 (C1), 21.8 (TsCH3). ESI-MS (+) 286 (100%,
[35Cl]M+Na+), 288 (33%, [37Cl]M+Na+).
N-(1-bromo-3-chloropropan-2-yl)-4-methylbenzenesulfonamide (171)
To a solution of bromomethylaziridine 147 (3.15 g, 10.9 mmol) in EtOH
(50 mL) was added 36% HCl(aq) (15 mL, 150 mmol), and the mixture
heated at reflux overnight. The mixture was cooled to room temperature, then diluted with
water (50 mL) and EtOAc (50 mL), and the aqueous phase extracted with EtOAc (3×30
mL), then the combined organic fractions washed with sat. NaHCO3 solution (3×40 mL),
dried (MgSO4) and the solvent removed to afford the mixed bromo-chloro species 171
(2.90 g, 82%) as an off-white amorphous solid, mp 82–85 ˚C. Rf (20% EtOAc/pet spirit)
0.50. 1H NMR (500 MHz, CDCl3) δ 7.76 (d, J = 8.3 Hz, 2H, TsH3ꞌ, H5ꞌ), 7.32 (d, J = 8.0
Hz, 2H, TsH2ꞌ, H6ꞌ), 5.03 (d, J = 8.0 Hz, 1H, NH), 3.79 – 3.70 (m, 3H, H2, H3a/b), 3.52
– 3.46 (m, 2H, CH2Cl), 2.43 (s, 3H, ArCH3).
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C NMR (125 MHz, CDCl3) δ 144.4

(TsC1ꞌ), 137.4 (TsC4ꞌ), 130.2 (TsC2ꞌ, C6ꞌ), 127.3 (TsC3ꞌ, C5ꞌ), 54.5 (C2), 43.9 (C3), 32.9
(C1), 21.8 (TsCH3). ESI-MS (+) 348 (60%, [35Cl/79Br]M+Na+), 350 (100%,
[37Cl/79Br]M+Na+ or [35Cl/81Br]M+Na+), 352 (20%, [37Cl/81Br]M+Na+).
(S)-N-(3-chloro-2-hydroxypropyl)-4-methylbenzenesulfonamide (172)
To a well-stirred suspension of chloramine-T trihydrate (3.59 g, 12.8
mmol) in dry acetonitrile (20 mL) in a 50 mL round-bottomed flask
fitted with a rubber septum was injected (S)-epichlorohydrin 144 (2.36 g, 25.5 mmol).
The mixture was warmed to 50 ˚C in an oil bath, and stirred vigorously for 24 h. Sat.
Na2S2O3 solution (5 mL) was added and the acetonitrile removed in vacuo, then the wet
residue was diluted with EtOAc (40 mL) and extracted with water (40 mL). The aqueous
phase was extracted with further EtOAc (3×20 mL) and the combined organic fractions
washed sequentially with sat. Na2S2O3 solution (2×10 mL), water (2×10 mL) and brine
(2×40 mL). The organic fraction was dried (MgSO4) and the solvent removed to give a
clear syrup, which solidified upon standing to give a pale ivory solid. The resulting
chlorohydrin 172 (3.25 g, 97%) was used directly for subsequent steps. Rf (9:1
CH2Cl2/EtOAc) 0.25. 1H NMR (400 MHz, CDCl3) δ 7.75 (d, J = 8.3 Hz, 2H, TsH3ꞌ, H5ꞌ),
7.33 (d, J = 8.0 Hz, 2H, TsH2ꞌ, H6ꞌ), 4.79 (t, J = 6.2 Hz, 1H, NH), 3.94 (dq, J = 10.7, 5.2
Hz, 1H, H2), 3.63 – 3.47 (m, 2H, CH2Cl), 3.22 – 3.14 (m, 1H, H1a), 3.07 – 2.99 (m, 1H,
H1b), 2.58 (d, J = 5.2 Hz, 1H, OH), 2.44 (s, 3H, ArCH3). 13C NMR (101 MHz, CDCl3) δ
143.9 (TsC1ꞌ), 136.4 (TsC4ꞌ), 130.1 (TsC2ꞌ, C6ꞌ), 127.2 (TsC3ꞌ, C5ꞌ), 70.0 (C2), 46.8 (C3),
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45.9 (C1), 21.6 (TsCH3). ESI-MS (+) 286 (100%, [35Cl]M+Na+), 288 (33%,
[37Cl]M+Na+). [α]D21 = -19.7 ˚ (c 0.64, CH2Cl2).
(S)-1-chloro-3-((4-methylphenyl)sulfonamido)propan-2-yl methanesulfonate (173)
To a solution of 172 (1.331 g, 5.05 mmol) and NEt3 (1.1 mL, 7.9
mmol) in dry CH2Cl2 (30 mL) was added slowly dropwise
methanesulfonyl chloride (0.58 mL, 7.5 mmol) at 0 ˚C, and the resulting pale golden
solution allowed to warm to room temperature overnight with stirring. The mixture was
partitioned with 1 M HCl solution (10 mL) and the resulting organic phase washed with
1 M HCl (2×20 mL), then sat. NaHCO3 solution (1×20 mL), and the resulting solution
dried (MgSO4) and the solvent removed to give chloromesylate 173 (1.566 g, 91%) as a
clear yellow oil. NMR showed the mesylate to be >90% pure, and was used directly for
the next step. Rf (9:1 CH2Cl2/EtOAc) 0.62. 1H NMR (400 MHz, CDCl3) δ 7.74 (d, J = 8.3
Hz, 2H, TsH3ꞌ, H5ꞌ), 7.34 (d, J = 8.1 Hz, 2H, TsH2ꞌ, H6ꞌ), 4.93 (d, J = 6.5 Hz, 1H, NH),
4.89 – 4.80 (m, 1H, H2), 3.77 (d, J = 5.4 Hz, 2H, H1a, H1b), 3.68 (s, 3H, SO2CH3), 3.37
– 3.29 (m, 2H, H3a, H3b), 2.44 (s, 3H, TsCH3). 13C NMR (101 MHz, CDCl3) δ 144.2
(TsC1ꞌ), 135.7 (TsC4ꞌ), 130.2 (TsC2ꞌ, C6ꞌ), 127.1 (TsC3ꞌ, C5ꞌ), 78.9 (C2), 52.6 (MsCH3),
44.5 (C3), 43.1 (C1), 21.6 (TsCH3). ESI-MS (+) 364 (100%, [35Cl]M+Na+), 366 (33%,
[37Cl]M+Na+]. [α]D21 = +14.1˚ (c 0.22, CH2Cl2).
(R)-N-tosyl-2-chloromethylaziridine (148)†††††††
To a 0 ˚C solution of 173 (621 mg, 1.82 mmol) in dry CH2Cl2 (160 mL) was
added pre-dried and ground cesium carbonate (976 mg, 3.00 mmol), and the
mixture stirred vigorously for 2 h at 0 ˚C, then allowed to warm to room
temperature overnight. The mixture was partitioned with water (100 mL), and the
resulting organic layer separated and washed with brine (2×50 mL), dried (MgSO4), and
the solvent removed to give a clear, bluish oil. Flash chromatography (20 g silica, 20%
EtOAc/pet spirit) gave the desired aziridine 148 (325 mg, 73%) as a colourless oil which
slowly crystallised on standing, mp 42–44 ˚C. Rf (20% EtOAc/pet spirit) 0.40. 1H-NMR
(CDCl3, 500 MHz) δ 7.82 (d, J = 8.0 Hz, 2H, TsH2ꞌ, H6ꞌ), 7.33 (d, J = 8.0 Hz, 2H, TsH3ꞌ,
H5ꞌ), 3.39-3.50 (m, 2H, CH2Cl), 3.04 (quint, J = 5.0 Hz, 1H, H2), 2.74 (d, J = 7.0 Hz, 1H,
H1b) 2.43 (s, 3H, TsCH3), 2.24 (d, J = 4.5 Hz, 1H, H1a). 13C NMR (125 MHz) δ 145.2
(TsC1ꞌ), 134.6 (TsC4ꞌ), 130.0 (TsC2ꞌ, C6ꞌ), 128.4 (TsC3ꞌ, C5ꞌ), 43.7 (CH2Cl), 39.9 (C3),

†††††††

rac-148 was also synthesised from the mixed bromo-chloro species 171 under identical conditions
to those for the chloro-mesylate 173. The isolated yield for this reaction was 90% on 8.88 mmol scale.
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33.1 (C2), 21.9 (TsCH3). ESI-MS (+) 268 (100%, [35Cl]M+Na+), 270 (33%,
[37Cl]M+Na+). [α]D21 = +61.5˚ (c 0.71, CH2Cl2).
(±)-N-tosyl-2-phenylaziridine (174)[189]
To a solution of chloramine-T trihydrate (8.46 g, 30 mmol) and iodine
(381 mg, 1.50 mmol, 5 mol%) in dry MeCN (90 mL) was added styrene
175 (3.6 mL, 31.6 mmol) with stirring under nitrogen at RT. The flask
was wrapped in aluminium foil, and stirred vigorously under static nitrogen for 2 days.
The resulting orange mixture was filtered through a pad of celite (eluted with MeCN,
3×20 mL), and the filtrate extracted with pet. spirit (3×50 mL) to remove unreacted
styrene. The solvent was removed in vacuo, then the residue dissolved in ethyl acetate
(100 mL) and washed with sat. Na2S2O3 solution (2×40 mL) and brine (50 mL), dried
(MgSO4) and the solvent removed. The resulting crystalline solid was triturated with
hexane (50 mL) and collected by vacuum filtration to give phenylaziridine 174 (7.66 g,
93%) as off-white crystals, mp 93–95 ˚C. Rf (10% EtOAc/pet spirit) 0.32. 1H NMR (500
MHz, CDCl3) δ 7.86 (d, J = 8.3 Hz, 2H, TsH2ꞌꞌ, H6ꞌꞌ), 7.32 (d, J = 8.0 Hz, 2H, TsH3ꞌꞌ,
H5ꞌꞌ), 7.30 – 7.12 (m, 5H, PhH2ꞌ, H3ꞌ, H4ꞌ, H5ꞌ, H6ꞌ), 3.77 (dd, J = 7.2, 4.5 Hz, 1H, H2),
2.97 (d, J = 7.2 Hz, 1H, H3a), 2.42 (s, 3H, TsCH3), 2.38 (d, J = 4.5 Hz, 1H, H3b). 13C
NMR (125 MHz, CDCl3) δ 144.8 (TsC1ꞌꞌ), 135.14 (TsC4ꞌꞌ or PhC1ꞌ), 135.07 (TsC4ꞌꞌ or
PhC1ꞌ), 129.9 (TsC2ꞌꞌ, C6ꞌꞌ), 128.7 (PhC3ꞌ, C5ꞌ), 128.4 (Ph C4ꞌ), 128.0 (TsC3ꞌꞌ, C5ꞌꞌ), 126.7
(PhC2ꞌ, C6ꞌ), 41.1 (C2), 36.0 (C3), 21.8 (Ts CH3). ESI-MS (+) 274 (32%, M+H+), 296
(100%, M+Na+).
(2S,3S)-2,3-dihydroxybutane-1,4-diyl dimethanesulfonate[141]
To a solution of the acetonide-protected dimesylate 131 (6.24 g, 21.5
mmol)‡‡‡‡‡‡‡ in 95% EtOH (70 mL) was added methanesulfonic acid (0.1
mL), and the mixture heated at reflux for 4 h, then allowed to cool to room temperature
overnight. The solution was chilled to 0 ˚C, and the crystalline product collected by
vacuum filtration and dried in vacuo to yield the desired diol (2.56 g, 48%) as fluffy white
crystals, mp 100–102 ˚C, lit 101–102 ˚C.[141] This was used directly for the next step
without further purification.
(2S,2'S)-2,2ꞌ-bioxirane (149)[141]
A 100 mL twin-necked round-bottomed flask equipped with a pressureequalised addition funnel and a nitrogen gas adaptor was charged with a

‡‡‡‡‡‡‡

Prepared over 3 steps from L-tartaric acid by Mr. Jamie Smyth.
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solution of the deprotected dimesylatediol (3.71 g, 13.3 mmol) in ether (30 mL), and a
solution of KOH(aq) (1.91 g in 6 mL, 34.1 mmol) added over 15 min via the dropping
funnel, and the mixture stirred vigorously for 1 h. The upper ether layer was collected,
and the aqueous layer extracted with ether (3×10 mL), and the combined organic layers
washed with brine (2×10 mL), dried (MgSO4) and the solvent removed to give the desired
bioxirane 149 (1.07 g, 93%) as a colourless oil. 1H NMR (400 MHz, CDCl3) δ 2.68 (m,
4H, H3a/b, H3ꞌa/b), 2.56 (m, 2H, H2, H2ꞌ). 13C NMR (101 MHz, CDCl3) δ 51.0 (C2, C2ꞌ),
44.4 (C3, C3ꞌ). [α]D25 +24.9 ˚ (c 0.62, CHCl3), lit. +25.7 ˚.[141]
(2R,2'R)-2,2ꞌ-biaziridine (150)[140c]
To

a

solution

of

the

disulfonamido-diol

N,N'-((2S,3S)-2,3-

dihydroxybutane-1,4-diyl) bis(4-methylbenzenesulfonamide) (15.2 g,
35.5 mmol)§§§§§§§ in pyridine (65 mL) was added dropwise MsCl (11.8 g, 103 mmol) at
0 ˚C, and the mixture allowed to warm to room temperature overnight under nitrogen.
The mixture was diluted with 1 M HCl (300 mL) and EtOAc (500 mL), and the aqueous
phase repeatedly extracted with EtOAc (3×250 mL). The combined organic fractions
were washed with 1 M HCl (2×500 mL), water (8×500 mL), then NaHCO3 (2×100 mL),
and the solution dried (MgSO4) and the solvent removed to afford an intermediate
dimesylate (19.2 g, 92% crude yield) as a dark tan powder which was used directly.
The crude dimesylate was suspended in benzene (200 mL), and 10% KOH solution (100
mL) added slowly. The mixture was stirred vigorously at room temperature overnight,
then diluted with EtOAc (400 mL) and water (100 mL), and the aqueous phase extracted
with EtOAc (4×50 mL). The combined organic layers were washed with water (100 mL)
and NaHCO3 (4×50 mL), then dried (MgSO4) and the solvent removed. Flash
chromatography (150 g silica, 30% EtOAc/pet spirit) afforded a highly-crystalline major
fraction, which was condensed and recrystallised from CHCl3/pet spirit to afford the
desired biaziridine 150 (9.18 g, 67% over two steps) as fluffy, white crystals, mp 120–
121 ˚C, lit. 128–129.5 ˚C.[190] Rf (20% EtOAc/pet spirit) 0.26. 1H NMR (CDCl3, 400
MHz) δ 7.75 (d, J = 8.4 Hz, 4H, 2×TsH2ꞌꞌ, H6ꞌꞌ), 7.32 (d, J = 8.4 Hz, 4H, 2×TsH3ꞌꞌ, H5ꞌꞌ),
2.90-2.96 (m, 2H, H2, H2ꞌ), 2.54 (d, J = 6.9 Hz, 2H, H3a, H3ꞌa), 2.45 (s, 6H, 2×TsCH3),
2.08 (d, J = 3.9 Hz, 2H, H3b, H3ꞌb).
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C NMR (CDCl3, 101 MHz) δ 144.8 (2×TsC1ꞌꞌ),

134.2 (2×TsC4ꞌꞌ), 129.7 (2×TsC2ꞌꞌ, C6ꞌꞌ), 127.9 (2×TsC3ꞌꞌ, C5ꞌꞌ), 36.6 (C2), 31.7 (C3),
21.6 (TsCH3). ESI-MS (+) 415 (27%, M+Na+), 393 (100%, M+H+). [α]D20 = +97.0 ˚ (c

§§§§§§§

Prepared over 7 steps from L-tartaric acid by Mr. Jamie Smyth.
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0.69, CHCl3), lit. +110 ˚.[140c]
7.3.2. Reaction of indigo with (S)-epichlorohydrin (144)
(S)-6-(hydroxymethyl)-6,7-dihydropyrazino[1,2-a:4,3-a']diindole-13,14-dione (152)
Prepared following General Procedure A (see Section
7.2.3), using (S)-epichlorohydrin (462 mg, 5.0 mmol), and a
30 min reaction time. The resulting crude residue was
dissolved in a minimum of hot CHCl3, and gradual dilution
with a tenfold volume of hot pet. spirit precipitated an intense blue powder, which was
collected on a Hirsch funnel and combined with Fraction 5 (see below). The combined
solids were dried in vacuo to furnish the dihydropyrazinodiindole 152 (141 mg, 44%) as
a dark blue powder, mp >350 ˚C. Rf (9:1 CH2Cl2/EtOAc) 0.14. UV-Vis (CH2Cl2) λmax/nm
(ε, M-1cm-1) 241 (12773), 303 (6339), 579 (2819). 1H-NMR (DMSO-d6, 500 MHz) 7.567.64 (m, 4H, H1, H3, H10, H12), 7.35 (d, J = 8.0 Hz, 2H, H4, H9), 6.99-7.06 (m, 2H, H2,
H11), 5.28 (s, 1H, CH2OH), 4.66 (s, 1H, H6), 4.44 (d, J = 12.0 Hz, 1H, H7a), 3.71 (dd, J
= 3.5, 12.0 Hz, 1H, H7b), 3.47-3.57 (m, 2H, CH2OH). 13C NMR (126 MHz) δ 179.9 (C13
or C14), 179.7 (C13 or C14), 150.2 (C4a or C8a), 149.4 (C4a or C8a), 135.3 (C3 or C10),
135.0 (C3 or C10), 123.9 (C13b), 123.5 (C1 or C12), 123.1 (C13a), 122.0 (C12a or C14a),
121.5 (C12a or C14a), 120.8 (C1 or C12), 120.6 (C2 or C11), 120.4 (C2 or C11), 110.9
(C4 or C9), 110.5 (C4 or C9), 59.9 (CH2OH), 51.2 (C6), 51.1 (C7). IR (neat) 3432 (br,
m), 2937 (w), 2876 (w), 1689 (s), 1607 (s), 1561 (s), 1470 (m), 1465 (m), 1369 (m), 1340
(w), 1298 (s), 1180 (s), 1158 (m), 1144 (s), 743 (s). HRESI-MS calcd. for C19H14N2O3Na+
341.0902, found 341.0888. [α]D29 = -6.4 ˚ (c 0.10, CHCl3).
(7S,9aR)-7,8-dihydro-6H-7,9a-epoxy[1,5]oxazocino[5,4-a:3,2-b']diindol-15(14H)one (153)
The mother liquor from compound 152 was concentrated,
and subjected to flash chromatography (gradient elution, 550% EtOAc:CH2Cl2) to afford five major fractions.
Fraction 1 was subjected to PTLC (10% EtOAc/CH2Cl2),
and the selected band scraped off and soaked in EtOAc. The silica was removed by
filtration and the luminescent, yellow solution was combined with Fraction 2 and the
solvent removed to furnish the title compound 153 as small, bright orange crystals (101
mg, 32%), mp 189–191 ˚C (dec). X-ray quality crystals were grown by slow evaporation
of a saturated solution in EtOAc at -20 ˚C. Rf (9:1 CH2Cl2/EtOAc) 0.57. UV-Vis (CH2Cl2)
λmax/nm (ε, M-1cm-1) 236 (8964), 287 (5169), 364 (2651), 483 (3573). 1H NMR (500 MHz,
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CDCl3) δ 7.81 (d, J = 7.7 Hz, 1H, H1), 7.49 (m, 2H, H3, H10), 7.35 (app t, J = 7.7 Hz,
1H, H12), 7.08 (d, J = 8.3 Hz, 1H, H4), 7.02 (app t, J = 7.5 Hz, 2H, H2, H11), 6.92 (d, J
= 7.9 Hz, 1H, H13), 5.16 – 5.08 (m, 1H, H7), 4.37 (t, J = 7.2 Hz, 1H, H8b), 4.26 (dd, J =
7.0 Hz, 3.0 Hz, H8a) 4.20 (dd, J = 14.0, 3.0 Hz, 1H, H6a), 3.74 (d, J = 14.0 Hz, 1H, H6b).
C NMR (126 MHz, CDCl3) δ 184.1 (C15), 152.6 (C4a), 145.5 (C13a), 145.1 (C14a),
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133.9 (C3), 132.4 (C12), 125.4 (C10), 124.5 (C9b), 124.1 (C1), 123.1 (C15a), 122.2 (C2),
120.1 (C11), 118.5 (C14b), 111.6 (C9a), 111.2 (C13), 110.9 (C4), 74.2 (C7), 65.6 (C8),
51.9 (C6). IR (neat) 3310 (br, w) 2966 (w), 2953 (w), 2893 (w), 1689 (s), 1614 (s), 1576
(s), 1098 (m), 995 (s), 747 (s). HRESI-MS calcd. for C19H14N2O3Na+ 341.0902, found
341.0900. [α]D27 = -6.5 ˚ (c 0.17, CHCl3).
(7R,9aR)-14-((E)-3-hydroxyprop-1-en-1-yl)-7,8-dihydro-6H-7,9a-epoxy[1,5]
oxazocino[5,4-a:3,2-b']diindol-15(14H)-one (155)
Fraction 3 was subjected to PTLC (developed twice; 20%
EtOAc:CH2Cl2, then EtOAc) and the selected band scraped
off and soaked in EtOAc. The silica was removed, and the
solution combined with Fraction 4 to give the title
compound 154 as red-orange crystals (75.2 mg, 21%), mp
152–154 ˚C (dec.). X-ray quality crystals were grown by
slow evaporation of a saturated solution in 9:1 CH2Cl2/hexane. Rf 0.21 (20%
EtOAc/CH2Cl2). UV-Vis (CH2Cl2) λmax/nm (ε, M-1cm-1) 243 (18482), 274 (20838), 355
(1472), 500 (1174). 1H NMR (500 MHz, CDCl3) δ 7.78 (d, J = 7.6 Hz, 1H, H1), 7.55 –
7.48 (m, 2H, H3, H10), 7.45 (t, J = 7.7 Hz, 1H, H12), 7.36 – 7.30 (m, 1H, H13), 7.17 (t,
J = 7.4 Hz, 1H, H11), 7.06 (d, J = 8.3 Hz, 1H, H4), 7.02 (t, J = 7.4 Hz, 1H, H2), 6.87 (d,
J = 14.2 Hz, 1H, H1ꞌ), 6.07 (dt, J = 6.5, 14.0 Hz, 1H, H2ꞌ), 5.05 – 5.01 (m, 1H, H7), 4.44
– 4.21 (m, 6H, H6b, H8a, H8b, H3ꞌa, H3ꞌb, OH), 3.74 (d, J = 14.3 Hz, 1H, H6a). 13C NMR
(125 MHz, CDCl3) δ 181.5 (C15), 152.7 (C4a), 149.7 (C14a), 145.9 (C13a), 134.2 (C3),
131.9 (C12), 130.8 (C1ꞌ), 125.5 (C9b), 125.2 (C15a), 124.9 (C10), 124.5 (C14b), 124.3
(C1), 123.6 (C11), 120.0 (C2), 119.1 (C2ꞌ), 111.7 (C13), 111.1 (C9a), 109.9 (C4), 73.4
(C7), 67.6 (C8), 61.9 (C3ꞌ), 52.2 (C6). IR (neat) 3349 (br, m), 1726 (m), 1466 (s), 1265
(s), 702 (s). HRESI-MS calcd. for C22H19N2O4+ 375.1345, found 375.1357. [α]D29 = -6.7
˚ (c 0.11, CHCl3).
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14-((2-oxo-1,3-dioxolan-4-yl)methyl)-7,8-dihydro-6H-7,9a-epoxy[1,5]oxazocino[5,4a:3,2-b']diindol-15(14H)-one (154)
Prepared following General Procedure A, using (±)epichlorohydrin (5.0 mmol, 462 mg), and a 2 h reaction time.
Following the above separation protocol, the racemic
products (±)-152 (134.4 mg, 43%), (±)-153 (19.8 mg, 6%),
and (±)-155 (27.9 mg, 7%) were isolated. Fraction 4 was
condensed, and recrystallisation from a minimum volume of
EtOAc afforded cyclic carbonate 154 (27 mg, 6%) as
luminescent orange crystals, mp 146–149 ˚C (dec.). X-ray quality crystals were grown
from slow evaporation of a saturated solution in 9:1 EtOAc/pet spirit at 4 ˚C. Rf (10%
EtOAc/CH2Cl2) 0.45. UV-Vis (CH2Cl2) λmax/nm (ε, M-1cm-1) 238 (17364), 344 (5999),
499 (2531). 1H NMR (400 MHz, CDCl3) δ 7.68 (d, J = 7.1 Hz, 1H, H1), 7.52 – 7.41 (m,
3H, H3, H10, H12), 7.33 (d, J = 8.1 Hz, 1H, H13), 7.13 (td, J = 7.4, 0.8 Hz, 1H, H11),
7.04 – 6.94 (m, 2H, H2, H4), 5.53 – 5.43 (m, 1H, H2ꞌ), 5.20 (d, J = 9.2 Hz, 1H, H3ꞌa),
5.00 – 4.94 (m, 1H, H7), 4.33 – 4.22 (m, 4H, H6a, H8a, H8b, H3ꞌb), 4.22 – 4.08 (m, 2H,
H6a, H1ꞌb), 3.68 (d, J = 14.3 Hz, 1H, H6b). 13C NMR (101 MHz, CDCl3) δ 182.2 (C15),
155.2 (O=COO), 152.9 (C4a), 148.0 (C14a), 146.6 (C13a), 134.3 (C3), 132.7 (C12),
128.3 (C15a), 124.8 (C9b), 124.6 (C10), 124.2 (C1), 123.4 (C11), 120.7 (C14b), 119.9
(C2), 112.0 (C9a), 111.1 (C13), 110.2 (C4), 81.3 (C2ꞌ), 73.4 (C7), 69.0 (C3ꞌ), 67.9 (C8),
55.5 (C1ꞌ), 52.4 (C6). IR (neat) 3431 (w), 1799 (m), 1734 (s), 1611 (s), 1466 (s), 1065 (s),
774 (m). HRESI-MS calcd. for C23H18N2O6Na+ 441.1063, found 441.1082; calcd. for
C23H19N2O6+ 419.1243, found 419.1257.
(7R,9aR)-(((S)-2-oxo-1,3-dioxolan-4-yl)methyl)-7,8-dihydro-6H-7,9aepoxy[1,5]oxazocino[5,4-a:3,2-b']diindol-15(14H)-one (154)
Prepared following General Procedure A, using (S)epichlorohydrin (462 mg, 5.0 mmol) and a 30 min reaction
time. Following the above separation protocol, products
152 (133 mg, 41%), and 153 (97 mg, 30%) were isolated.
Fraction 4 was subjected to PTLC (20% EtOAc/CH2Cl2).
Recrystallisation from a minimum volume of EtOAc
afforded cyclic carbonate 154 (87 mg, 20%) as luminescent
orange crystals. [α]D29 = -6.1 ˚ (c 0.09, CHCl3).
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(±)-6-(hydroxymethyl)-6,7-dihydropyrazino[1,2-a:4,3-a']diindole-13,14-dione (rac152)
Prepared following General Procedure A, using (±)epibromohydrin 145 (685 mg, 5.0 mmol), and a 10 min
reaction time. The crude residue was dissolved in a minimum
of hot CHCl3, and gradual dilution with a tenfold volume of
hot pet spirit precipitated an intense blue powder, which was collected on a Hirsch funnel.
The mother liquor was condensed, and a second recrystallization of the residue afforded
a second crop of product. The combined solids were dried in vacuo to furnish the title
compound rac-152 as a dark blue powder (266.9 mg, 84%). Spectral characteristics
(excepting optical rotation) were identical to those reported for (S)-152.
(R)-6-(hydroxymethyl)-6,7-dihydropyrazino[1,2-a:4,3-a']diindole-13,14-dione (R152)
Prepared following General Procedure A, using of (R)glycidyl tosylate 146 (1.141 g, 5.0 mmol), and a 10 min
reaction time. The crude residue was dissolved in a
minimum of hot CHCl3, and gradual dilution with a tenfold
volume of hot pet spirit precipitated an intense blue powder, which was collected on a
Hirsch funnel. The mother liquor was condensed, and a second recrystallization of the
residue afforded a further crop of product. The combined solids were dried in vacuo to
furnish the title compound (R)-152 as a dark blue powder (242.3 mg, 76%). Spectral
characteristics (excepting optical rotation) were identical to those obtained from its
enantiomer. [α]D29 = +3.7˚ (c 0.33, CH2Cl2).
7.3.3. Reaction of indigo with (R)-N-tosyl-2-chloromethylaziridine (148)
(R)-N-((13,14-dioxo-6,7,13,14-tetrahydropyrazino[1,2-a:4,3-a']diindol-6-yl)methyl)4-methylbenzenesulfonamide (176)
A suspension of indigo (131 mg, 0.500 mmol) in anhydrous
DMF (20 mL) was sonicated at 60 ˚C for one hour. The
resulting hot suspension was transferred by cannula under
positive pressure of nitrogen into a 50 mL round-bottomed
flask containing a magnetic stir bar, pre-dried and ground Cs2CO3 (603 mg, 1.85 mmol),
and fitted with a rubber septum. The resulting dark-green to amber solution was stirred
for one hour in an oil bath, pre-heated to strictly 85-87 ˚C under dry nitrogen. The nitrogen
flow was cut, and a solution of (R)-N-tosyl-2-chloromethylaziridine 148 (627 mg, 2.56
mmol) in DMF (2 mL) was injected through the septum, and the mixture stirred at 85–87
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˚C for 30 min. The resulting intensely-coloured solution was quenched over crushed ice
(ca. 50 g), and the flask rinsed with EtOAc (ca. 10 mL) to remove adhered products. Upon
warming to RT, the emulsion was extracted with EtOAc (5×40 mL) until the aqueous
phase became clear. The combined organic fractions were washed with brine (4×40mL),
dried (MgSO4), and filtered through a 2 cm plug of celite, and the solvent removed in
vacuo. The crude residue was fractionated on silica (60 g) using CHCl3 as eluent to afford
two major fractions. Removal of the solvent from Fraction 2 afforded the N,N-cyclised
mono-adduct 176 (108.2 mg, 46%) as a glassy, intense-blue solid, mp 165–167 ˚C (dec.).
Rf (9:1 CHCl3/MeCN) 0.23. UV-VIS (CH2Cl2) λmax/nm (ε, M-1cm-1) 236 (18847), 302
(14297), 380 (2329), 576 (8879). 1H NMR (500 MHz, DMSO) δ 8.06 (t, J = 5.9 Hz, 1H,
NH), 7.64 – 7.57 (m, 6H, H1, H3, H10, H12, H3ꞌꞌ, H5ꞌꞌ), 7.34 – 7.27 (m, 3H, H9, H2ꞌꞌ,
H6ꞌꞌ), 7.24 (d, J = 8.3 Hz, 1H, H4), 7.07 – 6.98 (m, 2H, H2, H11), 4.68 – 4.59 (m, 1H,
H6), 4.42 (d, J = 12.3 Hz, 1H, H7a), 3.70 (d, J = 9.4 Hz, 1H, H7b), 3.06 – 2.81 (m, 2H,
H1ꞌ), 2.30 (s, 3H, TsCH3). 13C NMR (126 MHz, DMSO) δ 179.71 (C13 or C14), 179.69
(C13 or C14), 150.4 (C9a), 148.9 (C4a), 142.8 (C4ꞌꞌ), 135.3 (C3 or C10), 135.2 (C3 or
C10), 134.9 (C1ꞌꞌ), 129.6 (C2ꞌꞌ, C6ꞌꞌ), 126.2 (C3ꞌꞌ, C5ꞌꞌ), 125.4 (C12a), 124.6 (C13b), 123.9
(C13a), 123.7 (C1 or C12), 123.5 (C1 or C12), 122.8 (C14a), 122.1 (C2 or C11), 121.7
(C2 or C11), 110.8 (C9), 110.2 (C4), 49.6 (C6), 42.5 (C1ꞌ), 40.5 (C7), 20.8 (TsCH3). IR
(neat) 3566 (w), 2987 (w), 1737 (w), 1697 (m), 1609 (s), 1159 (s), 1132 (s) 754 (s).
HRESI-MS calcd. for C26H21N3O4SNa+ 472.1331, found 472.1319. [α]D25 = -9.3˚ (c 0.41,
CHCl3).
Fraction 1 was concentrated to dryness then dissolved in acetonitrile (20.0 mL), of which
10.0 mL was subjected to preparative RP-HPLC over 5×2.0 mL injections, using a
Prominence Preparatory Liquid Chromatograph (Shimadzu) with PDA detector, and a
Shim-Pack GIS C18 5 μm column (Shimadzu) with 150×20 mm I.D. Gradient elution
from 80% to 0% Solvent A (0.1% TFA in H2O) in 60 minutes with Solvent B (0.1% TFA
in MeCN) at a flow rate of 10.0 mL/min afforded three major fractions at tR 35 min, 37
min, and 47.7 min, and their purity was confirmed by analytical RP-HPLC, using a
Prominence LC-2030C 3D system (Shimadzu) with PDA detector, and a Shim-Pack GIS
C18 5 μm column (Shimadzu) with 4.6×150 mm I.D. Gradient elution from 80% to 0%
Solvent A (0.1% TFA in H2O) in 30 minutes with Solvent B (0.1% TFA in MeCN) at a
flow rate of 1.0 mL/min showed the three fractions (tR 16.5, 17.2, and 21.4 min,
respectively) to be free of neighbouring impurities.
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N-(((R)-13,14-dioxo-6,7,13,14-tetrahydropyrazino[1,2-a:4,3-a']diindol-6-yl)methyl)4-methyl-N-(((S)-1-tosylaziridin-2-yl)methyl)benzenesulfonamide (177)
Removal of the solvent from the fraction collected at tR
35 min afforded the di-substituted N,Nꞌ-cyclised indigo
derivative 177 (27.4 mg, 8%) as an intense blue-purple
solid, mp 121–123 ˚C (dec.). Rf (9:1 CHCl3/MeCN)
0.49. UV-Vis (CH2Cl2) λmax/nm (ε, M-1cm-1) 281
(37018), 360 (2022), 578 (7659). 1H NMR (400 MHz, CDCl3) δ 7.81 – 7.71 (m, 2H, H1,
H12), 7.60 (d, J = 8.1 Hz, 2H, Ts1 or Ts2 H3/H5), 7.57 – 7.48 (m, 4H, H3, H10, Ts1 or
Ts2 H3/H5), 7.29 (d, J = 8.1 Hz, 2H, Ts1 or Ts2 H2/H6), 7.21 (d, J = 8.0 Hz, 2H, Ts1 or
Ts2 H2/H6), 7.16 (s, 2H, H2, H11), 7.02 (s, 2H, 2×ArH, H4, H9), 4.63 (s, 1H, H6), 4.47
(d, J = 10.8 Hz, 1H, H7a), 3.64 (d, J = 15.8 Hz, 1H, H3ꞌa), 3.51 – 3.37 (m, 1H, H7b), 3.31
– 3.19 (m, 1H, H5ꞌa), 3.05 – 2.95 (m, 1H, H3ꞌb), 2.95 – 2.86 (m, 2H, H5ꞌb, H2ꞌ), 2.57 (d,
J = 6.9 Hz, 1H, H1ꞌa), 2.39 (s, 3H, Ts1 or Ts2 CH3), 2.38 (s, 3H, Ts1 or Ts2 CH3), 2.21 (d,
J = 4.1 Hz, 1H, H1ꞌb). 13C NMR (126 MHz, DMSO) δ 180.4 (C13 or C14), 180.1 (C13
or C14), 150.9 (C4a or C8a), 149.0 (C4a or C8a), 145.4 (Ts1 or Ts2 C4), 144.5 (Ts1 or Ts2
C4), 136.0 (Ts1 or Ts2 C1), 135.8 (Ts1 or Ts2 C1), 135.7 (C3 or C10), 133.9 (C3 or C10),
130.6 (Ts1 or Ts2 C2/C6), 130.3 (Ts1 or Ts2 C2/C6), 130.1 (C13b), 128.0 (Ts1 or Ts2
C3/C5), 127.7 (Ts1 or Ts2 C3/C5), 127.0 (C13a), 124.7 (C1 or C12), 124.4 (C1 or C12),
124.2 (C12a or C14a), 124.1 (C12a or C14a), 121.4 (C2 or C11), 121.3 (C2 or C11),
111.6 (C4 or C9), 110.9 (C4 or C9), 60.6 (C3ꞌ), 54.4 (C6), 49.5 (C5ꞌ), 48.9 (C7), 47.3
(C2ꞌ), 40.8 (C1ꞌ), 21.5 (Ts1 or Ts2 CH3), 21.4 (Ts1 or Ts2 CH3). IR (neat) 2987 (w), 1738
(w), 1697 (m), 1609 (s), 1132 (s), 754 (s). HRESI-MS calcd. for C36H32N4O6S2Na+
703.1655, found 703.1661. [α]D25 = -12.6˚ (c 0.11, CHCl3).
N-((R)-3-chloro-2-((4-methylphenyl)sulfonamido)propyl)-N-(((R)-13,14-dioxo6,7,13,14-tetrahydropyrazino[1,2-a:4,3-a']diindol-6-yl)methyl)-4methylbenzenesulfonamide (178)
Removal of the solvent from the fraction collected at tR
37 min afforded the di-substituted N,Nꞌ-cyclised indigo
derivative 178 (33.3 mg, 9%) as an intense blue-purple
solid, mp 132–134 ˚C (dec.). Rf (9:1 CHCl3/MeCN)
0.49. UV-Vis (CH2Cl2) λmax/nm (ε, M-1cm-1) 574
(8850). 1H NMR (500 MHz, CDCl3) δ 7.82 (d, J = 7.9
Hz, 2H, Ts1 or Ts2 H3/H5), 7.78 – 7.71 (m, 2H, H1, H12), 7.58 – 7.52 (m, 3H, Ts1 or Ts2
H3/H5, H3 or H10), 7.49 (t, J = 7.7 Hz, 1H, H3 or H10), 7.36 (d, J = 7.9 Hz, 2H, Ts1 or
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Ts2 H2/H6), 7.27 (d, 2H, Ts1 or Ts2 H2/H6), 7.12 (d, J = 8.1 Hz, 1H, H4 or H9), 7.09 –
6.94 (m, 3H, H4 or H9, H2, H11), 5.69 (s, 1H, NH), 4.60 (app d, J = 10.3 Hz, 1H, H6),
4.39 (d, J = 12.1 Hz, 1H, ), 4.07 – 3.94 (m, 1H, H2ꞌ), 3.86 (d, J = 11.6 Hz, 1H, H1ꞌa), 3.57
– 3.37 (m, 4H, H7b, H1ꞌb, H3ꞌa, H5ꞌa), 3.19 (dd, J = 15.1, 6.8 Hz, 1H, H3ꞌb), 2.65 (d, J =
14.3 Hz, 1H, H5ꞌb), 2.42 (s, 3H, Ts1 or Ts2 CH3), 2.38 (s, 3H, Ts1 or Ts2 CH3). 13C NMR
(126 MHz, CDCl3) δ 181.2 (C13 or C14), 180.5 (C13 or C14), 150.7 (C4a or C8a), 148.4
(C4a or C8a), 145.2 (Ts1 or Ts2 C4), 144.3 (Ts1 or Ts2 C4), 137.3 (Ts1 or Ts2 C1), 135.8
(C3 or C10), 135.7 (C3 or C10), 133.2 (Ts1 or Ts2 C1), 130.4 (Ts1 or Ts2 C2/C6), 130.2
(Ts1 or Ts2 C2/C6), 127.7 (Ts1 or Ts2 C3/C5), 127.4 (Ts1 or Ts2 C3/C5), 125.7 (C1 or
C12), 125.2 (C13a), 125.1 (C1 or C12), 123.1 (C12a or C14a), 123.0 (C13b), 122.9 (C12a
or C14a), 121.8 (C2 or C11), 121.6 (C2 or C11), 110.7 (C4 or C9), 108.9 (C4 or C9), 53.9
(C2ꞌ), 53.1 (C3ꞌ), 51.0 (C5ꞌ), 49.5 (C6), 45.4 (C1ꞌ), 40.2 (C7), 21.8 (Ts1 or Ts2 CH3), 21.7
(Ts1 or Ts2 CH3). IR (neat) 3013 (w), 1743 (w), 1608 (m), 1304 (m), 756 (s). HRESI-MS
calcd. for C36H33N4O6S235ClNa+ 739.1428, found 739.1448. [α]D25 = -11.4˚ (c 0.12,
CHCl3)
(±)-N-((13,14-dioxo-6,7,13,14-tetrahydropyrazino[1,2-a:4,3-a']diindol-6yl)methyl)-4-methylbenzenesulfonamide (rac-176)
Prepared following General Procedure A, using (±)-Ntosyl-2-bromomethylaziridine (1.00 g, 3.45 mmol), and a 5
min reaction time.******** The crude residue was fractionated
on silica (80 g) using 5% MeCN:CHCl3 as eluent. Removal
of the solvent from Fraction B afforded the N,N-cyclised mono-adduct rac-176 (247.2
mg, 52%) as a glassy, intense-blue solid. Spectral and physical characteristics (excepting
optical rotation) were identical to those reported above for (R)-176.
Fraction A was condensed and assessed by analytical RP-HPLC (80%-0% H2O/MeCN;
1.0 mL/min), which showed the presence of small amounts of 177, though this was not
quantified.

********

Longer reaction times typically led to extensive polymerisation
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7.3.4. Reaction of indigo with N-tosyl-2-phenylaziridine (174)
(E)-N-(2-(3,3'-dioxo-[2,2'-biindolinylidene]-1-yl)-1-phenylethyl)-4methylbenzenesulfonamide (179)
Prepared

following

General

Procedure

A,

using

phenylaziridine 174 (1.363 g, 4.99 mmol) and a 5 min
reaction time. The crude residue was fractionated on silica
(60 g) by sequential elution with 1) 10% pet spirit/CH2Cl2
(Fraction 1), 2) CH2Cl2 (Fraction 2), and the column
stripped with 10% EtOAc/CH2Cl2 (Fraction 3). The solvent
was removed from Fraction 1 to give a dark blue residue, which was re-dissolved in a
minimum of hot CHCl3, and precipitated with a tenfold volume of pet. spirit. The resulting
solid was collected on a Hirsch funnel, and dried in vacuo to give the terminally ringopened aziridine adduct 179 (333.4 mg, 62%) as a dark teal powder, mp 211–213 ˚C. Rf
(10% pet spirit/CH2Cl2) 0.43. UV-Vis (CH2Cl2) λmax/nm (ε, M-1cm-1) 294 (24346), 341
(9142), 645 (13774). 1H NMR (500 MHz, CDCl3) δ 10.65 (s, 1H, NH), 7.72 (d, J = 7.6
Hz, 1H, H4), 7.64 (d, J = 7.5 Hz, 1H, H4ꞌ), 7.61 – 7.55 (m, 3H, H6, H3ꞌꞌꞌꞌ, H5ꞌꞌꞌ), 7.50 (t,
J = 7.4 Hz, 1H, H6ꞌ), 7.40 (t, J = 7.5 Hz, 2H, H3ꞌꞌꞌ, H5ꞌꞌꞌ), 7.32 (t, J = 7.3 Hz, 1H, H4ꞌꞌꞌ),
7.23 (d, J = 8.0 Hz, 2H, H2ꞌꞌꞌ, H6ꞌꞌꞌ), 7.06 (t, J = 7.4 Hz, 1H, ), 7.04 – 6.94 (m, 3H, H7,
H5ꞌ, H7ꞌ), 6.72 (d, J = 7.9 Hz, 2H, H2ꞌꞌꞌꞌ, H6ꞌꞌꞌꞌ), 5.23 – 5.11 (m, 1H, H2ꞌꞌa), 4.96 – 4.85
(m, 1H, H1ꞌꞌ), 3.97 – 3.87 (m, 1H, H2ꞌꞌb), 2.22 (s, 3H, TsCH3).

13

C NMR (126 MHz,

CDCl3) δ 189.0 (C3ꞌ), 188.8 (C3), 151.8 (C7aꞌ), 151.3 (C7a), 142.7 (TsC4ꞌꞌꞌꞌ), 139.6 (C1ꞌꞌꞌ
or TsC1ꞌꞌꞌꞌ), 138.1 (C1ꞌꞌꞌ or TsC1ꞌꞌꞌꞌ), 137.0 (C6ꞌ), 136.2 (C6), 129.2 (TsC2ꞌꞌꞌꞌ, C6ꞌꞌꞌꞌ), 129.1
(TsC3ꞌꞌꞌꞌ, C5ꞌꞌꞌꞌ), 128.3 (C4ꞌꞌꞌ), 126.8 (C3ꞌꞌꞌ, C5ꞌꞌꞌ), 126.1 (C2ꞌꞌꞌ, C6ꞌꞌꞌ), 125.5 (C4), 124.9
(C3a or C3aꞌ), 124.1 (C4ꞌ), 123.7 (C2 or C2ꞌ), 121.4 (C5), 120.9 (C3a or C3aꞌ), 120.8
(C5ꞌ), 120.0 (C2 or C2ꞌ), 112.0 (C7), 110.2 (C7ꞌ), 55.6 (C1ꞌꞌ), 51.9 (C2ꞌꞌ), 21.6 (TsCH3).
IR (neat) 3288 (w), 1630 (m), 1607 (s), 1026 (s). HRESI-MS calcd. for C31H26N3O4S+
536.1644, found 536.1664.
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(E)-N-(2-(3,3'-dioxo-[2,2'-biindolinylidene]-1-yl)-2-phenylethyl)-4methylbenzenesulfonamide (180)
Fraction 2 was combined with Fraction 3 and condensed to
give a dark blue-green residue, which was dissolved in a
minimum of hot CHCl3, then diluted with a tenfold volume of
hot pet spirit. The solution was chilled, and the resulting
precipitate collected by vacuum filtration and dried in vacuo to
give the title compound 180 (191.9 mg, 36%) as a dark blue powder, mp 194–196 ˚C. Xray quality crystals were grown by gradual diffusion of pet spirit into a saturated solution
in 1:1 CHCl3/MeOH in a sealed vapour chamber at room temperature. Rf (10% pet
spirit/CH2Cl2) 0.31. UV-Vis (CH2Cl2) λmax/nm (ε, M-1cm-1) 292 (23907), 340 (7457), 637
(9167). 1H NMR (500 MHz, CDCl3) δ 10.74 (s, 1H, N1ꞌ-H), 7.65 (d, J = 7.7 Hz, 1H, H4ꞌ)
7.62 (d, J = 7.7 Hz, 1H, H4), 7.54 – 7.46 (m, 3H, H6ꞌ, TsH3ꞌꞌꞌ, H5ꞌꞌꞌ), 7.29 – 7.16 (m, 6H,
H6, 5×Ph-Hꞌꞌꞌ), 7.02 (d, J = 8.0 Hz, 1H, H7ꞌ), 7.00 – 6.94 (m, 3H, H5ꞌ, TsH2ꞌꞌꞌꞌ, H6ꞌꞌꞌꞌ),
6.91 (t, J = 7.3 Hz, 1H, H5), 6.63 – 6.50 (m, 2H, H7, H2ꞌꞌ), 5.93 – 5.84 (m, 1H, C1ꞌꞌ-NH),
4.19 – 4.04 (m, 2H, H1ꞌꞌ), 2.26 (s, 3H, TsCH3).

13

C NMR (126 MHz, CDCl3) δ 189.3

(C3), 188.2 (C3ꞌ), 151.8 (C7aꞌ), 150.0 (C7a), 143.1 (TsC4ꞌꞌꞌꞌ), 136.9 (Ts C1ꞌꞌꞌꞌ), 136.7 (C6ꞌ),
135.5 (C1ꞌꞌꞌ), 135.2 (C6), 129.4 (TsC2ꞌꞌꞌꞌ, C6ꞌꞌꞌꞌ), 128.8 (C3ꞌꞌꞌ, C5ꞌꞌꞌ), 127.8 (C4ꞌꞌꞌ), 126.53
(C2ꞌꞌꞌ, C6ꞌꞌꞌ), 126.51 (TsC3ꞌꞌꞌꞌ, C5ꞌꞌꞌꞌ), 125.8 (C2 or C2ꞌ), 125.2 (C4), 125.1 (C2 or C2ꞌ),
124.2 (C4ꞌ), 122.2 (C3a), 121.2 (C5), 120.9 (C5ꞌ), 120.1 (C3aꞌ), 114.1 (C7), 112.1 (C7ꞌ),
60.0 (C2ꞌꞌ), 43.4 (C1ꞌꞌ), 21.6 (TsCH3). IR (neat) 3254 (w), 1628 (m), 1605 (s), 1069 (s).
HRESI-MS calcd. for C31H25N3O4SNa+ 558.1463, found 558.1481.
7.3.5. Reaction of indigo with (2S,2'S)-2,2ꞌ-bioxirane (149)
(7S,8R,9aS)-8-(hydroxymethyl)-7,8-dihydro-6H-7,9a-epoxy[1,5]oxazocino[5,4a:3,2-b']diindol-15(14H)-one (183)
Prepared following General Procedure A, using (2S,2'S)2,2ꞌ-bioxirane (281 mg, 3.3 mmol), and a 30 min reaction
time. The crude residue was separated into five fractions on
a plug of silica (70 g), eluting sequentially with 1) CH2Cl2
(250

mL

each)

2)

20%

EtOAc/CH2Cl2 3)

40%

EtOAc/CH2Cl2 4) 60% EtOAc/CH2Cl2 5) 80% EtOAc/CH2Cl2. Fractions 2 and 3 were
combined, and subjected to flash chromatography on 25 g silica, and elution with 20%
EtOAc:CH2Cl2 afforded the mono-substituted spirocycle 183 (216 mg, 62%) as a
luminescent orange powder, mp 155–156 ˚C (dec.). X-ray quality crystals were grown
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from slow evaporation of a hexane/ethyl acetate solution. Rf (20% EtOAc/CH2Cl2) 0.33.
UV-Vis (CH2Cl2) λmax/nm (ε, M-1cm-1) 244 (12573), 365 (2296), 485 (2882). 1H NMR
(500 MHz, CDCl3) δ 7.81 (d, J = 7.0 Hz, 1H, H1), 7.54 – 7.48 (m, 2H, H3, H10), 7.35
(td, J = 7.7, 1.3 Hz, 1H, H12), 7.11 (d, J = 8.3 Hz, 1H, H4), 7.06 – 6.99 (m, 2H, H2, H11),
6.92 (dt, J = 7.8, 0.8 Hz, 1H, H13), 5.04 – 4.97 (m, 1H, H7), 4.79 – 4.71 (m, 1H, H8),
4.38 (dd, J = 14.1, 2.8 Hz, 1H, H6b), 4.17 (dd, J = 11.3, 7.3 Hz, 1H, H1ꞌa), 3.96 (dd, J =
11.2, 5.7 Hz, 1H, H1ꞌb), 3.70 (dd, J = 14.0, 2.4 Hz, 1H, H6a), 1.26 (s, 1H, OH). 13C NMR
(101 MHz, CDCl3) δ 184.1 (C15), 151.8 (C4a), 145.2 (C13a), 144.5 (C14a), 134.0 (C3),
132.4 (C12), 125.3 (C10), 124.2 (C15a), 124.0 (C1), 123.5 (C9b), 122.3 (C11), 120.1
(C2), 117.8 (C14b), 111.7 (C9a), 111.2 (C13), 110.7 (C4), 77.7 (C8), 75.6 (C7), 60.4
(C1ꞌ), 48.3 (C6). IR (neat) 3420 (w), 2922 (w), 1715 (m), 1612 (s), 1317 (m), 735 (s).
HRESI-MS calcd. for C20H17N2O4+ 349.1188, found 349.1192. [α]D25 = -7.2˚ (c 0.21,
CH2Cl2).
(7S,8R,9aS)-14-((S)-2-hydroxy-2-((S)-oxiran-2-yl)ethyl)-8-(hydroxymethyl)-7,8dihydro-6H-7,9a-epoxy[1,5]oxazocino[5,4-a:3,2-b']diindol-15(14H)-one (184)
Further elution of Fractions 2 and 3 with 40%
EtOAc:CH2Cl2 gave a residue which was combined with
Fractions

4

and

5

and

concentrated,

and

flash

chromatography of this residue (20% EtOAc/CH2Cl2; 20 g
silica) gave the di-alkylated spirocycle 184 (82 mg, 19%) as
a pale green, amorphous solid. Rf (40% EtOAc/CH2Cl2)
0.63. UV-Vis (CH2Cl2) λmax/nm (ε, M-1cm-1) 323 (3820), 350 (4772), 425 (1723). 1H
NMR (400 MHz, DMSO) δ 7.65 – 7.46 (m, 4H, H1, H3, H10, H13), 7.26 – 7.19 (m, 1H,
H12), 7.12 – 7.00 (m, 2H, H4, H11), 6.82 (t, J = 7.3 Hz, 1H, H2), 5.83 (d, J = 4.8 Hz, 1H,
C1ꞌ-OH), 5.22 (d, J = 5.7 Hz, 1H, C2ꞌꞌ-OH), 4.61 (t, J = 6.0 Hz, 1H, H7), 4.54 (d, J = 12.6
Hz, 1H, H6a), 4.21 (dt, J = 11.6, 5.8 Hz, 1H, H6b), 4.11 – 3.96 (m, 2H, H8, H1ꞌa), 3.83
(dd, J = 9.2, 6.4 Hz, 1H, H1ꞌꞌa), 3.73 (dd, J = 9.2, 5.0 Hz, 1H, H1ꞌꞌb), 3.24 (dt, J = 11.6,
5.9 Hz, 1H, H2ꞌꞌ), 2.78 (dd, J = 12.3, 10.3 Hz, 1H, H1ꞌb), 2.73 – 2.68 (m, 1H, H3ꞌꞌ), 2.61
– 2.54 (m, 1H, H4ꞌꞌa), 2.33 (dd, J = 5.2, 2.7 Hz, 1H, H4ꞌꞌb). 13C NMR (101 MHz, DMSO)
δ 193.5 (C15), 158.4 (C4a), 139.2 (C3), 133.9 (C13a), 130.6 (C14a), 125.7 (C14b), 125.5
(C1), 122.6 (C12), 120.2 (C9b), 120.1 (C11), 118.8 (C2), 118.6 (C10), 118.1 (C15a),
110.7 (C13), 110.3 (C9a) 109.4 (C4), 75.9 (C1ꞌꞌ), 70.8 (C7), 70.5 (C2ꞌꞌ), 62.8 (C8), 53.7
(C3ꞌꞌ), 44.1 (C4ꞌꞌ), 43.2 (C1ꞌ), 37.4 (C6). IR (neat) 3566 (w), 2922 (w), 1737 (m), 1608
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(m), 1155 (s), 748 (s). HRESI-MS (+) calcd. for C24H23N2O6+ 435.1556, found 435.1575.
[α]D25 = -8.5˚ (c 0.32, CH2Cl2).
7.3.6. Reaction of indigo with (2R,2ꞌR)-N,Nꞌ-ditosyl-2,2ꞌ-biaziridine (150)
4-methyl-N-(((6R,7R)-7-((4-methylphenyl)sulfonamido)-14,15-dioxo-7,8,14,15tetrahydro-6H-[1,4]diazepino[1,2-a:4,3-a']diindol-6-yl)methyl)benzenesulfonamide
(185)
Prepared following General Procedure A using (2R,2ꞌR)N,Nꞌ-ditosyl-2,2ꞌ-biaziridine 150 (512 mg, 1.30 mmol) in
DMF (3 mL) over a 20 min reaction time. The crude residue
was dissolved in a minimum of hot CHCl3, and gradual
dilution with a tenfold volume of hot pet. spirit precipitated
an intense dark blue powder. The suspension was cooled to 0 ˚C overnight, and the fine
dark blue precipitate was collected on a Hirsch funnel and dried in vacuo to give the 1,3di-ring-opened biaziridine adduct 185 (610 mg, 93%) as an intense dark blue-black
powder, mp 135–136 ˚C (dec.). Rf (10% EtOAc/CH2Cl2) 0.29. UV-Vis (CH2Cl2) λmax/nm
(ε, M-1cm-1) 573 (6647). 1H NMR (400 MHz, CDCl3) δ 7.62 (d, J = 8.1 Hz, 2H, Ts1 or
Ts2 H3/H5), 7.56 (t, J = 7.6 Hz, 1H, H3 or H11), 7.52 – 7.45 (m, 3H, H1, H3 or H11,
H13), 7.38 – 7.31 (m, 3H, H4 or H10, Ts1 or Ts2 H3/H5), 7.22 – 7.13 (m, 3H, H4 or H10,
Ts1 or Ts2 H2/H6), 7.02 (t, J = 7.4 Hz, 1H, H2 or H12), 6.99 – 6.90 (m, 3H, H2 or H12,
Ts1 or Ts2 H2/H6), 6.69 (d, J = 5.9 Hz, 1H, C7-NH), 5.71 (br s, 1H, C1ꞌ-NH), 4.96 (app
t, J = 4.7 Hz, 1H, H6), 4.64 (d, J = 12.9 Hz, 1H, H8a), 3.69 – 3.54 (m, 2H, H8b, H7), 3.15
– 2.98 (m, 1H, H1ꞌa or H1ꞌb), 2.90 – 2.78 (m, 1H, H1ꞌa or H1ꞌb), 2.36 (s, 3H, Ts1 or Ts2
CH3), 2.24 (s, 3H, Ts1 or Ts2 CH3). 13C NMR (101 MHz, CDCl3) δ 180.9 (C14 or C15),
180.8 (C14 or C15), 149.9 (C4a or C9a), 149.3 (C4a or C9a), 144.1 (Ts1 or Ts2 C4), 143.8
(Ts1 or Ts2 C4), 136.0 (Ts1 or Ts2 C1), 135.9 (C3 or C11), 135.8 (C3 or C11), 135.4 (Ts1
or Ts2 C1), 129.9 (Ts1 or Ts2 C2/C6), 129.6 (Ts1 or Ts2 C2/C6), 127.1 (Ts1 or Ts2 C3/C5),
127.0 (Ts1 or Ts2 C3/C5), 125.0 (C1 or C13), 124.9 (C1 or C13), 124.3 (C14a), 124.0
(C14b), 123.0 (C13a or C15a), 122.2 (C13a or C15a), 121.7 (C2 or C12), 121.4 (C2 or
C12), 110.3 (C4 or C10), 110.1 (C4 or C10), 54.3 (C7), 52.5 (C6), 42.4 (C1ꞌ), 39.4 (C8),
21.7 (Ts1 or Ts2 CH3), 21.6 (Ts1 or Ts2 CH3). IR (neat) 3253 (w), 1741 (w), 1697 (w),
1609 (m), 1304 (m), 745 (s). HRESI-MS calcd. for C34H30N4O6S2Na+ 677.1499, found
677.1513. [α]D29 = -15.0 ˚ (c 0.04, CHCl3).
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7.4

Reactions of indigo with organometallic nucleophiles

7.4.1. General Procedure B for Grignard Addition
A solution of the Grignard reagent (2.50 mmol) in THF (5 mL) was added to a flamedried round-bottomed flask, equipped with a magnetic stir bar and pre-dried LiCl (106
mg, 2.50 mmol), and the mixture stirred vigorously at room temperature for 30 min. The
resulting complex was added slowly dropwise to a cooled (0 ˚C) suspension of indigo
(131 mg, 0.500 mmol) in THF (15 mL) with vigorous stirring, and the resulting mixture
allowed to warm to room temperature over 1 h, then stirred at room temperature
overnight. To the mixture was added sat. aq. NaHCO3 (3 mL) and transferred to a
separatory funnel containing further NaHCO3 solution (40 mL). The aqueous phase was
extracted with EtOAc (4×40 mL), and the combined organic phases washed with further
NaHCO3 solution (40 mL) and brine (40 mL), dried (MgSO4), and the solvent removed.
The residue was used directly for subsequent dehydration reactions.
7.4.2. General Procedure C for Grignard Addition
A solution of isopropylmagnesium chloride (titrated at 0.40–1.10 M, 2.00 mmol) in THF
was added to a flame-dried round-bottomed flask, equipped with a magnetic stir bar and
finely-powdered, pre-dried LiCl (106 mg, 2.50 mmol), and the mixture stirred vigorously
at room temperature for 30 min. The solution was cooled to 0 ˚C, and a solution of the
desired aryl iodide (2.50 mmol) in THF (3 mL) added dropwise, and the mixture stirred
for the indicated time. The resulting aryl Grignard reagent was added slowly dropwise to
a cooled (-84 ˚C – EtOAc/N2) suspension of indigo (131 mg, 0.500 mmol) in THF (15
mL) with vigorous stirring, and the resulting mixture allowed to warm to room
temperature over 1 h and stirred at room temperature for a further hour. The reaction was
quenched by addition of sat. aq. NaHCO3 (3 mL) and the mixture transferred to a
separatory funnel containing further NaHCO3 solution (40 mL). The aqueous phase was
extracted with EtOAc (4×40 mL), and the combined organic phases washed with further
NaHCO3 solution (40 mL) and brine (40 mL), dried (MgSO4), and the solvent removed.
The residue was used directly for subsequent dehydration reactions.
7.4.3. General Procedure D for Grignard Addition
A flame-dried round-bottomed flask, equipped with a magnetic stir bar was charged with
a solution of the desired aryl iodide (2.50 mmol) in THF (1 mL), and cooled to 0 ˚C.
Isopropylmagnesium chloride lithium chloride complex (titrated at 0.51 M, 2.00 mmol)
in THF was added slowly dropwise, and the mixture stirred for the indicated time. The
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resulting aryl Grignard reagent was added slowly dropwise to a cooled (-84 ˚C –
EtOAc/N2) suspension of indigo (131 mg, 0.500 mmol) in THF (15 mL) with vigorous
stirring, and the resulting mixture allowed to warm to room temperature over 1 h and
stirred at room temperature for a further hour. The reaction was quenched by addition of
sat. aq. NaHCO3 (3 mL) and transferred to a separatory funnel containing further NaHCO3
solution (40 mL). The aqueous phase was extracted with EtOAc (4×40 mL), and the
combined organic phases washed with further NaHCO3 solution (40 mL) and brine (40
mL), and dried (MgSO4), and the solvent removed. The residue was used directly for
subsequent dehydration reactions.
7.4.4. General Procedure E for Organolithium Addition
A flame-dried round-bottomed flask, equipped with a magnetic stir bar was charged with
a solution of the desired heterocycle (2.50 mmol) in THF (1 mL), and cooled to -84 ˚C
(EtOAc/N2). A solution of n-BuLi in hexane (titrated at 1.95 M, 2.00 mmol) was added
slowly dropwise, and the mixture allowed to warm to room temperature over the indicated
time. The resulting organolithium reagent was added slowly dropwise to a cooled (-84
˚C) suspension of indigo (131 mg, 0.500 mmol) in THF (15 mL) with vigorous stirring,
and the resulting deep red mixture allowed to warm to room temperature over 1 h, and
stirred at room temperature for a further hour. The reaction was quenched by addition of
sat. aq. NaHCO3 (3 mL), and the mixture transferred to a separatory funnel containing
further NaHCO3 solution (40 mL). The aqueous phase was extracted with EtOAc (4×40
mL), and the combined organic phases washed with further NaHCO3 solution (40 mL)
and brine (40 mL), dried (MgSO4), and the solvent removed. The residue was used
directly for subsequent dehydration reactions.
7.4.5. General Procedure F for Boc-mediated Dehydration:
The crude tertiary alcohol residue (ca. 0.5 mmol) was suspended in CH2Cl2 (100 mL),
then DMAP (131 mg, 1.1 mmol), NEt3 (0.2 mL) and di-tert-butyl dicarbonate (327 mg,
1.5 mmol) were added sequentially in air, and the mixture stirred vigorously at room
temperature for 1 h. The resulting intense orange solution was diluted with 0.2 N HCl (50
mL), and the lower organic layer collected and washed with a further 0.2 N HCl (50 mL),
sat. NaHCO3 (40 mL) and brine (40 mL), dried (Na2SO4) and the solvent removed.
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7.4.6. Isolated scaffolds
tert-butyl 3-isopropyl-3'-oxo-1H,3'H-[2,2'-biindole]-1-carboxylate (210)
Prepared

via

General

Procedure

B,

using

isopropylmagnesium chloride (0.598 M, 3.3 mL, 1.97
mmol) and LiCl (106 mg, 2.50 mmol). Subsequent Bocmediated dehydration (General Procedure F) of the crude
product afforded a red residue, which was fractionated on
silica (75 g, using 60% CH2Cl2/pet spirit as eluent) and
recrystallised from hexane to afford the N-Boc indole 210 (153 mg, 80%) as shiny, brightorange crystals, mp 62–64 ˚C. Rf (10% EtOAc/pet spirit) 0.56. UV-Vis (acetone) λmax/nm
(ε, M-1cm-1) 333 (5448), 434 (1702), 509 (1275). 1H NMR (400 MHz, CDCl3) δ 8.21 (d,
J = 8.4 Hz, 1H, H7), 7.83 (d, J = 8.0 Hz, 1H, H4), 7.60 (d, J = 7.4 Hz, 1H, H4ꞌ), 7.56 (app
t, J = 7.5 Hz, 1H, H6ꞌ), 7.49 (d, J = 7.5 Hz, 1H, H7ꞌ), 7.40 (app t, J = 7.6 Hz, 1H, H6),
7.31 – 7.21 (m, 2H, H5, H5ꞌ), 3.58 (hept, J = 7.1 Hz, 1H, H2ꞌꞌ), 1.49 (s, 9H, 3×Boc CH3),
1.46 (d, J = 7.1 Hz, 6H, H1ꞌꞌ, H3ꞌꞌ).
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C NMR (101 MHz, CDCl3) δ 192.1 (C3ꞌ), 160.8

(H7aꞌ), 160.7 (C2ꞌ), 150.1 (Boc C=O), 137.6 (C7a), 136.8 (C6ꞌ), 134.0 (C3), 128.52 (C3a
or C3aꞌ), 128.50 (C3a or C3aꞌ), 128.4 (C5ꞌ), 126.1 (C6), 125.0 (C4ꞌ), 124.2 (C2), 122.7
(C5), 122.5 (C7ꞌ), 121.8 (C4), 115.9 (C7), 84.9 (Boc Cq), 28.1 (Boc CH3), 26.1 (C2ꞌꞌ),
22.8 (C1ꞌꞌ, C3ꞌꞌ). IR (neat) 2962 (w), 2929 (w), 2630 (w), 2339 (w), 1734 (s), 1575 (m),
1452 (s), 1369 (s), 1344 (s), 1321 (s), 1234 (s), 1145 (s), 761 (s), 744 (s) cm -1. HRESIMS calcd. for C24H25N2O3+ 389.1860, found 389.1860.
3-phenyl-1H,3'H-[2,2'-biindol]-3'-one (214)
Prepared via General Procedure B using phenylmagnesium
chloride (0.805 M, 2.50 mL, 2.01 mmol) and LiCl (106 mg,
2.50

mmol).

Subsequent

Boc-mediated

dehydration

(General Procedure F) of the crude product afforded a dark
brown residue, which was fractionated on silica (40 g, using
60% CH2Cl2/pet spirit as eluent). Removal of the solvent from the first fraction afforded
the free indole 214 (22 mg, 13%) as an intense black-purple powder, mp 190–192 ˚C. Rf
(60% CH2Cl2/pet spirit) 0.58. UV-Vis (acetone) λmax/nm (ε, M-1cm-1) 326 (2627), 538
(1491). 1H NMR (500 MHz, CDCl3) δ 10.25 (s, 1H, NH), 7.70 (d, J = 7.6 Hz, 2H, H3ꞌꞌ,
H5ꞌꞌ), 7.67 (d, J = 8.1 Hz, 1H, H4), 7.54 – 7.45 (m, 5H, H4ꞌ, H7, H2ꞌꞌ, H6ꞌꞌ, H6ꞌ), 7.42 (t,
J = 7.4 Hz, 1H, H4ꞌꞌ), 7.35 (t, J = 7.6 Hz, 1H, H6), 7.23 (d, J = 7.6 Hz, 1H, H7ꞌ), 7.19 –
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7.11 (m, 2H, H5, H5ꞌ). 13C NMR (126 MHz, CDCl3) δ 196.1 (C3ꞌ), 162.1 (C7aꞌ), 154.3
(C2ꞌ), 138.2 (C7a), 137.5 (C6ꞌ), 133.9 (C1ꞌꞌ), 131.0 (C3ꞌꞌ, C5ꞌꞌ), 128.1 (C2ꞌꞌ, C6ꞌꞌ), 127.7
(C4ꞌꞌ), 127.5 (C5ꞌ), 126.7 (C3a), 126.4 (C6), 125.2 (C4ꞌ), 124.5 (C3), 122.4 (C3aꞌ), 122.2
(C3aꞌ), 121.7 (C4), 121.3 (C5), 114.2 (C2), 112.0 (C7). IR (neat) 3370 (br w), 2922 (s),
2850 (m), 1734 (m), 1558 (s), 1168 (m), 747 (m) cm-1. HRESI-MS calcd. for C22H15N2O+
323.1184, found 323.1187.
tert-butyl 3'-oxo-3-phenyl-1H,3'H-[2,2'-biindole]-1-carboxylate (211)
Further elution afforded a red-orange fraction, which was
subjected to flash chromatography (20 g silica, 10%
EtOAc/pet spirit), and removal of the solvent gave the NBoc indole 211 (174 mg, 79%) as shiny, bright orange
crystals, mp 132–133 ˚C (dec.). X-ray quality crystals were
grown by slow evaporation from hexane. Rf (60%
CH2Cl2/pet spirit) 0.56. UV-Vis (acetone) λmax/nm (ε, M1

cm-1) 323 (7900), 329 (2917), 499 (1440). 1H NMR (400 MHz, CDCl3) δ 8.24 (d, J =

8.4 Hz, 1H, H7), 7.66 – 7.60 (m, 3H, H2ꞌꞌ, H6ꞌꞌ, H4), 7.53 (d, J = 7.1 Hz, 1H, H4ꞌ), 7.51
– 7.33 (m, 6H, H3ꞌꞌ, H4ꞌꞌ, H5ꞌꞌ, H6, H6ꞌ, H7ꞌ), 7.28 (app t, J = 7.2 Hz, 1H, H5), 7.23 (app
t, J = 7.4 Hz, 1H, H5ꞌ), 1.52 (s, 9H, 3×Boc CH3). 13C NMR (101 MHz, CDCl3) δ 191.8
(C3ꞌ), 160.4 (C7aꞌ), 160.3 (C2ꞌ), 150.1 (Boc C=O), 136.8 (C7a), 136.7 (C6ꞌ), 131.8 (C3),
130.9 (C3ꞌꞌ, C5ꞌꞌ), 129.6 (C3a), 128.5 (C5ꞌ), 128.3 (C2ꞌꞌ, C6ꞌꞌ), 128.1 (C1ꞌꞌ), 128.0 (C7ꞌ),
126.7 (C6), 125.2 (C2), 125.0 (C4ꞌ), 123.5 (C5), 122.7 (C3aꞌ), 122.6 (C4ꞌꞌ), 121.2 (C4),
115.7 (C7), 85.3 (Boc Cq), 28.1 (Boc CH3). IR (neat) 2978 (w), 2920 (w), 2360 (m), 1734
(s), 1576 (m), 1319 (s) 1149 (s), 746 (s), 699 (s) cm-1. HRESI-MS calcd. for C27H23N2O3+
423.1703, found 423.1702.
tert-butyl 3-butyl-3'-oxo-1H,3'H-[2,2'-biindole]-1-carboxylate (215)
Prepared via General Procedure E, using n-BuLi (1.95 M,
1.4 mL, 2.73 mmol) and TMEDA (333 mg, 2.86 mmol).
Subsequent

Boc-mediated

dehydration

(General

Procedure F) of the crude product afforded a red-brown
residue, which was fractionated on silica (75 g, using 10%
EtOAc/hexane as eluent), and flash chromatography (30 g
silica, 60% CH2Cl2/hexane) afforded the N-Boc indole 215
(162 mg, 80%) as a deep orange amorphous solid, mp 42–43 ˚C. Rf (10% EtOAc/hexane)
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0.49. UV-Vis (acetone) λmax/nm (ε, M-1cm-1) 331 (3679), 438 (2134), 500 (1810). 1H
NMR (400 MHz, CDCl3) δ 8.17 (d, J = 8.4 Hz, 1H, H7), 7.65 (d, J = 7.7 Hz, 1H, H4),
7.62 – 7.53 (m, 2H, H4ꞌ, H6ꞌ), 7.48 (d, J = 7.6 Hz, 1H, H7ꞌ), 7.42 (ddd, J = 8.4, 7.1, 1.3
Hz, 1H, H6), 7.34 – 7.26 (m, 2H, H5, H5ꞌ), 2.94 (d, J = 7.6 Hz, 2H, H1ꞌꞌ), 1.74 – 1.64 (m,
2H, H2ꞌꞌ), 1.51 (s, 9H, 3×Boc CH3), 1.36 (h, J = 7.4 Hz, 2H, H3ꞌꞌ), 0.90 (t, J = 7.3 Hz, 3H,
H4ꞌꞌ). 13C NMR (101 MHz, CDCl3) δ 191.9 (C3ꞌ), 160.7 (C7aꞌ), 160.2 (C2ꞌ), 150.0 (Boc
C=O), 137.2 (C7a), 136.6 (C6), 129.8 (C3a), 129.3 (C3), 128.2 (C5ꞌ), 126.4 (C6), 125.4
(C2), 124.8 (C4ꞌ), 122.9 (C5), 122.5 (C3aꞌ), 122.2 (C7ꞌ), 120.3 (C4), 115.6 (C7), 84.7
(Boc Cq), 32.7 (C2ꞌꞌ), 28.0 (Boc CH3), 24.1 (C1ꞌꞌ), 22.6 (C3ꞌꞌ), 13.9 (C4ꞌꞌ). IR (neat) 2957
(w), 2930 (w), 1734 (s), 1558 (m), 1319 (m) 1149 (s), 1105 (m), 761 (m), 745 (m) cm-1.
HRESI-MS calcd. for C25H27N2O3+ 403.2022, found 403.2036.
3-methyl-1H,3'H-[2,2'-biindol]-3'-one (218)
To a cooled (-84 ˚C) suspension of indigo (131 mg, 0.500
mmol) and TMEDA (320 mg, 2.75 mmol) in THF (20 mL)
was added dropwise MeLi (2.74 M in DME, 0.90 mL, 2.47
mmol), and the mixture allowed to warm to RT over 1 h. The
resulting intense-red solution was stirred at RT for a further hour, then sat. NaHCO3
solution (3 mL) added, and the mixture transferred to a separatory funnel containing
additional NaHCO3 solution (40 mL). The aqueous phase was extracted with EtOAc
(4×40 mL), and the combined organic phases washed with NaHCO3 solution (40 mL) and
brine (40 mL), dried (MgSO4), and the solvent removed. The resulting golden residue
was dissolved in CH2Cl2 (100 mL), then PPh3 (159 mg, 0.606 mmol), imidazole (99 mg,
1.46 mmol), and I2 (162 mg, 0.638 mmol) added sequentially. The deep brown mixture
was stirred overnight, then diluted with water (50 mL) and transferred to a separatory
funnel. The aqueous phase was extracted with CH2Cl2 (3×30 mL), and the combined
organic phases washed with NaHCO3 solution (40 mL) and brine (40 mL), dried
(MgSO4), and the solvent removed. The residue was subjected to flash chromatography
(60 g silica, 60% CH2Cl2/pet spirit) and removal of the solvent from the intense deeppurple fraction afforded the desired indole 218 (97 mg, 74%) as feathery, dark purple
crystals, mp 252–253 ˚C (dec.). Rf (60% CH2Cl2/pet spirit) 0.71. UV-Vis (acetone)
λmax/nm (ε, M-1cm-1) 326 (8389), 538 (4881). 1H NMR (500 MHz, CDCl3) δ 9.98 (s, 1H,
NH), 7.68 (dd, J = 8.1, 1.0 Hz, 1H, H4), 7.58 – 7.50 (m, 2H, C4ꞌ, C7ꞌ), 7.43 – 7.36 (m,
2H, H7, H6ꞌ), 7.32 (ddd, J = 8.2, 6.9, 1.1 Hz, 1H, H6), 7.22 – 7.16 (m, 1H, H5ꞌ), 7.16 –
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7.11 (m, 1H, H5), 2.84 (s, 3H, Ar-CH3). 13C NMR (126 MHz, CDCl3) δ 196.9 (C3ꞌ), 163.0
(C7aꞌ), 154.8 (C2ꞌ), 138.4 (C7a), 137.7 (C6ꞌ), 128.8 (C3a), 127.4 (C5ꞌ), 126.3 (C6), 125.23
(C2), 125.19 (C4ꞌ), 124.3 (C3aꞌ), 122.04 (C3), 121.95 (C7ꞌ), 120.7 (C4), 120.4 (C5), 112.0
(C7), 11.6 (Ar-CH3). IR (neat) 3376 (m), 1708 (s), 1540 (s), 1452 (m), 1327 (s), 1241
(m), 1167 (s), 877 (m), 762 (s), 741 (s), 672 (s) cm-1. HRESI-MS calcd. for C17H13N2O+
261.1022, found 261.1022.
tert-butyl 3-benzyl-3'-oxo-1H,3'H-[2,2'-biindole]-1-carboxylate (219)
Prepared via General Procedure B using benzylmagnesium
chloride (1.89 M, 1.10 mL, 2.08 mmol), and LiCl (106 mg,
2.50

mmol).

Subsequent

Boc-mediated

dehydration

(General Procedure F) of the crude product afforded a deep
orange

residue,

which

was

separated

by

flash

chromatography (100 g silica, 10% EtOAc/hexane) to give
the N-Boc indole 219 (204 mg, 91%) as a deep orange
powder, mp 85–86 ˚C. Rf (10% EtOAc/hexane) 0.27. UV-Vis (acetone) λmax/nm (ε, M1

cm-1) 331 (3957), 409 (2129), 462 (1605), 499 (1561). 1H NMR (500 MHz, CDCl3) δ

8.16 (d, J = 8.4 Hz, 1H, H7), 7.58 (dd, J = 7.2, 0.6 Hz, 1H, H4ꞌ), 7.53 (td, J = 7.6, 1.2 Hz,
1H, H6ꞌ), 7.47 – 7.43 (m, 2H, H4, H7ꞌ), 7.38 (ddd, J = 8.4, 7.2, 1.2 Hz, 1H, H6), 7.31 (d,
J = 7.6 Hz, 2H, H2ꞌꞌ, H6ꞌꞌ), 7.28 – 7.24 (m, 1H, H4ꞌꞌ), 7.22 (dd, J = 10.9, 4.1 Hz, 2H, H3ꞌꞌ,
H5ꞌꞌ), 7.19 – 7.16 (m, 1H, H5), 7.13 (t, J = 7.4 Hz, 1H, H4ꞌꞌ), 4.32 (s, 2H, Ar-CH2Ph),
1.53 (s, 9H, 3×Boc CH3). 13C NMR (126 MHz, CDCl3) δ 191.9 (C3ꞌ), 160.5 (C7aꞌ), 160.0
(C2ꞌ), 150.1 (Boc C=O), 139.7 (C1ꞌꞌ), 137.3 (C7a), 136.8 (C6ꞌ), 129.6 (C3a), 128.7 (C2ꞌꞌ,
C6ꞌꞌ), 128.5 (C3ꞌꞌ, C5ꞌꞌ), 128.4 (C5ꞌ), 126.7 (C3), 126.6 (C6), 126.4 (C2), 126.3 (C4ꞌꞌ),
125.0 (C4ꞌ), 123.2 (C5), 122.5 (C7aꞌ), 122.4 (C7ꞌ), 121.0 (C4), 115.6 (C7), 85.1 (Boc Cq),
30.6 (Ar-CH2Ph), 28.1 (Boc CH3). IR (neat) 2979 (w), 1734 (s), 1558 (m), 1452 (m),
1319 (m) 1145 (s), 1105 (m), 762 (m), 745 (m), 698 (m) cm-1. HRESI-MS calcd. for
C28H25N2O3+ 437.1865, found 437.1880.
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tert-butyl 3-(4-methoxyphenyl)-3'-oxo-1H,3'H-[2,2'-biindole]-1-carboxylate (222)
Prepared via General Procedure C. The substituted
Grignard reagent (4-methoxyphenylmagnesium chloride
lithium

chloride

complex)

was

prepared

using

isopropylmagnesium chloride (1.08 M, 1.80 mL, 1.94
mmol), LiCl (106 mg, 2.50 mmol) and 4-iodoanisole (589
mg, 2.50 mmol), and the resulting mixture stirred at room
temperature for 1.5 h prior to combining with indigo.
Subsequent Boc-mediated dehydration (General Procedure F) of the crude product
afforded a deep red-orange mixture, which was separated by flash chromatography (80 g
silica, 10% EtOAc/pet spirit) to afford the title compound 222 (168 mg, 72%) as a bright
orange powder, mp 79–80 ˚C (dec.). Rf (10% EtOAc/pet spirit) 0.25. UV-Vis (acetone)
λmax/nm (ε, M-1cm-1) 347 (2250), 412 (1222), 469 (1104), 504 (979). 1H NMR (400 MHz,
CDCl3) δ 8.24 (d, J = 8.4 Hz, 1H, H7), 7.65 (d, J = 7.7 Hz, 1H, H4), 7.60 (d, J = 8.7 Hz,
2H, H2ꞌꞌ, H6ꞌꞌ), 7.55 (d, J = 7.1 Hz, 1H, H4ꞌ), 7.51 (td, J = 7.6, 1.3 Hz, 1H, H6ꞌ), 7.46
(ddd, J = 8.4, 7.2, 1.2 Hz, 1H, H6), 7.40 (d, J = 7.5 Hz, 1H, H7ꞌ), 7.30 (ddd, J = 8.1, 7.2,
1.0 Hz, 1H, H5), 7.26 – 7.21 (m, 1H, H5ꞌ), 6.97 (d, J = 8.7 Hz, 2H, H3ꞌꞌ, H5ꞌꞌ), 3.83 (s,
3H, -OCH3), 1.52 (s, 9H, 3×Boc CH3). 13C NMR (101 MHz, CDCl3) δ 191.9 (C3ꞌ), 160.6
(C7aꞌ), 160.3 (C2ꞌ), 159.5 (C4ꞌꞌ), 150.1 (Boc C=O), 136.9 (C7a), 136.7 (C6ꞌ), 132.2 (C2ꞌꞌ,
C6ꞌꞌ), 129.8 (C3a), 128.5 (C5ꞌ), 128.0 (C3), 126.6 (C6), 125.0 (C4ꞌ), 124.9 (C2), 124.0
(C1ꞌꞌ), 123.5 (C5), 122.7 (C3aꞌ), 122.6 (C7ꞌ), 121.3 (C4), 115.7 (C7), 113.7 (C3ꞌꞌ, C5ꞌꞌ),
85.2 (Boc Cq), 55.4 (-OCH3), 28.1 (Boc CH3). IR (neat) 2956 (w), 2923 (m), 2853 (w),
1734 (s), 1506 (m), 1250 (s) 1151 (s), 763 (m) cm-1. HRESI-MS calcd. for C28H25N2O4+
453.1809, found 453.1807.
tert-butyl 3-(3-methoxyphenyl)-3'-oxo-1H,3'H-[2,2'-biindole]-1-carboxylate (223)
Prepared via General Procedure C. The substituted
Grignard reagent (3-methoxyphenylmagnesium chloride
lithium

chloride

complex)

was

prepared

using

isopropylmagnesium chloride (1.08 M, 1.80 mL, 1.94
mmol), LiCl (106 mg, 2.50 mmol), and 3-iodoanisole (599
mg, 2.56 mmol), and the resulting mixture stirred at room
temperature for 1.5 h prior to combining with indigo.
Subsequent Boc-mediated dehydration (following General Procedure F) of the crude
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product afforded a deep red-orange residue, which was subjected to flash chromatography
(95 g silica, 10% EtOAc/hexane), to afford the N-Boc indole 223 (167 mg, 72%) as deep
orange crystals, mp 64–65 ˚C. Rf (10% EtOAc/hexane) 0.25. UV-Vis (acetone) λmax/nm
(ε, M-1cm-1) 327 (3430), 433 (1549), 467 (1357), 504 (1143). 1H NMR (400 MHz, CDCl3)
δ 8.24 (d, J = 8.4 Hz, 1H, H7), 7.69 (d, J = 7.9 Hz, 1H, H4), 7.55 (d, J = 7.1 Hz, 1H, H4ꞌ),
7.51 (td, J = 7.6, 1.2 Hz, 1H, H6ꞌ), 7.48 – 7.42 (m, 1H, H6), 7.37 (d, J = 7.5 Hz, 1H, H7ꞌ),
7.34 – 7.22 (m, 4H, H5, H5ꞌ, H2ꞌꞌ, H5ꞌꞌ), 7.20 – 7.16 (m, 1H, H6ꞌꞌ), 6.91 (ddd, J = 8.2, 2.5,
0.8 Hz, 1H, H4ꞌꞌ), 3.83 (s, 3H, -OCH3), 1.52 (s, 9H, 3×Boc CH3). 13C NMR (101 MHz,
CDCl3) δ 191.7 (C3ꞌ), 160.43 (C7aꞌ or C2ꞌ), 160.38 (C7aꞌ or C2ꞌ), 159.5 (C3ꞌꞌ), 150.1 (Boc
C=O), 136.8 (C7a), 136.7 (C6ꞌ), 133.0 (C1ꞌꞌ), 130.9 (C2), 129.5 (C3a), 129.2 (C5ꞌꞌ), 128.6
(C5ꞌ), 127.9 (C3), 126.7 (C6), 125.0 (C4ꞌ), 123.6 (C5), 123.2 (C6ꞌꞌ), 122.7 (C3aꞌ), 122.6
(C7ꞌ), 121.2 (C4), 116.2 (C2ꞌꞌ), 115.7 (C7), 114.4 (C4ꞌꞌ), 85.4 (Boc Cq), 55.4 (-OCH3),
28.1 (Boc CH3). IR (neat) 2976 (w), 2361 (m), 2853 (w), 1734 (s), 1149 (s), 763 (m), 750
(m) cm-1. HRESI-MS calcd. for C28H25N2O4+ 453.1809, found 453.1808.
tert-butyl 3-(2-methoxyphenyl)-3'-oxo-1H,3'H-[2,2'-biindole]-1-carboxylate (224)
Prepared via General Procedure C. The substituted
Grignard reagent (2-methoxyphenylmagnesium chloride
lithium

chloride

complex)

was

prepared

using

isopropylmagnesium chloride (1.08 M, 1.80 mL, 1.94
mmol), LiCl (106 mg, 2.50 mmol), and 2-iodoanisole (592
mg, 2.53 mmol), and the resulting mixture stirred at room
temperature for 1.5 h prior to combining with indigo.
Subsequent Boc-mediated dehydration (General Procedure F) of the crude product
afforded a deep red-orange residue, which was subjected to flash chromatography (80 g
silica, 10% EtOAc/hexane), to afford the N-Boc indole 224 (217 mg, 94%) as deep orange
crystals, mp 159–160 ˚C (dec.). X-ray quality crystals were grown by slow evaporation
of a 9:1 hexane:chloroform solution. Rf (10% EtOAc/hexane) 0.24. UV-Vis (acetone)
λmax/nm (ε, M-1cm-1) 329 (2794), 419 (1496), 505 (948). 1H NMR (400 MHz, CDCl3) δ
8.25 (d, J = 8.4 Hz, 1H, H7), 7.61 – 7.53 (m, 3H, H6ꞌꞌ, H4, H4ꞌ), 7.47 (td, J = 7.8, 1.2 Hz,
1H, H6ꞌ), 7.42 (ddd, J = 8.4, 7.3, 1.2 Hz, 1H, H6), 7.34 – 7.22 (m, 4H, H5, H5ꞌ, H7ꞌ, H4ꞌꞌ),
7.09 (td, J = 7.5, 0.9 Hz, 1H, H5ꞌꞌ), 6.83 (d, J = 8.0 Hz, 1H, H3ꞌꞌ), 3.37 (s, 3H, -OCH3),
1.51 (s, 9H, 3×Boc CH3). 13C NMR (101 MHz, CDCl3) δ 192.9 (C3ꞌ), 161.2 (C2ꞌ), 160.6
(C7aꞌ), 155.5 (C2ꞌꞌ), 149.9 (Boc C=O), 136.9 (C7a), 136.5 (C6ꞌ), 132.0 (C6ꞌꞌ), 129.6 (C3a),
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129.2 (C4ꞌꞌ), 128.3 (C5ꞌ), 126.18 (C6), 126.15 (C2), 124.4 (C4ꞌ), 123.4 (C5), 122.8 (C3aꞌ),
122.6 (C3), 122.3 (C7ꞌ), 121.1 (C1ꞌꞌ), 121.0 (C5ꞌꞌ), 120.9 (C4), 115.8 (C7), 111.4 (C3ꞌꞌ),
85.1 (Boc Cq), 55.2 (-OCH3), 28.1 (Boc CH3). IR (neat) 2981 (w), 2358 (w), 1718 (s),
1323 (s), 1149 (s), 748 (s) cm-1. HRESI-MS calcd. for C28H25N2O4+ 453.1809, found
453.1808.
tert-butyl 3-(2,4-dimethoxyphenyl)-3'-oxo-1H,3'H-[2,2'-biindole]-1-carboxylate
(228)
Prepared via General Procedure D. The substituted
Grignard

reagent

(2,4-dimethoxyphenylmagnesium

chloride lithium chloride complex) was prepared using
isopropylmagnesium chloride lithium chloride complex
(0.45 M, 4.4 mL, 1.98 mmol), and 1-iodo-2,4dimethoxybenzene (664 mg, 2.51 mmol), and the mixture
stirred at 0 ˚C for 2 h prior to combining with indigo.
Subsequent Boc-mediated dehydration (General Procedure F) of the crude product
afforded a deep red-orange residue, which was subjected to flash chromatography (80 g
silica, 20% EtOAc/hexane), to afford the N-Boc indole 228 (179 mg, 72%) as a deep
orange solid, mp 89–90 ˚C (dec.). Rf (20% EtOAc/hexane) 0.35. UV-Vis (acetone)
λmax/nm (ε, M-1cm-1) 330 (3138), 400 (1623), 421 (1610), 507 (1127). 1H NMR (500 MHz,
CDCl3) δ 8.24 (d, J = 8.5 Hz, 1H, H7), 7.59 (d, J = 7.1 Hz, 1H, H4ꞌ), 7.54 (d, J = 8.0 Hz,
1H, H4), 7.50 – 7.45 (m, 2H, H6ꞌ, H6ꞌꞌ), 7.41 (app t, J = 7.2 Hz, 1H, H6), 7.32 – 7.23 (m,
3H, H5, H5ꞌ, H7ꞌ), 6.63 (dd, J = 8.4, 2.4 Hz, 1H, H5ꞌꞌ), 6.40 (d, J = 2.4 Hz, 1H, H3ꞌꞌ), 3.83
(s, 3H, C4ꞌꞌ-OCH3), 3.36 (s, 3H, C2ꞌꞌ-OCH3), 1.51 (s, 9H, 3×Boc CH3). 13C NMR (126
MHz, CDCl3) δ 193.0 (C3ꞌ), 161.3 (C2ꞌ), 160.70 (C4ꞌꞌ or C7aꞌ), 160.65 (C4ꞌꞌ or C7aꞌ),
156.6 (C2ꞌꞌ), 149.9 (Boc C=O), 136.9 (C7a), 136.5 (C6ꞌ), 132.5 (C6ꞌꞌ), 129.8 (C3a), 128.2
(C5ꞌ), 126.1 (C6), 125.8 (C2), 124.4 (C4ꞌ), 123.3 (C5), 122.8 (C3aꞌ), 122.6 (C3), 122.3
(C7ꞌ), 120.9 (C4), 115.8 (C7), 113.7 (C1ꞌꞌ), 104.8 (C5ꞌꞌ), 99.4 (C3ꞌꞌ), 85.0 (Boc Cq), 55.5
(C4ꞌꞌ-OCH3), 55.2 (C2ꞌꞌ-OCH3), 28.1 (Boc CH3). IR (neat) 2978 (w), 2933 (w), 2361 (w),
1734 (s), 1451 (m), 1323 (m), 1149 (s), 748 (s) cm-1. HRESI-MS calcd. for C29H27N2O5+
483.1915, found 483.1914.
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tert-butyl 3-(4-fluorophenyl)-3'-oxo-1H,3'H-[2,2'-biindole]-1-carboxylate (231)
Prepared via General Procedure C. The substituted
Grignard
lithium

reagent
chloride

(4-fluorophenylmagnesium
complex)

was

chloride

prepared

using

isopropylmagnesium chloride (1.08 M, 1.70 mL, 1.84
mmol), LiCl (106 mg, 2.50 mmol), and 4-fluoroiodobenzene
(567 mg, 2.56 mmol and the resulting mixture stirred at
room temperature for 1.5 h prior to combining with indigo.
Subsequent Boc-mediated dehydration (General Procedure F) of the crude product
afforded a deep red-orange residue, which was subjected to flash chromatography (80 g
silica, 10% EtOAc/hexane), to afford the N-Boc indole 231 (167 mg, 75%) as bright
orange crystals, mp 137–138 ˚C (dec.). Rf (10% EtOAc/hexane) 0.53. UV-Vis (acetone)
λmax/nm (ε, M-1cm-1) 329 (3911), 418 (2023), 470 (1725), 503 (1448). 1H NMR (500 MHz,
CDCl3) δ 8.24 (d, J = 8.4 Hz, 1H, H7), 7.64 – 7.57 (m, 3H, H4, H2ꞌꞌ, H6ꞌꞌ), 7.56 (d, J =
7.1 Hz, 1H, H4), 7.52 (td, J = 7.6, 1.3 Hz, 1H, H6ꞌ), 7.47 (ddd, J = 8.4, 7.2, 1.2 Hz, 1H,
H6), 7.38 (d, J = 7.5 Hz, 1H, H7ꞌ), 7.31 (app t, J = 7.1 Hz, 1H, H5), 7.29 – 7.22 (m, 1H,
H5ꞌ), 7.11 (app tt, J = 8.8, 2.9 Hz, 2H, H3ꞌꞌ, H5ꞌꞌ), 1.53 (s, 9H, 3×Boc CH3). 13C NMR
(126 MHz, CDCl3) δ 191.7 (C3ꞌ), 162.7 (d, 1J C-F = 248.2 Hz, C4ꞌꞌ), 160.4 (C2ꞌ or C7aꞌ),
160.0 (C2ꞌ or C7aꞌ), 150.2 (Boc C=O), 136.82 (C7a), 136.80 (C6ꞌ), 132.7 (d, 3J C-F = 8.1
Hz, C2ꞌꞌ, C6ꞌꞌ), 129.5 (C3a), 128.6 (C5ꞌ), 127.7 (d, 4J C-F = 2.5 Hz, C1ꞌꞌ), 127.2 (C3), 126.8
(C6), 125.3 (C2), 125.1 (C4ꞌ), 123.6 (C5), 122.7 (C3aꞌ), 122.6 (C7ꞌ), 121.0 (C4), 115.8
(C7), 115.3 (d, 2J C-F = 21.3 Hz, C3ꞌꞌ, C5ꞌꞌ), 85.5 (Boc Cq), 28.1 (Boc CH3). 19F NMR (470
MHz, CDCl3, 1H-decoupled) δ -114.0. IR (neat) 2980 (w), 2931 (w), 2367 (w), 1734 (s),
1506 (m), 1319 (m), 1149 (s), 748 (s) cm-1. HRESI-MS calcd. for C27H22FN2O3+
441.1609, found 441.1608.
tert-butyl 3-(2-chlorophenyl)-3'-oxo-1H,3'H-[2,2'-biindole]-1-carboxylate (232)
Prepared via General Procedure C. The substituted
Grignard
lithium

reagent
chloride

(2-chlorophenylmagnesium
complex)

was

chloride

prepared

using

isopropylmagnesium chloride (1.08 M, 1.80 mL, 1.94
mmol),

LiCl

(106

mg,

2.50

mmol),

and

2-

chloroiodobenzene (605 mg, 2.54 mmol), and the resulting
mixture stirred at room temperature for 1.5 h prior to
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combining with indigo. Subsequent Boc-mediated dehydration (General Procedure F)
of the crude product afforded a deep red-orange residue, which was subjected to flash
chromatography (80 g silica, 10% EtOAc/hexane), to afford the N-Boc indole 232 (182
mg, 79%) as deep red-orange crystals, mp 108–109 ˚C (dec.). X-ray quality crystals were
grown by slow evaporation of a 9:1 hexane/chloroform solution. Rf (10% EtOAc/hexane)
0.30. UV-Vis (acetone) λmax/nm (ε, M-1cm-1) 327 (3120), 401 (1619), 466 (1220), 500
(952). 1H NMR (400 MHz, CDCl3) δ 8.25 (d, J = 8.5 Hz, 1H, H7), 7.57 (d, J = 7.2 Hz,
1H, H4ꞌ), 7.52 (dd, J = 7.5, 1.7 Hz, 1H, H6ꞌꞌ), 7.49 – 7.45 (m, 2H, H6, H6ꞌ), 7.43 (dd, J =
5.4, 1.3 Hz, 1H, H3ꞌꞌ), 7.41 – 7.39 (m, 1H, H4), 7.35 (dd, J = 7.4, 1.6 Hz, 1H, H5ꞌꞌ), 7.32
(dd, J = 7.6, 1.9 Hz, 1H, H4ꞌꞌ), 7.30 – 7.27 (m, 3H, H5, H5ꞌ, H7ꞌ), 1.53 (s, 9H, 3×Boc
CH3). 13C NMR (101 MHz, CDCl3) δ 191.8 (C3ꞌ), 160.5 (C7aꞌ), 160.1 (C2ꞌ), 149.9 (Boc
C=O), 136.8 (C7a), 136.6 (C6ꞌ), 133.6 (C2ꞌꞌ), 133.0 (C6ꞌꞌ), 131.3 (C1ꞌꞌ), 130.0 (C3ꞌꞌ), 129.4
(C4ꞌꞌ), 129.2 (C3a), 128.5 (C5ꞌ), 128.4 (C2), 126.8 (C5ꞌꞌ), 126.7 (C6), 126.6 (C3), 124.8
(C4ꞌ), 123.6 (C5), 122.54 (C3aꞌ), 122.52 (C7ꞌ), 121.0 (C4), 115.8 (C7), 85.5 (Boc Cq),
28.3 (Boc CH3). IR (neat) 2980 (w), 2931 (w), 2377 (w), 1734 (s), 1458 (m), 1320 (m),
1150 (s), 748 (s) cm-1. HRESI-MS calcd. for C27H2235ClN2O3+ 457.1314, found 457.1313;
calcd. for C27H2237ClN2O3+ 459.1284, found 459.1285.
tert-butyl 3'-oxo-3-(pyridin-3-yl)-1H,3'H-[2,2'-biindole]-1-carboxylate (233)
Prepared via General Procedure D. The substituted
Grignard reagent (pyridin-3-ylmagnesium chloride lithium
chloride complex) was prepared using isopropylmagnesium
chloride lithium chloride complex (0.45 M, 4.4 mL, 1.98
mmol), and 3-iodopyridine (534 mg, 2.60 mmol), and the
mixture stirred at room temperature for 1.5 h prior to
combining

with

indigo.

Subsequent

Boc-mediated

dehydration (General Procedure F) of the crude product afforded a deep orange residue,
which was subjected to flash chromatography (80 g silica, 10% EtOAc/CH2Cl2), to afford
the N-Boc indole 233 (190 mg, 89%) as a bright orange powder, mp 123–124 ˚C. Rf (10%
EtOAc/CH2Cl2) 0.35. UV-Vis (acetone) λmax/nm (ε, M-1cm-1) 338 (2624), 431 (2240), 463
(2057), 500 (1593). 1H NMR (500 MHz, CDCl3) δ 8.90 (s, 1H, H2ꞌꞌ), 8.60 (app s, 1H,
H4ꞌꞌ), 8.26 (d, J = 8.5 Hz, 1H, H7), 8.02 (d, J = 7.8 Hz, 1H, H6ꞌꞌ), 7.60 (d, J = 7.9 Hz, 1H,
H4), 7.56 (d, J = 7.0 Hz, 1H, H4ꞌ), 7.52 (d, J = 7.8 Hz, 1H, H6ꞌ), 7.48 (d, J = 8.3 Hz, 1H,
H6), 7.40 – 7.35 (m, 2H, H7ꞌ, H5ꞌꞌ), 7.33 (app t, J = 7.5 Hz, 1H, H5), 7.28 – 7.23 (m, 1H,
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H5ꞌ), 1.54 (s, 9H, 3×Boc CH3). 13C NMR (126 MHz, CDCl3) δ 191.4 (C3ꞌ), 160.2 (C7aꞌ),
159.6 (C2ꞌ), 151.4 (C2ꞌꞌ), 149.9 (Boc C=O), 149.1 (C4ꞌꞌ), 138.4 (C6ꞌꞌ), 136.9 (C7a), 136.8
(C6ꞌ), 129.1 (C3a), 128.7 (C5ꞌ), 127.9 (C1ꞌꞌ), 127.0 (C6), 126.1 (C2), 125.1 (C4ꞌ), 124.4
(C3), 123.9 (C5), 123.1 (C5ꞌꞌ), 122.7 (C7ꞌ), 122.6 (C3aꞌ), 120.6 (C4), 115.8 (C7), 85.7
(Boc Cq), 28.1 (Boc CH3). IR (neat) 2978 (w), 2933 (w), 1734 (s), 1559 (m), 1318 (s),
1149 (s), 909 (m), 763 (s), 731 (s), 715 (s) cm-1. HRESI-MS calcd. for C26H22N3O3+
424.1656, found 424.1655.
tert-butyl 3-(1-methyl-imidazol-2-yl)-3'-oxo-1H,3'H-[2,2'-biindole]-1-carboxylate
(235)
Prepared via General Procedure E. The substituted
organolithium

reagent

((1-methyl-1H-imidazol-2-

yl)lithium) was prepared using n-BuLi (1.95 M, 1.15 mL,
2.24 mmol), and N-methylimidazole (217 mg, 2.64 mmol),
and the mixture stirred for 1.5 h prior to combining with
indigo. Subsequent Boc-mediated dehydration (General
Procedure F) of the crude product afforded a deep orange
residue, which was subjected to flash chromatography (25 g silica, 20% EtOAc/CH2Cl2),
to afford the N-Boc indole 235 (204 mg, 94%) as a deep orange-brown solid, mp 101–
102 ˚C. Rf (10% MeCN/CHCl3) 0.46. UV-Vis (acetone) λmax/nm (ε, M-1cm-1) 334 (2215),
436 (1841), 465 (1653), 501 (1296). 1H NMR (500 MHz, CDCl3) δ 8.21 (d, J = 8.5 Hz,
1H, H7), 7.56 – 7.51 (m, 2H, H4, H4ꞌ), 7.51 – 7.43 (m, 2H, H6, H6ꞌ), 7.37 – 7.28 (m, 2H,
H5, H7ꞌ), 7.25 (app t, J = 7.5 Hz, 1H, H5ꞌ), 7.16 (app s, 1H, H4ꞌꞌ), 7.04 (app s, 1H, H5ꞌꞌ),
3.68 (s, 3H, -NCH3), 1.55 (s, 9H, 3×Boc CH3).

13

C NMR (126 MHz, CDCl3) δ 190.9

(C3ꞌ), 160.2 (C7aꞌ), 159.7 (C2ꞌ), 149.8 (Boc C=O), 140.1 (C2ꞌꞌ), 136.9 (C7a), 136.7 (C6ꞌ),
129.5 (C3a), 129.4 (C4ꞌꞌ), 128.7 (C2), 128.6 (C5ꞌ), 127.0 (C6), 125.0 (C4ꞌ), 123.9 (C5),
122.6 (C7ꞌ), 122.4 (C3aꞌ), 121.9 (C5ꞌꞌ), 121.5 (C4), 117.0 (C3), 115.5 (C7), 85.7 (Boc Cq),
34.3 (-NCH3), 28.1 (Boc CH3). IR (neat) 2980 (w), 2933 (w), 1734 (s), 1559 (m), 1456
(m), 1369 (m), 1315 (s), 1149 (s), 909 (m), 763 (s), 748 (s), 731 (s) cm-1. HRESI-MS
calcd. for C25H23N4O3+ 427.1765, found 427.1764.
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tert-butyl 3'-oxo-3-(thiophen-2-yl)-1H,3'H-[2,2'-biindole]-1-carboxylate (237)
Prepared via General Procedure C. The substituted
Grignard reagent (thiophen-2-ylmagnesium chloride lithium
chloride complex) was prepared using isopropylmagnesium
chloride (1.08 M, 1.70 mL, 1.84 mmol), LiCl (106 mg, 2.50
mmol), and 2-iodothiophene (537 mg, 2.56 mmol), and the
mixture stirred at room temperature for 1 h prior to
combining

with

indigo.

Subsequent

Boc-mediated

dehydration (General Procedure F) of the crude product afforded a deep orange residue,
which was subjected to flash chromatography (80 g silica, 10% EtOAc/hexane), to afford
the N-Boc indole 237 (210 mg, 95%) as bright orange crystals, mp 78–79 ˚C (dec.). Xray quality crystals were grown by evaporating a saturated 9:1 hexane/chloroform (1 mL)
solution to ¼ its original volume, then the mother liquor removed from the precipitated
solids and diluted with fresh hexane, and the resulting solution slowly evaporated. Rf
(10% EtOAc/hexane) 0.42. UV-Vis (acetone) λmax/nm (ε, M-1cm-1) 328 (5623), 436
(1945), 466 (1796), 506 (1540). 1H NMR (400 MHz, CDCl3) δ 8.25 (d, J = 8.4 Hz, 1H,
H7), 7.94 (d, J = 7.9 Hz, 1H, H4), 7.60 (dd, J = 3.6, 1.1 Hz, 1H, H5ꞌꞌ), 7.59 – 7.52 (m,
2H, H4ꞌ, H6ꞌ), 7.50 – 7.45 (m, 2H, H6, H7ꞌ), 7.40 (dd, J = 5.1, 1.1 Hz, 1H, H3ꞌꞌ), 7.35 (app
t, J = 7.2 Hz, 1H, H5), 7.28 (app t, J = 6.7 Hz, 1H, H5ꞌ), 7.14 (dd, J = 5.1, 3.6 Hz, 1H,
H4ꞌꞌ), 1.52 (s, 9H, 3×Boc CH3). 13C NMR (101 MHz, CDCl3) δ 191.5 (C3ꞌ), 160.4 (C7aꞌ),
159.6 (C2ꞌ), 149.9 (Boc C=O), 136.9 (C7a), 136.8 (C6ꞌ), 132.6 (C1ꞌꞌ), 129.6 (C5ꞌꞌ), 129.2
(C3a), 128.6 (C5ꞌ), 127.4 (C4ꞌꞌ), 126.9 (C6), 126.8 (C3ꞌꞌ), 125.5 (C2), 125.1 (C4ꞌ), 123.7
(C5), 122.9 (C3aꞌ), 122.7 (C7ꞌ), 121.4 (C4), 121.1 (C3), 115.7 (C7), 85.6 (Boc Cq), 28.1
(Boc CH3). IR (neat) 2979 (w), 2930 (w), 2373 (w), 1734 (s), 1558 (m), 1319 (s), 1148
(s), 841 (m), 761 (m), 747 (s), 700 (m) cm-1. HRESI-MS calcd. for C25H21N2O3S+
429.1267, found 429.1267.
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tert-butyl 3-(benzofuran-2-yl)-3'-oxo-1H,3'H-[2,2'-biindole]-1-carboxylate (239)
Prepared via General Procedure E. The substituted
organolithium

reagent

(benzofuran-2-yllithium)

was

prepared using n-BuLi (1.95 M, 1.2 mL, 2.34 mmol), and
benzofuran (299 mg, 2.53 mmol), and the mixture stirred for
1 h prior to combining with indigo. Subsequent Bocmediated dehydration (General Procedure F) of the crude
product afforded a deep orange residue, which was
fractionated on silica (80 g, using 10% EtOAc/hexane as
eluent), and the resulting deep red-orange residue subjected to flash chromatography (40
g silica, 60% CH2Cl2/pet spirit), to afford the N-Boc indole 239 (200 mg, 85%) as a deep
orange powder, mp 96–98 ˚C. Rf (10% EtOAc/hexane) 0.42. UV-Vis (acetone) λmax/nm
(ε, M-1cm-1) 332 (12256), 385 (3234), 436 (1841), 435 (2152), 510 (1797). 1H NMR (500
MHz, CDCl3) δ 8.29 – 8.23 (m, 2H, H4, H7), 7.64 – 7.59 (m, 2H, H4ꞌ, H4ꞌꞌ), 7.59 – 7.54
(m, 3H, H6ꞌ, H7ꞌ, H3ꞌꞌ), 7.50 (app t, J = 7.7 Hz, 1H, H6), 7.45 (d, J = 8.1 Hz, 1H, H7ꞌꞌ),
7.41 (app t, J = 7.6 Hz, 1H, H5), 7.33 – 7.25 (m, 2H, H5ꞌ, H6ꞌꞌ), 7.24 – 7.19 (m, 1H, H5ꞌꞌ),
1.53 (s, 9H, 3×Boc CH3). 13C NMR (126 MHz, CDCl3) δ 191.2 (C3ꞌ), 160.3 (C7aꞌ), 159.8
(C2ꞌ), 155.1 (C7aꞌꞌ), 149.8 (Boc C=O), 149.6 (C2ꞌꞌ), 137.0 (C7a), 136.8 (C6ꞌ), 128.8 (C5ꞌ),
128.7 (C3aꞌꞌ), 127.7 (C3a), 127.0 (C6), 125.8 (C3), 125.2 (C4ꞌ), 124.8 (C6ꞌꞌ), 124.0 (C5),
123.0 (C5ꞌꞌ), 122.8 (C3aꞌ), 122.70 (C4), 122.66 (C7ꞌ), 121.4 (C4ꞌꞌ), 117.2 (C2), 115.6 (C7),
111.2 (C7ꞌꞌ), 108.1 (C3ꞌꞌ), 85.8 (Boc Cq), 28.1 (Boc CH3). IR (neat) 2977 (w), 2932 (w),
1734 (s), 1717 (m), 1559 (s), 1507 (m), 1317 (m), 1148 (s), 761 (m), 747 (s) cm-1. HRESIMS calcd. for C29H22N2O4Na+ 485.1477, found 485.1479.
tert-butyl 1''-methyl-3-oxo-1'H,1''H,3H-[2,2':3',5''-terindole]-1'-carboxylate (245)
Prepared via General Procedure C. The substituted
Grignard

reagent

((1-methyl-1H-indol-5-yl)magnesium

chloride lithium chloride complex) was prepared using
isopropylmagnesium chloride lithium chloride complex
(0.512 M, 3.90 mL, 2.00 mmol), and 5-iodo-N-methylindole
243 (651 mg, 2.53 mmol), and the mixture stirred at 0 ˚C for
2 h prior to combining with indigo. Subsequent Bocmediated dehydration (General Procedure F) of the crude product afforded a deep redorange residue, which was subjected to flash chromatography (100 g silica, 10%
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EtOAc/hexane), to afford the crude N-Boc terindole 245 (186 mg, 61% corrected NMR
yield) as a bright orange amorphous solid, isolated alongside an unknown impurity which
proved irresolute by all trialled separation techniques, including recrystallisation, PTLC
separation and flash chromatographic separation. Rf (10% EtOAc/pet spirit) 0.28. 1H
NMR (500 MHz, CDCl3) δ 8.26 (d, J = 8.4 Hz, 1H, H7), 7.93 (d, J = 1.0 Hz, 1H, H4ꞌꞌ),
7.68 (d, J = 7.8 Hz, 1H, H4), 7.52 (d, J = 7.1 Hz, 1H, H4ꞌ), 7.49 – 7.42 (m, 3H, H6, H6ꞌ,
H6ꞌꞌ), 7.37 – 7.32 (m, 2H, H7ꞌ, H7ꞌꞌ), 7.28 (app t, J = 7.1 Hz, 1H, H5), 7.21 (dd, J = 7.3,
0.8 Hz, 1H, H5ꞌ), 7.06 (d, J = 3.1 Hz, 1H, H2ꞌꞌ), 6.52 (d, J = 2.3 Hz, 1H, H3ꞌꞌ), 3.80 (s,
3H, NꞌꞌCH3), 1.52 (s, 9H, 3×Boc CH3). 13C NMR (126 MHz, CDCl3) δ 192.0 (C3ꞌ), 160.5
(C7aꞌ), 160.4 (C2ꞌ), 150.1 (Boc C=O), 136.9 (C7a or C7aꞌꞌ), 136.6 (C6ꞌ), 136.5 (C7a or
C7aꞌꞌ), 130.2 (C3a), 129.7 (C2), 129.4 (C2ꞌꞌ), 129.0 (C3), 128.4 (C5ꞌ), 128.1 (C3aꞌꞌ), 126.4
(C6), 124.9 (C4ꞌ or C6ꞌꞌ), 124.8 (C4ꞌ or C6ꞌꞌ), 123.5 (C4ꞌꞌ), 123.2 (C5), 122.6 (C5ꞌꞌ), 122.5
(C3aꞌ), 122.4 (C7ꞌ), 121.5 (C4), 115.6 (C7), 109.0 (C7ꞌꞌ), 101.6 (C3ꞌꞌ), 84.9 (Boc Cq), 32.9
(NꞌꞌCH3), 27.3 (Boc CH3). HRESI-MS calcd. for C30H26N3O3+ 476.1969, found 476.1968.
7.4.7 General Procedure G for Boc Deprotection:
To a solution of the tert-butoxycarbonyl protected indole (ca. 0.1 mmol) in CH2Cl2 (0.1
M) was added neat trifluoroacetic acid (1 mL per 0.1 mmol of N-Boc indole). The
resulting solution was stirred at room temperature for the indicated time, then diluted to
ca. 20 mL with CH2Cl2, and transferred to a separatory funnel. The organic phase was
repeatedly washed with sat. NaHCO3 solution until foaming ceased (typically 2-3×20
mL), the organic layer dried (Na2SO4), and the solvent removed.
3-isopropyl-1H,3'H-[2,2'-biindol]-3'-one (209)
Prepared via General Procedure G, using 48.4 mg (0.124
mmol) of 210, and a 1 h reaction time. The resulting dark
purple residue was subjected to flash chromatography (20 g
silica, 10% EtOAc/hexane), and triturated with hot hexane
to afford the desired indole 209 (33.0 mg, 92%) as an intense, black-purple powder, mp
168–170 ˚C (dec.). Rf (10% EtOAc/hexane) 0.56. UV-Vis (acetone) λmax/nm (ε, M-1cm-1)
302 (7209), 552 (1594). 1H NMR (400 MHz, CDCl3) δ 10.11 (s, 1H, NH), 7.92 (d, J =
8.3 Hz, 1H, H4), 7.57 – 7.49 (m, 2H, H4ꞌ, H6ꞌ), 7.42 (d, J = 8.3 Hz, 1H, H7), 7.37 (d, J =
7.5 Hz, 1H, H7ꞌ), 7.32 – 7.27 (m, 1H, H6), 7.18 (app t, J = 7.1 Hz, 1H, H5ꞌ), 7.11 – 7.05
(m, 1H, H5), 4.55 (hept, J = 7.0 Hz, 1H, H2ꞌꞌ), 1.54 (d, J = 7.1 Hz, 6H, H1ꞌꞌ, H3ꞌꞌ). 13C
NMR (101 MHz, CDCl3) δ 197.1 (C3ꞌ), 162.7 (C7aꞌ), 154.6 (C2ꞌ), 138.8 (C7a), 137.5
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(C6ꞌ), 135.0 (C3), 127.3 (C5ꞌ), 126.6 (C3a), 125.7 (C6), 125.1 (C4ꞌ), 123.8 (C2), 122.6
(C4), 121.9 (C7ꞌ), 121.7 (C3aꞌ), 119.8 (C5), 112.3 (C7), 26.5 (C2ꞌꞌ), 22.6 (C1ꞌꞌ, C3ꞌꞌ). IR
(neat) 3378 (m), 1709 (s), 1540 (s), 1451 (m), 1329 (s), 1240 (m), 1168 (s), 875 (m), 761
(s), 741 (s), 672 (s) cm-1. HRESI-MS calcd. for C19H17N2O+ 289.1341, found 289.1353.
3-phenyl-1H,3'H-[2,2'-biindol]-3'-one (214)
Prepared via General Procedure G, using 51.1 mg (0.121
mmol) of 211, and a 2 h reaction time. The resulting dark
purple residue was subjected to flash chromatography (20 g
silica, 10% EtOAc/pet spirit), and removal of the solvent gave
the desired indole 214 (31.6 mg, 81%) as an intense, blackpurple powder. Spectral and physical characteristics were identical to those reported
above.
3-butyl-1H,3'H-[2,2'-biindol]-3'-one (250)
Prepared via General Procedure G, using 43.6 mg (0.108
mmol) of 215, and a 1.5 h reaction time. The resulting dark
purple residue was subjected to flash chromatography (20 g
silica, 10% EtOAc/hexane), and removal of the solvent
afforded the desired indole 250 (29.8 mg, 91%) as an
intense, black-purple powder, mp 131–132 ˚C. Rf (10% EtOAc/hexane) 0.45. UV-Vis
(acetone) λmax/nm (ε, M-1cm-1) 327 (2462), 542 (1654). 1H NMR (400 MHz, CDCl3) δ
10.00 (s, 1H, NH), 7.71 (dd, J = 8.2, 1.0 Hz, 1H, H4), 7.58 – 7.49 (m, 2H, H4ꞌ, H6ꞌ), 7.41
(d, J = 8.3 Hz, 1H, H7), 7.36 (d, J = 7.6 Hz, 1H, H7ꞌ), 7.33 – 7.28 (m, 1H, H6), 7.22 –
7.13 (m, 1H, H5ꞌ), 7.12 (ddd, J = 8.0, 6.9, 1.0 Hz, 1H, H5), 3.37 (t, J = 7.7 Hz, 2H, H1ꞌꞌ),
1.80 – 1.68 (m, 2H, H2ꞌꞌ), 1.47 (h, J = 7.4 Hz, 2H, H3ꞌꞌ), 0.97 (t, J = 7.4 Hz, 3H, H4ꞌꞌ). 13C
NMR (101 MHz, CDCl3) δ 197.0 (C3ꞌ), 163.0 (C7aꞌ), 154.6 (C2ꞌ), 138.4 (C7a), 137.6
(C6ꞌ), 129.7 (C3), 128.4 (C3a), 127.3 (C5ꞌ), 126.2 (C6), 125.1 (C4ꞌ), 125.0 (C2), 122.1
(C3aꞌ), 122.0 (C4), 120.9 (C7ꞌ), 120.3 (C5), 112.0 (C7), 32.7 (C2ꞌꞌ), 25.4 (C1ꞌꞌ), 23.0 (C3ꞌꞌ),
14.2 (C4ꞌꞌ). IR (neat) 3382 (m), 2955 (w), 2924 (w), 1715 (s), 1551 (s), 1449 (m), 1340
(w), 1237 (w), 1170 (m), 877 (w), 761 (m), 740 (m) cm-1. HRESI-MS calcd. for
C20H19N2O+ 303.1497, found 303.1508.
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3-benzyl-1H,3'H-[2,2'-biindol]-3'-one (251)
Prepared via General Procedure G, using 65.3 mg (0.150
mmol) of 219, and a 1.5 h reaction time. The resulting dark
purple residue was subjected to flash chromatography (20 g
silica, 10% EtOAc/hexane), and triturated with hexane to
give the desired indole 251 (35.7 mg, 71%) as an intense,
black-purple powder, mp 139–140 ˚C (dec.). Rf (10%
EtOAc/hexane) 0.36. UV-Vis (acetone) λmax/nm (ε, M-1cm-1) 327 (5752), 355 (4608), 537
(1655). 1H NMR (500 MHz, CDCl3) δ 10.09 (s, 1H), 7.59 (d, J = 8.2 Hz, 1H, H4), 7.54
(d, J = 7.0 Hz, 1H, H4ꞌ), 7.51 (td, J = 7.6, 1.3 Hz, 1H, H6ꞌ), 7.41 (d, J = 8.4 Hz, 1H, H7),
7.38 (d, J = 7.0 Hz, 2H, H2ꞌꞌ, H6ꞌꞌ), 7.35 (d, J = 7.5 Hz, 1H, H7ꞌ), 7.29 (ddd, J = 8.2, 6.9,
1.1 Hz, 1H, H6), 7.23 (dd, J = 8.3, 6.9 Hz, 2H, H3ꞌꞌ, H5ꞌꞌ), 7.18 (td, J = 7.5, 0.9 Hz, 1H,
H5ꞌ), 7.16 – 7.12 (m, 1H, H4ꞌꞌ), 7.08 (ddd, J = 8.0, 6.9, 1.0 Hz, 1H, H5), 4.81 (s, 2H, ArCH2Ph).

C NMR (126 MHz, CDCl3) δ 196.7 (C3ꞌ), 162.6 (C7aꞌ), 154.4 (C2ꞌ), 141.1
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(C1ꞌꞌ), 138.3 (C7a), 137.5 (C6ꞌ), 128.8 (C2ꞌꞌ), 128.24 (C3ꞌꞌ), 128.17 (C3a), 127.4 (C5ꞌ),
126.3 (C3), 126.1 (C6), 125.8 (C4ꞌꞌ), 125.2 (C2), 125.1 (C4ꞌ), 122.0 (C4), 121.9 (C3aꞌ),
121.1 (C7ꞌ), 120.5 (C5), 112.0 (C7), 31.3 (Ar-CH2Ph). IR (neat) 3421 (w), 2919 (w), 1734
(s), 1717 (s) 1558 (s), 1507 (s), 1457 (m), 1339 (w), 1237 (w), 1167 (m), 745 (s) cm-1.
HRESI-MS calcd. for C23H17N2O+ 337.1341, found 337.1326.
3-(4-methoxyphenyl)-1H,3'H-[2,2'-biindol]-3'-one (252)
Prepared via General Procedure G, using 31.8 mg (0.070
mmol) of 222, and a 1.5 h reaction time. The resulting dark
purple residue was subjected to flash chromatography (20 g
silica, 10% EtOAc/hexane), and removal of the solvent gave
the desired indole 252 (23.6 mg, 95%) as intense, blackpurple crystals, mp 227–228 ˚C. Rf (10% EtOAc/hexane)
0.33. UV-Vis (acetone) λmax/nm (ε, M-1cm-1) 327 (3173), 337 (3174), 390 (1478), 541
(1016). 1H NMR (500 MHz, CDCl3) δ 10.26 (s, 1H, NH), 7.70 – 7.65 (m, 3H, H4, H2ꞌꞌ,
H6ꞌꞌ), 7.52 (d, J = 7.1 Hz, 1H, H4ꞌ), 7.49 – 7.45 (m, 2H, H7, H6ꞌ), 7.35 (ddd, J = 8.2, 6.9,
1.0 Hz, 1H, H6), 7.24 (d, J = 7.6 Hz, 1H, H7ꞌ), 7.19 – 7.12 (m, 2H, H5, H5ꞌ), 7.04 (d, J =
8.8 Hz, 2H, H3ꞌꞌ, H5ꞌꞌ), 3.91 (s, 3H, -OCH3). 13C NMR (126 MHz, CDCl3) δ 196.6 (C3ꞌ),
162.4 (C7aꞌ), 159.1 (C2ꞌ), 154.1 (C4ꞌꞌ), 138.3 (C7a), 137.5 (C6ꞌ), 132.3 (C2ꞌꞌ, C6ꞌꞌ), 128.2
(C3), 127.6 (C5ꞌ), 126.8 (C3a), 126.4 (C6), 126.1 (C2), 125.2 (C4ꞌ), 124.3 (C1ꞌꞌ), 122.4
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(C4), 122.2 (C3aꞌ), 121.8 (C7ꞌ), 121.2 (C5), 113.6 (C3ꞌꞌ, C5ꞌꞌ), 112.0 (C7), 55.4 (-OCH3).
IR (neat) 3374 (w), 3349 (w), 1710 (s), 1539 (s), 1444 (s), 1320 (m), 1251 (m), 1166 (s),
877 (m), 832 (s), 758 (m), 744 (s), 691 (s) cm-1. HRESI-MS calcd. for C23H17N2O2+
353.1290, found 353.1280.
3-(2-methoxyphenyl)-1H,3'H-[2,2'-biindol]-3'-one (253)
Prepared via General Procedure G, using 70.9 mg (0.157
mmol) of 224, and a 1.5 h reaction time. The resulting dark
purple residue was subjected to flash chromatography (20 g
silica, 10% EtOAc/hexane), and removal of the solvent gave
the desired indole 253 (48.2 mg, 87%) as an intense, blackpurple solid, mp 168–170 ˚C (dec.). Rf (10% EtOAc/hexane) 0.56. UV-Vis (acetone)
λmax/nm (ε, M-1cm-1) 328 (5039), 535 (2864). 1H NMR (500 MHz, CDCl3) δ 10.09 (s, 1H,
NH), 7.56 (d, J = 8.2 Hz, 1H, H4), 7.51 – 7.48 (m, 2H, H4ꞌ, H6ꞌꞌ), 7.48 – 7.41 (m, 3H, H6,
H7, H6ꞌ), 7.36 – 7.31 (m, 1H, H4ꞌꞌ), 7.21 (d, J = 7.6 Hz, 1H, H7ꞌ), 7.18 – 7.08 (m, 3H, H5,
H5ꞌ, H5ꞌꞌ), 7.04 (d, J = 7.3 Hz, 1H, H3ꞌꞌ), 3.72 (s, 3H, -OCH3).
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C NMR (126 MHz,

CDCl3) δ 195.1 (C3ꞌ), 162.1 (C7aꞌ), 157.6 (C2ꞌ), 154.9 (C2ꞌꞌ), 138.1 (C7a), 137.3 (C6ꞌ),
132.1 (C6ꞌꞌ), 129.1 (C4ꞌꞌ), 128.5 (C3), 127.6 (C5ꞌ), 126.1 (C6), 125.6 (C3a), 125.0 (C4ꞌ),
123.4 (C2), 122.4 (C3aꞌ), 122.1 (C4), 121.9 (C1ꞌꞌ), 121.8 (C7ꞌ), 121.0 (C5ꞌꞌ), 120.6 (C5),
111.9 (C7), 111.3 (C3ꞌꞌ), 55.6 (-OCH3). IR (neat) 3402 (m), 1718 (s), 1549 (s), 1451 (m),
1326 (s), 1257 (m), 1239 (s), 1026 (m), 875 (m), 793 (m), 745 (s), 691 (s) cm -1. HRESIMS calcd. for C23H17N2O2+ 353.1290, found 353.1298.
3-(2,4-dimethoxyphenyl)-1H,3'H-[2,2'-biindol]-3'-one (254)
Prepared via General Procedure G, using 29.1 mg (0.0603
mmol) of 228 in neat TFA (2 mL), and the mixture allowed
to stir overnight. The resulting dark purple residue was
triturated with hexane to give the desired indole 254 (18.9
mg, 82%) as an intense, black-purple solid, mp 119–120 ˚C.
Rf (20% EtOAc/hexane) 0.25. UV-Vis (acetone) λmax/nm (ε,
M-1cm-1) 326 (4530), 546 (1547). 1H NMR (400 MHz, CDCl3) δ 10.15 (s, 1H, NH), 7.57
(d, J = 8.1 Hz, 1H, H4), 7.50 (d, J = 7.2 Hz, 1H, H4ꞌ), 7.48 – 7.40 (m, 3H, H7, H6ꞌ, H6ꞌꞌ),
7.32 (app t, J = 7.6 Hz, 1H, H6), 7.22 (d, J = 7.6 Hz, 1H, H7ꞌ), 7.17 – 7.08 (m, 2H, H5,
H5ꞌ), 6.67 – 6.60 (m, 2H, H3ꞌꞌ, H5ꞌꞌ), 3.91 (s, 3H, C4ꞌꞌ-OCH3), 3.70 (s, 3H, C2ꞌꞌ-OCH3).
C NMR (101 MHz, CDCl3) δ 195.2 (C3ꞌ), 162.2 (C4ꞌꞌ), 160.8 (C7aꞌ), 158.6 (C2ꞌ), 154.8
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(C2ꞌꞌ), 138.2 (C7a), 137.2 (C6ꞌ), 132.5 (C6ꞌꞌ), 128.6 (C3a), 127.4 (C5ꞌ), 126.1 (C6), 125.5
(C3), 125.0 (C4ꞌ), 122.4 (C2), 122.1 (C3aꞌ), 122.0 (C4), 121.9 (C7ꞌ), 120.8 (C5), 116.2
(C1ꞌꞌ), 111.9 (C7), 104.4 (C5ꞌꞌ), 99.3 (C3ꞌꞌ), 55.6 (C4ꞌꞌ-OCH3), 55.5 (C2ꞌꞌ-OCH3). IR (neat)
3414 (w), 2928 (m), 2360 (w), 1718 (s), 1612 (s), 1549 (s), 1451 (s), 1327 (m), 1301 (m),
1262 (m), 1209 (s), 1159 (s), 1032 (m), 876 (m), 746 (s), 692 (w) cm-1. HRESI-MS calcd.
for C24H18N2O3Na+ 405.1215, found 405.1213.
3-(2-chlorophenyl)-1H,3'H-[2,2'-biindol]-3'-one (255)
Prepared via General Procedure G, using 41.4 mg (0.0906
mmol) of 232, and the mixture allowed to stir overnight. The
resulting deep burgundy residue was subjected to flash
chromatography (20 g silica, 10% EtOAc/hexane), and
triturated with hexane to give the desired indole (26.4 mg,
82%) as an intense, black-purple solid, mp 203–204 ˚C. Rf (10% EtOAc/hexane) 0.44.
UV-Vis (acetone) λmax/nm (ε, M-1cm-1) 328 (3113), 535 (2301). 1H NMR (500 MHz,
CDCl3) δ 10.08 (s, 1H, NH), 7.57 – 7.54 (m, 1H, H6ꞌꞌ), 7.52 – 7.44 (m, 4H, H4, H7, H4ꞌ,
H6ꞌ), 7.43 (dd, J = 8.1, 0.8 Hz, 1H, H3ꞌꞌ), 7.41 – 7.34 (m, 3H, H6, H4ꞌꞌ, H5ꞌꞌ), 7.21 (d, J =
7.6 Hz, 1H, H7ꞌ), 7.20 – 7.13 (m, 1H, H5ꞌ), 7.17 – 7.11 (m, 1H, H5). 13C NMR (126 MHz,
CDCl3) δ 194.8 (C3ꞌ), 161.8 (C7aꞌ), 154.7 (C2ꞌ), 137.8 (C7a), 137.3 (C6ꞌ), 134.8 (C2ꞌꞌ),
133.6 (C1ꞌꞌ), 132.6 (C6ꞌꞌ), 129.8 (C3ꞌꞌ), 129.0 (C4ꞌꞌ), 128.4 (C3), 127.9 (C5ꞌ), 126.6 (C5ꞌꞌ),
126.3 (C6), 125.7 (C3a), 125.1 (C4ꞌ), 124.4 (C2), 122.6 (C3aꞌ), 122.4 (C4), 121.5 (C7ꞌ),
121.3 (C5), 112.0 (C7). IR (neat) 3407 (w), 2924 (m), 1718 (m), 1554 (s), 1451 (m), 1327
(m), 1163 (w), 877 (m), 747 (m), 690 (w) cm-1. HRESI-MS calcd. for C22H1435ClN2O+
357.0789, found 357.0795.
3-(4-fluorophenyl)-1H,3'H-[2,2'-biindol]-3'-one (256)
Prepared via General Procedure G, using 33.7 mg (0.0765
mmol) of 231, and a 2 h reaction time. The resulting dark
purple residue was subjected to flash chromatography (20 g
silica, 10% EtOAc/hexane), and triturated with hexane to
afford the desired indole 256 (23.2 mg, 89%) as an intense,
black-purple solid, mp 244–246 ˚C. Rf (10% EtOAc/hexane)
0.20. UV-Vis (acetone) λmax/nm (ε, M-1cm-1) 326 (3668), 534 (2307). 1H NMR (400 MHz,
CDCl3,19F-decoupled) δ 10.27 (s, 1H, NH), 7.68 (d, J = 8.7 Hz, 2H, H2ꞌꞌ, H6ꞌꞌ), 7.64 (d, J
= 8.2 Hz, 1H, H4), 7.53 (d, J = 7.1 Hz, 1H, H4ꞌ), 7.51 – 7.45 (m, 2H, H7, H6ꞌ), 7.36 (app
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t, J = 7.7 Hz, 1H, H6), 7.23 (d, J = 7.6 Hz, 1H, H7ꞌ), 7.21 – 7.12 (m, 4H, H5, H5ꞌ, H3ꞌꞌ,
H5ꞌꞌ). 13C NMR (101 MHz, CDCl3) δ 196.2 (C3ꞌ), 162.3 (d, 1J C-F = 246.6 Hz, C4ꞌꞌ), 162.0
(C7aꞌ), 153.9 (C2ꞌ), 138.0 (C7a), 137.4 (C6ꞌ), 132.6 (d, 3J C-F = 8.0 Hz, C2ꞌꞌ), 129.6 (d, 4J
C-F

= 3.3 Hz, C1ꞌꞌ), 128.0 (C3a), 127.7 (C5ꞌ), 126.3 (C6), 125.4 (C3), 125.1 (C4ꞌ), 124.4

(C2), 122.3 (C4), 122.0 (C3aꞌ), 121.3 (C7ꞌ), 121.2 (C5), 115.0 (d, 2J C-F = 21.4 Hz, C3ꞌꞌ),
112.0 (C7).
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F NMR (377 MHz, CDCl3, 1H-decoupled) δ -114.8. IR (neat) 3367 (w),

2998 (m), 1734 (m), 1714 (m), 1559 (s), 1507 (s), 1340 (m), 1255 (m), 879 (m), 834 (m),
746 (m), 692 (m) cm-1. HRESI-MS calcd. for C22H14N2OF+ 341.1090, found 341.1098.
3-(thiophen-2-yl)-1H,3'H-[2,2'-biindol]-3'-one (257)
Prepared via General Procedure G, using 49.0 mg (0.114
mmol) of 237, and a 1.5 h reaction time. The resulting dark
purple residue was subjected to flash chromatography (20 g
silica, 10% EtOAc/hexane), and removal of the solvent gave
the desired indole 257 (36.0 mg, 96%) as an intense, blackpurple powder, mp >300 ˚C. Rf (10% EtOAc/hexane) 0.42. UV-Vis (acetone) λmax/nm (ε,
M-1cm-1) 328 (4194), 545 (1342). 1H NMR (500 MHz, CDCl3) δ 10.36 (s, 1H, NH), 7.97
(dd, J = 8.2, 0.9 Hz, 1H, H4), 7.76 (dd, J = 3.6, 1.2 Hz, 1H, H5ꞌꞌ), 7.55 (ddd, J = 7.1, 1.4,
0.6 Hz, 1H, H4ꞌ), 7.53 – 7.46 (m, 3H, H7, H6ꞌ, H3ꞌꞌ), 7.37 (ddd, J = 8.1, 6.9, 1.1 Hz, 1H,
H6), 7.33 (d, J = 7.6 Hz, 1H, H7ꞌ), 7.23 (dd, J = 5.1, 3.6 Hz, 1H, H4ꞌꞌ), 7.22 – 7.17 (m,
2H, H5, H5ꞌ). 13C NMR (126 MHz, CDCl3) δ 196.4 (C3ꞌ), 162.1 (C7aꞌ), 153.5 (C2ꞌ), 139.2
(C2ꞌꞌ), 137.9 (C7a), 137.5 (C6ꞌ), 134.7 (C3), 129.5 (C5ꞌꞌ), 127.8 (C3a), 127.7 (C4ꞌꞌ), 127.1
(C5ꞌ), 126.4 (C3ꞌꞌ), 126.2 (C6), 125.2 (C4ꞌ), 125.0 (C2), 122.4 (C7ꞌ), 122.0 (C4), 121.4
(C5), 119.2 (C3aꞌ), 111.9 (C7). IR (neat) 3366 (w), 1734 (s), 1653 (s), 1558 (s), 1507 (s),
1340 (w), 1250 (w), 876 (w), 758 (w), 745 (m), 691 (m) cm-1. HRESI-MS calcd. for
C20H13N2OS+ 329.0749, found 329.0750.
3-(pyridin-3-yl)-1H,3'H-[2,2'-biindol]-3'-one (258)
Prepared via General Procedure G, using 36.8 mg (0.0869
mmol) of 233, and the mixture allowed to stir overnight. The
resulting deep burgundy residue was subjected to flash
chromatography (20 g silica, 10% EtOAc/CH2Cl2), and
triturated with hexane to give the desired indole 258 (26.4
mg, 94%) as an intense, black-purple powder, mp 276–277 ˚C (dec.). Rf (10%
EtOAc/CH2Cl2) 0.46. UV-Vis (acetone) λmax/nm (ε, M-1cm-1) 326 (5139), 530 (3061). 1H
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NMR (400 MHz, CDCl3) δ 10.40 (s, 1H, NH), 8.95 (app s, 1H, H2ꞌꞌ), 8.65 (app s, 1H,
H4ꞌꞌ), 8.04 (d, J = 7.8 Hz, 1H, H6ꞌꞌ), 7.62 (d, J = 8.2 Hz, 1H, H4), 7.53 – 7.41 (m, 4H, H7,
H4ꞌ, H6ꞌ, H5ꞌꞌ), 7.36 (ddd, J = 8.2, 7.0, 0.9 Hz, 1H, H6), 7.23 – 7.12 (m, 3H, H5, H5ꞌ, H7ꞌ).
C NMR (101 MHz, CDCl3) δ 195.9 (C3ꞌ), 161.8 (C7aꞌ), 153.9 (C2ꞌ), 151.6 (br, C2ꞌꞌ),
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148.2 (br, C4ꞌꞌ), 138.3 (br, C6ꞌꞌ), 138.1 (C7a), 137.6 (C6ꞌ), 127.94 (C5ꞌ), 127.92 (C3a),
127.7 (C3), 126.5 (C6), 125.3 (C4ꞌ), 125.0 (C1ꞌꞌ), 123.1 (br, C5ꞌꞌ), 122.5 (C5), 122.2 (C2),
122.0 (C3aꞌ), 121.8 (C4), 120.9 (C7ꞌ), 112.3 (C7). IR (neat) 3393 (w), 1718 (s), 1556 (s),
1507 (w), 1452 (m), 1340 (w), 1261 (w), 1167 (w), 877 (m), 759 (w), 745 (m), 732 (m),
714 (w), 688 (m) cm-1. HRESI-MS calcd. for C21H14N3O+ 324.1137, found 324.1142.

7.5

Biological testing

7.5.1. General considerations
All biological assays were performed by collaborators at Griffith University (Prof. Vicky
Avery and Dr. Leonardo Lucantoni). The antiplasmodial activity of the experimental
compounds was assessed against Plasmodium falciparum 3D7 (chloroquine sensitive)
and Dd2 (drug resistant) parasite strains. Preliminary cytotoxicity assessment was carried
out using Human Embryonic Kidney (HEK293) cells. The compounds were tested in a
22-point concentration-response range of 80 µM – 0.01 nM (160 µM – 0.02 nM for
Compound 155). Artesunate, dihydroartemisinin (DHA), chloroquine, puromycin and
pyrimethamine were used as reference compounds / drugs, and were tested in both
experiments using 22-point concentration-response range of 40 µM – 0.01 nM (10 µM –
0.003 nM for DHA and artesunate). 0.4% DMSO and 5 µM puromycin were used as
negative and positive in-plate controls, respectively. Raw data from each assay was
normalized using the in-plate positive and negative controls to obtain normalized %
inhibition data, which was then used to calculate IC50 values, through a 4-parameter
logistic curve fitting in Prism v 6.0 (GraphPad). All experiments were carried out in two
biological replicates, each consisting of two technical repeats.
7.5.2. Antimalarial assay
Plasmodium falciparum 3D7 (chloroquine sensitive) and Dd2 (drug resistant) parasite
strains were maintained in RPMI 1640 supplemented with 25 mM HEPES, 5% AB human
male serum, 2.5 mg/ml Albumax II, and 0.37 mM hypoxanthine. Parasites were subjected
to two rounds of sorbitol synchronization before undergoing compound treatment. Ring
stage parasites at 2% parasitemia and 0.3% hematocrit were exposed to the experimental
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compounds in 384-wells imaging CellCarrier microplates (PerkinElmer), as previously
described.[191] Plates were incubated for 72 h at 37 °C, 90% N2, 5% CO2, 5% O2, then the
parasites were stained with 2-(4-amidinophenyl)-1H-indole-6-carboxamidine (DAPI) in
permeabilization buffer (PBS, 5mM EDTA, 0.5ug/ml DAPI, 0.01% Triton X-100, and
0.001% saponin), and imaged with an Opera QEHS micro-plate confocal imaging system
(PerkinElmer) using 20x water-immersion objective and 405 nm excitation, 450/50 nm
emission filters. Images were analysed using a custom Acapella spot detection script to
quantify DAPI-stained parasites in each well, as previously described.[191]
7.5.3. Cytotoxicity Assay
Human Embryonic Kidney cells (HEK293) were maintained in DMEM medium
supplemented with 10% FBS. Cells were seeded at 2,000 cells/well in TC-treated 384wells clear-bottom plates (Greiner), 24 h before the addition of compounds. Compounds
were added to the plates as described above, then the plates were incubated for 72 h at 37
°C, 5% CO2. At the end of the incubation, the media was removed from the wells and
replaced with an equal volume of 44 µM resazurin. After an additional 5-6 hours
incubation at standard conditions, the total fluorescence (excitation/emission: 530 nm /
595 nm) was measured using an Envision plate reader (PerkinElmer).

7.6

X-ray crystallographic data

7.6.1. Crystallographic data for compound 133:
Crystal data
Compound 133. C34H22N2O2, M = 490.56, T = 150 K, monoclinic, space group P21/c, Z
= 4, a = 19.0715 (5), b = 14.3956 (5), c = 8.8496 (2), β = 98.221 (2) ˚, V = 2404.65 (12)
Å3, Dx = 1.355 Mg m-3, CuKα radiation, λ = 1.54184 Å, 35145 reflections measured (θ =
5–72˚), merged to 4690 unique data, R = 0.054 [for 4185 data with I > 2σ(I)], Rw = 0.062
[all data], S = 1.07.
Structure determination of compound 133
Images were measured on an Agilent SuperNova diffractometer (Cu Kα radiation, mirror
monochromator, λ = 1.54184 Å) and data extracted using the CrysAlis PRO package.[192]
Structure solution was by direct methods (SIR92).[193] The structure was refined using the
CRYSTALS program package.[194]
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7.6.2. Crystallographic data for compounds 134 and 135:
Crystal data
Compounds 134 and 135. 0.688×(C36H27BrN2O4)·0.312×(C36H26N2O4)·0.172×(H2O), M
= 608.92, T = 150 K, Triclinic, space group P1, Z = 2, a = 9.4687 (3), b = 11.7407 (3), c
= 13.5610 (3), α = 91.4143 (19) ˚, β = 100.6415 (19) ˚, γ = 109.760 (3) ˚, V = 1388.20 (7)
Å3, Dx = 1.457 Mg m-3, CuKα radiation, λ = 1.54184 Å, 22229 reflections measured (θ =
3–74 ˚), merged to 5600 unique data, R = 0.022 [for 5462 data with I > 2σ(I)], Rw = 0.045
[all data], S = 1.12.
Structure determination of compounds 133 and 135
Images were measured on an Agilent SuperNova diffractometer (Cu Kα radiation, mirror
monochromator, λ = 1.54184 Å) and data extracted using the CrysAlis PRO package.[192]
Structure solution was by direct methods (SIR92).[193] The structure was refined using the
CRYSTALS program package.[194]
7.6.3. Crystallographic data for compound 153:
Crystal data
Compound 153. C19H14N2O3, M = 318.33, T = 150 K, orthorhombic, space group Pccn,
Z = 8, a = 10.8798(1), b = 18.4104(1), c = 14.5081(1) Å, V = 2905.99 (4) Å3, Dx = 1.455
Mg m-3, CuKα radiation, λ = 1.54184 Å, 54126 reflections measured (θ = 5–72˚), merged
to 2881 unique data, R = 0.030 [for 2749 data with I > 2σ(I)], Rw= 0.075 [all data], S =
1.00
Structure determination of compound 153
Images were measured on an Agilent SuperNova diffractometer (Cu Kα radiation, mirror
monochromator, λ = 1.54184 Å) and data extracted using the CrysAlis PRO package.[192]
Structure solution was by direct methods (SIR92).[193] The structure was refined using the
CRYSTALS program package.[194] Atomic coordinates, bond lengths and angles and
displacement parameters have been deposited at the Cambridge Crystallographic Data
Centre (CCDC no. 1590267). These data can be obtained free-of-charge via
www.ccdc.cam.ac.uk/data_request/cif, by emailing data_request@ccdc.cam.ac.uk, or by
contacting The Cambridge Crystallographic Data Centre, 12 Union Road, Cambridge
CB2 1EZ, UK; fax: +44 1223 336033.
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7.6.4. Crystallographic data for compound 154:
Crystal data
Compound 154. C23H18N2O6, M = 418.41, T = 150 K, monoclinic, space group C2/c, Z =
8, a = 23.9584 (7), b = 9.6484 (3), c = 16.0090 (6) Å, β = 90.165 (3)˚, V = 3700.6 (2) Å3,
Dx = 1.502 Mg m-3, MoKα radiation, λ = 0.71073 Å, 39146 reflections measured (θ = 2–
29˚), merged to 4736 unique data, R = 0.044 [for 4495 data with I > 2σ(I)], Rw = 0.109
[all data], S = 1.03
Structure determination of compound 154
Images were measured on an Agilent SuperNova diffractometer (Mo Kα radiation, mirror
monochromator, λ = 0.71073 Å) and data extracted using the CrysAlis PRO package.[192]
Structure solution was by direct methods (SIR92).[193] The structure was refined using the
CRYSTALS program package.[194] Atomic coordinates, bond lengths and angles and
displacement parameters have been deposited at the Cambridge Crystallographic Data
Centre (CCDC no. 1590269). These data can be obtained free-of-charge via
www.ccdc.cam.ac.uk/data_request/cif, by emailing data_request@ccdc.cam.ac.uk, or by
contacting The Cambridge Crystallographic Data Centre, 12 Union Road, Cambridge
CB2 1EZ, UK; fax: +44 1223 336033.
7.6.5. Crystallographic data for compound 155:
Crystal data
Compound 154. C22H18N2O4, M = 374.40, T = 150 K, orthorhombic, space group P212121,
Z = 4, a = 8.64640 (7), b = 11.41283 (8), c = 17.69376 (13) Å, V = 1746.02 (2) Å3, Dx =
1.424 Mg m-3, CuKα radiation, λ = 1.54184 Å, 28445 reflections measured (θ = 5–72˚),
merged to 3528 unique data, R = 0.030 [for 3486 data with I > 2σ(I)], Rw = 0.081 [all
data], S = 1.00
Structure determination of compound 154
Images were measured on an Agilent SuperNova diffractometer (Cu Kα radiation, mirror
monochromator, λ = 1.54184 Å) and data extracted using the CrysAlis PRO package.[192]
Structure solution was by direct methods (SIR92).[193] The structure was refined using the
CRYSTALS program package.[194] Atomic coordinates, bond lengths and angles and
displacement parameters have been deposited at the Cambridge Crystallographic Data
Centre (CCDC no. 1590268). These data can be obtained free-of-charge via
www.ccdc.cam.ac.uk/data_request/cif, by emailing data_request@ccdc.cam.ac.uk, or by
contacting The Cambridge Crystallographic Data Centre, 12 Union Road, Cambridge
CB2 1EZ, UK; fax: +44 1223 336033.
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7.6.6. Crystallographic data for compound 180:
Crystal data
Compound 180. C31H25N3O4S, M = 535.62, T = 150 K, monoclinic, space group P21/c, Z
= 4, a = 23.5193 (13), b = 11.6263 (7), c = 9.3856 (5) Å, β = 90.966(5)˚, V = 2566.1 (3)
Å3, Dx = 1.386 Mg m-3, CuKα radiation, λ = 1.54184 Å, 16907 reflections measured (θ =
4–72˚), merged to 4953 unique data, R = 0.071 [for 3162 data with I > 2σ(I)], Rw = 0.153
[all data], S = 1.01
Structure determination of compound 180
Images were measured on an Agilent SuperNova diffractometer (Cu Kα radiation, mirror
monochromator, λ = 1.54184 Å) and data extracted using the CrysAlis PRO package.[192]
Structure solution was by direct methods (SIR92).[193] The structure was refined using the
CRYSTALS program package.[194] Atomic coordinates, bond lengths and angles and
displacement parameters have been deposited at the Cambridge Crystallographic Data
Centre (CCDC no. 1590271). These data can be obtained free-of-charge via
www.ccdc.cam.ac.uk/data_request/cif, by emailing data_request@ccdc.cam.ac.uk, or by
contacting The Cambridge Crystallographic Data Centre, 12 Union Road, Cambridge
CB2 1EZ, UK; fax: +44 1223 336033.
7.6.7. Crystallographic data for compound 183:
Crystal data
Compound 183. 2(C20H16N2O4).1.85(CH2Cl2).0.15(CHCl3), M = 871.73, T = 150 K,
orthorhombic, space group P212121, Z = 4, a = 10.5565 (2), b = 14.9406 (2), c = 25.9563
(4) Å, V = 4093.84 (11) Å3, Dx = 1.414 Mg m-3, CuKα radiation, λ = 1.54184 Å, 61022
reflections measured (θ = 3–64˚), merged to 7974 unique data, R = 0.068 [for 6934 data
with I > 2σ(I)], Rw = 0.151 [all data], S = 0.98
Structure determination of compound 183.
Images were measured on an Agilent SuperNova diffractometer (Cu Kα radiation, mirror
monochromator, λ = 1.54184 Å) and data extracted using the CrysAlis PRO package.[192]
Structure solution was by direct methods (SIR92).[193] The structure was refined using the
CRYSTALS program package.[194] Atomic coordinates, bond lengths and angles and
displacement parameters have been deposited at the Cambridge Crystallographic Data
Centre (CCDC no. 1590270). These data can be obtained free-of-charge via
www.ccdc.cam.ac.uk/data_request/cif, by emailing data_request@ccdc.cam.ac.uk, or by
contacting The Cambridge Crystallographic Data Centre, 12 Union Road, Cambridge
CB2 1EZ, UK; fax: +44 1223 336033.
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7.6.8. Crystallographic data for compound 211:
Crystal data
Compound 211. C27H22N2O3, M = 422.28, T = 150 K, monoclinic, space group P21/c, Z
= 4, a = 9.4461 (1), b = 10.2612 (1), c = 23.0912 (2), β = 100.4899 (8) ˚ V = 2200.78 (4)
Å3, Dx = 1.275 Mg m-3, CuKα radiation, λ = 1.54184 Å, 42054 reflections measured (θ =
4–74˚), merged to 4448 unique data, R = 0.031 [for 4255 data with I > 2σ(I)], Rw = 0.036
[all data], S = 1.00.
Structure determination of compound 211
Images were measured on an Agilent SuperNova diffractometer (Cu Kα radiation, mirror
monochromator, λ = 1.54184 Å) and data extracted using the CrysAlis PRO package.[192]
Structure solution was by direct methods (SIR92).[193] The structure was refined using the
CRYSTALS program package.[194]
7.6.9. Crystallographic data for compound 213:
Crystal data
Compound 213. C26H26N2O6, M = 462.50, T = 150 K, monoclinic, space group C2/c, Z =
4, a = 20.9084 (10), b = 7.3041 (2), c = 17.0572 (7), β = 100.4899 (8) ˚, V = 2383.40 (19)
Å3, Dx = 1.289 Mg m-3, MoKα radiation, λ = 0.71073 Å, 19845 reflections measured (θ
= 2–30 ˚), merged to 3017 unique data, R = 0.033 [for 2600 data with I > 2σ(I)], Rw =
0.051 [all data], S = 1.04.
Structure determination of compound 213
Images were measured on an Agilent SuperNova diffractometer (Mo Kα radiation, mirror
monochromator, λ = 0.71073 Å) and data extracted using the CrysAlis PRO package.[192]
Structure solution was by direct methods (SIR92).[193] The structure was refined using the
CRYSTALS program package.[194]
7.6.10. Crystallographic data for compound 224:
Crystal data
Compound 224. C28H24N2O4, M = 452.51, T = 150 K, monoclinic, space group P21/c, Z
= 4, a = 7.6361 (2), b = 13.7150 (3), c = 22.4168 (5), β = 98.156 (2) ˚, V = 2323.95 (10)
Å3, Dx = 1.293 Mg m-3, CuKα radiation, λ = 1.54184 Å, 4583 reflections measured (θ =
4–74˚), 4583 unique data, R = 0.062 [for 4398 data with I > 2σ(I)], Rw = 0.074 [all data],
S = 1.00.

253

Structure determination of compound 224
Images were measured on an Agilent SuperNova diffractometer (Cu Kα radiation, mirror
monochromator, λ = 1.54184 Å) and data extracted using the CrysAlis PRO package.[192]
Structure solution was by direct methods (SIR92).[193] The structure was refined using the
CRYSTALS program package.[194]
7.6.11. Crystallographic data for compound 232:
Crystal data
Compound 232. C27H21ClN2O3, M = 456.93, T = 150 K, orthorhombic, space group
Pna21, Z = 4, a = 18.76631 (12), b = 14.88559 (11), c = 7.88336 (7), V = 2202.21 (3) Å3,
Dx = 1.378 Mg m-3, CuKα radiation, λ = 1.54184 Å, 34133 reflections measured (θ = 2–
74˚), merged to 4142 unique data, R = 0.024 [for 4091 data with I > 2σ(I)], Rw = 0.033
[all data], S = 1.01.
Structure determination of compound 232
Images were measured on an Agilent SuperNova diffractometer (Cu Kα radiation, mirror
monochromator, λ = 1.54184 Å) and data extracted using the CrysAlis PRO package.[192]
Structure solution was by direct methods (SIR92).[193] The structure was refined using the
CRYSTALS program package.[194]
7.6.12. Crystallographic data for compound 237:
Crystal data
Compound 237. C25H20N2O3S, M = 428.51, T=150 K, monoclinic, space group P21/c, Z
= 4, a = 9.4271 (1), b = 10.0632 (1), c = 23.0963 (2), β = 101.1492 (11) ˚, V = 2149.72
(4) Å3, Dx = 1.324 Mg m-3, CuKα radiation, λ = 1.54184 Å, 32752 reflections measured
(θ = 5–72˚), merged to 4347 unique data, R = 0.034 [for 3948 data with I > 2σ(I)], Rw =
0.037 [all data], S = 1.00.
Structure determination of compound 237
Images were measured on an Agilent SuperNova diffractometer (Cu Kα radiation, mirror
monochromator, λ = 1.54184 Å) and data extracted using the CrysAlis PRO package.[192]
Structure solution was by direct methods (SIR92).[193] The structure was refined using the
CRYSTALS program package.[194]
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